data_6gcj_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6gcj _Structure_validation_residue.Date_analyzed 2019-03-22 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.309 0.576 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -78.0 -25.64 48.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.422 -178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -125.67 89.3 52.73 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.43 146.0 73.11 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.688 2.258 . . . . 0.0 113.184 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.53 132.57 46.52 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.306 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -51.63 135.01 48.2 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.226 1.95 . . . . 0.0 112.073 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.53 -18.23 64.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.38 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -92.32 9.82 32.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.74 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.5 mm -96.96 119.44 45.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.095 0.474 . . . . 0.0 110.553 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 71.6 p -76.49 160.97 29.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.333 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.31 -36.54 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.004 0.43 . . . . 0.0 110.582 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -67.08 -46.95 72.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.693 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -63.79 -40.99 98.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 110.758 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.63 94.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.798 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 m -65.84 -43.21 89.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.898 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -64.06 -34.82 78.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.993 0.425 . . . . 0.0 110.846 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -68.34 -40.48 81.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.941 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 96.0 m -87.52 -5.78 58.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.33 170.38 23.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.92 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.43 -16.59 54.06 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.771 -0.252 . . . . 0.0 111.437 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -97.92 15.29 24.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.916 0.388 . . . . 0.0 110.862 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.15 146.34 51.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.902 0.382 . . . . 0.0 111.06 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.502 ' HB2' HD22 ' A' ' 136' ' ' ASN . 45.1 tt0 -135.03 144.19 47.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.89 136.68 56.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 110.984 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.3 t -139.1 140.19 37.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.254 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.554 ' SG ' HD12 ' A' ' 108' ' ' LEU . 56.3 m -109.54 117.37 33.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.525 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 1.8 m -117.04 141.88 47.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.746 -175.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 129' ' ' GLN . 56.3 t30 -84.66 -22.15 29.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.415 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -124.7 140.59 52.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.13 127.43 28.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.691 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.8 m -119.1 115.15 23.67 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -90.22 134.42 34.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.99 -31.36 72.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.55 -169.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.02 -9.49 86.9 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.692 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.26 -16.58 24.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.037 0.446 . . . . 0.0 110.606 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.8 m -120.46 150.2 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.822 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.0 p -96.31 -20.48 18.48 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -82.45 0.67 41.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.813 0.339 . . . . 0.0 111.472 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.0 mt -120.61 130.21 74.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -88.5 109.78 20.33 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.198 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -63.92 -29.22 70.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.432 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.84 -35.84 91.38 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.548 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.7 mt -68.25 -48.07 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.942 0.401 . . . . 0.0 110.318 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.28 -40.18 89.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.999 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.68 -34.73 77.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.989 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.8 -47.97 88.55 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.581 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 p -73.68 -41.31 62.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.867 0.365 . . . . 0.0 111.794 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -24.84 61.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.145 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 38.5 ttmt -55.7 -30.26 60.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 110.727 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -61.48 -27.72 68.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.819 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 135' ' ' GLN . 86.3 mt -88.41 -29.63 20.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.507 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.4 mt -72.76 -40.56 61.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.085 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.27 -70.32 2.15 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.161 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.74 104.76 0.3 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.17 -169.41 39.02 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.8 m -148.57 128.6 13.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.965 0.382 . . . . 0.0 110.83 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.69 49.45 0.11 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.712 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.4 p -74.11 -11.91 60.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.951 0.405 . . . . 0.0 111.377 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -64.76 -13.85 56.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.547 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.47 24.76 8.97 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.78 143.83 39.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.37 -147.87 13.5 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.655 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.0 mt -106.72 128.91 54.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.051 0.453 . . . . 0.0 109.945 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.443 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 20.8 m-85 -114.2 131.89 56.3 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.816 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -120.36 154.53 34.95 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.506 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 59.35 58.18 3.1 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.33 0.586 . . . . 0.0 109.576 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 4.2 t -116.36 155.74 27.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.29 -171.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 t -138.53 131.52 29.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -72.41 147.38 46.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.099 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.554 HD12 ' SG ' ' A' ' 64' ' ' CYS . 91.4 mt -98.73 124.83 43.82 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -82.97 135.88 34.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.971 0.415 . . . . 0.0 110.637 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.5 mt . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.513 -177.068 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 . . . . . 0 C--O 1.234 0.25 0 CA-C-O 121.098 0.475 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 60.1 mt -87.3 138.86 31.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.495 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.471 HG21 ' OD1' ' A' ' 124' ' ' ASN . 15.8 m -61.52 -40.42 86.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.158 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.471 ' OD1' HG21 ' A' ' 123' ' ' VAL . 2.0 m-20 -71.25 -15.58 62.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.032 0.444 . . . . 0.0 110.823 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -84.35 -25.68 28.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.93 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -109.18 -17.16 13.92 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.679 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 48.3 t -111.11 135.64 51.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.503 0.192 . . . . 0.0 111.496 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -119.52 14.34 12.74 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.886 0.851 . . . . 0.0 109.266 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 59.8 mm-40 -108.24 171.25 7.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.094 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -64.69 114.9 4.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.317 . . . . 0.0 110.354 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.1 mt -88.52 120.81 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.649 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.73 159.62 41.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 0.0 110.989 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 78.8 m -103.13 127.23 50.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 61.1 m -112.85 143.48 44.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.11 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.416 ' HA ' HD12 ' A' ' 89' ' ' LEU . 5.3 tp-100 -71.09 123.45 22.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.319 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.502 HD22 ' HB2' ' A' ' 61' ' ' GLN . 94.2 m-20 . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 121.224 0.535 . . . . 0.0 110.252 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 121.368 0.604 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -171.97 -173.61 38.86 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.596 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.99 122.86 51.22 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.08 120.71 7.23 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.378 1.385 . . . . 0.0 110.623 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 47.7 m -152.87 162.0 41.84 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.4 tt -127.57 136.46 60.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.776 0.322 . . . . 0.0 110.351 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.48 123.44 19.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.563 HD22 ' O ' ' A' ' 155' ' ' LEU . 5.6 tt -58.73 -28.56 65.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.653 -176.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -65.92 -17.01 64.82 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.701 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.5 m -80.68 -29.51 36.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 117.003 0.401 . . . . 0.0 111.505 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.8 pt -95.15 -9.47 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.746 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--O 1.245 0.857 0 O-C-N 124.206 0.941 . . . . 0.0 111.33 179.326 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 130' ' ' ASN . 7.3 p . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -78.62 -23.81 45.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.43 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 82.0 m-85 -130.0 90.98 40.89 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.433 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.81 148.94 72.2 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.597 2.198 . . . . 0.0 113.294 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -89.3 135.9 30.73 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.439 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -51.87 135.34 50.28 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.452 2.101 . . . . 0.0 112.234 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.0 -11.14 60.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.176 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -92.57 8.11 40.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 111.272 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.2 mm -90.01 126.98 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.893 0.378 . . . . 0.0 110.106 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 81.7 p -82.67 159.6 22.6 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.672 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.2 t -54.98 -43.15 67.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.108 0.48 . . . . 0.0 110.574 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -62.3 -46.62 87.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.547 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -66.46 -40.48 89.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.141 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 56' ' ' CYS . . . -61.15 -38.34 86.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.861 0.362 . . . . 0.0 110.443 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.436 HG23 HD11 ' A' ' 110' ' ' LEU . 62.9 m -67.47 -46.35 73.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.134 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.97 -41.77 97.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 110.449 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -69.67 -24.04 63.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.615 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 13.6 t -73.83 -21.25 60.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.132 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.42 170.6 24.79 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.622 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.99 -33.09 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.843 0.321 . . . . 0.0 111.714 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.96 19.91 12.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.225 0.536 . . . . 0.0 110.372 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.1 139.86 53.52 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.149 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -99.21 122.17 42.04 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.24 118.56 10.12 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.2 t -139.94 150.33 44.41 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.096 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.595 ' SG ' HD13 ' A' ' 108' ' ' LEU . 49.5 m -113.71 124.13 51.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.858 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 8.4 m -114.93 141.51 47.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.06 0.457 . . . . 0.0 110.946 -173.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -75.25 -37.78 60.85 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.891 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -123.92 140.19 53.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.889 0.376 . . . . 0.0 110.611 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.31 121.76 29.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.816 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 m -116.76 115.58 25.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -92.57 134.5 34.93 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.35 -30.3 70.67 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.208 -167.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.2 -21.83 70.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.297 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.81 -18.36 25.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.306 . . . . 0.0 111.277 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.558 ' HB ' ' OD1' ' A' ' 76' ' ' ASP . 14.9 m -121.28 129.99 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.155 0.502 . . . . 0.0 111.149 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.2 t -88.88 -6.71 57.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.26 -175.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.558 ' OD1' ' HB ' ' A' ' 74' ' ' VAL . 10.1 p-10 -84.23 2.75 38.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.1 mt -125.09 138.17 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.15 108.42 19.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.032 0.444 . . . . 0.0 110.679 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.02 -36.9 68.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.204 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.22 -45.82 83.88 Favored Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.956 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.92 -45.95 89.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.377 0.608 . . . . 0.0 110.191 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.8 tp -66.32 -40.68 90.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.035 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -44.84 80.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.797 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.17 -42.0 98.42 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.882 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.6 p -72.42 -43.91 63.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.741 0.305 . . . . 0.0 111.807 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.73 -27.47 60.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.844 0.354 . . . . 0.0 110.417 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.67 -35.44 74.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.969 0.414 . . . . 0.0 110.55 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -69.54 -22.37 63.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.601 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.4 tp -83.57 -37.43 22.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.961 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.7 mt -72.44 -44.77 61.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.482 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.96 -100.49 1.1 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.74 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.55 46.4 1.17 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.126 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.62 159.03 30.92 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.76 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 p -146.57 70.21 1.21 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.117 0.484 . . . . 0.0 110.717 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.51 76.75 1.11 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.116 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 p -62.8 -19.29 63.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.12 0.486 . . . . 0.0 111.575 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.81 -30.86 66.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.365 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -113.59 17.01 21.22 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.964 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.0 tp -98.83 142.53 30.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.65 0.262 . . . . 0.0 111.012 -175.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.88 -158.99 30.92 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.095 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.3 tp -109.24 126.45 53.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -114.29 138.33 50.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.753 0.311 . . . . 0.0 110.805 -173.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -123.54 152.3 41.94 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.376 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 60.64 59.16 2.24 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.62 0.575 . . . . 0.0 109.958 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 4.0 t -118.48 139.33 51.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.3 p -122.74 132.28 54.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.606 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -65.83 147.85 52.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.505 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.595 HD13 ' SG ' ' A' ' 64' ' ' CYS . 75.4 mt -97.45 140.66 31.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.182 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -86.8 140.54 29.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.326 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.436 HD11 HG23 ' A' ' 53' ' ' THR . 62.3 mt . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.678 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 C--O 1.237 0.411 0 CA-C-O 121.478 0.656 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 80.0 mt -74.22 135.45 42.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.44 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.89 -34.56 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.727 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -71.78 -13.47 61.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.724 0.297 . . . . 0.0 111.387 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -82.98 -25.71 31.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.736 0.303 . . . . 0.0 110.908 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -109.34 -12.4 14.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.068 0.461 . . . . 0.0 111.255 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 53.3 t -106.81 135.22 48.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -119.93 6.78 10.86 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.306 0.574 . . . . 0.0 110.751 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 46.0 mt-30 -108.42 169.2 8.79 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 14.5 p30 -70.22 134.36 47.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.936 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.409 HG23 HD13 ' A' ' 131' ' ' ILE . 34.6 mt -94.07 126.24 46.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.549 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.58 158.81 43.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.205 0.526 . . . . 0.0 111.623 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 56.2 m -97.67 121.0 39.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.679 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 82.1 m -112.2 140.37 46.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.61 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -69.4 133.55 47.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.167 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.282 0.563 . . . . 0.0 111.368 -177.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 67.0 mt . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.644 0.259 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 167.54 -165.76 38.86 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.06 138.61 22.34 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 117.114 0.457 . . . . 0.0 109.928 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.53 121.92 6.23 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.766 1.644 . . . . 0.0 110.693 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 31.9 m -149.78 157.57 43.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.202 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 14.9 tt -124.91 129.75 73.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.183 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.35 121.13 12.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.246 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.4 tt -65.12 -20.74 66.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.408 -173.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.43 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.81 -9.45 70.4 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.166 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.403 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 74.6 p -78.14 -25.91 47.57 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 117.378 0.589 . . . . 0.0 110.901 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.9 pt -96.01 -9.45 9.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.171 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--O 1.242 0.71 0 O-C-N 124.104 0.877 . . . . 0.0 112.537 177.778 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' HB ' ' OD1' ' A' ' 130' ' ' ASN . 7.3 p . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.247 0.546 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 40' ' ' ARG . 27.0 mtm180 -76.96 -24.33 52.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.599 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.404 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 86.0 m-85 -123.44 87.21 52.01 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.24 148.25 68.03 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.245 1.963 . . . . 0.0 112.43 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.5 t -85.01 132.66 45.01 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.68 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.49 136.0 48.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.569 2.18 . . . . 0.0 112.386 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -10.28 57.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -90.05 2.35 55.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.567 0.222 . . . . 0.0 111.187 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.476 ' O ' HG11 ' A' ' 123' ' ' VAL . 34.1 mm -87.94 126.82 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.281 0.563 . . . . 0.0 110.527 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 59.3 p -87.42 160.0 18.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.539 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 m -57.11 -36.93 52.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.025 0.44 . . . . 0.0 110.76 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 50.8 tptt -68.4 -46.84 68.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.41 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -62.35 -41.22 98.42 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.502 0.192 . . . . 0.0 111.011 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.34 98.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.051 0.453 . . . . 0.0 110.99 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.8 m -67.69 -47.77 68.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.097 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 65.3 mm-40 -66.36 -28.15 68.43 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.005 0.431 . . . . 0.0 110.882 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.464 ' HE2' ' OXT' ' A' ' 159' ' ' LEU . 51.1 tptt -59.97 -40.89 90.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.334 177.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.56 ' SG ' HD12 ' A' ' 155' ' ' LEU . 80.8 m -92.96 -20.66 20.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.912 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.43 177.09 23.34 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.73 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.48 -8.04 57.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.86 0.362 . . . . 0.0 111.668 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -94.35 4.27 54.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.004 0.43 . . . . 0.0 110.988 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.65 147.44 48.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.262 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -104.31 121.55 43.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.15 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.7 tp -70.93 118.68 14.01 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.7 t -135.38 149.02 49.56 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.368 -171.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.549 ' SG ' HD21 ' A' ' 108' ' ' LEU . 62.0 m -102.54 118.77 37.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.819 174.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -117.51 130.27 56.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.171 0.51 . . . . 0.0 111.162 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -77.97 -24.94 47.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.786 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.93 138.69 54.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.197 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.14 120.92 19.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.082 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 m -114.46 116.46 28.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -88.03 126.26 34.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.04 77.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.41 -169.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.63 -7.8 75.04 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.562 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.9 -17.73 17.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.841 0.353 . . . . 0.0 110.8 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.54 131.67 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.22 0.533 . . . . 0.0 111.134 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.0 p -83.56 -9.01 59.21 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.88 -0.74 49.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.904 0.383 . . . . 0.0 111.401 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mt -124.78 142.94 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -89.26 98.52 11.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.525 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.74 -33.53 76.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.647 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.52 -38.81 96.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.6 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.72 -48.84 49.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.671 0.272 . . . . 0.0 110.455 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.88 -40.11 91.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.854 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.6 -37.5 86.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.753 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.25 -46.88 39.59 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.751 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 p -72.85 -44.93 60.79 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.412 ' CD2' ' HB ' ' A' ' 153' ' ' ILE . 11.3 tp -73.97 -24.92 59.69 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.756 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 41.1 ttmt -56.86 -32.03 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.004 0.431 . . . . 0.0 110.543 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -68.5 -24.08 64.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.691 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.2 tp -83.46 -35.0 25.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 109.897 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.0 mt -71.5 -40.8 72.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.329 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.42 -103.76 2.98 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -103.62 82.78 0.39 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.951 -0.643 . . . . 0.0 111.826 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.38 173.11 25.38 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.0 t -161.62 151.9 17.32 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.44 69.11 0.29 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.608 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 34.5 p -61.87 -25.75 67.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.859 0.361 . . . . 0.0 111.91 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -59.11 -22.46 60.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.163 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -122.55 27.1 6.1 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -109.8 148.49 31.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.692 0.282 . . . . 0.0 111.054 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 158.49 -148.37 17.46 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.729 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.9 mt -106.6 129.73 54.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.01 0.433 . . . . 0.0 109.928 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.547 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 15.7 m-85 -112.1 137.02 50.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.836 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.95 149.67 45.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.312 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 63.4 51.6 2.58 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.532 0.52 . . . . 0.0 110.334 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.5 m -92.23 135.62 33.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.711 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.5 p -114.97 145.48 42.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.091 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -77.12 133.71 38.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.549 HD21 ' SG ' ' A' ' 64' ' ' CYS . 19.2 mt -88.88 138.24 31.59 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.961 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.8 108.08 8.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.032 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.83 176.637 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--O 1.233 0.203 0 CA-C-O 121.281 0.562 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 96.2 mt -76.99 133.71 39.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.709 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.476 HG11 ' O ' ' A' ' 47' ' ' ILE . 11.4 p -67.07 -37.98 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.714 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -71.33 -16.44 62.44 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.071 0.462 . . . . 0.0 110.825 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -84.68 -26.54 27.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.503 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -100.09 -17.07 17.63 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.257 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 16.2 t -110.96 139.35 46.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.26 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.588 ' HB2' ' HZ1' ' A' ' 128' ' ' LYS . 4.3 ttmp? -111.89 2.22 16.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.758 0.79 . . . . 0.0 109.547 172.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 1.8 mp0 -108.2 170.73 7.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.918 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.446 ' OD1' ' HB ' ' A' ' 39' ' ' VAL . 22.2 m-80 -65.2 134.62 54.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.428 HD13 HG22 ' A' ' 131' ' ' ILE . 21.9 mm -95.74 124.26 48.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.87 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.07 159.29 42.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.874 0.369 . . . . 0.0 111.102 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 78.6 m -107.86 118.96 38.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 73.7 m -110.24 147.26 34.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.118 0.485 . . . . 0.0 111.348 -169.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -69.78 122.17 18.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.204 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.463 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.953 0.406 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 170.5 -179.66 42.45 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.39 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.16 129.36 25.71 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.76 122.79 11.24 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 121.881 1.72 . . . . 0.0 110.289 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.519 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . 2.6 t -153.54 159.4 42.2 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.319 -171.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.412 ' HB ' ' CD2' ' A' ' 86' ' ' LEU . 7.4 tp -127.12 130.76 71.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.278 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.89 122.29 14.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.286 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.56 HD12 ' SG ' ' A' ' 56' ' ' CYS . 59.7 tp -62.67 -25.32 68.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.638 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.404 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -72.83 -16.82 78.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.901 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.5 m -74.6 -29.12 61.19 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.228 0.514 . . . . 0.0 111.326 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.4 pt -95.56 -4.41 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.069 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.464 ' OXT' ' HE2' ' A' ' 55' ' ' LYS . 89.3 mt . . . . . 0 C--O 1.252 1.188 0 O-C-N 123.804 0.69 . . . . 0.0 111.885 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 130' ' ' ASN . 7.4 p . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.079 0.466 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -76.43 -22.9 54.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.12 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 157' ' ' SER . 60.2 m-85 -122.61 86.91 49.37 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.421 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.78 144.85 55.21 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.179 1.92 . . . . 0.0 112.487 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.23 132.01 54.47 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.59 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.28 135.09 45.79 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.113 1.876 . . . . 0.0 111.537 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -72.9 -10.22 59.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.037 -170.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -90.13 2.44 55.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.434 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.4 mm -86.75 127.25 40.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.981 0.419 . . . . 0.0 110.736 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 43.2 p -82.16 159.95 23.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.659 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.0 t -57.91 -40.92 78.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.9 0.381 . . . . 0.0 110.792 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -64.4 -44.97 89.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.759 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -62.67 -46.13 89.61 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.962 0.411 . . . . 0.0 110.611 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.04 -37.6 83.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.813 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.8 m -67.43 -45.08 77.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.803 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -63.73 -31.49 72.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.336 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 159' ' ' LEU . 57.1 tptt -62.42 -40.89 98.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.817 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.585 ' SG ' HD13 ' A' ' 155' ' ' LEU . 71.8 m -94.29 -16.21 23.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.855 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.06 161.96 23.75 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.182 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -74.62 -11.08 60.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.969 0.414 . . . . 0.0 110.851 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -91.41 14.63 14.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.109 0.481 . . . . 0.0 110.204 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.75 141.77 51.5 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.469 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -111.9 124.61 52.73 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.08 121.28 14.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.965 0.412 . . . . 0.0 110.165 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 41.2 t -122.62 134.36 54.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.662 -175.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 67.8 m -93.9 116.13 28.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.366 174.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.415 ' HB2' ' ND2' ' A' ' 130' ' ' ASN . 50.3 m -120.32 130.19 54.33 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.709 0.29 . . . . 0.0 110.751 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -79.92 -21.5 43.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.003 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -123.93 142.03 51.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.49 126.65 33.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.17 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.0 m -120.71 115.1 22.67 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -92.24 135.07 34.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.63 72.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.022 -171.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.18 -7.37 82.0 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.784 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -98.26 -17.53 18.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.088 0.47 . . . . 0.0 110.865 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.0 m -120.63 132.35 70.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.299 0.571 . . . . 0.0 111.264 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.3 p -82.56 -18.2 42.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.504 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -86.78 11.71 12.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.6 mt -130.3 136.01 59.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.612 0.244 . . . . 0.0 110.617 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -87.85 107.57 18.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.947 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.63 -28.35 67.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.336 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.1 -41.48 97.07 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.589 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.26 -44.23 97.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.052 0.453 . . . . 0.0 110.319 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.31 -38.88 88.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.843 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.18 -36.97 85.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.344 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.19 -46.18 94.7 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.614 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 p -73.07 -43.42 61.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.938 0.399 . . . . 0.0 111.773 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.34 -26.33 58.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.353 -176.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 29.8 ttpp -56.98 -30.69 64.33 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.751 0.31 . . . . 0.0 110.926 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -63.15 -22.79 67.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.322 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.66 -27.55 20.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.951 0.405 . . . . 0.0 110.769 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.2 mt -82.23 -40.85 17.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.136 0.493 . . . . 0.0 110.801 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.03 -126.14 8.44 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.66 41.11 3.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.339 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -153.73 173.77 32.38 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.2 m -153.56 91.93 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.794 0.33 . . . . 0.0 111.335 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.54 69.86 3.21 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.3 p -68.2 -12.51 61.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.78 -33.94 73.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.82 0.343 . . . . 0.0 111.511 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -107.49 20.06 32.94 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.998 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.2 tp -100.24 139.88 35.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.879 0.371 . . . . 0.0 111.252 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.88 -146.97 11.83 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.819 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.56 125.33 52.41 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.77 136.83 47.69 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.167 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -120.03 152.74 37.07 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.999 -175.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 61.33 57.84 2.3 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.545 0.688 . . . . 0.0 109.803 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.487 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 96.7 m -106.42 135.66 47.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.548 -174.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.0 m -128.34 131.1 48.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -79.84 145.83 32.55 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.417 . . . . 0.0 111.228 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -95.55 140.84 29.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -75.76 131.24 39.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.153 0.501 . . . . 0.0 109.757 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.8 tp . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -177.114 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 . . . . . 0 CA--C 1.517 -0.302 0 CA-C-O 120.792 0.33 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 76.1 mt -71.48 131.32 43.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.928 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.4 -35.46 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.467 -174.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.99 -12.68 61.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.134 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.456 ' HB2' ' HB2' ' A' ' 122' ' ' LEU . 8.1 tp-100 -83.19 -25.92 31.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.725 0.298 . . . . 0.0 110.656 -173.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -102.3 -17.35 15.93 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.212 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 16.8 t -110.33 137.06 48.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.688 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.417 ' N ' ' HD3' ' A' ' 128' ' ' LYS . 3.4 mppt? -110.36 3.88 20.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.376 0.608 . . . . 0.0 109.93 172.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 27.8 mp0 -108.75 169.85 8.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.849 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.501 ' HB2' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -66.72 140.56 57.88 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.673 0.273 . . . . 0.0 110.813 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.458 HD13 HG23 ' A' ' 131' ' ' ILE . 26.5 mm -97.53 120.5 46.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.138 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.22 154.86 45.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.836 0.351 . . . . 0.0 110.741 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.408 ' C ' ' SG ' ' A' ' 152' ' ' CYS . 73.9 m -105.64 114.28 28.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.015 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 59.6 m -109.6 140.94 42.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.72 136.4 50.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.728 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 . . . . . 0 N--CA 1.464 0.237 0 CA-C-O 121.305 0.574 . . . . 0.0 111.043 -177.84 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 46.1 mt . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 121.425 0.631 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 152.17 -155.81 26.34 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.734 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.7 mp -104.8 127.66 28.38 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -66.46 121.32 8.57 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.44 1.427 . . . . 0.0 110.21 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.408 ' SG ' ' C ' ' A' ' 133' ' ' CYS . 0.7 OUTLIER -155.41 169.15 24.92 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.379 -172.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.36 132.45 55.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.388 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.11 123.39 17.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.341 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.585 HD13 ' SG ' ' A' ' 56' ' ' CYS . 42.4 tp -61.79 -25.82 67.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.781 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.442 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.24 -17.14 75.69 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.409 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.494 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 8.5 t -73.41 -26.77 61.11 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.968 0.384 . . . . 0.0 110.95 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 pt -102.21 -2.34 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.532 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.434 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 90.2 mt . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.595 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.258 0.551 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -76.47 -29.04 56.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.357 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -125.14 91.91 48.33 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.51 150.64 75.46 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.395 2.063 . . . . 0.0 112.643 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.71 133.36 29.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.736 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.86 136.31 51.39 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.732 2.288 . . . . 0.0 112.395 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.81 -11.73 61.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.208 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -86.02 3.2 43.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.677 0.275 . . . . 0.0 111.732 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.473 ' O ' HG13 ' A' ' 123' ' ' VAL . 34.9 mm -92.06 123.91 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 0.0 110.274 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 61.4 p -80.29 160.84 25.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.298 175.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.33 -40.87 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.604 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 65.7 tttp -65.46 -47.52 75.83 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.879 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -59.6 -43.5 93.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 110.69 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.7 98.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.732 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.403 HG21 HD23 ' A' ' 110' ' ' LEU . 29.6 m -68.97 -39.03 79.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.689 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 73.8 mm-40 -59.56 -32.19 70.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.042 0.448 . . . . 0.0 110.756 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -60.58 -33.52 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.082 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 85.5 m -100.49 9.55 42.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.752 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.57 80.05 0.66 Allowed Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.45 -172.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -177.5 -72.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.977 0.418 . . . . 0.0 110.864 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -116.86 12.92 14.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.452 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -149.08 163.89 36.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.05 0.453 . . . . 0.0 111.591 -171.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -134.52 143.23 47.32 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.9 tp -67.29 134.59 51.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.057 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 t -139.69 145.97 39.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.858 0.361 . . . . 0.0 110.358 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.694 ' SG ' HD11 ' A' ' 108' ' ' LEU . 29.5 m -113.9 120.63 41.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.745 176.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 129' ' ' GLN . 13.5 m -115.49 144.71 43.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -89.91 -26.55 20.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -124.69 145.24 49.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.35 128.36 33.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.614 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 m -120.38 115.09 22.84 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 171.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -91.65 136.58 33.03 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.34 -27.51 69.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.564 -170.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.41 -12.26 80.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.881 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.61 -17.47 19.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 0.0 111.364 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.473 ' HB ' ' OD1' ' A' ' 76' ' ' ASP . 10.5 m -121.23 125.96 74.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.427 0.632 . . . . 0.0 111.09 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.2 p -86.85 -6.57 58.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.975 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.473 ' OD1' ' HB ' ' A' ' 74' ' ' VAL . 8.8 p-10 -83.12 -2.26 54.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.939 0.399 . . . . 0.0 111.351 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mt -110.41 143.14 20.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.456 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -88.2 99.45 12.22 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.11 -26.93 68.76 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.27 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.08 -42.66 91.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.391 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.3 -44.8 94.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.961 0.41 . . . . 0.0 110.461 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.7 mt -62.89 -40.52 97.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.714 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.73 -42.03 91.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.74 -41.28 99.86 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.684 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.6 p -72.48 -43.99 62.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.699 0.285 . . . . 0.0 111.531 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.72 -27.6 61.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.846 0.355 . . . . 0.0 110.803 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 18.4 ttmm -57.75 -32.65 67.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.048 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.35 -22.72 64.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.562 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.408 HD23 ' SG ' ' A' ' 133' ' ' CYS . 59.3 tp -79.92 -33.81 39.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.2 0.524 . . . . 0.0 110.245 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.4 mt -85.21 -47.31 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.998 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.26 -100.72 0.34 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.827 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -111.57 12.99 27.8 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.426 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.65 171.11 24.19 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.795 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.5 p -157.51 102.26 1.89 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.719 0.295 . . . . 0.0 110.886 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.28 85.48 0.6 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.191 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.4 p -67.09 -9.05 35.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.817 0.341 . . . . 0.0 111.724 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -62.54 -31.33 72.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.223 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.6 23.21 9.69 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.787 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.9 tp -105.14 144.44 31.94 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.403 0.281 . . . . 0.0 110.945 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 163.96 -149.52 16.82 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.845 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.8 mt -107.89 132.96 52.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 152' ' ' CYS . 22.5 m-85 -114.9 143.18 45.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -125.84 152.96 44.79 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 110.483 -0.192 . . . . 0.0 110.483 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 57.97 58.15 3.74 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.575 0.702 . . . . 0.0 109.643 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 6.9 t -120.35 144.25 47.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.83 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.1 t -126.06 140.65 52.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.446 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -79.09 147.44 32.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.911 0.386 . . . . 0.0 110.71 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.694 HD11 ' SG ' ' A' ' 64' ' ' CYS . 62.3 mt -102.31 141.49 35.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.594 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -100.29 126.03 46.57 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.403 HD23 HG21 ' A' ' 53' ' ' THR . 3.0 pp . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 121.027 0.441 . . . . 0.0 110.305 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.573 0.225 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 97.6 mt -70.36 131.76 44.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.067 0.46 . . . . 0.0 110.256 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 47' ' ' ILE . 10.5 p -66.74 -35.78 75.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.497 -173.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -70.95 -16.37 62.65 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.912 0.387 . . . . 0.0 110.999 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -83.58 -28.32 28.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.509 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -114.42 -14.72 12.16 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.823 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.3 t -108.38 116.68 32.42 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -100.16 -4.48 29.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.445 0.641 . . . . 0.0 110.18 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.533 ' HB3' ' O ' ' A' ' 65' ' ' CYS . 23.1 mp0 -91.56 168.29 11.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.242 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.65 131.68 45.0 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.589 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 29.3 mt -93.79 126.96 46.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.569 -174.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.38 158.43 44.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.327 0.585 . . . . 0.0 111.656 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.408 ' SG ' HD23 ' A' ' 89' ' ' LEU . 37.1 t -110.0 115.13 29.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.653 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.5 m -110.78 139.49 46.04 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.731 -170.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.44 139.33 49.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.628 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.4 t30 . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 121.473 0.654 . . . . 0.0 110.558 -178.207 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 36.2 mt . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.148 0.499 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 165.51 173.26 33.86 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.457 HD22 ' H ' ' A' ' 150' ' ' LEU . 0.7 OUTLIER -95.02 134.16 25.18 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 117.031 0.416 . . . . 0.0 110.53 -178.518 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.64 123.84 11.95 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.596 2.197 . . . . 0.0 111.182 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.471 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 3.6 t -153.67 163.83 39.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.857 -174.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.44 133.15 60.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.58 130.05 34.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.539 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.64 -24.61 67.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.315 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -72.91 -15.37 78.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.586 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 m -80.6 -29.61 36.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.033 0.417 . . . . 0.0 111.299 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 29.4 pt -100.49 -9.65 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.787 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 C--O 1.249 1.078 0 O-C-N 123.85 0.719 . . . . 0.0 112.382 177.907 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.428 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 7.1 p . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 121.423 0.63 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.566 ' HD2' ' CE1' ' A' ' 41' ' ' PHE . 3.3 tmt_? -68.37 -34.27 75.76 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.411 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.566 ' CE1' ' HD2' ' A' ' 40' ' ' ARG . 90.3 m-85 -118.69 87.49 32.42 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.6 151.25 69.94 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.508 2.139 . . . . 0.0 112.542 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.3 t -82.35 128.26 67.95 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.294 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.16 137.15 45.97 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.049 2.499 . . . . 0.0 112.613 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.23 -11.04 47.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.575 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -86.37 -1.42 57.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.122 0.487 . . . . 0.0 111.243 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.34 122.39 41.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.162 0.506 . . . . 0.0 111.01 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 70.5 p -81.93 163.81 21.96 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.436 174.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.0 -39.43 65.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 0.0 110.594 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.503 ' HZ1' ' HB3' ' A' ' 50' ' ' LYS . 10.0 mtpm? -67.41 -46.37 73.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.164 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -58.77 -44.31 90.62 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 110.378 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.503 ' CB ' HD11 ' A' ' 62' ' ' LEU . . . -61.89 -45.9 91.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.095 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.477 ' OG1' HD21 ' A' ' 110' ' ' LEU . 90.9 m -64.56 -46.68 81.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.211 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -67.3 -28.39 67.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.013 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -64.26 -40.92 96.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.44 . . . . 0.0 110.061 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.485 ' SG ' HD13 ' A' ' 155' ' ' LEU . 81.0 m -101.09 14.03 33.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.196 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.42 168.8 8.66 Favored Glycine 0 CA--C 1.518 0.26 0 N-CA-C 114.266 0.467 . . . . 0.0 114.266 -171.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 72.02 -67.84 0.24 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.014 0.926 . . . . 0.0 111.991 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -94.21 -8.49 39.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -171.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 56' ' ' CYS . . . -138.65 163.6 31.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.412 0.625 . . . . 0.0 111.864 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -128.3 138.23 52.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.296 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.503 HD11 ' CB ' ' A' ' 52' ' ' ALA . 12.1 mt -69.27 134.77 49.58 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.787 0.327 . . . . 0.0 110.837 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.478 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 38.2 t -140.62 129.94 23.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.133 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.472 ' SG ' HD13 ' A' ' 108' ' ' LEU . 59.9 m -102.33 116.99 33.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.65 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 129' ' ' GLN . 9.0 m -118.98 143.33 47.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.307 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -71.33 -37.38 71.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.719 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -126.83 141.27 51.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.036 0.446 . . . . 0.0 111.594 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.22 122.58 28.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.424 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 m -103.32 115.25 30.19 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.428 ' OH ' ' HA ' ' A' ' 39' ' ' VAL . 87.7 m-85 -91.36 133.18 35.67 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.68 67.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.582 -168.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.32 -20.84 76.63 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.581 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.86 -14.5 26.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.643 0.259 . . . . 0.0 111.471 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 m -121.72 150.31 25.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.562 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -108.39 2.91 22.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -95.64 1.77 53.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.03 0.443 . . . . 0.0 110.893 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.0 mt -119.25 136.5 56.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.946 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -86.86 108.01 18.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.049 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.34 -30.2 69.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.084 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.25 -39.67 96.18 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.608 -176.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.9 -47.43 88.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.121 0.486 . . . . 0.0 110.189 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 88.5 mt -67.43 -45.58 75.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.896 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -63.78 -41.14 98.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.952 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.85 -46.81 93.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.421 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.9 p -73.32 -40.6 64.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.901 0.382 . . . . 0.0 111.854 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -74.24 -23.21 59.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.425 -177.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 38.2 ttpt -54.63 -32.64 59.28 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.708 -174.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.9 -32.41 73.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.84 0.352 . . . . 0.0 110.485 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.439 HD11 ' O ' ' A' ' 89' ' ' LEU . 3.1 tm? -82.73 -34.86 27.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.42 -44.83 99.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.42 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.7 -74.78 2.47 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.492 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.81 -89.11 0.85 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.242 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.77 -172.28 45.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.996 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.6 m 62.91 59.08 1.41 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.71 0.404 . . . . 0.0 111.629 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.77 12.69 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.969 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.7 p -75.98 -18.87 59.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.829 0.347 . . . . 0.0 111.708 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.04 -13.7 62.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.323 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.44 23.93 10.83 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.38 142.5 38.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.56 -149.62 12.97 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.619 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.07 126.19 54.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -112.38 139.78 47.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.928 -173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -120.25 154.03 35.49 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.671 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 61.9 58.7 1.86 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.691 0.757 . . . . 0.0 109.898 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.478 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 90.4 m -101.72 142.69 32.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.037 -173.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.8 p -132.94 137.33 46.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.567 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -80.89 144.92 31.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.793 0.33 . . . . 0.0 110.359 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.472 HD13 ' SG ' ' A' ' 64' ' ' CYS . 62.3 mt -91.33 124.99 35.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.54 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -85.71 145.65 27.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.697 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.477 HD21 ' OG1' ' A' ' 53' ' ' THR . 91.9 mt . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.316 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 C--O 1.235 0.315 0 CA-C-O 121.105 0.478 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 64.8 mt -70.85 136.69 48.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.437 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.1 p -65.96 -29.65 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.241 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.14 -13.35 61.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.077 0.465 . . . . 0.0 110.842 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -83.77 -27.69 28.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -108.74 -16.13 14.25 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.014 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 48.6 t -109.16 111.93 23.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.781 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -103.43 9.52 37.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.607 0.718 . . . . 0.0 109.97 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' ' 65' ' ' CYS . 2.1 mp0 -105.12 168.56 8.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.692 -1.14 . . . . 0.0 107.967 176.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.413 ' CB ' ' HB ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -70.1 128.56 36.71 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.378 178.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 23.3 mt -88.18 125.24 41.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.825 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.09 155.9 49.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.202 0.525 . . . . 0.0 111.275 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 64.8 m -106.0 129.76 54.06 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.8 m -111.34 139.34 46.82 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -77.36 134.18 38.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.075 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.65 . . . . 0.0 110.293 -178.797 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 53.7 mt . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 121.066 0.46 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 148.58 -176.7 27.26 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.218 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.5 mp -111.0 135.55 20.84 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.42 121.04 6.52 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.356 1.371 . . . . 0.0 110.727 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 42.5 m -152.55 160.54 43.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.131 -173.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.06 136.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.198 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.31 124.57 20.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.334 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.485 HD13 ' SG ' ' A' ' 56' ' ' CYS . 57.6 tp -61.12 -29.57 69.85 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.641 -175.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.401 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -66.27 -16.02 64.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.661 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.1 m -70.87 -30.16 66.46 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 117.061 0.43 . . . . 0.0 111.102 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 41.5 pt -99.8 -9.1 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.425 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 C--O 1.251 1.152 0 O-C-N 123.639 0.587 . . . . 0.0 111.784 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -76.25 -27.81 56.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.889 0.376 . . . . 0.0 111.081 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.515 ' O ' ' HA3' ' A' ' 156' ' ' GLY . 54.8 m-85 -136.71 97.57 11.29 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.77 139.66 44.4 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.874 2.383 . . . . 0.0 112.76 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -81.64 134.75 50.27 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.406 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.93 135.05 50.39 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.272 1.981 . . . . 0.0 111.914 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.06 -10.39 59.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.695 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.66 4.68 48.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.799 0.333 . . . . 0.0 111.177 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.3 mm -93.15 117.48 36.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.139 0.495 . . . . 0.0 110.586 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 32.9 p -77.38 159.68 29.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.531 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.1 t -54.27 -42.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.918 0.389 . . . . 0.0 110.614 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -60.63 -47.07 87.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.997 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -67.26 -35.95 80.58 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.488 0.185 . . . . 0.0 111.045 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.25 80.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 110.062 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.1 m -67.71 -47.52 69.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.659 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -65.08 -34.56 78.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -63.38 -37.54 87.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.629 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.624 ' SG ' HD11 ' A' ' 155' ' ' LEU . 92.5 m -91.04 -19.85 22.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.748 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.47 178.78 29.82 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.479 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -82.54 -16.52 48.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -91.97 11.82 23.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.237 0.542 . . . . 0.0 110.606 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 134' ' ' CYS . . . -132.67 126.51 32.79 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.838 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -95.45 128.41 42.28 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.214 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 33.0 mt -65.44 122.87 18.17 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.871 0.367 . . . . 0.0 110.196 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.403 ' HB3' ' SG ' ' A' ' 105' ' ' CYS . 19.6 m -134.01 131.72 39.25 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.31 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.493 ' SG ' HD13 ' A' ' 108' ' ' LEU . 66.7 m -107.75 118.06 35.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.182 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER -116.68 140.05 49.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.812 -175.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.42 -19.76 49.2 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.818 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -126.42 140.98 52.06 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.608 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.23 127.0 32.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.282 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.4 m -119.95 115.83 24.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -95.1 132.03 40.46 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.76 -27.27 68.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.856 -171.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.81 -23.64 72.57 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.877 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -94.67 -18.58 21.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.184 0.492 . . . . 0.0 111.507 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.8 m -121.52 125.01 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.324 0.583 . . . . 0.0 111.429 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 p -85.99 -14.75 43.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.827 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -73.45 -15.04 61.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.187 0.518 . . . . 0.0 111.178 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.9 mt -103.75 130.32 54.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.89 106.73 3.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.125 0.488 . . . . 0.0 110.587 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.69 -29.4 68.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.03 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.41 -44.11 95.8 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.721 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.8 mt -63.25 -46.41 95.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.247 0.546 . . . . 0.0 110.266 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.35 -43.15 95.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.123 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.65 -39.1 88.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.721 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.25 -46.2 88.15 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.438 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 p -68.75 -42.74 77.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.829 0.347 . . . . 0.0 111.498 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.96 -26.21 59.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -57.89 -32.55 67.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.822 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -63.17 -28.65 70.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.487 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.5 tp -86.83 -37.41 17.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.458 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.0 mt -72.3 -37.16 57.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.77 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.92 -73.12 0.22 Allowed Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -135.52 128.75 4.78 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.142 -0.552 . . . . 0.0 111.838 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.8 -170.05 33.12 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.575 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.7 p -157.97 115.28 2.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.93 0.395 . . . . 0.0 111.053 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.06 78.83 1.67 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.452 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 29.8 p -70.06 -18.87 63.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -172.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.41 -33.17 74.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.835 0.35 . . . . 0.0 111.324 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA3' ' OG ' ' A' ' 157' ' ' SER . . . -108.03 15.03 37.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.881 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 96' ' ' THR . 45.1 tp -104.02 141.6 35.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.591 0.234 . . . . 0.0 110.7 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 166.4 -156.47 28.38 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.576 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.1 mt -106.25 122.87 47.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.453 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 16.4 m-85 -106.34 133.72 50.6 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.016 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -119.69 154.49 34.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.717 -175.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.424 ' HA ' ' OE1' ' A' ' 104' ' ' GLN . 13.4 mm-40 59.08 58.15 3.24 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 3.5 t -120.66 138.86 53.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.25 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.7 m -129.73 149.93 51.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.822 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -78.93 147.47 33.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.947 0.403 . . . . 0.0 110.753 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.493 HD13 ' SG ' ' A' ' 64' ' ' CYS . 69.8 mt -89.93 137.74 32.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.614 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.91 129.06 34.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.039 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 120.919 0.39 . . . . 0.0 111.074 -176.86 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t0 . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 121.134 0.492 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 52.8 mt -72.86 135.64 45.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.433 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.24 -29.67 47.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.925 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -71.5 -16.77 62.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.995 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -83.86 -26.04 29.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.789 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.41 -17.1 14.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.359 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.474 ' SG ' HG12 ' A' ' 131' ' ' ILE . 38.4 t -111.95 114.77 27.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.643 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.478 ' HZ2' ' HB2' ' A' ' 128' ' ' LYS . 9.4 mtmp? -99.88 2.12 43.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.473 0.654 . . . . 0.0 110.043 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 0.8 OUTLIER -107.51 173.4 6.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.649 -176.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -63.13 122.78 16.95 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.474 HG12 ' SG ' ' A' ' 127' ' ' CYS . 17.7 mt -91.29 117.33 34.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.161 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.69 154.07 50.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.201 0.524 . . . . 0.0 111.012 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 75.7 m -109.81 129.11 55.67 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.477 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 21.3 m -112.35 140.57 46.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -70.62 129.52 39.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.204 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 . . . . . 0 C--N 1.326 -0.417 0 CA-C-O 121.101 0.477 . . . . 0.0 111.78 -176.568 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 154.52 -170.86 32.95 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.977 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.3 mp -108.08 129.18 24.45 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -70.77 120.96 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.634 1.556 . . . . 0.0 110.95 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 61.3 m -153.45 161.92 41.79 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.6 133.42 68.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.838 0.351 . . . . 0.0 110.651 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.43 125.89 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.01 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.624 HD11 ' SG ' ' A' ' 56' ' ' CYS . 45.4 tp -65.11 -26.82 68.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.158 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 41' ' ' PHE . . . -66.8 -19.4 69.44 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.891 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.426 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 30.8 m -68.88 -29.13 67.35 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.176 0.488 . . . . 0.0 110.997 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.4 pt -101.03 -1.43 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.863 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.247 0.924 0 O-C-N 124.034 0.834 . . . . 0.0 111.79 178.366 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.406 ' HB ' ' OD1' ' A' ' 130' ' ' ASN . 7.2 p . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -62.78 -30.83 71.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.744 -175.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.506 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 51.0 m-85 -138.03 91.47 13.15 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.223 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.56 144.95 62.61 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.188 1.925 . . . . 0.0 112.508 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -82.16 131.95 54.82 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.89 134.43 41.92 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.99 1.793 . . . . 0.0 111.943 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.13 -17.28 64.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.91 -172.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -81.81 2.87 28.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.87 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.447 ' O ' HG11 ' A' ' 123' ' ' VAL . 30.9 mm -89.6 127.24 42.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.976 0.417 . . . . 0.0 110.53 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 55.5 p -83.93 163.78 19.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.419 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.1 t -56.15 -43.18 75.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.936 0.398 . . . . 0.0 110.795 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -62.43 -46.59 87.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -67.98 -37.42 81.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.245 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.32 99.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.839 0.352 . . . . 0.0 110.713 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.456 HG23 HD11 ' A' ' 110' ' ' LEU . 39.8 m -62.68 -45.75 91.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.42 -30.6 71.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.23 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -72.67 -31.44 65.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.336 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 133' ' ' CYS . 83.0 m -77.71 -22.33 50.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.124 0.488 . . . . 0.0 110.122 173.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.07 172.88 34.26 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.218 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -78.82 -21.01 48.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.879 0.371 . . . . 0.0 110.651 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.81 19.63 6.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.799 0.333 . . . . 0.0 110.908 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 134' ' ' CYS . . . -140.68 143.57 35.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.992 0.425 . . . . 0.0 110.663 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -117.88 134.84 54.54 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.747 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.92 125.73 25.79 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.782 0.325 . . . . 0.0 110.295 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 107' ' ' LYS . 16.7 m -129.84 126.14 37.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.194 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 89.5 m -103.92 115.43 30.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.555 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 3.0 m -119.27 138.67 52.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 -172.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -81.0 -18.86 45.39 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.002 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -123.24 138.3 54.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.181 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.18 121.51 23.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.715 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 m -118.6 115.79 25.29 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -95.07 126.69 40.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.076 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.51 -31.32 72.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.531 -169.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.41 -20.42 67.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.934 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -102.36 -16.73 16.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.5 m -119.11 135.69 58.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.075 0.464 . . . . 0.0 111.331 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.1 p -86.11 -16.11 39.02 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -72.45 -6.1 41.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 111.476 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.6 mt -119.09 139.05 47.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.381 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -89.13 102.39 15.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.85 -35.9 82.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.021 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.21 97.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.577 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.5 mt -64.97 -48.53 83.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.053 0.454 . . . . 0.0 110.528 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.424 HD23 ' HB3' ' A' ' 151' ' ' PRO . 41.7 mt -68.12 -45.53 73.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.071 -175.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.37 -37.19 84.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.662 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.93 -45.05 96.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.068 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 p -72.8 -42.23 64.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.814 0.34 . . . . 0.0 111.798 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.78 -26.29 59.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.501 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 53.7 tttp -56.87 -29.0 62.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.889 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -60.57 -26.37 66.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.257 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.37 -36.95 26.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.913 0.387 . . . . 0.0 110.673 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.3 mt -72.02 -36.19 56.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.63 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.76 -118.59 4.86 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.742 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.86 58.39 1.25 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.255 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.75 -174.36 30.49 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -149.59 152.46 35.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.933 0.397 . . . . 0.0 110.405 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.84 51.41 0.19 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.6 p -71.7 -14.1 61.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.306 -0.447 . . . . 0.0 111.959 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.17 -21.16 64.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.435 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.53 19.22 24.3 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.5 HD21 ' N ' ' A' ' 100' ' ' GLY . 7.3 tt -113.33 143.15 44.93 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -175.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.5 ' N ' HD21 ' A' ' 99' ' ' LEU . . . 165.63 -136.72 4.31 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.008 -1.092 . . . . 0.0 113.234 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 94.2 mt -113.5 133.22 55.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.555 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 33.3 m-85 -118.81 124.86 48.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.317 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -120.47 159.58 24.86 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.724 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 60.24 58.0 2.75 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 7.0 t -121.97 153.59 38.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.941 -168.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.1 p -136.53 130.51 32.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.042 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 68.6 mttm -81.87 148.93 28.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.146 0.498 . . . . 0.0 110.837 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.449 HD12 ' SG ' ' A' ' 64' ' ' CYS . 94.2 mt -92.46 135.54 33.96 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.863 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -100.63 132.29 46.09 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 53' ' ' THR . 61.9 mt . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 121.037 0.446 . . . . 0.0 110.736 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.236 0.39 0 CA-C-O 121.397 0.618 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 71.7 mt -67.01 134.14 51.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.591 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 47' ' ' ILE . 12.1 p -66.12 -32.5 58.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.573 -174.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -68.82 -16.12 63.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.639 0.256 . . . . 0.0 110.797 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -85.13 -26.6 26.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.655 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -95.35 -19.04 20.27 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.472 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.63 ' SG ' HG12 ' A' ' 131' ' ' ILE . 45.6 t -111.88 112.45 24.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.592 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.4 2.01 36.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.143 0.497 . . . . 0.0 110.703 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 2.1 mp0 -105.54 172.03 7.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.571 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.406 ' OD1' ' HB ' ' A' ' 39' ' ' VAL . 28.9 m-80 -63.97 125.97 26.16 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.63 HG12 ' SG ' ' A' ' 127' ' ' CYS . 14.1 mt -92.64 125.36 45.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.773 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.5 157.16 47.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.033 0.444 . . . . 0.0 111.316 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.571 ' SG ' HD12 ' A' ' 155' ' ' LEU . 30.6 m -105.74 116.42 31.92 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 57.1 m -108.98 139.74 43.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -79.42 129.62 34.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.058 0.456 . . . . 0.0 111.102 -173.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.372 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.5 mt . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.851 0.357 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 147.18 -179.97 23.7 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 20.5 mt -95.37 130.54 31.96 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.424 ' HB3' HD23 ' A' ' 82' ' ' LEU . 17.2 Cg_exo -66.45 122.95 10.5 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.124 1.883 . . . . 0.0 111.114 175.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.09 168.88 25.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.7 tt -135.48 136.26 50.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.38 124.62 21.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.624 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.571 HD12 ' SG ' ' A' ' 133' ' ' CYS . 53.4 tp -64.55 -25.69 68.09 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.999 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.506 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.52 -17.11 76.1 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.449 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.9 m -74.06 -29.35 61.85 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 117.249 0.525 . . . . 0.0 111.205 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.5 pt -97.16 -3.77 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.756 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.341 -0.838 . . . . 0.0 111.858 178.949 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 121.184 0.516 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -73.19 -26.67 61.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.145 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -130.85 88.71 45.21 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.11 147.96 74.32 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.742 2.295 . . . . 0.0 113.264 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.29 134.69 45.25 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.14 176.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.91 135.82 43.52 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.655 2.237 . . . . 0.0 112.287 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.77 -16.06 63.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.144 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -92.09 10.37 29.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.769 0.319 . . . . 0.0 111.234 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.4 mm -93.59 123.32 45.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.218 0.533 . . . . 0.0 110.683 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 66.4 p -80.19 160.83 25.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.415 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.64 -40.38 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.216 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -62.39 -46.46 88.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.869 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -62.44 -43.83 97.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.863 0.363 . . . . 0.0 110.473 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 56' ' ' CYS . . . -61.4 -39.48 90.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.712 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.2 m -62.66 -47.54 83.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.798 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -71.71 -36.27 70.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.496 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -75.25 -20.37 59.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.18 0.514 . . . . 0.0 110.553 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 20.7 t -72.49 -21.73 61.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.229 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.45 160.06 20.02 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.993 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -82.83 -14.52 54.2 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -115.57 23.54 12.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.142 0.496 . . . . 0.0 110.534 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.444 ' HB2' HD12 ' A' ' 89' ' ' LEU . . . -124.99 148.68 48.32 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.468 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -113.67 129.21 56.61 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.505 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 26.2 mt -64.45 119.22 10.0 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.533 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 42.6 t -129.5 127.25 40.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.383 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.532 ' SG ' HD21 ' A' ' 108' ' ' LEU . 45.0 m -97.68 119.72 36.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.923 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 41.7 m -117.38 129.36 55.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.753 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -71.86 -27.95 63.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -123.34 139.03 54.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.712 0.291 . . . . 0.0 110.379 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.6 124.3 26.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.528 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.8 m -117.19 115.33 25.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.836 0.351 . . . . 0.0 110.286 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -93.52 133.05 37.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.05 -33.89 75.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.362 -169.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.53 -12.7 64.39 Favored Glycine 0 C--O 1.229 -0.189 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.06 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.99 -15.48 18.26 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.622 -0.34 . . . . 0.0 111.418 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.7 m -120.79 127.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.536 0.684 . . . . 0.0 111.5 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p -85.62 -11.64 53.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.279 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.55 -1.09 55.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.842 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.416 HD13 HD21 ' A' ' 101' ' ' LEU . 30.0 mt -118.08 134.54 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.896 0.379 . . . . 0.0 111.387 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.07 102.13 10.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.873 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.34 -30.08 68.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.112 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.76 -42.34 99.74 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.32 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.96 -44.77 99.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.162 0.506 . . . . 0.0 110.041 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.78 -44.29 97.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.608 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.37 -45.4 84.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.712 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.98 -45.02 97.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.659 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.5 p -73.34 -44.83 58.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.432 ' CD2' HD11 ' A' ' 99' ' ' LEU . 18.2 tp -73.83 -22.55 59.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.623 0.249 . . . . 0.0 111.411 -177.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 63.2 tttm -54.16 -29.79 46.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 111.043 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -63.01 -22.23 66.7 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.938 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 60' ' ' ALA . 52.4 tp -90.62 -30.5 17.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.04 -40.29 51.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.694 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.79 -78.67 1.99 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.437 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.33 84.91 0.31 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.275 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.98 -174.76 34.59 Favored Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.919 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -155.75 120.94 4.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.77 0.319 . . . . 0.0 110.435 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -136.56 62.4 0.6 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 32.1 p -69.6 -15.91 63.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -172.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -60.02 -29.08 68.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.401 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.72 16.95 43.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.763 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.432 HD11 ' CD2' ' A' ' 86' ' ' LEU . 37.7 tp -103.16 143.2 32.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.055 0.455 . . . . 0.0 110.962 -176.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.63 -150.16 13.77 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.286 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.416 HD21 HD13 ' A' ' 77' ' ' ILE . 4.2 mm? -111.01 129.1 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.439 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 33.3 m-85 -113.46 136.4 52.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.387 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -119.97 151.94 38.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.363 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 62.29 58.19 1.81 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.345 0.593 . . . . 0.0 109.952 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.533 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 76.3 m -108.42 136.37 48.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.711 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.6 t -132.66 143.99 50.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -72.11 140.51 48.93 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.546 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.532 HD21 ' SG ' ' A' ' 64' ' ' CYS . 33.8 mt -83.85 142.71 30.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.1 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -74.68 132.71 41.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.589 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.6 mt . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 -175.017 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.3 p30 . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.163 0.506 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 91.4 mt -69.03 129.53 40.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.587 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.66 -36.08 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.844 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -69.97 -18.02 63.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.227 0.537 . . . . 0.0 110.549 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -84.14 -26.16 29.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.481 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -103.26 -17.78 15.17 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.326 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 36.7 t -111.48 123.28 49.9 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.847 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -100.79 7.0 44.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.321 0.581 . . . . 0.0 109.978 172.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -108.83 170.04 8.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.117 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -65.4 128.87 37.66 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 131' ' ' ILE . 35.3 mt -96.08 123.64 48.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.336 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.88 158.6 43.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.119 0.485 . . . . 0.0 111.668 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 46.9 m -107.48 114.25 28.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.917 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 26.3 m -110.42 141.91 42.86 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -175.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -66.38 122.13 16.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.105 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 121.124 0.487 . . . . 0.0 111.515 -174.781 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 121.76 -166.71 14.49 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.592 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.437 ' H ' HD23 ' A' ' 150' ' ' LEU . 1.1 pt? -111.0 142.14 25.65 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 30.5 Cg_exo -62.18 123.68 12.95 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.458 2.106 . . . . 0.0 111.307 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 4.1 t -154.01 164.77 37.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.8 tt -133.95 135.76 54.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.874 0.369 . . . . 0.0 110.668 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.25 128.22 35.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.5 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.439 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.9 tt -62.94 -29.02 70.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.894 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -67.72 -16.19 67.58 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.831 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.9 m -77.2 -27.66 53.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.019 0.41 . . . . 0.0 111.161 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.6 pt -103.6 -1.44 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.168 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.594 179.343 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.44 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 8.3 p . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 121.307 0.575 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -74.38 -24.47 59.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.129 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -125.57 87.34 55.95 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.01 152.87 73.11 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.551 2.167 . . . . 0.0 113.044 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.9 t -93.02 132.7 30.24 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.399 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.27 136.01 46.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.381 2.054 . . . . 0.0 112.06 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -71.76 -10.24 59.48 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.187 -172.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -92.97 12.57 23.45 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 123' ' ' VAL . 40.0 mm -95.17 132.08 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.737 0.303 . . . . 0.0 110.751 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 71.1 p -80.37 159.52 25.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.883 176.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.68 -44.2 80.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.874 0.368 . . . . 0.0 110.367 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 52.9 tptt -62.25 -46.82 87.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.079 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -64.75 -41.84 95.61 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.599 0.238 . . . . 0.0 111.415 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HB1' HD13 ' A' ' 62' ' ' LEU . . . -63.89 -42.3 97.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.572 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.3 m -64.13 -39.03 93.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 15.9 mm-40 -60.94 -34.98 75.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.803 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -74.04 -29.88 62.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.498 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 133' ' ' CYS . 73.7 m -73.51 -20.7 60.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.882 0.372 . . . . 0.0 110.679 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.56 -177.92 20.23 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.713 -178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.29 -13.25 28.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.966 0.383 . . . . 0.0 111.529 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -105.18 14.52 28.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.175 0.512 . . . . 0.0 110.666 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.14 144.38 51.19 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.82 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -123.21 142.63 50.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.738 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.523 HD13 ' HB1' ' A' ' 52' ' ' ALA . 87.4 mt -65.72 129.47 39.88 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.104 0.478 . . . . 0.0 110.928 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.482 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 48.4 t -124.85 131.83 53.39 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.159 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.557 ' SG ' HD12 ' A' ' 108' ' ' LEU . 59.3 m -96.3 115.79 27.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.702 175.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.5 m -121.34 132.68 54.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.834 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -84.1 -20.33 32.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.125 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -123.95 137.83 54.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.715 0.293 . . . . 0.0 110.229 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.88 126.65 30.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.293 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -120.08 115.94 24.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.456 ' O ' HG21 ' A' ' 74' ' ' VAL . 62.3 m-85 -94.43 129.84 41.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.021 0.439 . . . . 0.0 110.294 -175.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.65 -28.53 69.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.578 -172.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -64.23 -24.97 69.38 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.736 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.84 -18.64 17.06 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.364 -0.492 . . . . 0.0 111.345 -175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 70' ' ' TYR . 18.7 m -113.69 134.14 57.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.331 0.586 . . . . 0.0 111.051 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.6 p -90.69 -11.54 39.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.574 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.31 -5.99 53.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.871 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.0 mt -117.85 138.91 47.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.148 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.46 99.47 7.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.3 0.571 . . . . 0.0 109.793 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -66.61 -32.55 73.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.179 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.64 -38.44 95.67 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.608 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.85 -48.13 72.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.189 0.518 . . . . 0.0 110.416 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 88.1 mt -62.64 -44.4 96.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.911 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.47 -43.69 98.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.17 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.36 -44.17 97.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.681 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 p -72.37 -42.49 65.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.878 0.37 . . . . 0.0 111.683 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.446 HD13 HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -74.48 -27.09 60.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.347 -176.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.1 -29.16 65.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.895 0.379 . . . . 0.0 110.904 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -60.98 -24.21 65.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.191 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.468 HD21 ' OE1' ' A' ' 135' ' ' GLN . 92.6 mt -85.53 -35.0 21.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.014 0.435 . . . . 0.0 110.538 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.9 mt -70.34 -41.81 78.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.232 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.82 -88.17 0.78 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.855 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.01 62.83 0.6 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.005 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.55 178.7 40.88 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.2 p -146.63 138.8 24.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.728 0.264 . . . . 0.0 110.999 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.82 63.24 0.42 Allowed Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.7 p -69.73 -22.66 63.36 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -72.44 -18.63 61.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.799 0.333 . . . . 0.0 111.45 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.519 ' HA3' ' OG ' ' A' ' 157' ' ' SER . . . -110.65 12.63 30.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.596 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tt -110.43 141.42 43.54 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -174.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 167.79 -142.95 7.84 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.33 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.5 tp -114.03 128.93 56.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -116.18 140.3 49.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.627 0.251 . . . . 0.0 110.608 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -124.26 153.31 41.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.424 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 61.99 57.91 2.0 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.639 0.733 . . . . 0.0 109.703 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.482 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 89.4 m -106.41 130.35 54.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.416 -175.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.1 m -115.03 134.26 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.408 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -73.7 139.49 45.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.1 0.476 . . . . 0.0 111.25 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.557 HD12 ' SG ' ' A' ' 64' ' ' CYS . 77.0 mt -99.24 121.58 41.24 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 172.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -74.91 134.47 41.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.948 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.8 mt . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.783 -172.972 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.293 0.568 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 89.2 mt -79.16 134.92 36.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.82 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 47' ' ' ILE . 14.8 p -66.94 -41.25 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.841 -175.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -72.18 -9.16 58.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.744 0.307 . . . . 0.0 111.338 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HB2' ' HB2' ' A' ' 122' ' ' LEU . 27.2 tt0 -84.11 -25.96 29.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.872 -173.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -106.88 -16.35 14.48 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.855 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.6 t -109.59 132.96 53.66 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.968 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -112.21 12.05 20.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.256 0.55 . . . . 0.0 110.319 173.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 25.8 mp0 -107.64 169.26 8.7 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.32 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -66.34 136.59 56.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.772 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 131' ' ' ILE . 23.6 mm -95.48 125.67 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.835 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.02 155.05 47.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 0.0 111.176 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 13.1 m -98.29 128.72 44.87 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 64.4 m -112.97 140.37 47.84 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.986 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.468 ' OE1' HD21 ' A' ' 89' ' ' LEU . 5.4 tp60 -83.18 141.74 31.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.265 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 121.299 0.571 . . . . 0.0 111.029 -179.708 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.5 mt . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 121.172 0.511 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 152.68 -171.82 31.8 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.29 134.6 22.55 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -71.97 121.05 7.25 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.55 1.5 . . . . 0.0 110.566 174.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 53.7 m -152.72 162.69 40.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.03 137.25 57.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.627 0.251 . . . . 0.0 110.549 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.32 123.79 19.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.385 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 68.8 tp -62.47 -27.35 69.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.197 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.403 ' HA2' ' CD2' ' A' ' 159' ' ' LEU . . . -69.81 -16.19 72.08 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.61 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.519 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 26.6 m -82.86 -24.59 33.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.974 0.387 . . . . 0.0 111.729 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.7 pt -103.97 11.14 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.403 ' CD2' ' HA2' ' A' ' 156' ' ' GLY . 4.7 pp . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.245 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.309 0.576 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -78.0 -25.64 48.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.422 -178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -125.67 89.3 52.73 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.43 146.0 73.11 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.688 2.258 . . . . 0.0 113.184 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.53 132.57 46.52 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.306 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -51.63 135.01 48.2 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.226 1.95 . . . . 0.0 112.073 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.53 -18.23 64.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.38 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -92.32 9.82 32.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.74 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.5 mm -96.96 119.44 45.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.095 0.474 . . . . 0.0 110.553 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 71.6 p -76.49 160.97 29.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.333 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.31 -36.54 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.004 0.43 . . . . 0.0 110.582 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -67.08 -46.95 72.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.693 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -63.79 -40.99 98.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 110.758 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.63 94.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.798 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 m -65.84 -43.21 89.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.898 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -64.06 -34.82 78.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.993 0.425 . . . . 0.0 110.846 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -68.34 -40.48 81.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.941 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 96.0 m -87.52 -5.78 58.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.33 170.38 23.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.92 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.43 -16.59 54.06 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.771 -0.252 . . . . 0.0 111.437 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -97.92 15.29 24.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.916 0.388 . . . . 0.0 110.862 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.15 146.34 51.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.902 0.382 . . . . 0.0 111.06 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.502 ' HB2' HD22 ' A' ' 136' ' ' ASN . 45.1 tt0 -135.03 144.19 47.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.89 136.68 56.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 110.984 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.3 t -139.1 140.19 37.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.254 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.554 ' SG ' HD12 ' A' ' 108' ' ' LEU . 56.3 m -109.54 117.37 33.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.525 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 1.8 m -117.04 141.88 47.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.746 -175.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 129' ' ' GLN . 56.3 t30 -84.66 -22.15 29.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.415 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -124.7 140.59 52.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.13 127.43 28.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.691 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.8 m -119.1 115.15 23.67 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -90.22 134.42 34.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.99 -31.36 72.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.55 -169.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.02 -9.49 86.9 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.692 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.26 -16.58 24.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.037 0.446 . . . . 0.0 110.606 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.8 m -120.46 150.2 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.822 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.0 p -96.31 -20.48 18.48 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -82.45 0.67 41.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.813 0.339 . . . . 0.0 111.472 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.0 mt -120.61 130.21 74.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -88.5 109.78 20.33 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.198 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -63.92 -29.22 70.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.432 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.84 -35.84 91.38 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.548 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.7 mt -68.25 -48.07 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.942 0.401 . . . . 0.0 110.318 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.28 -40.18 89.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.999 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.68 -34.73 77.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.989 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.8 -47.97 88.55 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.581 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 142' ' ' SER . 3.0 p -73.68 -41.31 62.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.867 0.365 . . . . 0.0 111.794 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -24.84 61.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.145 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 38.5 ttmt -55.7 -30.26 60.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 110.727 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -61.48 -27.72 68.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.819 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 135' ' ' GLN . 86.3 mt -88.41 -29.63 20.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.507 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.4 mt -72.76 -40.56 61.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.085 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.27 -70.32 2.15 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.161 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.74 104.76 0.3 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.17 -169.41 39.02 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.8 m -148.57 128.6 13.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.965 0.382 . . . . 0.0 110.83 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.69 49.45 0.11 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.712 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.4 p -74.11 -11.91 60.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.951 0.405 . . . . 0.0 111.377 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -64.76 -13.85 56.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.547 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.47 24.76 8.97 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.78 143.83 39.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.37 -147.87 13.5 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.655 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.0 mt -106.72 128.91 54.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.051 0.453 . . . . 0.0 109.945 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.443 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 20.8 m-85 -114.2 131.89 56.3 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.816 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -120.36 154.53 34.95 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.506 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 59.35 58.18 3.1 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.33 0.586 . . . . 0.0 109.576 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 4.2 t -116.36 155.74 27.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.29 -171.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 t -138.53 131.52 29.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -72.41 147.38 46.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.099 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.554 HD12 ' SG ' ' A' ' 64' ' ' CYS . 91.4 mt -98.73 124.83 43.82 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -82.97 135.88 34.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.971 0.415 . . . . 0.0 110.637 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.5 mt -67.67 132.81 48.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.513 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -83.58 154.77 23.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.356 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.9 mt -70.02 117.04 50.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.928 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.31 101.96 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.997 2.464 . . . . 0.0 112.746 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.8 mm 56.49 77.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.74 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.4 tp -89.3 64.44 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 122.288 1.042 . . . . 0.0 109.779 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.75 -54.73 4.68 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.508 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 58.3 mt -91.25 130.72 38.89 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.03 79.64 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.197 1.931 . . . . 0.0 112.176 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 58.0 mt -91.86 129.11 43.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.902 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -109.54 82.09 1.54 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.168 0.508 . . . . 0.0 109.942 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -74.03 104.28 4.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.222 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 60.1 mt -87.3 138.86 31.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.495 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.471 HG21 ' OD1' ' A' ' 124' ' ' ASN . 15.8 m -61.52 -40.42 86.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.158 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.471 ' OD1' HG21 ' A' ' 123' ' ' VAL . 2.0 m-20 -71.25 -15.58 62.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.032 0.444 . . . . 0.0 110.823 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -84.35 -25.68 28.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.93 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -109.18 -17.16 13.92 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.679 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 48.3 t -111.11 135.64 51.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.503 0.192 . . . . 0.0 111.496 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -119.52 14.34 12.74 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.886 0.851 . . . . 0.0 109.266 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 59.8 mm-40 -108.24 171.25 7.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.094 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -64.69 114.9 4.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.317 . . . . 0.0 110.354 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.1 mt -88.52 120.81 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.649 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.73 159.62 41.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 0.0 110.989 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 78.8 m -103.13 127.23 50.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 61.1 m -112.85 143.48 44.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.11 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.416 ' HA ' HD12 ' A' ' 89' ' ' LEU . 5.3 tp-100 -71.09 123.45 22.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.319 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.502 HD22 ' HB2' ' A' ' 61' ' ' GLN . 94.2 m-20 -97.47 42.72 1.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.224 0.535 . . . . 0.0 110.252 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.6 m -134.16 100.2 13.07 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.158 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.22 99.25 0.89 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.36 2.04 . . . . 0.0 112.137 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.8 t -108.33 154.52 21.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.756 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.41 ' HA ' ' OG ' ' A' ' 144' ' ' SER . 4.0 p-10 -88.46 -1.35 58.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.33 0.586 . . . . 0.0 110.157 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -112.3 113.45 25.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.528 174.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.408 ' HB3' HG22 ' A' ' 85' ' ' THR . 45.4 t 62.97 48.18 4.0 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.242 0.544 . . . . 0.0 110.428 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -161.97 -57.29 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.642 -0.789 . . . . 0.0 113.094 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 140' ' ' ASP . 29.1 p -78.4 -41.12 34.01 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -172.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.84 11.3 29.84 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.5 pt -132.37 46.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.504 0.668 . . . . 0.0 110.5 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -81.1 33.83 2.42 Favored Glycine 0 N--CA 1.453 -0.199 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.684 -175.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.5 mt -77.21 -16.04 59.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.368 0.604 . . . . 0.0 109.956 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -171.97 -173.61 38.86 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.596 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.99 122.86 51.22 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.08 120.71 7.23 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.378 1.385 . . . . 0.0 110.623 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 47.7 m -152.87 162.0 41.84 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.4 tt -127.57 136.46 60.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.776 0.322 . . . . 0.0 110.351 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.48 123.44 19.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.563 HD22 ' O ' ' A' ' 155' ' ' LEU . 5.6 tt -58.73 -28.56 65.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.653 -176.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -65.92 -17.01 64.82 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.701 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.5 m -80.68 -29.51 36.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 117.003 0.401 . . . . 0.0 111.505 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.8 pt -95.15 -9.47 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.746 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--O 1.245 0.857 0 O-C-N 124.206 0.941 . . . . 0.0 111.33 179.326 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 130' ' ' ASN . 7.3 p . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -78.62 -23.81 45.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.43 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 82.0 m-85 -130.0 90.98 40.89 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.433 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.81 148.94 72.2 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.597 2.198 . . . . 0.0 113.294 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -89.3 135.9 30.73 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.439 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -51.87 135.34 50.28 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.452 2.101 . . . . 0.0 112.234 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.0 -11.14 60.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.176 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -92.57 8.11 40.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 111.272 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.2 mm -90.01 126.98 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.893 0.378 . . . . 0.0 110.106 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 81.7 p -82.67 159.6 22.6 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.672 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.453 ' HB ' HE22 ' A' ' 111' ' ' GLN . 38.2 t -54.98 -43.15 67.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.108 0.48 . . . . 0.0 110.574 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -62.3 -46.62 87.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.547 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -66.46 -40.48 89.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.141 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 56' ' ' CYS . . . -61.15 -38.34 86.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.861 0.362 . . . . 0.0 110.443 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.436 HG23 HD11 ' A' ' 110' ' ' LEU . 62.9 m -67.47 -46.35 73.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.134 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.97 -41.77 97.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 110.449 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -69.67 -24.04 63.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.615 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 13.6 t -73.83 -21.25 60.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.132 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.42 170.6 24.79 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.622 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.99 -33.09 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.843 0.321 . . . . 0.0 111.714 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.96 19.91 12.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.225 0.536 . . . . 0.0 110.372 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.1 139.86 53.52 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.149 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -99.21 122.17 42.04 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.24 118.56 10.12 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.2 t -139.94 150.33 44.41 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.096 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.595 ' SG ' HD13 ' A' ' 108' ' ' LEU . 49.5 m -113.71 124.13 51.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.858 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 8.4 m -114.93 141.51 47.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.06 0.457 . . . . 0.0 110.946 -173.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -75.25 -37.78 60.85 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.891 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -123.92 140.19 53.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.889 0.376 . . . . 0.0 110.611 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.31 121.76 29.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.816 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 m -116.76 115.58 25.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -92.57 134.5 34.93 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.35 -30.3 70.67 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.208 -167.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.2 -21.83 70.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.297 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.81 -18.36 25.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.306 . . . . 0.0 111.277 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.558 ' HB ' ' OD1' ' A' ' 76' ' ' ASP . 14.9 m -121.28 129.99 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.155 0.502 . . . . 0.0 111.149 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.2 t -88.88 -6.71 57.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.26 -175.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.558 ' OD1' ' HB ' ' A' ' 74' ' ' VAL . 10.1 p-10 -84.23 2.75 38.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.1 mt -125.09 138.17 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.15 108.42 19.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.032 0.444 . . . . 0.0 110.679 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.02 -36.9 68.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.204 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.22 -45.82 83.88 Favored Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.956 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.92 -45.95 89.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.377 0.608 . . . . 0.0 110.191 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.8 tp -66.32 -40.68 90.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.035 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -44.84 80.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.797 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.17 -42.0 98.42 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.882 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.6 p -72.42 -43.91 63.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.741 0.305 . . . . 0.0 111.807 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.73 -27.47 60.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.844 0.354 . . . . 0.0 110.417 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.67 -35.44 74.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.969 0.414 . . . . 0.0 110.55 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -69.54 -22.37 63.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.601 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.4 tp -83.57 -37.43 22.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.961 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.7 mt -72.44 -44.77 61.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.482 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.96 -100.49 1.1 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.74 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.55 46.4 1.17 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.126 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.62 159.03 30.92 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.76 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 p -146.57 70.21 1.21 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.117 0.484 . . . . 0.0 110.717 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.51 76.75 1.11 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.116 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 p -62.8 -19.29 63.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.12 0.486 . . . . 0.0 111.575 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.81 -30.86 66.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.365 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -113.59 17.01 21.22 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.964 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.0 tp -98.83 142.53 30.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.65 0.262 . . . . 0.0 111.012 -175.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.88 -158.99 30.92 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.095 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.3 tp -109.24 126.45 53.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -114.29 138.33 50.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.753 0.311 . . . . 0.0 110.805 -173.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -123.54 152.3 41.94 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.376 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 60.64 59.16 2.24 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.62 0.575 . . . . 0.0 109.958 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 4.0 t -118.48 139.33 51.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.3 p -122.74 132.28 54.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.606 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -65.83 147.85 52.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.505 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.595 HD13 ' SG ' ' A' ' 64' ' ' CYS . 75.4 mt -97.45 140.66 31.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.182 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -86.8 140.54 29.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.326 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.436 HD11 HG23 ' A' ' 53' ' ' THR . 62.3 mt -92.69 123.19 35.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.678 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 119' ' ' ILE . 0.4 OUTLIER -67.66 139.0 56.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.024 176.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 58.1 mt -96.82 120.92 60.81 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.994 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -45.31 117.11 1.52 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.396 2.731 . . . . 0.0 113.424 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 49.0 mm 72.97 -62.08 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.714 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.4 mm -95.86 80.6 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.282 0.563 . . . . 0.0 110.522 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.22 63.36 0.11 Allowed Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.227 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 59.4 mt 66.09 87.88 0.11 Allowed Pre-proline 0 N--CA 1.464 0.259 0 CA-C-O 121.153 0.502 . . . . 0.0 110.864 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.59 38.73 0.69 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.172 2.581 . . . . 0.0 112.957 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.483 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 51.6 mt -119.85 122.35 68.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.812 0.339 . . . . 0.0 110.676 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -87.36 74.94 9.33 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -80.82 157.91 25.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.257 -170.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 80.0 mt -74.22 135.45 42.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.44 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.89 -34.56 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.727 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -71.78 -13.47 61.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.724 0.297 . . . . 0.0 111.387 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -82.98 -25.71 31.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.736 0.303 . . . . 0.0 110.908 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -109.34 -12.4 14.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.068 0.461 . . . . 0.0 111.255 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 53.3 t -106.81 135.22 48.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -119.93 6.78 10.86 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.306 0.574 . . . . 0.0 110.751 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 46.0 mt-30 -108.42 169.2 8.79 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 14.5 p30 -70.22 134.36 47.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.936 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.409 HG23 HD13 ' A' ' 131' ' ' ILE . 34.6 mt -94.07 126.24 46.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.549 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.58 158.81 43.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.205 0.526 . . . . 0.0 111.623 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 56.2 m -97.67 121.0 39.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.679 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 82.1 m -112.2 140.37 46.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.61 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -69.4 133.55 47.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.167 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -80.48 33.71 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.282 0.563 . . . . 0.0 111.368 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.8 t -141.17 117.85 7.55 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.851 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.8 139.98 58.16 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.232 2.622 . . . . 0.0 112.519 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.1 m -79.57 7.17 8.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.933 0.397 . . . . 0.0 111.302 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.01 -32.35 73.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.972 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.64 -25.58 66.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.926 0.393 . . . . 0.0 110.931 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.3 t -90.43 -5.89 55.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.065 0.46 . . . . 0.0 110.254 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.66 133.96 1.61 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.136 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.3 p -82.91 -10.76 58.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.897 0.38 . . . . 0.0 111.126 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.5 mt -110.57 11.08 22.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.915 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 48.1 pt -116.16 33.44 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.399 -0.521 . . . . 0.0 112.171 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -84.18 42.22 3.06 Favored Glycine 0 C--N 1.321 -0.297 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 67.0 mt -87.93 -2.56 58.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.172 -0.514 . . . . 0.0 111.689 -171.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 167.54 -165.76 38.86 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.06 138.61 22.34 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 117.114 0.457 . . . . 0.0 109.928 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.53 121.92 6.23 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.766 1.644 . . . . 0.0 110.693 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 31.9 m -149.78 157.57 43.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.202 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 14.9 tt -124.91 129.75 73.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.183 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.35 121.13 12.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.246 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.4 tt -65.12 -20.74 66.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.408 -173.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.43 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.81 -9.45 70.4 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.166 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.403 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 74.6 p -78.14 -25.91 47.57 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 117.378 0.589 . . . . 0.0 110.901 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.9 pt -96.01 -9.45 9.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.171 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--O 1.242 0.71 0 O-C-N 124.104 0.877 . . . . 0.0 112.537 177.778 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' HB ' ' OD1' ' A' ' 130' ' ' ASN . 7.3 p . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.247 0.546 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 40' ' ' ARG . 27.0 mtm180 -76.96 -24.33 52.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.599 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.404 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 86.0 m-85 -123.44 87.21 52.01 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.24 148.25 68.03 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.245 1.963 . . . . 0.0 112.43 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.5 t -85.01 132.66 45.01 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.68 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.49 136.0 48.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.569 2.18 . . . . 0.0 112.386 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -10.28 57.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -90.05 2.35 55.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.567 0.222 . . . . 0.0 111.187 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.476 ' O ' HG11 ' A' ' 123' ' ' VAL . 34.1 mm -87.94 126.82 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.281 0.563 . . . . 0.0 110.527 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 59.3 p -87.42 160.0 18.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.539 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 m -57.11 -36.93 52.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.025 0.44 . . . . 0.0 110.76 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 50.8 tptt -68.4 -46.84 68.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.41 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -62.35 -41.22 98.42 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.502 0.192 . . . . 0.0 111.011 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.34 98.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.051 0.453 . . . . 0.0 110.99 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.8 m -67.69 -47.77 68.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.097 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 65.3 mm-40 -66.36 -28.15 68.43 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.005 0.431 . . . . 0.0 110.882 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.464 ' HE2' ' OXT' ' A' ' 159' ' ' LEU . 51.1 tptt -59.97 -40.89 90.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.334 177.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.56 ' SG ' HD12 ' A' ' 155' ' ' LEU . 80.8 m -92.96 -20.66 20.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.912 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.43 177.09 23.34 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.73 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.48 -8.04 57.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.86 0.362 . . . . 0.0 111.668 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -94.35 4.27 54.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.004 0.43 . . . . 0.0 110.988 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.65 147.44 48.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.262 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -104.31 121.55 43.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.15 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.7 tp -70.93 118.68 14.01 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.7 t -135.38 149.02 49.56 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.368 -171.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.549 ' SG ' HD21 ' A' ' 108' ' ' LEU . 62.0 m -102.54 118.77 37.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.819 174.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -117.51 130.27 56.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.171 0.51 . . . . 0.0 111.162 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -77.97 -24.94 47.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.786 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.93 138.69 54.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.197 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.14 120.92 19.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.082 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 m -114.46 116.46 28.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -88.03 126.26 34.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.04 77.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.41 -169.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.63 -7.8 75.04 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.562 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.9 -17.73 17.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.841 0.353 . . . . 0.0 110.8 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.54 131.67 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.22 0.533 . . . . 0.0 111.134 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.0 p -83.56 -9.01 59.21 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.88 -0.74 49.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.904 0.383 . . . . 0.0 111.401 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mt -124.78 142.94 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -89.26 98.52 11.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.525 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.74 -33.53 76.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.647 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.52 -38.81 96.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.6 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.72 -48.84 49.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.671 0.272 . . . . 0.0 110.455 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.88 -40.11 91.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.854 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.6 -37.5 86.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.753 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.25 -46.88 39.59 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.751 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 p -72.85 -44.93 60.79 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.412 ' CD2' ' HB ' ' A' ' 153' ' ' ILE . 11.3 tp -73.97 -24.92 59.69 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.756 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 41.1 ttmt -56.86 -32.03 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.004 0.431 . . . . 0.0 110.543 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -68.5 -24.08 64.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.691 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.2 tp -83.46 -35.0 25.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 109.897 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.0 mt -71.5 -40.8 72.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.329 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.42 -103.76 2.98 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -103.62 82.78 0.39 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.951 -0.643 . . . . 0.0 111.826 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.38 173.11 25.38 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.0 t -161.62 151.9 17.32 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.44 69.11 0.29 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.608 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 34.5 p -61.87 -25.75 67.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.859 0.361 . . . . 0.0 111.91 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -59.11 -22.46 60.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.163 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -122.55 27.1 6.1 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -109.8 148.49 31.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.692 0.282 . . . . 0.0 111.054 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 158.49 -148.37 17.46 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.729 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.9 mt -106.6 129.73 54.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.01 0.433 . . . . 0.0 109.928 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.547 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 15.7 m-85 -112.1 137.02 50.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.836 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.95 149.67 45.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.312 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 63.4 51.6 2.58 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.532 0.52 . . . . 0.0 110.334 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.5 m -92.23 135.62 33.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.711 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.5 p -114.97 145.48 42.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.091 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -77.12 133.71 38.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.549 HD21 ' SG ' ' A' ' 64' ' ' CYS . 19.2 mt -88.88 138.24 31.59 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.961 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.8 108.08 8.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.032 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.29 119.5 37.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.83 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -96.95 138.98 33.65 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.4 mt -70.23 124.23 90.37 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.413 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.67 95.89 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.247 1.964 . . . . 0.0 111.011 174.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.9 mm -80.41 122.45 35.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.056 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 77.9 mt -59.02 96.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.483 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 144.33 -29.63 1.9 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -175.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.3 pt -128.54 103.81 19.63 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.844 0.354 . . . . 0.0 110.064 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.19 78.26 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.796 2.331 . . . . 0.0 112.841 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 55.8 mt -97.07 115.26 36.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.498 ' HG3' HG22 ' A' ' 48' ' ' THR . 0.1 OUTLIER -153.44 86.74 1.22 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.031 0.443 . . . . 0.0 110.28 -176.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -88.11 145.06 26.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.092 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 96.2 mt -76.99 133.71 39.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.709 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.476 HG11 ' O ' ' A' ' 47' ' ' ILE . 11.4 p -67.07 -37.98 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.714 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -71.33 -16.44 62.44 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.071 0.462 . . . . 0.0 110.825 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -84.68 -26.54 27.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.503 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -100.09 -17.07 17.63 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.257 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 16.2 t -110.96 139.35 46.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.26 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.588 ' HB2' ' HZ1' ' A' ' 128' ' ' LYS . 4.3 ttmp? -111.89 2.22 16.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.758 0.79 . . . . 0.0 109.547 172.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 1.8 mp0 -108.2 170.73 7.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.918 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.446 ' OD1' ' HB ' ' A' ' 39' ' ' VAL . 22.2 m-80 -65.2 134.62 54.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.428 HD13 HG22 ' A' ' 131' ' ' ILE . 21.9 mm -95.74 124.26 48.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.87 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.07 159.29 42.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.874 0.369 . . . . 0.0 111.102 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 78.6 m -107.86 118.96 38.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 73.7 m -110.24 147.26 34.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.118 0.485 . . . . 0.0 111.348 -169.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -69.78 122.17 18.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.204 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.11 -8.96 58.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.463 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.0 m -100.83 136.98 19.69 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.22 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.32 51.86 3.66 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.435 2.09 . . . . 0.0 111.694 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.3 p -67.76 -54.0 22.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.019 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.41 6.38 48.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.607 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -140.64 51.21 1.65 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.863 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 m -76.92 60.99 1.87 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.949 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 174.41 156.55 14.05 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.5 m -91.41 -26.17 19.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.806 0.336 . . . . 0.0 110.807 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 95.1 mt -83.26 4.5 26.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.944 0.402 . . . . 0.0 111.201 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.8 pt -125.42 43.23 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.545 0.688 . . . . 0.0 110.252 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.24 46.6 3.24 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.584 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.14 -32.0 72.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.953 0.406 . . . . 0.0 110.32 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 170.5 -179.66 42.45 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.39 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.16 129.36 25.71 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.76 122.79 11.24 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 121.881 1.72 . . . . 0.0 110.289 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.519 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . 2.6 t -153.54 159.4 42.2 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.319 -171.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.412 ' HB ' ' CD2' ' A' ' 86' ' ' LEU . 7.4 tp -127.12 130.76 71.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.278 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.89 122.29 14.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.286 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.56 HD12 ' SG ' ' A' ' 56' ' ' CYS . 59.7 tp -62.67 -25.32 68.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.638 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.404 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -72.83 -16.82 78.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.901 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.5 m -74.6 -29.12 61.19 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.228 0.514 . . . . 0.0 111.326 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.4 pt -95.56 -4.41 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.069 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.464 ' OXT' ' HE2' ' A' ' 55' ' ' LYS . 89.3 mt . . . . . 0 C--O 1.252 1.188 0 O-C-N 123.804 0.69 . . . . 0.0 111.885 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 130' ' ' ASN . 7.4 p . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.079 0.466 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -76.43 -22.9 54.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.12 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 157' ' ' SER . 60.2 m-85 -122.61 86.91 49.37 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.421 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.78 144.85 55.21 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.179 1.92 . . . . 0.0 112.487 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.23 132.01 54.47 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.59 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.28 135.09 45.79 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.113 1.876 . . . . 0.0 111.537 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -72.9 -10.22 59.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.037 -170.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -90.13 2.44 55.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.434 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.4 mm -86.75 127.25 40.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.981 0.419 . . . . 0.0 110.736 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 43.2 p -82.16 159.95 23.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.659 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.0 t -57.91 -40.92 78.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.9 0.381 . . . . 0.0 110.792 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -64.4 -44.97 89.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.759 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -62.67 -46.13 89.61 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.962 0.411 . . . . 0.0 110.611 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.04 -37.6 83.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.813 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.8 m -67.43 -45.08 77.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.803 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -63.73 -31.49 72.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.336 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 159' ' ' LEU . 57.1 tptt -62.42 -40.89 98.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.817 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.585 ' SG ' HD13 ' A' ' 155' ' ' LEU . 71.8 m -94.29 -16.21 23.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.855 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.06 161.96 23.75 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.182 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -74.62 -11.08 60.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.969 0.414 . . . . 0.0 110.851 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -91.41 14.63 14.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.109 0.481 . . . . 0.0 110.204 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.75 141.77 51.5 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.469 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -111.9 124.61 52.73 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.08 121.28 14.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.965 0.412 . . . . 0.0 110.165 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 41.2 t -122.62 134.36 54.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.662 -175.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 67.8 m -93.9 116.13 28.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.366 174.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.415 ' HB2' ' ND2' ' A' ' 130' ' ' ASN . 50.3 m -120.32 130.19 54.33 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.709 0.29 . . . . 0.0 110.751 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -79.92 -21.5 43.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.003 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -123.93 142.03 51.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.49 126.65 33.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.17 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.0 m -120.71 115.1 22.67 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -92.24 135.07 34.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.63 72.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.022 -171.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.18 -7.37 82.0 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.784 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -98.26 -17.53 18.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.088 0.47 . . . . 0.0 110.865 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.0 m -120.63 132.35 70.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.299 0.571 . . . . 0.0 111.264 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.3 p -82.56 -18.2 42.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.504 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -86.78 11.71 12.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.6 mt -130.3 136.01 59.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.612 0.244 . . . . 0.0 110.617 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -87.85 107.57 18.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.947 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.63 -28.35 67.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.336 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.1 -41.48 97.07 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.589 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.26 -44.23 97.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.052 0.453 . . . . 0.0 110.319 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.31 -38.88 88.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.843 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.18 -36.97 85.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.344 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.19 -46.18 94.7 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.614 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 p -73.07 -43.42 61.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.938 0.399 . . . . 0.0 111.773 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.34 -26.33 58.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.353 -176.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 29.8 ttpp -56.98 -30.69 64.33 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.751 0.31 . . . . 0.0 110.926 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -63.15 -22.79 67.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.322 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.66 -27.55 20.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.951 0.405 . . . . 0.0 110.769 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.2 mt -82.23 -40.85 17.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.136 0.493 . . . . 0.0 110.801 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.03 -126.14 8.44 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.66 41.11 3.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.339 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -153.73 173.77 32.38 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.2 m -153.56 91.93 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.794 0.33 . . . . 0.0 111.335 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.54 69.86 3.21 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.3 p -68.2 -12.51 61.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.78 -33.94 73.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.82 0.343 . . . . 0.0 111.511 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -107.49 20.06 32.94 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.998 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.2 tp -100.24 139.88 35.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.879 0.371 . . . . 0.0 111.252 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.88 -146.97 11.83 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.819 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.56 125.33 52.41 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.77 136.83 47.69 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.167 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -120.03 152.74 37.07 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.999 -175.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 61.33 57.84 2.3 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.545 0.688 . . . . 0.0 109.803 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.487 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 96.7 m -106.42 135.66 47.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.548 -174.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.0 m -128.34 131.1 48.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -79.84 145.83 32.55 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.417 . . . . 0.0 111.228 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -95.55 140.84 29.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -75.76 131.24 39.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.153 0.501 . . . . 0.0 109.757 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.8 tp -83.09 119.44 24.5 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -90.29 117.88 29.37 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 60.1 mt -100.68 113.95 65.7 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.13 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.25 115.83 2.85 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.46 2.107 . . . . 0.0 111.509 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 25.1 pt -132.16 174.8 12.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.302 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.3 mm -66.09 105.62 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.504 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.99 -36.89 2.83 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.906 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.4 pt -144.07 78.01 14.1 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 121.213 0.53 . . . . 0.0 110.789 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -85.75 60.25 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.623 2.215 . . . . 0.0 111.022 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.1 mt -78.59 122.18 33.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.882 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -123.83 82.31 2.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.027 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -87.58 144.81 26.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.475 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 76.1 mt -71.48 131.32 43.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.928 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.4 -35.46 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.467 -174.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.99 -12.68 61.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.134 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.456 ' HB2' ' HB2' ' A' ' 122' ' ' LEU . 8.1 tp-100 -83.19 -25.92 31.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.725 0.298 . . . . 0.0 110.656 -173.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -102.3 -17.35 15.93 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.212 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 16.8 t -110.33 137.06 48.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.688 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.417 ' N ' ' HD3' ' A' ' 128' ' ' LYS . 3.4 mppt? -110.36 3.88 20.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.376 0.608 . . . . 0.0 109.93 172.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 27.8 mp0 -108.75 169.85 8.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.849 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.501 ' HB2' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -66.72 140.56 57.88 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.673 0.273 . . . . 0.0 110.813 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.458 HD13 HG23 ' A' ' 131' ' ' ILE . 26.5 mm -97.53 120.5 46.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.138 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.22 154.86 45.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.836 0.351 . . . . 0.0 110.741 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.408 ' C ' ' SG ' ' A' ' 152' ' ' CYS . 73.9 m -105.64 114.28 28.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.015 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 59.6 m -109.6 140.94 42.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.72 136.4 50.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.728 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -80.27 55.09 2.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.305 0.574 . . . . 0.0 111.043 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.7 t -138.84 103.58 7.54 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.557 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -78.15 46.73 2.17 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.594 2.196 . . . . 0.0 112.471 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.5 m -84.77 0.79 49.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.627 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -86.86 -20.21 27.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.157 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -101.12 15.87 27.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.681 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 m -91.85 33.47 1.04 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.267 -176.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.52 -0.97 63.69 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.796 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.3 m -70.93 134.55 47.32 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 96.2 mt -88.21 45.2 1.26 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.519 0.676 . . . . 0.0 110.485 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.435 ' C ' ' H ' ' A' ' 148' ' ' LEU . 33.6 pt -113.18 43.05 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.236 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -77.6 39.12 1.71 Allowed Glycine 0 N--CA 1.454 -0.153 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.169 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.435 ' H ' ' C ' ' A' ' 146' ' ' ILE . 46.1 mt -82.99 -16.31 47.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.425 0.631 . . . . 0.0 109.711 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 152.17 -155.81 26.34 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.734 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.7 mp -104.8 127.66 28.38 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -66.46 121.32 8.57 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.44 1.427 . . . . 0.0 110.21 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.408 ' SG ' ' C ' ' A' ' 133' ' ' CYS . 0.7 OUTLIER -155.41 169.15 24.92 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.379 -172.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.36 132.45 55.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.388 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.11 123.39 17.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.341 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.585 HD13 ' SG ' ' A' ' 56' ' ' CYS . 42.4 tp -61.79 -25.82 67.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.781 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.442 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.24 -17.14 75.69 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.409 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.494 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 8.5 t -73.41 -26.77 61.11 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.968 0.384 . . . . 0.0 110.95 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 pt -102.21 -2.34 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.532 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.434 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 90.2 mt . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.595 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.258 0.551 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -76.47 -29.04 56.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.357 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -125.14 91.91 48.33 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.51 150.64 75.46 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.395 2.063 . . . . 0.0 112.643 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.71 133.36 29.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.736 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.86 136.31 51.39 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.732 2.288 . . . . 0.0 112.395 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.81 -11.73 61.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.208 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -86.02 3.2 43.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.677 0.275 . . . . 0.0 111.732 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.473 ' O ' HG13 ' A' ' 123' ' ' VAL . 34.9 mm -92.06 123.91 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 0.0 110.274 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 61.4 p -80.29 160.84 25.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.298 175.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.33 -40.87 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.604 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 65.7 tttp -65.46 -47.52 75.83 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.879 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -59.6 -43.5 93.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 110.69 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.7 98.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.732 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.403 HG21 HD23 ' A' ' 110' ' ' LEU . 29.6 m -68.97 -39.03 79.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.689 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 73.8 mm-40 -59.56 -32.19 70.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.042 0.448 . . . . 0.0 110.756 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -60.58 -33.52 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.082 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 85.5 m -100.49 9.55 42.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.752 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.57 80.05 0.66 Allowed Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.45 -172.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -177.5 -72.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.977 0.418 . . . . 0.0 110.864 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -116.86 12.92 14.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.452 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -149.08 163.89 36.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.05 0.453 . . . . 0.0 111.591 -171.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -134.52 143.23 47.32 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.9 tp -67.29 134.59 51.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.057 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 t -139.69 145.97 39.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.858 0.361 . . . . 0.0 110.358 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.694 ' SG ' HD11 ' A' ' 108' ' ' LEU . 29.5 m -113.9 120.63 41.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.745 176.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 129' ' ' GLN . 13.5 m -115.49 144.71 43.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -89.91 -26.55 20.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -124.69 145.24 49.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.35 128.36 33.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.614 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 m -120.38 115.09 22.84 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 171.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -91.65 136.58 33.03 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.34 -27.51 69.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.564 -170.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.41 -12.26 80.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.881 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.61 -17.47 19.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 0.0 111.364 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.473 ' HB ' ' OD1' ' A' ' 76' ' ' ASP . 10.5 m -121.23 125.96 74.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.427 0.632 . . . . 0.0 111.09 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.2 p -86.85 -6.57 58.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.975 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.473 ' OD1' ' HB ' ' A' ' 74' ' ' VAL . 8.8 p-10 -83.12 -2.26 54.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.939 0.399 . . . . 0.0 111.351 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mt -110.41 143.14 20.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.456 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -88.2 99.45 12.22 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.11 -26.93 68.76 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.27 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.08 -42.66 91.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.391 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.3 -44.8 94.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.961 0.41 . . . . 0.0 110.461 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.7 mt -62.89 -40.52 97.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.714 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.73 -42.03 91.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.74 -41.28 99.86 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.684 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.6 p -72.48 -43.99 62.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.699 0.285 . . . . 0.0 111.531 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.72 -27.6 61.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.846 0.355 . . . . 0.0 110.803 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 18.4 ttmm -57.75 -32.65 67.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.048 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.35 -22.72 64.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.562 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.408 HD23 ' SG ' ' A' ' 133' ' ' CYS . 59.3 tp -79.92 -33.81 39.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.2 0.524 . . . . 0.0 110.245 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.4 mt -85.21 -47.31 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.998 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.26 -100.72 0.34 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.827 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -111.57 12.99 27.8 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.426 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.65 171.11 24.19 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.795 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.5 p -157.51 102.26 1.89 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.719 0.295 . . . . 0.0 110.886 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.28 85.48 0.6 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.191 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.4 p -67.09 -9.05 35.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.817 0.341 . . . . 0.0 111.724 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -62.54 -31.33 72.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.223 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.6 23.21 9.69 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.787 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.9 tp -105.14 144.44 31.94 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.403 0.281 . . . . 0.0 110.945 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 163.96 -149.52 16.82 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.845 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.8 mt -107.89 132.96 52.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 152' ' ' CYS . 22.5 m-85 -114.9 143.18 45.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -125.84 152.96 44.79 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 110.483 -0.192 . . . . 0.0 110.483 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 57.97 58.15 3.74 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.575 0.702 . . . . 0.0 109.643 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 6.9 t -120.35 144.25 47.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.83 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.1 t -126.06 140.65 52.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.446 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -79.09 147.44 32.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.911 0.386 . . . . 0.0 110.71 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.694 HD11 ' SG ' ' A' ' 64' ' ' CYS . 62.3 mt -102.31 141.49 35.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.594 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -100.29 126.03 46.57 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.403 HD23 HG21 ' A' ' 53' ' ' THR . 3.0 pp -77.95 136.2 37.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.027 0.441 . . . . 0.0 110.305 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -73.95 126.28 30.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.37 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 60.0 mt -99.74 114.3 65.55 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.109 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.79 83.95 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.044 1.83 . . . . 0.0 111.481 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.5 mt -77.37 -80.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.645 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.8 mm -112.1 93.57 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.047 0.451 . . . . 0.0 111.129 -175.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.13 49.73 64.89 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.109 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 41.1 mt -111.76 89.08 10.57 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -89.35 39.58 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.757 2.305 . . . . 0.0 111.888 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.4 mm -103.79 120.95 54.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.093 0.473 . . . . 0.0 110.482 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -101.4 85.75 2.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.34 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.78 103.73 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.604 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 97.6 mt -70.36 131.76 44.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.067 0.46 . . . . 0.0 110.256 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 47' ' ' ILE . 10.5 p -66.74 -35.78 75.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.497 -173.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -70.95 -16.37 62.65 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.912 0.387 . . . . 0.0 110.999 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -83.58 -28.32 28.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.509 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -114.42 -14.72 12.16 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.823 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.3 t -108.38 116.68 32.42 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -100.16 -4.48 29.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.445 0.641 . . . . 0.0 110.18 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.533 ' HB3' ' O ' ' A' ' 65' ' ' CYS . 23.1 mp0 -91.56 168.29 11.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.242 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.65 131.68 45.0 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.589 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 29.3 mt -93.79 126.96 46.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.569 -174.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.38 158.43 44.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.327 0.585 . . . . 0.0 111.656 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.408 ' SG ' HD23 ' A' ' 89' ' ' LEU . 37.1 t -110.0 115.13 29.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.653 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.5 m -110.78 139.49 46.04 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.731 -170.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.44 139.33 49.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.628 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.13 64.0 3.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.473 0.654 . . . . 0.0 110.558 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.4 m -105.23 92.96 6.08 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.404 173.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -77.86 50.76 3.37 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.532 2.155 . . . . 0.0 112.869 -174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.0 t -166.27 136.52 3.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.43 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -77.82 -12.39 59.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.309 0.576 . . . . 0.0 110.307 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.71 54.14 2.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.847 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.4 t -135.58 33.94 2.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.954 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.18 50.0 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.216 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.8 t 65.51 43.73 3.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.005 0.431 . . . . 0.0 110.344 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 92.7 mt 59.0 86.06 0.09 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.294 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.416 ' C ' ' H ' ' A' ' 148' ' ' LEU . 12.7 pt -122.26 61.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.321 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -78.73 14.8 11.6 Favored Glycine 0 C--O 1.23 -0.148 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.756 175.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 146' ' ' ILE . 36.2 mt -87.93 -10.34 50.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.148 0.499 . . . . 0.0 110.146 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 165.51 173.26 33.86 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.457 HD22 ' H ' ' A' ' 150' ' ' LEU . 0.7 OUTLIER -95.02 134.16 25.18 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 117.031 0.416 . . . . 0.0 110.53 -178.518 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.64 123.84 11.95 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.596 2.197 . . . . 0.0 111.182 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.471 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 3.6 t -153.67 163.83 39.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.857 -174.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.44 133.15 60.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.58 130.05 34.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.539 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.64 -24.61 67.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.315 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -72.91 -15.37 78.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.586 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 m -80.6 -29.61 36.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.033 0.417 . . . . 0.0 111.299 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 29.4 pt -100.49 -9.65 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.787 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 C--O 1.249 1.078 0 O-C-N 123.85 0.719 . . . . 0.0 112.382 177.907 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.428 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 7.1 p . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 121.423 0.63 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.566 ' HD2' ' CE1' ' A' ' 41' ' ' PHE . 3.3 tmt_? -68.37 -34.27 75.76 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.411 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.566 ' CE1' ' HD2' ' A' ' 40' ' ' ARG . 90.3 m-85 -118.69 87.49 32.42 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.6 151.25 69.94 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.508 2.139 . . . . 0.0 112.542 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.3 t -82.35 128.26 67.95 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.294 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.16 137.15 45.97 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.049 2.499 . . . . 0.0 112.613 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.23 -11.04 47.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.575 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -86.37 -1.42 57.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.122 0.487 . . . . 0.0 111.243 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.34 122.39 41.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.162 0.506 . . . . 0.0 111.01 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 70.5 p -81.93 163.81 21.96 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.436 174.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -57.0 -39.43 65.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 0.0 110.594 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.503 ' HZ1' ' HB3' ' A' ' 50' ' ' LYS . 10.0 mtpm? -67.41 -46.37 73.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.164 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -58.77 -44.31 90.62 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 110.378 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.503 ' CB ' HD11 ' A' ' 62' ' ' LEU . . . -61.89 -45.9 91.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.095 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.477 ' OG1' HD21 ' A' ' 110' ' ' LEU . 90.9 m -64.56 -46.68 81.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.211 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -67.3 -28.39 67.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.013 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -64.26 -40.92 96.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.44 . . . . 0.0 110.061 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.485 ' SG ' HD13 ' A' ' 155' ' ' LEU . 81.0 m -101.09 14.03 33.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.196 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.42 168.8 8.66 Favored Glycine 0 CA--C 1.518 0.26 0 N-CA-C 114.266 0.467 . . . . 0.0 114.266 -171.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 72.02 -67.84 0.24 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.014 0.926 . . . . 0.0 111.991 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -94.21 -8.49 39.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -171.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 56' ' ' CYS . . . -138.65 163.6 31.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.412 0.625 . . . . 0.0 111.864 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -128.3 138.23 52.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.296 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.503 HD11 ' CB ' ' A' ' 52' ' ' ALA . 12.1 mt -69.27 134.77 49.58 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.787 0.327 . . . . 0.0 110.837 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.478 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 38.2 t -140.62 129.94 23.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.133 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.472 ' SG ' HD13 ' A' ' 108' ' ' LEU . 59.9 m -102.33 116.99 33.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.65 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 129' ' ' GLN . 9.0 m -118.98 143.33 47.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.307 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -71.33 -37.38 71.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.719 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -126.83 141.27 51.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.036 0.446 . . . . 0.0 111.594 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.22 122.58 28.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.424 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 m -103.32 115.25 30.19 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.428 ' OH ' ' HA ' ' A' ' 39' ' ' VAL . 87.7 m-85 -91.36 133.18 35.67 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.68 67.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.582 -168.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.32 -20.84 76.63 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.581 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.86 -14.5 26.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.643 0.259 . . . . 0.0 111.471 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 m -121.72 150.31 25.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.562 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -108.39 2.91 22.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -95.64 1.77 53.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.03 0.443 . . . . 0.0 110.893 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.0 mt -119.25 136.5 56.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.946 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -86.86 108.01 18.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.049 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.34 -30.2 69.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.084 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.25 -39.67 96.18 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.608 -176.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.9 -47.43 88.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.121 0.486 . . . . 0.0 110.189 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 88.5 mt -67.43 -45.58 75.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.896 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -63.78 -41.14 98.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.952 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.85 -46.81 93.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.421 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.9 p -73.32 -40.6 64.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.901 0.382 . . . . 0.0 111.854 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -74.24 -23.21 59.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.425 -177.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 38.2 ttpt -54.63 -32.64 59.28 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.708 -174.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.9 -32.41 73.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.84 0.352 . . . . 0.0 110.485 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.439 HD11 ' O ' ' A' ' 89' ' ' LEU . 3.1 tm? -82.73 -34.86 27.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.42 -44.83 99.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.42 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.7 -74.78 2.47 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.492 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.81 -89.11 0.85 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.242 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.77 -172.28 45.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.996 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.6 m 62.91 59.08 1.41 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.71 0.404 . . . . 0.0 111.629 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.77 12.69 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.969 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.7 p -75.98 -18.87 59.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.829 0.347 . . . . 0.0 111.708 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.04 -13.7 62.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.323 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.44 23.93 10.83 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.38 142.5 38.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.56 -149.62 12.97 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.619 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.07 126.19 54.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -112.38 139.78 47.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.928 -173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -120.25 154.03 35.49 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.671 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 61.9 58.7 1.86 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.691 0.757 . . . . 0.0 109.898 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.478 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 90.4 m -101.72 142.69 32.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.037 -173.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.8 p -132.94 137.33 46.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.567 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -80.89 144.92 31.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.793 0.33 . . . . 0.0 110.359 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.472 HD13 ' SG ' ' A' ' 64' ' ' CYS . 62.3 mt -91.33 124.99 35.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.54 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -85.71 145.65 27.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.697 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.477 HD21 ' OG1' ' A' ' 53' ' ' THR . 91.9 mt -97.49 126.21 42.63 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.316 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -89.28 101.86 14.52 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 170.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 54.1 mt -98.97 123.22 50.0 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.901 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.22 90.34 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.432 2.088 . . . . 0.0 112.169 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 55.8 mt -79.6 92.86 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.4 tp 39.53 64.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 122.125 0.964 . . . . 0.0 111.842 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -149.79 -100.04 0.21 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.04 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.7 pt -130.68 106.49 15.56 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.942 0.401 . . . . 0.0 110.966 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.77 96.97 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.839 2.359 . . . . 0.0 112.173 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 67.8 mt -97.91 127.56 50.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.369 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -78.82 73.42 5.37 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.35 106.43 10.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.422 -175.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 64.8 mt -70.85 136.69 48.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.437 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.1 p -65.96 -29.65 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.241 -174.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.14 -13.35 61.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.077 0.465 . . . . 0.0 110.842 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -83.77 -27.69 28.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -108.74 -16.13 14.25 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.014 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 48.6 t -109.16 111.93 23.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.781 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -103.43 9.52 37.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.607 0.718 . . . . 0.0 109.97 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' ' 65' ' ' CYS . 2.1 mp0 -105.12 168.56 8.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.692 -1.14 . . . . 0.0 107.967 176.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.413 ' CB ' ' HB ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -70.1 128.56 36.71 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.378 178.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 23.3 mt -88.18 125.24 41.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.825 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.09 155.9 49.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.202 0.525 . . . . 0.0 111.275 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 64.8 m -106.0 129.76 54.06 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.8 m -111.34 139.34 46.82 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -77.36 134.18 38.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.075 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -84.47 54.23 2.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.65 . . . . 0.0 110.293 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.1 m -118.4 123.28 29.42 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.583 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.58 98.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.52 2.147 . . . . 0.0 112.448 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.0 m -78.39 56.48 1.75 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.436 0.636 . . . . 0.0 109.878 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -83.43 47.7 1.3 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.919 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.41 -27.99 56.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.467 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.2 t -130.64 37.29 3.84 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.33 -141.97 41.9 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.61 -176.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 47.1 m -84.07 -14.91 49.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.177 0.513 . . . . 0.0 110.148 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.8 tp -80.75 72.36 7.71 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.371 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.411 ' C ' ' H ' ' A' ' 148' ' ' LEU . 23.0 pt -130.61 51.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.183 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.32 33.7 2.01 Favored Glycine 0 N--CA 1.455 -0.089 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.426 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.411 ' H ' ' C ' ' A' ' 146' ' ' ILE . 53.7 mt -89.38 -26.99 20.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.066 0.46 . . . . 0.0 109.875 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 148.58 -176.7 27.26 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.218 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.5 mp -111.0 135.55 20.84 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.42 121.04 6.52 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.356 1.371 . . . . 0.0 110.727 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 42.5 m -152.55 160.54 43.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.131 -173.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.06 136.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.198 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.31 124.57 20.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.334 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.485 HD13 ' SG ' ' A' ' 56' ' ' CYS . 57.6 tp -61.12 -29.57 69.85 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.641 -175.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.401 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -66.27 -16.02 64.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.661 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.1 m -70.87 -30.16 66.46 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 117.061 0.43 . . . . 0.0 111.102 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 41.5 pt -99.8 -9.1 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.425 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 C--O 1.251 1.152 0 O-C-N 123.639 0.587 . . . . 0.0 111.784 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -76.25 -27.81 56.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.889 0.376 . . . . 0.0 111.081 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.515 ' O ' ' HA3' ' A' ' 156' ' ' GLY . 54.8 m-85 -136.71 97.57 11.29 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.77 139.66 44.4 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.874 2.383 . . . . 0.0 112.76 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -81.64 134.75 50.27 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.406 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.93 135.05 50.39 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.272 1.981 . . . . 0.0 111.914 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.06 -10.39 59.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.695 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.66 4.68 48.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.799 0.333 . . . . 0.0 111.177 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.3 mm -93.15 117.48 36.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.139 0.495 . . . . 0.0 110.586 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 32.9 p -77.38 159.68 29.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.531 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.1 t -54.27 -42.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.918 0.389 . . . . 0.0 110.614 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -60.63 -47.07 87.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.997 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -67.26 -35.95 80.58 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.488 0.185 . . . . 0.0 111.045 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.25 80.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 110.062 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.1 m -67.71 -47.52 69.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.659 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -65.08 -34.56 78.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -63.38 -37.54 87.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.629 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.624 ' SG ' HD11 ' A' ' 155' ' ' LEU . 92.5 m -91.04 -19.85 22.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.748 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.47 178.78 29.82 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.479 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -82.54 -16.52 48.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -91.97 11.82 23.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.237 0.542 . . . . 0.0 110.606 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 134' ' ' CYS . . . -132.67 126.51 32.79 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.838 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -95.45 128.41 42.28 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.214 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 33.0 mt -65.44 122.87 18.17 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.871 0.367 . . . . 0.0 110.196 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.403 ' HB3' ' SG ' ' A' ' 105' ' ' CYS . 19.6 m -134.01 131.72 39.25 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.31 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.493 ' SG ' HD13 ' A' ' 108' ' ' LEU . 66.7 m -107.75 118.06 35.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.182 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER -116.68 140.05 49.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.812 -175.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.42 -19.76 49.2 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.818 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -126.42 140.98 52.06 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.608 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.23 127.0 32.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.282 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.4 m -119.95 115.83 24.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -95.1 132.03 40.46 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.76 -27.27 68.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.856 -171.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.81 -23.64 72.57 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.877 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -94.67 -18.58 21.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.184 0.492 . . . . 0.0 111.507 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.8 m -121.52 125.01 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.324 0.583 . . . . 0.0 111.429 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 p -85.99 -14.75 43.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.827 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -73.45 -15.04 61.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.187 0.518 . . . . 0.0 111.178 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.9 mt -103.75 130.32 54.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.89 106.73 3.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.125 0.488 . . . . 0.0 110.587 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.69 -29.4 68.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.03 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.41 -44.11 95.8 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.721 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.8 mt -63.25 -46.41 95.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.247 0.546 . . . . 0.0 110.266 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.35 -43.15 95.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.123 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.65 -39.1 88.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.721 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.25 -46.2 88.15 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.438 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 p -68.75 -42.74 77.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.829 0.347 . . . . 0.0 111.498 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.96 -26.21 59.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -57.89 -32.55 67.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.822 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -63.17 -28.65 70.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.487 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.5 tp -86.83 -37.41 17.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.458 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.0 mt -72.3 -37.16 57.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.77 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.92 -73.12 0.22 Allowed Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -135.52 128.75 4.78 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.142 -0.552 . . . . 0.0 111.838 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.8 -170.05 33.12 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.575 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.7 p -157.97 115.28 2.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.93 0.395 . . . . 0.0 111.053 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.06 78.83 1.67 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.452 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 29.8 p -70.06 -18.87 63.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -172.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.41 -33.17 74.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.835 0.35 . . . . 0.0 111.324 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA3' ' OG ' ' A' ' 157' ' ' SER . . . -108.03 15.03 37.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.881 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 96' ' ' THR . 45.1 tp -104.02 141.6 35.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.591 0.234 . . . . 0.0 110.7 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 166.4 -156.47 28.38 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.576 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.1 mt -106.25 122.87 47.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.453 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 16.4 m-85 -106.34 133.72 50.6 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.016 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -119.69 154.49 34.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.717 -175.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.424 ' HA ' ' OE1' ' A' ' 104' ' ' GLN . 13.4 mm-40 59.08 58.15 3.24 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 3.5 t -120.66 138.86 53.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.25 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.7 m -129.73 149.93 51.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.822 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -78.93 147.47 33.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.947 0.403 . . . . 0.0 110.753 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.493 HD13 ' SG ' ' A' ' 64' ' ' CYS . 69.8 mt -89.93 137.74 32.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.614 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.91 129.06 34.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.039 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.27 118.79 30.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.919 0.39 . . . . 0.0 111.074 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -105.51 101.42 10.95 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 56.3 mt -114.73 113.53 44.79 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.094 -175.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.97 122.49 3.38 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.246 1.964 . . . . 0.0 111.288 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.4 mt -100.73 80.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.948 0.404 . . . . 0.0 110.309 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.0 mm 64.37 98.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.285 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 167.97 -68.74 0.17 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.484 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.1 mm -110.03 115.13 55.37 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -65.84 89.46 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.565 2.177 . . . . 0.0 111.837 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.7 mt -109.18 124.24 65.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.983 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -113.14 76.25 0.97 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -87.48 104.46 16.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.647 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 52.8 mt -72.86 135.64 45.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.433 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.24 -29.67 47.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.925 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -71.5 -16.77 62.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.995 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -83.86 -26.04 29.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.789 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.41 -17.1 14.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.359 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.474 ' SG ' HG12 ' A' ' 131' ' ' ILE . 38.4 t -111.95 114.77 27.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.643 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.478 ' HZ2' ' HB2' ' A' ' 128' ' ' LYS . 9.4 mtmp? -99.88 2.12 43.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.473 0.654 . . . . 0.0 110.043 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 0.8 OUTLIER -107.51 173.4 6.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.649 -176.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -63.13 122.78 16.95 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.474 HG12 ' SG ' ' A' ' 127' ' ' CYS . 17.7 mt -91.29 117.33 34.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.161 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.69 154.07 50.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.201 0.524 . . . . 0.0 111.012 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 75.7 m -109.81 129.11 55.67 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.477 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 21.3 m -112.35 140.57 46.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' A' ' 137' ' ' SER . 6.4 tp60 -70.62 129.52 39.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.204 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -86.87 28.46 0.89 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.101 0.477 . . . . 0.0 111.78 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.441 ' H ' ' HG3' ' A' ' 135' ' ' GLN . 60.7 m -102.33 108.18 56.21 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.836 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.69 45.74 2.03 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.329 2.019 . . . . 0.0 112.124 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.9 p -79.85 -59.12 2.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.672 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.19 3.73 15.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.084 0.468 . . . . 0.0 110.616 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.59 -15.65 36.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.687 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.0 m -82.03 67.36 8.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.788 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -141.09 139.99 10.01 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.539 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.7 t -94.75 -14.96 24.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.111 0.482 . . . . 0.0 110.093 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.3 mt -95.08 19.95 9.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.883 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 148' ' ' LEU . 40.5 pt -127.55 55.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.569 0.7 . . . . 0.0 110.795 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -78.44 21.4 3.66 Favored Glycine 0 CA--C 1.517 0.159 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.329 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.422 ' H ' ' C ' ' A' ' 146' ' ' ILE . 85.3 mt -71.22 -29.38 65.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.875 0.369 . . . . 0.0 110.48 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 154.52 -170.86 32.95 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.977 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.3 mp -108.08 129.18 24.45 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -70.77 120.96 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.634 1.556 . . . . 0.0 110.95 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 61.3 m -153.45 161.92 41.79 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.6 133.42 68.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.838 0.351 . . . . 0.0 110.651 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.43 125.89 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.01 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.624 HD11 ' SG ' ' A' ' 56' ' ' CYS . 45.4 tp -65.11 -26.82 68.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.158 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 41' ' ' PHE . . . -66.8 -19.4 69.44 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.891 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.426 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 30.8 m -68.88 -29.13 67.35 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.176 0.488 . . . . 0.0 110.997 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.4 pt -101.03 -1.43 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.863 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.247 0.924 0 O-C-N 124.034 0.834 . . . . 0.0 111.79 178.366 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.406 ' HB ' ' OD1' ' A' ' 130' ' ' ASN . 7.2 p . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -62.78 -30.83 71.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.744 -175.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.506 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 51.0 m-85 -138.03 91.47 13.15 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.223 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.56 144.95 62.61 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.188 1.925 . . . . 0.0 112.508 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -82.16 131.95 54.82 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.89 134.43 41.92 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.99 1.793 . . . . 0.0 111.943 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.13 -17.28 64.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.91 -172.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -81.81 2.87 28.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.87 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.447 ' O ' HG11 ' A' ' 123' ' ' VAL . 30.9 mm -89.6 127.24 42.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.976 0.417 . . . . 0.0 110.53 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 55.5 p -83.93 163.78 19.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.419 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.1 t -56.15 -43.18 75.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.936 0.398 . . . . 0.0 110.795 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -62.43 -46.59 87.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -67.98 -37.42 81.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.245 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.32 99.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.839 0.352 . . . . 0.0 110.713 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.456 HG23 HD11 ' A' ' 110' ' ' LEU . 39.8 m -62.68 -45.75 91.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.42 -30.6 71.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.23 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -72.67 -31.44 65.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.336 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 133' ' ' CYS . 83.0 m -77.71 -22.33 50.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.124 0.488 . . . . 0.0 110.122 173.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.07 172.88 34.26 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.218 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -78.82 -21.01 48.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.879 0.371 . . . . 0.0 110.651 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.81 19.63 6.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.799 0.333 . . . . 0.0 110.908 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 134' ' ' CYS . . . -140.68 143.57 35.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.992 0.425 . . . . 0.0 110.663 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -117.88 134.84 54.54 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.747 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.92 125.73 25.79 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.782 0.325 . . . . 0.0 110.295 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 107' ' ' LYS . 16.7 m -129.84 126.14 37.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.194 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 89.5 m -103.92 115.43 30.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.555 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 3.0 m -119.27 138.67 52.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 -172.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -81.0 -18.86 45.39 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.002 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -123.24 138.3 54.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.181 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.18 121.51 23.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.715 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 m -118.6 115.79 25.29 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -95.07 126.69 40.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.076 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.51 -31.32 72.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.531 -169.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.41 -20.42 67.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.934 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -102.36 -16.73 16.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.5 m -119.11 135.69 58.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.075 0.464 . . . . 0.0 111.331 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.1 p -86.11 -16.11 39.02 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -72.45 -6.1 41.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 111.476 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.6 mt -119.09 139.05 47.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.381 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -89.13 102.39 15.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.85 -35.9 82.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.021 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.21 97.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.577 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.5 mt -64.97 -48.53 83.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.053 0.454 . . . . 0.0 110.528 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.424 HD23 ' HB3' ' A' ' 151' ' ' PRO . 41.7 mt -68.12 -45.53 73.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.071 -175.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.37 -37.19 84.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.662 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.93 -45.05 96.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.068 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 p -72.8 -42.23 64.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.814 0.34 . . . . 0.0 111.798 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.78 -26.29 59.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.501 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 53.7 tttp -56.87 -29.0 62.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.889 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -60.57 -26.37 66.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.257 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.37 -36.95 26.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.913 0.387 . . . . 0.0 110.673 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.3 mt -72.02 -36.19 56.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.63 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.76 -118.59 4.86 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.742 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.86 58.39 1.25 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.255 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.75 -174.36 30.49 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -149.59 152.46 35.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.933 0.397 . . . . 0.0 110.405 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.84 51.41 0.19 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.6 p -71.7 -14.1 61.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.306 -0.447 . . . . 0.0 111.959 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.17 -21.16 64.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.435 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.53 19.22 24.3 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.5 HD21 ' N ' ' A' ' 100' ' ' GLY . 7.3 tt -113.33 143.15 44.93 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -175.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.5 ' N ' HD21 ' A' ' 99' ' ' LEU . . . 165.63 -136.72 4.31 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.008 -1.092 . . . . 0.0 113.234 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 94.2 mt -113.5 133.22 55.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.555 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 33.3 m-85 -118.81 124.86 48.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.317 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -120.47 159.58 24.86 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.724 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 60.24 58.0 2.75 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 7.0 t -121.97 153.59 38.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.941 -168.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.1 p -136.53 130.51 32.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.042 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 68.6 mttm -81.87 148.93 28.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.146 0.498 . . . . 0.0 110.837 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.449 HD12 ' SG ' ' A' ' 64' ' ' CYS . 94.2 mt -92.46 135.54 33.96 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.863 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -100.63 132.29 46.09 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 53' ' ' THR . 61.9 mt -66.69 116.04 7.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.037 0.446 . . . . 0.0 110.736 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -106.68 101.13 10.6 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.552 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.8 mm -112.89 111.68 50.91 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.51 88.35 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.964 1.776 . . . . 0.0 111.856 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 51.7 mt -86.06 81.37 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.444 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 115' ' ' ILE . 9.8 tp -162.7 43.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 122.214 1.007 . . . . 0.0 109.607 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 126.09 -75.59 0.4 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.029 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 65.2 mt -115.94 112.87 42.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -78.55 78.3 3.71 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.265 1.977 . . . . 0.0 111.538 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.1 mt -63.44 132.03 29.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.83 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -122.16 97.5 5.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.786 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -87.95 160.52 17.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.397 0.618 . . . . 0.0 111.399 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 71.7 mt -67.01 134.14 51.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.591 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 47' ' ' ILE . 12.1 p -66.12 -32.5 58.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.573 -174.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -68.82 -16.12 63.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.639 0.256 . . . . 0.0 110.797 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -85.13 -26.6 26.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.655 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -95.35 -19.04 20.27 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.472 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.63 ' SG ' HG12 ' A' ' 131' ' ' ILE . 45.6 t -111.88 112.45 24.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.592 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.4 2.01 36.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.143 0.497 . . . . 0.0 110.703 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 2.1 mp0 -105.54 172.03 7.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.571 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.406 ' OD1' ' HB ' ' A' ' 39' ' ' VAL . 28.9 m-80 -63.97 125.97 26.16 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.63 HG12 ' SG ' ' A' ' 127' ' ' CYS . 14.1 mt -92.64 125.36 45.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.773 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.5 157.16 47.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.033 0.444 . . . . 0.0 111.316 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.571 ' SG ' HD12 ' A' ' 155' ' ' LEU . 30.6 m -105.74 116.42 31.92 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 57.1 m -108.98 139.74 43.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -79.42 129.62 34.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.058 0.456 . . . . 0.0 111.102 -173.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -82.62 68.65 9.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.372 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 p -57.05 126.09 72.15 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.243 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.91 51.79 3.76 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.88 2.387 . . . . 0.0 112.223 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.1 t -157.94 139.26 13.53 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.914 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -94.01 104.28 16.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.933 0.397 . . . . 0.0 111.047 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -106.97 25.22 11.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.31 0.576 . . . . 0.0 109.494 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 m -77.99 69.92 4.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.848 -175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -119.63 -141.31 6.4 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.879 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.1 t -98.35 -11.54 22.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.775 0.321 . . . . 0.0 110.799 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 91.7 mt -89.12 15.55 8.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.902 0.382 . . . . 0.0 111.441 -174.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 39.7 pt -122.71 33.6 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.241 0.543 . . . . 0.0 110.708 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -81.45 -6.54 89.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.306 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.5 mt -75.33 -35.34 61.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.851 0.357 . . . . 0.0 110.616 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 147.18 -179.97 23.7 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 20.5 mt -95.37 130.54 31.96 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.424 ' HB3' HD23 ' A' ' 82' ' ' LEU . 17.2 Cg_exo -66.45 122.95 10.5 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.124 1.883 . . . . 0.0 111.114 175.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.09 168.88 25.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.7 tt -135.48 136.26 50.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.38 124.62 21.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.624 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.571 HD12 ' SG ' ' A' ' 133' ' ' CYS . 53.4 tp -64.55 -25.69 68.09 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.999 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.506 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.52 -17.11 76.1 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.449 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.9 m -74.06 -29.35 61.85 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 117.249 0.525 . . . . 0.0 111.205 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.5 pt -97.16 -3.77 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.756 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.341 -0.838 . . . . 0.0 111.858 178.949 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 121.184 0.516 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -73.19 -26.67 61.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.145 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -130.85 88.71 45.21 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.11 147.96 74.32 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.742 2.295 . . . . 0.0 113.264 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.29 134.69 45.25 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.14 176.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.91 135.82 43.52 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.655 2.237 . . . . 0.0 112.287 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.77 -16.06 63.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.144 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -92.09 10.37 29.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.769 0.319 . . . . 0.0 111.234 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.4 mm -93.59 123.32 45.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.218 0.533 . . . . 0.0 110.683 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 66.4 p -80.19 160.83 25.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.415 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.64 -40.38 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.216 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -62.39 -46.46 88.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.869 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -62.44 -43.83 97.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.863 0.363 . . . . 0.0 110.473 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 56' ' ' CYS . . . -61.4 -39.48 90.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.712 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.2 m -62.66 -47.54 83.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.798 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -71.71 -36.27 70.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.496 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -75.25 -20.37 59.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.18 0.514 . . . . 0.0 110.553 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 20.7 t -72.49 -21.73 61.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.229 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.45 160.06 20.02 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.993 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -82.83 -14.52 54.2 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -115.57 23.54 12.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.142 0.496 . . . . 0.0 110.534 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.444 ' HB2' HD12 ' A' ' 89' ' ' LEU . . . -124.99 148.68 48.32 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.468 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -113.67 129.21 56.61 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.505 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 26.2 mt -64.45 119.22 10.0 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.533 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 42.6 t -129.5 127.25 40.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.383 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.532 ' SG ' HD21 ' A' ' 108' ' ' LEU . 45.0 m -97.68 119.72 36.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.923 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 41.7 m -117.38 129.36 55.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.753 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -71.86 -27.95 63.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -123.34 139.03 54.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.712 0.291 . . . . 0.0 110.379 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.6 124.3 26.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.528 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.8 m -117.19 115.33 25.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.836 0.351 . . . . 0.0 110.286 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -93.52 133.05 37.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.05 -33.89 75.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.362 -169.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.53 -12.7 64.39 Favored Glycine 0 C--O 1.229 -0.189 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.06 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.99 -15.48 18.26 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.622 -0.34 . . . . 0.0 111.418 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.7 m -120.79 127.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.536 0.684 . . . . 0.0 111.5 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p -85.62 -11.64 53.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.279 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.55 -1.09 55.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.842 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.416 HD13 HD21 ' A' ' 101' ' ' LEU . 30.0 mt -118.08 134.54 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.896 0.379 . . . . 0.0 111.387 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.07 102.13 10.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.873 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.34 -30.08 68.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.112 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.76 -42.34 99.74 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.32 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.96 -44.77 99.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.162 0.506 . . . . 0.0 110.041 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.78 -44.29 97.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.608 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.37 -45.4 84.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.712 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.98 -45.02 97.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.659 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.5 p -73.34 -44.83 58.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.432 ' CD2' HD11 ' A' ' 99' ' ' LEU . 18.2 tp -73.83 -22.55 59.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.623 0.249 . . . . 0.0 111.411 -177.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 63.2 tttm -54.16 -29.79 46.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 111.043 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -63.01 -22.23 66.7 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.938 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 60' ' ' ALA . 52.4 tp -90.62 -30.5 17.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.04 -40.29 51.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.694 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.79 -78.67 1.99 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.437 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.33 84.91 0.31 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.275 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.98 -174.76 34.59 Favored Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.919 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -155.75 120.94 4.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.77 0.319 . . . . 0.0 110.435 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -136.56 62.4 0.6 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 32.1 p -69.6 -15.91 63.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -172.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -60.02 -29.08 68.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.401 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.72 16.95 43.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.763 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.432 HD11 ' CD2' ' A' ' 86' ' ' LEU . 37.7 tp -103.16 143.2 32.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.055 0.455 . . . . 0.0 110.962 -176.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.63 -150.16 13.77 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.286 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.416 HD21 HD13 ' A' ' 77' ' ' ILE . 4.2 mm? -111.01 129.1 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.439 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 33.3 m-85 -113.46 136.4 52.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.387 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -119.97 151.94 38.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.363 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 62.29 58.19 1.81 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.345 0.593 . . . . 0.0 109.952 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.533 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 76.3 m -108.42 136.37 48.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.711 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.6 t -132.66 143.99 50.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -72.11 140.51 48.93 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.546 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.532 HD21 ' SG ' ' A' ' 64' ' ' CYS . 33.8 mt -83.85 142.71 30.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.1 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -74.68 132.71 41.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.589 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.6 mt -81.81 146.78 29.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 -175.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -85.96 104.04 15.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.505 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.9 mt -88.48 116.04 65.08 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.229 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.92 120.21 7.78 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.974 2.449 . . . . 0.0 112.722 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' A' ' 117' ' ' ILE . 66.6 mt -91.21 120.33 39.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.686 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.1 mm -65.99 93.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.094 0.473 . . . . 0.0 110.039 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 131.32 -32.79 2.9 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.707 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.442 ' O ' ' HB ' ' A' ' 114' ' ' ILE . 42.3 mt -130.1 96.71 24.67 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.25 84.14 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.44 2.094 . . . . 0.0 112.33 -176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.9 mt -86.56 131.64 34.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.849 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.439 ' HB2' HG22 ' A' ' 48' ' ' THR . 13.0 pt20 -134.63 90.25 2.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.815 0.817 . . . . 0.0 109.489 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.3 p30 -85.05 132.67 34.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.845 -173.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 91.4 mt -69.03 129.53 40.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.587 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.66 -36.08 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.844 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -69.97 -18.02 63.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.227 0.537 . . . . 0.0 110.549 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -84.14 -26.16 29.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.481 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -103.26 -17.78 15.17 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.326 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 36.7 t -111.48 123.28 49.9 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.847 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -100.79 7.0 44.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.321 0.581 . . . . 0.0 109.978 172.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -108.83 170.04 8.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.117 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -65.4 128.87 37.66 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 131' ' ' ILE . 35.3 mt -96.08 123.64 48.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.336 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.88 158.6 43.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.119 0.485 . . . . 0.0 111.668 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 46.9 m -107.48 114.25 28.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.917 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 26.3 m -110.42 141.91 42.86 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -175.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -66.38 122.13 16.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.105 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -85.72 24.08 1.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.124 0.487 . . . . 0.0 111.515 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.3 m -77.52 143.22 67.79 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.073 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.49 60.05 4.92 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.79 2.326 . . . . 0.0 112.19 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.0 m -60.32 121.86 13.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.596 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.91 83.46 5.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.319 0.58 . . . . 0.0 110.835 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -125.29 74.27 1.37 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.996 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.5 t -101.64 49.24 0.87 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.278 0.561 . . . . 0.0 110.255 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -112.43 169.61 13.13 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.864 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 37.1 t -99.74 -16.35 18.16 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.188 0.518 . . . . 0.0 110.01 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.6 pp -79.66 8.39 6.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.558 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 34.6 pt -106.64 51.46 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.542 0.686 . . . . 0.0 110.826 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -81.76 8.13 60.43 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.714 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.9 mt -71.2 -30.71 66.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.898 0.38 . . . . 0.0 110.147 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 121.76 -166.71 14.49 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.592 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.437 ' H ' HD23 ' A' ' 150' ' ' LEU . 1.1 pt? -111.0 142.14 25.65 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 30.5 Cg_exo -62.18 123.68 12.95 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.458 2.106 . . . . 0.0 111.307 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 4.1 t -154.01 164.77 37.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.8 tt -133.95 135.76 54.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.874 0.369 . . . . 0.0 110.668 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.25 128.22 35.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.5 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.439 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.9 tt -62.94 -29.02 70.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.894 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -67.72 -16.19 67.58 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.831 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.9 m -77.2 -27.66 53.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.019 0.41 . . . . 0.0 111.161 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.6 pt -103.6 -1.44 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.168 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.594 179.343 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.44 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 8.3 p . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 121.307 0.575 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -74.38 -24.47 59.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.129 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -125.57 87.34 55.95 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.01 152.87 73.11 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.551 2.167 . . . . 0.0 113.044 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.9 t -93.02 132.7 30.24 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.399 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.27 136.01 46.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.381 2.054 . . . . 0.0 112.06 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -71.76 -10.24 59.48 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.187 -172.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -92.97 12.57 23.45 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 123' ' ' VAL . 40.0 mm -95.17 132.08 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.737 0.303 . . . . 0.0 110.751 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 71.1 p -80.37 159.52 25.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.883 176.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.68 -44.2 80.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.874 0.368 . . . . 0.0 110.367 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 52.9 tptt -62.25 -46.82 87.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.079 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -64.75 -41.84 95.61 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.599 0.238 . . . . 0.0 111.415 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HB1' HD13 ' A' ' 62' ' ' LEU . . . -63.89 -42.3 97.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.572 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.3 m -64.13 -39.03 93.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 15.9 mm-40 -60.94 -34.98 75.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.803 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -74.04 -29.88 62.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.498 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 133' ' ' CYS . 73.7 m -73.51 -20.7 60.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.882 0.372 . . . . 0.0 110.679 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.56 -177.92 20.23 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.713 -178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.29 -13.25 28.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.966 0.383 . . . . 0.0 111.529 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -105.18 14.52 28.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.175 0.512 . . . . 0.0 110.666 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.14 144.38 51.19 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.82 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -123.21 142.63 50.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.738 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.523 HD13 ' HB1' ' A' ' 52' ' ' ALA . 87.4 mt -65.72 129.47 39.88 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.104 0.478 . . . . 0.0 110.928 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.482 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 48.4 t -124.85 131.83 53.39 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.159 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.557 ' SG ' HD12 ' A' ' 108' ' ' LEU . 59.3 m -96.3 115.79 27.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.702 175.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.5 m -121.34 132.68 54.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.834 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -84.1 -20.33 32.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.125 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -123.95 137.83 54.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.715 0.293 . . . . 0.0 110.229 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.88 126.65 30.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.293 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -120.08 115.94 24.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.456 ' O ' HG21 ' A' ' 74' ' ' VAL . 62.3 m-85 -94.43 129.84 41.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.021 0.439 . . . . 0.0 110.294 -175.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.65 -28.53 69.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.578 -172.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -64.23 -24.97 69.38 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.736 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.84 -18.64 17.06 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.364 -0.492 . . . . 0.0 111.345 -175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 70' ' ' TYR . 18.7 m -113.69 134.14 57.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.331 0.586 . . . . 0.0 111.051 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.6 p -90.69 -11.54 39.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.574 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.31 -5.99 53.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.871 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.0 mt -117.85 138.91 47.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.148 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.46 99.47 7.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.3 0.571 . . . . 0.0 109.793 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -66.61 -32.55 73.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.179 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.64 -38.44 95.67 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.608 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.85 -48.13 72.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.189 0.518 . . . . 0.0 110.416 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 88.1 mt -62.64 -44.4 96.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.911 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.47 -43.69 98.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.17 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.36 -44.17 97.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.681 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 p -72.37 -42.49 65.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.878 0.37 . . . . 0.0 111.683 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.446 HD13 HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -74.48 -27.09 60.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.347 -176.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.1 -29.16 65.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.895 0.379 . . . . 0.0 110.904 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -60.98 -24.21 65.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.191 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.468 HD21 ' OE1' ' A' ' 135' ' ' GLN . 92.6 mt -85.53 -35.0 21.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.014 0.435 . . . . 0.0 110.538 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.9 mt -70.34 -41.81 78.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.232 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.82 -88.17 0.78 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.855 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.01 62.83 0.6 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.005 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.55 178.7 40.88 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.2 p -146.63 138.8 24.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.728 0.264 . . . . 0.0 110.999 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.82 63.24 0.42 Allowed Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.7 p -69.73 -22.66 63.36 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -72.44 -18.63 61.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.799 0.333 . . . . 0.0 111.45 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.519 ' HA3' ' OG ' ' A' ' 157' ' ' SER . . . -110.65 12.63 30.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.596 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tt -110.43 141.42 43.54 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -174.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 167.79 -142.95 7.84 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.33 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.5 tp -114.03 128.93 56.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -116.18 140.3 49.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.627 0.251 . . . . 0.0 110.608 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -124.26 153.31 41.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.424 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 61.99 57.91 2.0 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.639 0.733 . . . . 0.0 109.703 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.482 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 89.4 m -106.41 130.35 54.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.416 -175.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.1 m -115.03 134.26 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.408 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -73.7 139.49 45.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.1 0.476 . . . . 0.0 111.25 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.557 HD12 ' SG ' ' A' ' 64' ' ' CYS . 77.0 mt -99.24 121.58 41.24 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 172.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -74.91 134.47 41.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.948 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.8 mt -79.5 135.14 36.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.783 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -101.73 139.78 36.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.731 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.2 mt -100.01 116.35 64.7 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.65 78.5 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.302 2.001 . . . . 0.0 111.0 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.65 130.19 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.079 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.57 107.05 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 124.11 -34.21 3.61 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 22.8 mt -122.08 83.62 44.87 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.38 88.6 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.015 2.477 . . . . 0.0 112.909 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.3 mm -98.91 119.75 47.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.793 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -139.61 69.28 1.36 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.373 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -87.82 136.26 33.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.293 0.568 . . . . 0.0 111.345 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 89.2 mt -79.16 134.92 36.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.82 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 47' ' ' ILE . 14.8 p -66.94 -41.25 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.841 -175.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -72.18 -9.16 58.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.744 0.307 . . . . 0.0 111.338 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HB2' ' HB2' ' A' ' 122' ' ' LEU . 27.2 tt0 -84.11 -25.96 29.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.872 -173.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -106.88 -16.35 14.48 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.855 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.6 t -109.59 132.96 53.66 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.968 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -112.21 12.05 20.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.256 0.55 . . . . 0.0 110.319 173.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 25.8 mp0 -107.64 169.26 8.7 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.32 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -66.34 136.59 56.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.772 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 131' ' ' ILE . 23.6 mm -95.48 125.67 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.835 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.02 155.05 47.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 0.0 111.176 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 13.1 m -98.29 128.72 44.87 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 64.4 m -112.97 140.37 47.84 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.986 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.468 ' OE1' HD21 ' A' ' 89' ' ' LEU . 5.4 tp60 -83.18 141.74 31.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.265 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -78.45 44.48 0.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.299 0.571 . . . . 0.0 111.029 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.4 m -59.82 135.02 89.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.758 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.84 51.8 2.82 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.91 2.406 . . . . 0.0 112.508 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.2 t -153.96 98.75 2.2 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -105.03 168.19 9.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.775 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.78 -50.71 71.27 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.284 0.365 . . . . 0.0 111.872 -174.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.2 m -77.63 -21.29 52.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.294 -172.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -91.62 -49.57 2.93 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.882 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.3 m -92.35 2.99 56.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.796 0.331 . . . . 0.0 111.244 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.7 mt 61.04 48.35 6.55 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.202 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.467 ' C ' ' H ' ' A' ' 148' ' ' LEU . 32.3 pt -130.58 63.9 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.571 0.7 . . . . 0.0 110.733 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -77.21 25.87 1.88 Allowed Glycine 0 CA--C 1.516 0.102 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.32 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 146' ' ' ILE . 45.5 mt -73.93 -27.09 60.85 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.172 0.511 . . . . 0.0 110.159 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 152.68 -171.82 31.8 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.29 134.6 22.55 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -71.97 121.05 7.25 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.55 1.5 . . . . 0.0 110.566 174.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 53.7 m -152.72 162.69 40.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.03 137.25 57.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.627 0.251 . . . . 0.0 110.549 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.32 123.79 19.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.385 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 68.8 tp -62.47 -27.35 69.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.197 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.403 ' HA2' ' CD2' ' A' ' 159' ' ' LEU . . . -69.81 -16.19 72.08 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.61 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.519 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 26.6 m -82.86 -24.59 33.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.974 0.387 . . . . 0.0 111.729 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.7 pt -103.97 11.14 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.403 ' CD2' ' HA2' ' A' ' 156' ' ' GLY . 4.7 pp . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.245 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.309 0.576 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -78.0 -25.64 48.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.422 -178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -125.67 89.3 52.73 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.43 146.0 73.11 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.688 2.258 . . . . 0.0 113.184 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 155' ' ' LEU . 41.1 t -84.53 132.57 46.52 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.306 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -51.63 135.01 48.2 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.226 1.95 . . . . 0.0 112.073 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.53 -18.23 64.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.38 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -92.32 9.82 32.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.74 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.5 mm -96.96 119.44 45.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.095 0.474 . . . . 0.0 110.553 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 71.6 p -76.49 160.97 29.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.333 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.31 -36.54 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.004 0.43 . . . . 0.0 110.582 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -67.08 -46.95 72.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.693 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -63.79 -40.99 98.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 110.758 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.63 94.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.798 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 m -65.84 -43.21 89.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.898 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -64.06 -34.82 78.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.993 0.425 . . . . 0.0 110.846 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -68.34 -40.48 81.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.941 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 96.0 m -87.52 -5.78 58.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.33 170.38 23.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.92 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.43 -16.59 54.06 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.771 -0.252 . . . . 0.0 111.437 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -97.92 15.29 24.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.916 0.388 . . . . 0.0 110.862 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.474 ' HB2' HD13 ' A' ' 89' ' ' LEU . . . -130.15 146.34 51.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.902 0.382 . . . . 0.0 111.06 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -135.03 144.19 47.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.89 136.68 56.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 110.984 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.3 t -139.1 140.19 37.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.254 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.548 ' SG ' HD11 ' A' ' 108' ' ' LEU . 56.3 m -109.54 117.37 33.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.525 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 1.8 m -117.04 141.88 47.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.746 -175.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.469 ' HA ' ' OE1' ' A' ' 129' ' ' GLN . 56.3 t30 -84.66 -22.15 29.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.415 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -124.7 140.59 52.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.13 127.43 28.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.691 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.8 m -119.1 115.15 23.67 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -90.22 134.42 34.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.99 -31.36 72.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.55 -169.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.02 -9.49 86.9 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.692 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.26 -16.58 24.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.037 0.446 . . . . 0.0 110.606 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.454 HG21 HD12 ' A' ' 77' ' ' ILE . 16.8 m -120.46 150.2 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.822 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.0 p -96.31 -20.48 18.48 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -82.45 0.67 41.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.813 0.339 . . . . 0.0 111.472 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.454 HD12 HG21 ' A' ' 74' ' ' VAL . 39.0 mt -120.61 130.21 74.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -88.5 109.78 20.33 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.198 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -63.92 -29.22 70.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.432 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.84 -35.84 91.38 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.548 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.7 mt -68.25 -48.07 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.942 0.401 . . . . 0.0 110.318 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.28 -40.18 89.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.999 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.68 -34.73 77.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.989 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.8 -47.97 88.55 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.581 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 p -73.68 -41.31 62.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.867 0.365 . . . . 0.0 111.794 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.464 HD13 HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -72.73 -24.84 61.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.145 -177.559 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 38.5 ttmt -55.7 -30.26 60.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 110.727 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -61.48 -27.72 68.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.819 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 60' ' ' ALA . 86.3 mt -88.41 -29.63 20.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.507 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.4 mt -72.76 -40.56 61.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.085 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.27 -70.32 2.15 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.161 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.74 104.76 0.3 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.17 -169.41 39.02 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.8 m -148.57 128.6 13.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.965 0.382 . . . . 0.0 110.83 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.69 49.45 0.11 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.712 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.4 p -74.11 -11.91 60.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.951 0.405 . . . . 0.0 111.377 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -64.76 -13.85 56.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.547 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.47 24.76 8.97 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.78 143.83 39.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.37 -147.87 13.5 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.655 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.0 mt -106.72 128.91 54.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.051 0.453 . . . . 0.0 109.945 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.453 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 20.8 m-85 -114.2 131.89 56.3 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.816 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -120.36 154.53 34.95 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.506 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 59.35 58.18 3.1 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.33 0.586 . . . . 0.0 109.576 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 4.2 t -116.36 155.74 27.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.29 -171.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 t -138.53 131.52 29.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -72.41 147.38 46.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.099 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.548 HD11 ' SG ' ' A' ' 64' ' ' CYS . 91.4 mt -98.73 124.83 43.82 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -82.97 135.88 34.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.971 0.415 . . . . 0.0 110.637 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.5 mt . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.513 -177.068 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 . . . . . 0 C--O 1.234 0.25 0 CA-C-O 121.098 0.475 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 60.1 mt -87.3 138.86 31.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.495 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.478 HG23 ' OD1' ' A' ' 124' ' ' ASN . 15.8 m -61.52 -40.42 86.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.158 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.478 ' OD1' HG23 ' A' ' 123' ' ' VAL . 2.0 m-20 -71.25 -15.58 62.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.032 0.444 . . . . 0.0 110.823 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -84.35 -25.68 28.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.93 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -109.18 -17.16 13.92 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.679 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 48.3 t -111.11 135.64 51.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.503 0.192 . . . . 0.0 111.496 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -119.52 14.34 12.74 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.886 0.851 . . . . 0.0 109.266 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 59.8 mm-40 -108.24 171.25 7.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.094 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -64.69 114.9 4.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.317 . . . . 0.0 110.354 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.1 mt -88.52 120.81 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.649 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.73 159.62 41.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 0.0 110.989 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 78.8 m -103.13 127.23 50.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 61.1 m -112.85 143.48 44.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.11 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.411 ' HA ' HD11 ' A' ' 89' ' ' LEU . 5.3 tp-100 -71.09 123.45 22.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.319 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 12.9 m120 . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 121.224 0.535 . . . . 0.0 110.252 -179.355 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 121.368 0.604 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -171.97 -173.61 38.86 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.596 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.99 122.86 51.22 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.08 120.71 7.23 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.378 1.385 . . . . 0.0 110.623 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 47.7 m -152.87 162.0 41.84 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.4 tt -127.57 136.46 60.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.776 0.322 . . . . 0.0 110.351 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.48 123.44 19.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 155' ' ' LEU . 5.6 tt -58.73 -28.56 65.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.653 -176.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -65.92 -17.01 64.82 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.701 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.5 m -80.68 -29.51 36.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 117.003 0.401 . . . . 0.0 111.505 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.8 pt -95.15 -9.47 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.746 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--O 1.245 0.857 0 O-C-N 124.206 0.941 . . . . 0.0 111.33 179.326 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 130' ' ' ASN . 7.3 p . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -78.62 -23.81 45.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.444 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 82.0 m-85 -130.0 90.98 40.89 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.433 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.81 148.94 72.2 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.597 2.198 . . . . 0.0 113.294 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -89.3 135.9 30.73 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.439 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -51.87 135.34 50.28 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.452 2.101 . . . . 0.0 112.234 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.0 -11.14 60.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.176 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -92.57 8.11 40.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 111.272 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.2 mm -90.01 126.98 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.893 0.378 . . . . 0.0 110.106 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 81.7 p -82.67 159.6 22.6 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.672 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.2 t -54.98 -43.15 67.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.108 0.48 . . . . 0.0 110.574 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -62.3 -46.62 87.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.547 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -66.46 -40.48 89.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.141 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' CYS . . . -61.15 -38.34 86.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.861 0.362 . . . . 0.0 110.443 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.457 HG21 HD11 ' A' ' 110' ' ' LEU . 62.9 m -67.47 -46.35 73.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.134 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.97 -41.77 97.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 110.449 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -69.67 -24.04 63.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.615 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 13.6 t -73.83 -21.25 60.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.132 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.42 170.6 24.79 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.622 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.99 -33.09 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.843 0.321 . . . . 0.0 111.714 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -96.96 19.91 12.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.225 0.536 . . . . 0.0 110.372 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.1 139.86 53.52 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.149 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -99.21 122.17 42.04 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.24 118.56 10.12 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.2 t -139.94 150.33 44.41 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.096 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.592 ' SG ' HD11 ' A' ' 108' ' ' LEU . 49.5 m -113.71 124.13 51.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.858 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 8.4 m -114.93 141.51 47.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.06 0.457 . . . . 0.0 110.946 -173.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.401 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 22.1 t-20 -75.25 -37.78 60.85 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.891 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.401 ' HG3' ' OD1' ' A' ' 66' ' ' ASN . 61.6 mttp -123.92 140.19 53.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.889 0.376 . . . . 0.0 110.611 -176.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.31 121.76 29.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.816 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 m -116.76 115.58 25.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -92.57 134.5 34.93 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.35 -30.3 70.67 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.208 -167.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.2 -21.83 70.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.297 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.81 -18.36 25.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.306 . . . . 0.0 111.277 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.57 ' HB ' ' OD1' ' A' ' 76' ' ' ASP . 14.9 m -121.28 129.99 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.155 0.502 . . . . 0.0 111.149 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.2 t -88.88 -6.71 57.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.26 -175.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.57 ' OD1' ' HB ' ' A' ' 74' ' ' VAL . 10.1 p-10 -84.23 2.75 38.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.1 mt -125.09 138.17 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.15 108.42 19.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.032 0.444 . . . . 0.0 110.679 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.02 -36.9 68.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.204 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.22 -45.82 83.88 Favored Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.956 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.92 -45.95 89.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.377 0.608 . . . . 0.0 110.191 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.8 tp -66.32 -40.68 90.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.035 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -44.84 80.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.797 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.17 -42.0 98.42 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.882 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.6 p -72.42 -43.91 63.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.741 0.305 . . . . 0.0 111.807 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.73 -27.47 60.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.844 0.354 . . . . 0.0 110.417 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.67 -35.44 74.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.969 0.414 . . . . 0.0 110.55 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -69.54 -22.37 63.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.601 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.4 tp -83.57 -37.43 22.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.961 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.7 mt -72.44 -44.77 61.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.482 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.96 -100.49 1.1 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.74 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.55 46.4 1.17 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.126 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.62 159.03 30.92 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.76 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 p -146.57 70.21 1.21 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.117 0.484 . . . . 0.0 110.717 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.51 76.75 1.11 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.116 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 p -62.8 -19.29 63.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.12 0.486 . . . . 0.0 111.575 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 2.0 mp0 -57.81 -30.86 66.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.365 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -113.59 17.01 21.22 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.964 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.0 tp -98.83 142.53 30.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.65 0.262 . . . . 0.0 111.012 -175.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.88 -158.99 30.92 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.095 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.3 tp -109.24 126.45 53.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -114.29 138.33 50.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.753 0.311 . . . . 0.0 110.805 -173.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -123.54 152.3 41.94 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.376 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 60.64 59.16 2.24 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.62 0.575 . . . . 0.0 109.958 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 4.0 t -118.48 139.33 51.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.3 p -122.74 132.28 54.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.606 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -65.83 147.85 52.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.505 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.592 HD11 ' SG ' ' A' ' 64' ' ' CYS . 75.4 mt -97.45 140.66 31.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.182 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -86.8 140.54 29.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.326 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.457 HD11 HG21 ' A' ' 53' ' ' THR . 62.3 mt . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.678 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 C--O 1.237 0.411 0 CA-C-O 121.478 0.656 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 80.0 mt -74.22 135.45 42.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.44 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.89 -34.56 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.727 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -71.78 -13.47 61.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.724 0.297 . . . . 0.0 111.387 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -82.98 -25.71 31.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.736 0.303 . . . . 0.0 110.908 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -109.34 -12.4 14.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.068 0.461 . . . . 0.0 111.255 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 53.3 t -106.81 135.22 48.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -119.93 6.78 10.86 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.306 0.574 . . . . 0.0 110.751 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 46.0 mt-30 -108.42 169.2 8.79 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.437 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 14.5 p30 -70.22 134.36 47.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.936 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.6 mt -94.07 126.24 46.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.549 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.58 158.81 43.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.205 0.526 . . . . 0.0 111.623 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 56.2 m -97.67 121.0 39.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.679 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 82.1 m -112.2 140.37 46.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.61 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -69.4 133.55 47.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.167 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.282 0.563 . . . . 0.0 111.368 -177.991 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 67.0 mt . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.644 0.259 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 167.54 -165.76 38.86 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.06 138.61 22.34 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 117.114 0.457 . . . . 0.0 109.928 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.53 121.92 6.23 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.766 1.644 . . . . 0.0 110.693 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 31.9 m -149.78 157.57 43.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.202 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 14.9 tt -124.91 129.75 73.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.183 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.35 121.13 12.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.246 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.4 tt -65.12 -20.74 66.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.408 -173.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.444 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.81 -9.45 70.4 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.166 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.409 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 74.6 p -78.14 -25.91 47.57 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 117.378 0.589 . . . . 0.0 110.901 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.9 pt -96.01 -9.45 9.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.171 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--O 1.242 0.71 0 O-C-N 124.104 0.877 . . . . 0.0 112.537 177.778 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.459 ' HB ' ' OD1' ' A' ' 130' ' ' ASN . 7.3 p . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.247 0.546 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 40' ' ' ARG . 27.0 mtm180 -76.96 -24.33 52.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.599 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.419 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 86.0 m-85 -123.44 87.21 52.01 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.24 148.25 68.03 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.245 1.963 . . . . 0.0 112.43 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.5 t -85.01 132.66 45.01 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.68 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.49 136.0 48.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.569 2.18 . . . . 0.0 112.386 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -10.28 57.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -90.05 2.35 55.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.567 0.222 . . . . 0.0 111.187 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.484 ' O ' HG12 ' A' ' 123' ' ' VAL . 34.1 mm -87.94 126.82 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.281 0.563 . . . . 0.0 110.527 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 59.3 p -87.42 160.0 18.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.539 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 m -57.11 -36.93 52.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.025 0.44 . . . . 0.0 110.76 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 50.8 tptt -68.4 -46.84 68.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.41 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -62.35 -41.22 98.42 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.502 0.192 . . . . 0.0 111.011 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.34 98.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.051 0.453 . . . . 0.0 110.99 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.8 m -67.69 -47.77 68.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.097 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 65.3 mm-40 -66.36 -28.15 68.43 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.005 0.431 . . . . 0.0 110.882 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.468 ' HE2' ' OXT' ' A' ' 159' ' ' LEU . 51.1 tptt -59.97 -40.89 90.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.334 177.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.561 ' SG ' HD13 ' A' ' 155' ' ' LEU . 80.8 m -92.96 -20.66 20.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.912 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.43 177.09 23.34 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.73 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.48 -8.04 57.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.86 0.362 . . . . 0.0 111.668 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -94.35 4.27 54.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.004 0.43 . . . . 0.0 110.988 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.65 147.44 48.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.262 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -104.31 121.55 43.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.15 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.7 tp -70.93 118.68 14.01 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.7 t -135.38 149.02 49.56 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.368 -171.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.582 ' SG ' HD21 ' A' ' 108' ' ' LEU . 62.0 m -102.54 118.77 37.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.819 174.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -117.51 130.27 56.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.171 0.51 . . . . 0.0 111.162 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -77.97 -24.94 47.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.786 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.93 138.69 54.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.197 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.14 120.92 19.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.082 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 m -114.46 116.46 28.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -88.03 126.26 34.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.04 77.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.41 -169.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.63 -7.8 75.04 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.562 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.9 -17.73 17.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.841 0.353 . . . . 0.0 110.8 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.54 131.67 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.22 0.533 . . . . 0.0 111.134 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.0 p -83.56 -9.01 59.21 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.88 -0.74 49.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.904 0.383 . . . . 0.0 111.401 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mt -124.78 142.94 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -89.26 98.52 11.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.525 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.74 -33.53 76.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.647 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.52 -38.81 96.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.6 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.72 -48.84 49.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.671 0.272 . . . . 0.0 110.455 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.88 -40.11 91.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.854 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.6 -37.5 86.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.753 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.25 -46.88 39.59 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.751 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 p -72.85 -44.93 60.79 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.421 ' CD2' ' HB ' ' A' ' 153' ' ' ILE . 11.3 tp -73.97 -24.92 59.69 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.756 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 41.1 ttmt -56.86 -32.03 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.004 0.431 . . . . 0.0 110.543 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -68.5 -24.08 64.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.691 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.2 tp -83.46 -35.0 25.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 109.897 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.0 mt -71.5 -40.8 72.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.329 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.42 -103.76 2.98 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -103.62 82.78 0.39 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.951 -0.643 . . . . 0.0 111.826 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.38 173.11 25.38 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.0 t -161.62 151.9 17.32 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.44 69.11 0.29 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.608 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 34.5 p -61.87 -25.75 67.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.859 0.361 . . . . 0.0 111.91 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 1.5 mp0 -59.11 -22.46 60.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.163 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -122.55 27.1 6.1 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -109.8 148.49 31.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.692 0.282 . . . . 0.0 111.054 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 158.49 -148.37 17.46 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.729 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.9 mt -106.6 129.73 54.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.01 0.433 . . . . 0.0 109.928 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.564 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 15.7 m-85 -112.1 137.02 50.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.836 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.95 149.67 45.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.312 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 63.4 51.6 2.58 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.532 0.52 . . . . 0.0 110.334 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.5 m -92.23 135.62 33.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.711 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.5 p -114.97 145.48 42.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.091 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -77.12 133.71 38.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.582 HD21 ' SG ' ' A' ' 64' ' ' CYS . 19.2 mt -88.88 138.24 31.59 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.961 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.8 108.08 8.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.032 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.83 176.637 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--O 1.233 0.203 0 CA-C-O 121.281 0.562 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 96.2 mt -76.99 133.71 39.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.709 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 47' ' ' ILE . 11.4 p -67.07 -37.98 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.714 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -71.33 -16.44 62.44 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.071 0.462 . . . . 0.0 110.825 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -84.68 -26.54 27.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.503 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -100.09 -17.07 17.63 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.257 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 16.2 t -110.96 139.35 46.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.26 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -111.89 2.22 16.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.758 0.79 . . . . 0.0 109.547 172.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 26.7 mp0 -108.2 170.73 7.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.918 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.459 ' OD1' ' HB ' ' A' ' 39' ' ' VAL . 22.2 m-80 -65.2 134.62 54.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 21.9 mm -95.74 124.26 48.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.87 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.07 159.29 42.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.874 0.369 . . . . 0.0 111.102 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 78.6 m -107.86 118.96 38.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 73.7 m -110.24 147.26 34.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.118 0.485 . . . . 0.0 111.348 -169.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -69.78 122.17 18.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.204 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.463 -177.537 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.953 0.406 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 170.5 -179.66 42.45 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.39 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.16 129.36 25.71 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.76 122.79 11.24 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 121.881 1.72 . . . . 0.0 110.289 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . 2.6 t -153.54 159.4 42.2 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.319 -171.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.421 ' HB ' ' CD2' ' A' ' 86' ' ' LEU . 7.4 tp -127.12 130.76 71.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.278 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.89 122.29 14.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.286 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.561 HD13 ' SG ' ' A' ' 56' ' ' CYS . 59.7 tp -62.67 -25.32 68.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.638 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.419 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -72.83 -16.82 78.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.901 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.5 m -74.6 -29.12 61.19 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.228 0.514 . . . . 0.0 111.326 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.4 pt -95.56 -4.41 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.069 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.468 ' OXT' ' HE2' ' A' ' 55' ' ' LYS . 89.3 mt . . . . . 0 C--O 1.252 1.188 0 O-C-N 123.804 0.69 . . . . 0.0 111.885 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 130' ' ' ASN . 7.4 p . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.079 0.466 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -76.43 -22.9 54.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.12 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 157' ' ' SER . 60.2 m-85 -122.61 86.91 49.37 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.421 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.78 144.85 55.21 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.179 1.92 . . . . 0.0 112.487 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.23 132.01 54.47 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.59 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.28 135.09 45.79 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.113 1.876 . . . . 0.0 111.537 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -72.9 -10.22 59.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.037 -170.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -90.13 2.44 55.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.434 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.4 mm -86.75 127.25 40.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.981 0.419 . . . . 0.0 110.736 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 43.2 p -82.16 159.95 23.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.659 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.0 t -57.91 -40.92 78.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.9 0.381 . . . . 0.0 110.792 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -64.4 -44.97 89.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.759 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -62.67 -46.13 89.61 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.962 0.411 . . . . 0.0 110.611 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.483 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -61.04 -37.6 83.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.813 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.8 m -67.43 -45.08 77.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.803 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -63.73 -31.49 72.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.336 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 159' ' ' LEU . 57.1 tptt -62.42 -40.89 98.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.817 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.601 ' SG ' HD13 ' A' ' 155' ' ' LEU . 71.8 m -94.29 -16.21 23.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.855 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.06 161.96 23.75 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.182 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -74.62 -11.08 60.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.969 0.414 . . . . 0.0 110.851 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -91.41 14.63 14.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.109 0.481 . . . . 0.0 110.204 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.75 141.77 51.5 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.469 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -111.9 124.61 52.73 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.483 HD11 ' HB3' ' A' ' 52' ' ' ALA . 95.9 mt -66.08 121.28 14.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.965 0.412 . . . . 0.0 110.165 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 41.2 t -122.62 134.36 54.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.662 -175.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 67.8 m -93.9 116.13 28.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.366 174.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.423 ' HB2' ' ND2' ' A' ' 130' ' ' ASN . 50.3 m -120.32 130.19 54.33 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.709 0.29 . . . . 0.0 110.751 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -79.92 -21.5 43.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.003 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -123.93 142.03 51.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.49 126.65 33.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.17 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.0 m -120.71 115.1 22.67 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -92.24 135.07 34.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.63 72.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.022 -171.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.18 -7.37 82.0 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.784 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -98.26 -17.53 18.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.088 0.47 . . . . 0.0 110.865 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.568 HG21 HD12 ' A' ' 77' ' ' ILE . 13.0 m -120.63 132.35 70.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.299 0.571 . . . . 0.0 111.264 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.3 p -82.56 -18.2 42.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.504 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -86.78 11.71 12.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.568 HD12 HG21 ' A' ' 74' ' ' VAL . 27.6 mt -130.3 136.01 59.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.612 0.244 . . . . 0.0 110.617 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -87.85 107.57 18.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.947 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.63 -28.35 67.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.336 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.1 -41.48 97.07 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.589 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.26 -44.23 97.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.052 0.453 . . . . 0.0 110.319 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.31 -38.88 88.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.843 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.18 -36.97 85.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.344 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.19 -46.18 94.7 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.614 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 p -73.07 -43.42 61.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.938 0.399 . . . . 0.0 111.773 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.34 -26.33 58.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.353 -176.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 29.8 ttpp -56.98 -30.69 64.33 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.751 0.31 . . . . 0.0 110.926 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -63.15 -22.79 67.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.322 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.66 -27.55 20.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.951 0.405 . . . . 0.0 110.769 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.2 mt -82.23 -40.85 17.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.136 0.493 . . . . 0.0 110.801 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.03 -126.14 8.44 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.66 41.11 3.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.339 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -153.73 173.77 32.38 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.2 m -153.56 91.93 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.794 0.33 . . . . 0.0 111.335 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.54 69.86 3.21 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.3 p -68.2 -12.51 61.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.78 -33.94 73.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.82 0.343 . . . . 0.0 111.511 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -107.49 20.06 32.94 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.998 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.2 tp -100.24 139.88 35.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.879 0.371 . . . . 0.0 111.252 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.88 -146.97 11.83 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.819 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.56 HD23 HD13 ' A' ' 77' ' ' ILE . 4.2 mm? -109.56 125.33 52.41 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.77 136.83 47.69 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.167 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -120.03 152.74 37.07 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.999 -175.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 61.33 57.84 2.3 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.545 0.688 . . . . 0.0 109.803 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 96.7 m -106.42 135.66 47.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.548 -174.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.0 m -128.34 131.1 48.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -79.84 145.83 32.55 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.417 . . . . 0.0 111.228 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -95.55 140.84 29.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -75.76 131.24 39.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.153 0.501 . . . . 0.0 109.757 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.8 tp . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -177.114 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 . . . . . 0 CA--C 1.517 -0.302 0 CA-C-O 120.792 0.33 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 76.1 mt -71.48 131.32 43.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.928 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.4 -35.46 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.467 -174.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.99 -12.68 61.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.134 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 122' ' ' LEU . 53.1 tp60 -83.19 -25.92 31.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.725 0.298 . . . . 0.0 110.656 -173.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -102.3 -17.35 15.93 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.212 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 16.8 t -110.33 137.06 48.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.688 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 128' ' ' LYS . 3.4 mppt? -110.36 3.88 20.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.376 0.608 . . . . 0.0 109.93 172.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 27.8 mp0 -108.75 169.85 8.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.849 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.522 ' HB2' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -66.72 140.56 57.88 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.673 0.273 . . . . 0.0 110.813 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.5 mm -97.53 120.5 46.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.138 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.22 154.86 45.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.836 0.351 . . . . 0.0 110.741 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.408 ' C ' ' SG ' ' A' ' 152' ' ' CYS . 73.9 m -105.64 114.28 28.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.015 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 59.6 m -109.6 140.94 42.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -69.72 136.4 50.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.728 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 . . . . . 0 N--CA 1.464 0.237 0 CA-C-O 121.305 0.574 . . . . 0.0 111.043 -177.84 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 46.1 mt . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 121.425 0.631 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 152.17 -155.81 26.34 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.734 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.7 mp -104.8 127.66 28.38 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -66.46 121.32 8.57 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.44 1.427 . . . . 0.0 110.21 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.408 ' SG ' ' C ' ' A' ' 133' ' ' CYS . 0.7 OUTLIER -155.41 169.15 24.92 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.379 -172.504 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.36 132.45 55.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.388 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.11 123.39 17.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.341 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.601 HD13 ' SG ' ' A' ' 56' ' ' CYS . 42.4 tp -61.79 -25.82 67.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.781 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.452 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.24 -17.14 75.69 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.409 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.5 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 8.5 t -73.41 -26.77 61.11 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.968 0.384 . . . . 0.0 110.95 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 pt -102.21 -2.34 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.532 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.44 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 90.2 mt . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.595 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.258 0.551 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -76.47 -29.04 56.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.357 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -125.14 91.91 48.33 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.51 150.64 75.46 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.395 2.063 . . . . 0.0 112.643 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.71 133.36 29.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.736 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.86 136.31 51.39 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.732 2.288 . . . . 0.0 112.395 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.81 -11.73 61.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.208 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -86.02 3.2 43.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.677 0.275 . . . . 0.0 111.732 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.483 ' O ' HG12 ' A' ' 123' ' ' VAL . 34.9 mm -92.06 123.91 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 0.0 110.274 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 61.4 p -80.29 160.84 25.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.298 175.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.33 -40.87 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 65.7 tttp -65.46 -47.52 75.83 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.879 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -59.6 -43.5 93.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 110.69 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.7 98.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.732 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.44 HG21 HD23 ' A' ' 110' ' ' LEU . 29.6 m -68.97 -39.03 79.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.689 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 73.8 mm-40 -59.56 -32.19 70.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.042 0.448 . . . . 0.0 110.756 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -60.58 -33.52 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.082 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 60' ' ' ALA . 85.5 m -100.49 9.55 42.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.752 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.57 80.05 0.66 Allowed Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.45 -172.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -177.5 -72.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.977 0.418 . . . . 0.0 110.864 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -116.86 12.92 14.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.452 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . . . -149.08 163.89 36.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.05 0.453 . . . . 0.0 111.591 -171.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -134.52 143.23 47.32 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.9 tp -67.29 134.59 51.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.057 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 t -139.69 145.97 39.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.858 0.361 . . . . 0.0 110.358 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.702 ' SG ' HD11 ' A' ' 108' ' ' LEU . 29.5 m -113.9 120.63 41.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.745 176.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.544 ' O ' ' HB3' ' A' ' 129' ' ' GLN . 13.5 m -115.49 144.71 43.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -89.91 -26.55 20.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -124.69 145.24 49.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.35 128.36 33.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.614 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 m -120.38 115.09 22.84 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 171.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -91.65 136.58 33.03 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.34 -27.51 69.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.564 -170.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.41 -12.26 80.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.881 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.61 -17.47 19.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 0.0 111.364 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.483 ' HB ' ' OD1' ' A' ' 76' ' ' ASP . 10.5 m -121.23 125.96 74.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.427 0.632 . . . . 0.0 111.09 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.2 p -86.85 -6.57 58.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.975 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD1' ' HB ' ' A' ' 74' ' ' VAL . 8.8 p-10 -83.12 -2.26 54.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.939 0.399 . . . . 0.0 111.351 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mt -110.41 143.14 20.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.456 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -88.2 99.45 12.22 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.11 -26.93 68.76 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.27 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.08 -42.66 91.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.391 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.3 -44.8 94.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.961 0.41 . . . . 0.0 110.461 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.7 mt -62.89 -40.52 97.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.714 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.73 -42.03 91.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.74 -41.28 99.86 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.684 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.6 p -72.48 -43.99 62.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.699 0.285 . . . . 0.0 111.531 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.72 -27.6 61.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.846 0.355 . . . . 0.0 110.803 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 18.4 ttmm -57.75 -32.65 67.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.048 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.35 -22.72 64.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.562 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.414 HD21 ' SG ' ' A' ' 133' ' ' CYS . 59.3 tp -79.92 -33.81 39.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.2 0.524 . . . . 0.0 110.245 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 94' ' ' SER . 71.4 mt -85.21 -47.31 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.998 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.26 -100.72 0.34 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.827 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -111.57 12.99 27.8 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.426 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.65 171.11 24.19 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.795 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.438 ' HA ' HD12 ' A' ' 90' ' ' ILE . 7.5 p -157.51 102.26 1.89 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.719 0.295 . . . . 0.0 110.886 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.28 85.48 0.6 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.191 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.4 p -67.09 -9.05 35.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.817 0.341 . . . . 0.0 111.724 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -62.54 -31.33 72.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.223 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.6 23.21 9.69 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.787 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.9 tp -105.14 144.44 31.94 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.403 0.281 . . . . 0.0 110.945 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 163.96 -149.52 16.82 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.845 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.8 mt -107.89 132.96 52.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 152' ' ' CYS . 22.5 m-85 -114.9 143.18 45.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -125.84 152.96 44.79 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 110.483 -0.192 . . . . 0.0 110.483 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 57.97 58.15 3.74 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.575 0.702 . . . . 0.0 109.643 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 6.9 t -120.35 144.25 47.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.83 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.1 t -126.06 140.65 52.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.446 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -79.09 147.44 32.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.911 0.386 . . . . 0.0 110.71 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.702 HD11 ' SG ' ' A' ' 64' ' ' CYS . 62.3 mt -102.31 141.49 35.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.594 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -100.29 126.03 46.57 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.44 HD23 HG21 ' A' ' 53' ' ' THR . 3.0 pp . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 121.027 0.441 . . . . 0.0 110.305 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.573 0.225 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 97.6 mt -70.36 131.76 44.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.067 0.46 . . . . 0.0 110.256 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 47' ' ' ILE . 10.5 p -66.74 -35.78 75.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.497 -173.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -70.95 -16.37 62.65 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.912 0.387 . . . . 0.0 110.999 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -83.58 -28.32 28.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.509 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -114.42 -14.72 12.16 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.823 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.3 t -108.38 116.68 32.42 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -100.16 -4.48 29.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.445 0.641 . . . . 0.0 110.18 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 65' ' ' CYS . 23.1 mp0 -91.56 168.29 11.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.242 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.65 131.68 45.0 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.589 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 29.3 mt -93.79 126.96 46.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.569 -174.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.42 ' HB1' ' SG ' ' A' ' 152' ' ' CYS . . . -135.38 158.43 44.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.327 0.585 . . . . 0.0 111.656 -176.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.414 ' SG ' HD21 ' A' ' 89' ' ' LEU . 37.1 t -110.0 115.13 29.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.653 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.5 m -110.78 139.49 46.04 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.731 -170.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.44 139.33 49.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.628 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.4 t30 . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 121.473 0.654 . . . . 0.0 110.558 -178.207 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 36.2 mt . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.148 0.499 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 165.51 173.26 33.86 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.553 ' H ' HD23 ' A' ' 150' ' ' LEU . 0.7 OUTLIER -95.02 134.16 25.18 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 117.031 0.416 . . . . 0.0 110.53 -178.518 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.64 123.84 11.95 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.596 2.197 . . . . 0.0 111.182 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.492 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 3.6 t -153.67 163.83 39.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.857 -174.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.44 133.15 60.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.58 130.05 34.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.539 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.64 -24.61 67.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.315 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -72.91 -15.37 78.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.586 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 m -80.6 -29.61 36.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.033 0.417 . . . . 0.0 111.299 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 29.4 pt -100.49 -9.65 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.787 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 C--O 1.249 1.078 0 O-C-N 123.85 0.719 . . . . 0.0 112.382 177.907 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.436 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 7.1 p . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 121.423 0.63 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.572 ' HD2' ' CE1' ' A' ' 41' ' ' PHE . 3.3 tmt_? -68.37 -34.27 75.76 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.411 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CE1' ' HD2' ' A' ' 40' ' ' ARG . 90.3 m-85 -118.69 87.49 32.42 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.6 151.25 69.94 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.508 2.139 . . . . 0.0 112.542 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.3 t -82.35 128.26 67.95 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.294 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.16 137.15 45.97 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.049 2.499 . . . . 0.0 112.613 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.23 -11.04 47.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.575 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -86.37 -1.42 57.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.122 0.487 . . . . 0.0 111.243 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.34 122.39 41.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.162 0.506 . . . . 0.0 111.01 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 70.5 p -81.93 163.81 21.96 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.436 174.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.505 HG12 HD23 ' A' ' 110' ' ' LEU . 21.9 t -57.0 -39.43 65.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 0.0 110.594 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.41 -46.37 73.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.164 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -58.77 -44.31 90.62 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 110.378 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 62' ' ' LEU . . . -61.89 -45.9 91.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.095 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.495 ' OG1' HD21 ' A' ' 110' ' ' LEU . 90.9 m -64.56 -46.68 81.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.211 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -67.3 -28.39 67.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.013 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -64.26 -40.92 96.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.44 . . . . 0.0 110.061 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' HD13 ' A' ' 155' ' ' LEU . 81.0 m -101.09 14.03 33.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.196 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.42 168.8 8.66 Favored Glycine 0 CA--C 1.518 0.26 0 N-CA-C 114.266 0.467 . . . . 0.0 114.266 -171.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 72.02 -67.84 0.24 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.014 0.926 . . . . 0.0 111.991 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -94.21 -8.49 39.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -171.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 56' ' ' CYS . . . -138.65 163.6 31.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.412 0.625 . . . . 0.0 111.864 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -128.3 138.23 52.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.296 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' ' 52' ' ' ALA . 12.1 mt -69.27 134.77 49.58 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.787 0.327 . . . . 0.0 110.837 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.478 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 38.2 t -140.62 129.94 23.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.133 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.483 ' SG ' HD11 ' A' ' 108' ' ' LEU . 59.9 m -102.33 116.99 33.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.65 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 129' ' ' GLN . 9.0 m -118.98 143.33 47.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.307 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -71.33 -37.38 71.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.719 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -126.83 141.27 51.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.036 0.446 . . . . 0.0 111.594 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.22 122.58 28.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.424 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 m -103.32 115.25 30.19 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.436 ' OH ' ' HA ' ' A' ' 39' ' ' VAL . 87.7 m-85 -91.36 133.18 35.67 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.68 67.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.582 -168.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.32 -20.84 76.63 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.581 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.86 -14.5 26.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.643 0.259 . . . . 0.0 111.471 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 77' ' ' ILE . 21.8 m -121.72 150.31 25.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.562 178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -108.39 2.91 22.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -95.64 1.77 53.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.03 0.443 . . . . 0.0 110.893 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.407 HD12 HG21 ' A' ' 74' ' ' VAL . 46.0 mt -119.25 136.5 56.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.946 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -86.86 108.01 18.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.049 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.34 -30.2 69.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.084 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.25 -39.67 96.18 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.608 -176.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.9 -47.43 88.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.121 0.486 . . . . 0.0 110.189 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 88.5 mt -67.43 -45.58 75.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.896 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -63.78 -41.14 98.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.952 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.85 -46.81 93.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.421 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.9 p -73.32 -40.6 64.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.901 0.382 . . . . 0.0 111.854 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -74.24 -23.21 59.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.425 -177.532 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 38.2 ttpt -54.63 -32.64 59.28 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.708 -174.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -62.9 -32.41 73.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.84 0.352 . . . . 0.0 110.485 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 89' ' ' LEU . 3.1 tm? -82.73 -34.86 27.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.42 -44.83 99.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.42 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.7 -74.78 2.47 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.492 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.81 -89.11 0.85 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.242 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.77 -172.28 45.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.996 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.6 m 62.91 59.08 1.41 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.71 0.404 . . . . 0.0 111.629 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.77 12.69 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.969 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.7 p -75.98 -18.87 59.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.829 0.347 . . . . 0.0 111.708 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.04 -13.7 62.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.323 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.44 23.93 10.83 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.38 142.5 38.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.56 -149.62 12.97 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.619 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.07 126.19 54.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -112.38 139.78 47.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.928 -173.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -120.25 154.03 35.49 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.671 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 61.9 58.7 1.86 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.691 0.757 . . . . 0.0 109.898 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.478 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 90.4 m -101.72 142.69 32.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.037 -173.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.8 p -132.94 137.33 46.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.567 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -80.89 144.92 31.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.793 0.33 . . . . 0.0 110.359 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.483 HD11 ' SG ' ' A' ' 64' ' ' CYS . 62.3 mt -91.33 124.99 35.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.54 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -85.71 145.65 27.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.697 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.505 HD23 HG12 ' A' ' 49' ' ' VAL . 91.9 mt . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.316 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 C--O 1.235 0.315 0 CA-C-O 121.105 0.478 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 64.8 mt -70.85 136.69 48.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.437 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.475 ' HA ' HG22 ' A' ' 49' ' ' VAL . 13.1 p -65.96 -29.65 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.241 -174.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.14 -13.35 61.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.077 0.465 . . . . 0.0 110.842 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -83.77 -27.69 28.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -108.74 -16.13 14.25 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.014 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.408 ' SG ' HG12 ' A' ' 131' ' ' ILE . 48.6 t -109.16 111.93 23.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.781 177.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -103.43 9.52 37.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.607 0.718 . . . . 0.0 109.97 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 65' ' ' CYS . 2.1 mp0 -105.12 168.56 8.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.692 -1.14 . . . . 0.0 107.967 176.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.42 ' CB ' ' HB ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -70.1 128.56 36.71 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.378 178.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.408 HG12 ' SG ' ' A' ' 127' ' ' CYS . 23.3 mt -88.18 125.24 41.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.825 -174.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.09 155.9 49.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.202 0.525 . . . . 0.0 111.275 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 64.8 m -106.0 129.76 54.06 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.8 m -111.34 139.34 46.82 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -77.36 134.18 38.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.075 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.65 . . . . 0.0 110.293 -178.797 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 53.7 mt . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 121.066 0.46 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 148.58 -176.7 27.26 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.218 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.5 mp -111.0 135.55 20.84 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.42 121.04 6.52 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.356 1.371 . . . . 0.0 110.727 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 42.5 m -152.55 160.54 43.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.131 -173.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.06 136.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.198 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.31 124.57 20.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.334 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.495 HD13 ' SG ' ' A' ' 56' ' ' CYS . 57.6 tp -61.12 -29.57 69.85 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.641 -175.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.414 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -66.27 -16.02 64.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.661 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.1 m -70.87 -30.16 66.46 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 117.061 0.43 . . . . 0.0 111.102 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 41.5 pt -99.8 -9.1 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.425 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 C--O 1.251 1.152 0 O-C-N 123.639 0.587 . . . . 0.0 111.784 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -76.25 -27.81 56.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.889 0.376 . . . . 0.0 111.081 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.519 ' O ' ' HA3' ' A' ' 156' ' ' GLY . 54.8 m-85 -136.71 97.57 11.29 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.77 139.66 44.4 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.874 2.383 . . . . 0.0 112.76 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -81.64 134.75 50.27 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.406 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.93 135.05 50.39 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.272 1.981 . . . . 0.0 111.914 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.06 -10.39 59.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.695 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.66 4.68 48.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.799 0.333 . . . . 0.0 111.177 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.3 mm -93.15 117.48 36.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.139 0.495 . . . . 0.0 110.586 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 32.9 p -77.38 159.68 29.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.531 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 123' ' ' VAL . 44.1 t -54.27 -42.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.918 0.389 . . . . 0.0 110.614 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -60.63 -47.07 87.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.997 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -67.26 -35.95 80.58 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.488 0.185 . . . . 0.0 111.045 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.25 80.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 110.062 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.1 m -67.71 -47.52 69.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.659 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -65.08 -34.56 78.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -63.38 -37.54 87.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.629 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.64 ' SG ' HD13 ' A' ' 155' ' ' LEU . 92.5 m -91.04 -19.85 22.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.748 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.47 178.78 29.82 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.479 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -82.54 -16.52 48.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -91.97 11.82 23.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.237 0.542 . . . . 0.0 110.606 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 134' ' ' CYS . . . -132.67 126.51 32.79 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.838 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -95.45 128.41 42.28 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.214 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 33.0 mt -65.44 122.87 18.17 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.871 0.367 . . . . 0.0 110.196 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.425 ' HB3' ' SG ' ' A' ' 105' ' ' CYS . 19.6 m -134.01 131.72 39.25 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.31 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.495 ' SG ' HD11 ' A' ' 108' ' ' LEU . 66.7 m -107.75 118.06 35.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.182 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER -116.68 140.05 49.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.812 -175.69 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.42 -19.76 49.2 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.818 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -126.42 140.98 52.06 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.608 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.23 127.0 32.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.282 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.4 m -119.95 115.83 24.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -95.1 132.03 40.46 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.76 -27.27 68.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.856 -171.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.81 -23.64 72.57 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.877 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -94.67 -18.58 21.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.184 0.492 . . . . 0.0 111.507 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.478 HG21 HD12 ' A' ' 77' ' ' ILE . 16.8 m -121.52 125.01 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.324 0.583 . . . . 0.0 111.429 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 p -85.99 -14.75 43.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.827 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -73.45 -15.04 61.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.187 0.518 . . . . 0.0 111.178 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.478 HD12 HG21 ' A' ' 74' ' ' VAL . 43.9 mt -103.75 130.32 54.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.89 106.73 3.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.125 0.488 . . . . 0.0 110.587 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.69 -29.4 68.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.03 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.41 -44.11 95.8 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.721 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.8 mt -63.25 -46.41 95.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.247 0.546 . . . . 0.0 110.266 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.35 -43.15 95.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.123 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.65 -39.1 88.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.721 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.25 -46.2 88.15 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.438 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 p -68.75 -42.74 77.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.829 0.347 . . . . 0.0 111.498 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.96 -26.21 59.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -57.89 -32.55 67.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.822 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -63.17 -28.65 70.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.487 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 60' ' ' ALA . 66.5 tp -86.83 -37.41 17.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.458 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.0 mt -72.3 -37.16 57.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.77 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.92 -73.12 0.22 Allowed Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -135.52 128.75 4.78 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.142 -0.552 . . . . 0.0 111.838 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.8 -170.05 33.12 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.575 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.7 p -157.97 115.28 2.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.93 0.395 . . . . 0.0 111.053 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.06 78.83 1.67 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 29.8 p -70.06 -18.87 63.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -172.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.41 -33.17 74.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.835 0.35 . . . . 0.0 111.324 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.438 ' HA3' ' OG ' ' A' ' 157' ' ' SER . . . -108.03 15.03 37.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.881 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 96' ' ' THR . 45.1 tp -104.02 141.6 35.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.591 0.234 . . . . 0.0 110.7 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 166.4 -156.47 28.38 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.576 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.1 mt -106.25 122.87 47.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.463 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 16.4 m-85 -106.34 133.72 50.6 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.016 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -119.69 154.49 34.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.717 -175.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.452 ' HA ' ' OE1' ' A' ' 104' ' ' GLN . 13.4 mm-40 59.08 58.15 3.24 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 3.5 t -120.66 138.86 53.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.25 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.7 m -129.73 149.93 51.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.822 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -78.93 147.47 33.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.947 0.403 . . . . 0.0 110.753 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 64' ' ' CYS . 69.8 mt -89.93 137.74 32.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.614 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.91 129.06 34.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.039 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 120.919 0.39 . . . . 0.0 111.074 -176.86 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t0 . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 121.134 0.492 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 52.8 mt -72.86 135.64 45.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.433 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.427 ' HA ' HG22 ' A' ' 49' ' ' VAL . 10.9 p -65.24 -29.67 47.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.925 -176.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -71.5 -16.77 62.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.995 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -83.86 -26.04 29.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.789 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.41 -17.1 14.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.359 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 131' ' ' ILE . 38.4 t -111.95 114.77 27.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.643 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.452 ' HB2' ' NZ ' ' A' ' 128' ' ' LYS . 9.4 mtmp? -99.88 2.12 43.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.473 0.654 . . . . 0.0 110.043 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 0.8 OUTLIER -107.51 173.4 6.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.649 -176.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -63.13 122.78 16.95 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.485 HG12 ' SG ' ' A' ' 127' ' ' CYS . 17.7 mt -91.29 117.33 34.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.161 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.69 154.07 50.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.201 0.524 . . . . 0.0 111.012 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.421 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 75.7 m -109.81 129.11 55.67 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.477 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 21.3 m -112.35 140.57 46.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -70.62 129.52 39.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.204 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 . . . . . 0 C--N 1.326 -0.417 0 CA-C-O 121.101 0.477 . . . . 0.0 111.78 -176.568 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 154.52 -170.86 32.95 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.977 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.3 mp -108.08 129.18 24.45 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -70.77 120.96 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.634 1.556 . . . . 0.0 110.95 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 61.3 m -153.45 161.92 41.79 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.6 133.42 68.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.838 0.351 . . . . 0.0 110.651 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.43 125.89 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.01 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.64 HD13 ' SG ' ' A' ' 56' ' ' CYS . 45.4 tp -65.11 -26.82 68.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.158 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 41' ' ' PHE . . . -66.8 -19.4 69.44 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.891 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.438 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 30.8 m -68.88 -29.13 67.35 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.176 0.488 . . . . 0.0 110.997 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.4 pt -101.03 -1.43 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.863 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.247 0.924 0 O-C-N 124.034 0.834 . . . . 0.0 111.79 178.366 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.419 ' HB ' ' OD1' ' A' ' 130' ' ' ASN . 7.2 p . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -62.78 -30.83 71.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.744 -175.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.519 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 51.0 m-85 -138.03 91.47 13.15 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.223 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.56 144.95 62.61 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.188 1.925 . . . . 0.0 112.508 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -82.16 131.95 54.82 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.89 134.43 41.92 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.99 1.793 . . . . 0.0 111.943 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.13 -17.28 64.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.91 -172.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -81.81 2.87 28.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.87 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.45 ' O ' HG12 ' A' ' 123' ' ' VAL . 30.9 mm -89.6 127.24 42.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.976 0.417 . . . . 0.0 110.53 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 55.5 p -83.93 163.78 19.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.419 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.1 t -56.15 -43.18 75.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.936 0.398 . . . . 0.0 110.795 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -62.43 -46.59 87.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -67.98 -37.42 81.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.245 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.32 99.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.839 0.352 . . . . 0.0 110.713 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.477 HG21 HD11 ' A' ' 110' ' ' LEU . 39.8 m -62.68 -45.75 91.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.42 -30.6 71.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.23 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -72.67 -31.44 65.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.336 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 133' ' ' CYS . 83.0 m -77.71 -22.33 50.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.124 0.488 . . . . 0.0 110.122 173.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.07 172.88 34.26 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.218 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -78.82 -21.01 48.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.879 0.371 . . . . 0.0 110.651 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.81 19.63 6.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.799 0.333 . . . . 0.0 110.908 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 134' ' ' CYS . . . -140.68 143.57 35.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.992 0.425 . . . . 0.0 110.663 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -117.88 134.84 54.54 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.747 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.92 125.73 25.79 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.782 0.325 . . . . 0.0 110.295 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 107' ' ' LYS . 16.7 m -129.84 126.14 37.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.194 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 89.5 m -103.92 115.43 30.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 3.0 m -119.27 138.67 52.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 -172.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -81.0 -18.86 45.39 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.002 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -123.24 138.3 54.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.181 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.18 121.51 23.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.715 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 m -118.6 115.79 25.29 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 74' ' ' VAL . 59.2 m-85 -95.07 126.69 40.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.076 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.51 -31.32 72.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.531 -169.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.41 -20.42 67.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.934 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -102.36 -16.73 16.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 70' ' ' TYR . 19.5 m -119.11 135.69 58.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.075 0.464 . . . . 0.0 111.331 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.1 p -86.11 -16.11 39.02 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -72.45 -6.1 41.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 111.476 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.6 mt -119.09 139.05 47.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.381 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -89.13 102.39 15.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.85 -35.9 82.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.021 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.21 97.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.577 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.5 mt -64.97 -48.53 83.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.053 0.454 . . . . 0.0 110.528 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 151' ' ' PRO . 41.7 mt -68.12 -45.53 73.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.071 -175.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.37 -37.19 84.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.662 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.93 -45.05 96.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.068 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 p -72.8 -42.23 64.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.814 0.34 . . . . 0.0 111.798 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.78 -26.29 59.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.501 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 53.7 tttp -56.87 -29.0 62.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.889 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -60.57 -26.37 66.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.257 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.37 -36.95 26.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.913 0.387 . . . . 0.0 110.673 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.3 mt -72.02 -36.19 56.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.63 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.76 -118.59 4.86 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.742 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.86 58.39 1.25 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.255 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.75 -174.36 30.49 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -149.59 152.46 35.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.933 0.397 . . . . 0.0 110.405 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.84 51.41 0.19 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.6 p -71.7 -14.1 61.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.306 -0.447 . . . . 0.0 111.959 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.17 -21.16 64.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.435 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.53 19.22 24.3 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 100' ' ' GLY . 7.3 tt -113.33 143.15 44.93 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -175.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.501 ' N ' HD23 ' A' ' 99' ' ' LEU . . . 165.63 -136.72 4.31 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.008 -1.092 . . . . 0.0 113.234 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 94.2 mt -113.5 133.22 55.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.567 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 33.3 m-85 -118.81 124.86 48.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.317 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -120.47 159.58 24.86 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.724 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 60.24 58.0 2.75 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 7.0 t -121.97 153.59 38.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.941 -168.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.1 p -136.53 130.51 32.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.042 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 68.6 mttm -81.87 148.93 28.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.146 0.498 . . . . 0.0 110.837 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.436 HD11 ' SG ' ' A' ' 64' ' ' CYS . 94.2 mt -92.46 135.54 33.96 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.863 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -100.63 132.29 46.09 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 53' ' ' THR . 61.9 mt . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 121.037 0.446 . . . . 0.0 110.736 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.236 0.39 0 CA-C-O 121.397 0.618 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 71.7 mt -67.01 134.14 51.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.591 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 47' ' ' ILE . 12.1 p -66.12 -32.5 58.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.573 -174.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -68.82 -16.12 63.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.639 0.256 . . . . 0.0 110.797 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -85.13 -26.6 26.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.655 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -95.35 -19.04 20.27 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.472 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.641 ' SG ' HG12 ' A' ' 131' ' ' ILE . 45.6 t -111.88 112.45 24.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.592 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.4 2.01 36.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.143 0.497 . . . . 0.0 110.703 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 2.1 mp0 -105.54 172.03 7.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.571 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.419 ' OD1' ' HB ' ' A' ' 39' ' ' VAL . 28.9 m-80 -63.97 125.97 26.16 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.641 HG12 ' SG ' ' A' ' 127' ' ' CYS . 14.1 mt -92.64 125.36 45.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.773 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.5 157.16 47.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.033 0.444 . . . . 0.0 111.316 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 155' ' ' LEU . 30.6 m -105.74 116.42 31.92 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 57.1 m -108.98 139.74 43.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -79.42 129.62 34.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.058 0.456 . . . . 0.0 111.102 -173.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.372 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.5 mt . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.851 0.357 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 147.18 -179.97 23.7 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 20.5 mt -95.37 130.54 31.96 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.45 ' HB3' HD22 ' A' ' 82' ' ' LEU . 17.2 Cg_exo -66.45 122.95 10.5 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.124 1.883 . . . . 0.0 111.114 175.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.409 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -155.09 168.88 25.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -177.04 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.7 tt -135.48 136.26 50.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.38 124.62 21.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.624 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.584 HD13 ' SG ' ' A' ' 133' ' ' CYS . 53.4 tp -64.55 -25.69 68.09 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.999 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.519 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.52 -17.11 76.1 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.449 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.9 m -74.06 -29.35 61.85 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 117.249 0.525 . . . . 0.0 111.205 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.5 pt -97.16 -3.77 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.756 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.341 -0.838 . . . . 0.0 111.858 178.949 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 121.184 0.516 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -73.19 -26.67 61.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.145 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -130.85 88.71 45.21 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.11 147.96 74.32 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.742 2.295 . . . . 0.0 113.264 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.29 134.69 45.25 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.14 176.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.91 135.82 43.52 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.655 2.237 . . . . 0.0 112.287 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.77 -16.06 63.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.144 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -92.09 10.37 29.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.769 0.319 . . . . 0.0 111.234 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.4 mm -93.59 123.32 45.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.218 0.533 . . . . 0.0 110.683 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 66.4 p -80.19 160.83 25.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.415 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.64 -40.38 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.216 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -62.39 -46.46 88.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.869 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -62.44 -43.83 97.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.863 0.363 . . . . 0.0 110.473 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' CYS . . . -61.4 -39.48 90.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.712 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.2 m -62.66 -47.54 83.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.798 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -71.71 -36.27 70.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.496 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -75.25 -20.37 59.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.18 0.514 . . . . 0.0 110.553 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 20.7 t -72.49 -21.73 61.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.229 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.45 160.06 20.02 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.993 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -82.83 -14.52 54.2 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -115.57 23.54 12.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.142 0.496 . . . . 0.0 110.534 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 89' ' ' LEU . . . -124.99 148.68 48.32 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.468 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -113.67 129.21 56.61 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.505 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 26.2 mt -64.45 119.22 10.0 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.545 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 42.6 t -129.5 127.25 40.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.383 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.543 ' SG ' HD21 ' A' ' 108' ' ' LEU . 45.0 m -97.68 119.72 36.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.923 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 41.7 m -117.38 129.36 55.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.753 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -71.86 -27.95 63.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -123.34 139.03 54.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.712 0.291 . . . . 0.0 110.379 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.6 124.3 26.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.528 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.8 m -117.19 115.33 25.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.836 0.351 . . . . 0.0 110.286 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -93.52 133.05 37.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.05 -33.89 75.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.362 -169.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.53 -12.7 64.39 Favored Glycine 0 C--O 1.229 -0.189 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.06 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.99 -15.48 18.26 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.622 -0.34 . . . . 0.0 111.418 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.585 HG21 HD12 ' A' ' 77' ' ' ILE . 14.7 m -120.79 127.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.536 0.684 . . . . 0.0 111.5 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p -85.62 -11.64 53.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.279 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.55 -1.09 55.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.842 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.619 HD13 HD23 ' A' ' 101' ' ' LEU . 30.0 mt -118.08 134.54 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.896 0.379 . . . . 0.0 111.387 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.07 102.13 10.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.873 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.34 -30.08 68.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.112 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.76 -42.34 99.74 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.32 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.96 -44.77 99.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.162 0.506 . . . . 0.0 110.041 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.78 -44.29 97.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.608 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.37 -45.4 84.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.712 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.98 -45.02 97.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.659 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.5 p -73.34 -44.83 58.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.508 HD22 HD13 ' A' ' 99' ' ' LEU . 18.2 tp -73.83 -22.55 59.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.623 0.249 . . . . 0.0 111.411 -177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 63.2 tttm -54.16 -29.79 46.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 111.043 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -63.01 -22.23 66.7 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.938 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 60' ' ' ALA . 52.4 tp -90.62 -30.5 17.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.04 -40.29 51.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.694 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.79 -78.67 1.99 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.437 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.33 84.91 0.31 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.275 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.98 -174.76 34.59 Favored Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.919 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -155.75 120.94 4.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.77 0.319 . . . . 0.0 110.435 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -136.56 62.4 0.6 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 32.1 p -69.6 -15.91 63.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -172.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -60.02 -29.08 68.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.401 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.72 16.95 43.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.763 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.508 HD13 HD22 ' A' ' 86' ' ' LEU . 37.7 tp -103.16 143.2 32.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.055 0.455 . . . . 0.0 110.962 -176.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.63 -150.16 13.77 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.286 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.619 HD23 HD13 ' A' ' 77' ' ' ILE . 4.2 mm? -111.01 129.1 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.45 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 33.3 m-85 -113.46 136.4 52.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.387 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -119.97 151.94 38.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.363 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 62.29 58.19 1.81 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.345 0.593 . . . . 0.0 109.952 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.545 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 76.3 m -108.42 136.37 48.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.711 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.6 t -132.66 143.99 50.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -72.11 140.51 48.93 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.546 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.543 HD21 ' SG ' ' A' ' 64' ' ' CYS . 33.8 mt -83.85 142.71 30.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.1 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -74.68 132.71 41.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.589 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.6 mt . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 -175.017 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.3 p30 . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.163 0.506 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 91.4 mt -69.03 129.53 40.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.587 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.66 -36.08 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.844 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -69.97 -18.02 63.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.227 0.537 . . . . 0.0 110.549 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -84.14 -26.16 29.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.481 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -103.26 -17.78 15.17 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.326 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 36.7 t -111.48 123.28 49.9 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.847 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -100.79 7.0 44.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.321 0.581 . . . . 0.0 109.978 172.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 28.1 mp0 -108.83 170.04 8.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.117 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -65.4 128.87 37.66 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.3 mt -96.08 123.64 48.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.336 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.88 158.6 43.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.119 0.485 . . . . 0.0 111.668 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 46.9 m -107.48 114.25 28.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.917 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 26.3 m -110.42 141.91 42.86 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -175.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -66.38 122.13 16.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.105 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 121.124 0.487 . . . . 0.0 111.515 -174.781 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 101' ' ' LEU . 78.9 mt . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 121.76 -166.71 14.49 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.592 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 150' ' ' LEU . 1.1 pt? -111.0 142.14 25.65 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 30.5 Cg_exo -62.18 123.68 12.95 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.458 2.106 . . . . 0.0 111.307 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.449 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 4.1 t -154.01 164.77 37.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.8 tt -133.95 135.76 54.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.874 0.369 . . . . 0.0 110.668 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.25 128.22 35.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.5 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.9 tt -62.94 -29.02 70.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.894 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -67.72 -16.19 67.58 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.831 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.9 m -77.2 -27.66 53.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.019 0.41 . . . . 0.0 111.161 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.6 pt -103.6 -1.44 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.168 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.594 179.343 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 8.3 p . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 121.307 0.575 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -74.38 -24.47 59.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.129 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -125.57 87.34 55.95 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.01 152.87 73.11 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.551 2.167 . . . . 0.0 113.044 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.9 t -93.02 132.7 30.24 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.399 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.27 136.01 46.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.381 2.054 . . . . 0.0 112.06 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -71.76 -10.24 59.48 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.187 -172.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -92.97 12.57 23.45 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.414 ' O ' HG12 ' A' ' 123' ' ' VAL . 40.0 mm -95.17 132.08 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.737 0.303 . . . . 0.0 110.751 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 71.1 p -80.37 159.52 25.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.883 176.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.68 -44.2 80.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.874 0.368 . . . . 0.0 110.367 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 52.9 tptt -62.25 -46.82 87.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.079 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -64.75 -41.84 95.61 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.599 0.238 . . . . 0.0 111.415 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -63.89 -42.3 97.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.572 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.3 m -64.13 -39.03 93.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 15.9 mm-40 -60.94 -34.98 75.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.803 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -74.04 -29.88 62.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.498 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 133' ' ' CYS . 73.7 m -73.51 -20.7 60.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.882 0.372 . . . . 0.0 110.679 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.56 -177.92 20.23 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.713 -178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.29 -13.25 28.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.966 0.383 . . . . 0.0 111.529 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -105.18 14.52 28.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.175 0.512 . . . . 0.0 110.666 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.516 ' HB2' HD13 ' A' ' 89' ' ' LEU . . . -129.14 144.38 51.19 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.82 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -123.21 142.63 50.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.738 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 52' ' ' ALA . 87.4 mt -65.72 129.47 39.88 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.104 0.478 . . . . 0.0 110.928 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 48.4 t -124.85 131.83 53.39 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.159 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.554 ' SG ' HD11 ' A' ' 108' ' ' LEU . 59.3 m -96.3 115.79 27.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.702 175.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.5 m -121.34 132.68 54.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.834 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -84.1 -20.33 32.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.125 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -123.95 137.83 54.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.715 0.293 . . . . 0.0 110.229 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.88 126.65 30.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.293 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -120.08 115.94 24.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.469 ' O ' HG22 ' A' ' 74' ' ' VAL . 62.3 m-85 -94.43 129.84 41.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.021 0.439 . . . . 0.0 110.294 -175.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.65 -28.53 69.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.578 -172.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -64.23 -24.97 69.38 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.736 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.84 -18.64 17.06 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.364 -0.492 . . . . 0.0 111.345 -175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 70' ' ' TYR . 18.7 m -113.69 134.14 57.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.331 0.586 . . . . 0.0 111.051 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.6 p -90.69 -11.54 39.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.574 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.31 -5.99 53.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.871 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.0 mt -117.85 138.91 47.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.148 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.46 99.47 7.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.3 0.571 . . . . 0.0 109.793 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -66.61 -32.55 73.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.179 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.64 -38.44 95.67 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.608 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.85 -48.13 72.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.189 0.518 . . . . 0.0 110.416 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 88.1 mt -62.64 -44.4 96.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.911 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.47 -43.69 98.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.17 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.36 -44.17 97.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.681 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 p -72.37 -42.49 65.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.878 0.37 . . . . 0.0 111.683 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.432 HD13 HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -74.48 -27.09 60.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.347 -176.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.1 -29.16 65.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.895 0.379 . . . . 0.0 110.904 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -60.98 -24.21 65.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.191 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 60' ' ' ALA . 92.6 mt -85.53 -35.0 21.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.014 0.435 . . . . 0.0 110.538 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.9 mt -70.34 -41.81 78.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.232 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.82 -88.17 0.78 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.855 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.01 62.83 0.6 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.005 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.55 178.7 40.88 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.2 p -146.63 138.8 24.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.728 0.264 . . . . 0.0 110.999 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.82 63.24 0.42 Allowed Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.7 p -69.73 -22.66 63.36 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -72.44 -18.63 61.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.799 0.333 . . . . 0.0 111.45 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.53 ' HA3' ' OG ' ' A' ' 157' ' ' SER . . . -110.65 12.63 30.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.596 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 100' ' ' GLY . 1.5 tt -110.43 141.42 43.54 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.422 ' N ' HD23 ' A' ' 99' ' ' LEU . . . 167.79 -142.95 7.84 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.33 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.5 tp -114.03 128.93 56.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -116.18 140.3 49.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.627 0.251 . . . . 0.0 110.608 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -124.26 153.31 41.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.424 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 61.99 57.91 2.0 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.639 0.733 . . . . 0.0 109.703 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.484 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 89.4 m -106.41 130.35 54.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.416 -175.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.1 m -115.03 134.26 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.408 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -73.7 139.49 45.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.1 0.476 . . . . 0.0 111.25 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.554 HD11 ' SG ' ' A' ' 64' ' ' CYS . 77.0 mt -99.24 121.58 41.24 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 172.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -74.91 134.47 41.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.948 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.8 mt . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.783 -172.972 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.293 0.568 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 89.2 mt -79.16 134.92 36.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.82 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 47' ' ' ILE . 14.8 p -66.94 -41.25 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.841 -175.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -72.18 -9.16 58.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.744 0.307 . . . . 0.0 111.338 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 122' ' ' LEU . 27.2 tt0 -84.11 -25.96 29.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.872 -173.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -106.88 -16.35 14.48 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.855 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.6 t -109.59 132.96 53.66 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.968 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -112.21 12.05 20.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.256 0.55 . . . . 0.0 110.319 173.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 25.8 mp0 -107.64 169.26 8.7 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.32 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -66.34 136.59 56.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.772 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 23.6 mm -95.48 125.67 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.835 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.02 155.05 47.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 0.0 111.176 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 13.1 m -98.29 128.72 44.87 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 64.4 m -112.97 140.37 47.84 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.986 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.477 ' OE1' HD21 ' A' ' 89' ' ' LEU . 5.4 tp60 -83.18 141.74 31.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.265 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 121.299 0.571 . . . . 0.0 111.029 -179.708 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.5 mt . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 121.172 0.511 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 152.68 -171.82 31.8 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.29 134.6 22.55 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -71.97 121.05 7.25 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.55 1.5 . . . . 0.0 110.566 174.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 53.7 m -152.72 162.69 40.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.03 137.25 57.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.627 0.251 . . . . 0.0 110.549 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.32 123.79 19.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.385 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 68.8 tp -62.47 -27.35 69.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.197 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.409 ' HA2' ' CD2' ' A' ' 159' ' ' LEU . . . -69.81 -16.19 72.08 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.61 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.53 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 26.6 m -82.86 -24.59 33.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.974 0.387 . . . . 0.0 111.729 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.7 pt -103.97 11.14 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.409 ' CD2' ' HA2' ' A' ' 156' ' ' GLY . 4.7 pp . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.245 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.309 0.576 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -78.0 -25.64 48.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.422 -178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -125.67 89.3 52.73 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.43 146.0 73.11 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.688 2.258 . . . . 0.0 113.184 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 155' ' ' LEU . 41.1 t -84.53 132.57 46.52 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.306 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -51.63 135.01 48.2 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.226 1.95 . . . . 0.0 112.073 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.53 -18.23 64.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.38 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -92.32 9.82 32.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.74 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.5 mm -96.96 119.44 45.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.095 0.474 . . . . 0.0 110.553 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 71.6 p -76.49 160.97 29.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.333 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.31 -36.54 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.004 0.43 . . . . 0.0 110.582 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -67.08 -46.95 72.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.693 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -63.79 -40.99 98.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 110.758 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.63 94.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.798 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 m -65.84 -43.21 89.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.898 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -64.06 -34.82 78.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.993 0.425 . . . . 0.0 110.846 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -68.34 -40.48 81.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.941 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 96.0 m -87.52 -5.78 58.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.33 170.38 23.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.92 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.43 -16.59 54.06 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.771 -0.252 . . . . 0.0 111.437 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -97.92 15.29 24.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.916 0.388 . . . . 0.0 110.862 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.474 ' HB2' HD13 ' A' ' 89' ' ' LEU . . . -130.15 146.34 51.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.902 0.382 . . . . 0.0 111.06 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -135.03 144.19 47.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.89 136.68 56.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 110.984 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.3 t -139.1 140.19 37.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.254 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.548 ' SG ' HD11 ' A' ' 108' ' ' LEU . 56.3 m -109.54 117.37 33.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.525 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 1.8 m -117.04 141.88 47.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.746 -175.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.469 ' HA ' ' OE1' ' A' ' 129' ' ' GLN . 56.3 t30 -84.66 -22.15 29.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.415 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -124.7 140.59 52.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.13 127.43 28.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.691 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.8 m -119.1 115.15 23.67 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -90.22 134.42 34.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.99 -31.36 72.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.55 -169.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.02 -9.49 86.9 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.692 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.26 -16.58 24.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.037 0.446 . . . . 0.0 110.606 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.454 HG21 HD12 ' A' ' 77' ' ' ILE . 16.8 m -120.46 150.2 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.822 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.0 p -96.31 -20.48 18.48 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -82.45 0.67 41.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.813 0.339 . . . . 0.0 111.472 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.454 HD12 HG21 ' A' ' 74' ' ' VAL . 39.0 mt -120.61 130.21 74.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -88.5 109.78 20.33 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.198 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -63.92 -29.22 70.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.432 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.84 -35.84 91.38 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.548 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.7 mt -68.25 -48.07 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.942 0.401 . . . . 0.0 110.318 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.28 -40.18 89.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.999 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.68 -34.73 77.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.989 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.8 -47.97 88.55 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.581 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 142' ' ' SER . 3.0 p -73.68 -41.31 62.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.867 0.365 . . . . 0.0 111.794 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.464 HD13 HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -72.73 -24.84 61.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.145 -177.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 38.5 ttmt -55.7 -30.26 60.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 110.727 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -61.48 -27.72 68.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.819 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 60' ' ' ALA . 86.3 mt -88.41 -29.63 20.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.507 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.4 mt -72.76 -40.56 61.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.085 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.27 -70.32 2.15 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.161 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.74 104.76 0.3 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.17 -169.41 39.02 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.8 m -148.57 128.6 13.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.965 0.382 . . . . 0.0 110.83 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.69 49.45 0.11 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.712 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.4 p -74.11 -11.91 60.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.951 0.405 . . . . 0.0 111.377 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -64.76 -13.85 56.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.547 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.47 24.76 8.97 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.78 143.83 39.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.37 -147.87 13.5 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.655 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.0 mt -106.72 128.91 54.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.051 0.453 . . . . 0.0 109.945 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.453 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 20.8 m-85 -114.2 131.89 56.3 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.816 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -120.36 154.53 34.95 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.506 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 59.35 58.18 3.1 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.33 0.586 . . . . 0.0 109.576 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 4.2 t -116.36 155.74 27.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.29 -171.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 t -138.53 131.52 29.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -72.41 147.38 46.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.099 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.548 HD11 ' SG ' ' A' ' 64' ' ' CYS . 91.4 mt -98.73 124.83 43.82 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -82.97 135.88 34.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.971 0.415 . . . . 0.0 110.637 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.5 mt -67.67 132.81 48.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.513 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -83.58 154.77 23.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.356 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.9 mt -70.02 117.04 50.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.928 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.31 101.96 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.997 2.464 . . . . 0.0 112.746 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.8 mm 56.49 77.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.74 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.4 tp -89.3 64.44 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 122.288 1.042 . . . . 0.0 109.779 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.75 -54.73 4.68 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.508 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 58.3 mt -91.25 130.72 38.89 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.03 79.64 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.197 1.931 . . . . 0.0 112.176 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 58.0 mt -91.86 129.11 43.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.902 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -109.54 82.09 1.54 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.168 0.508 . . . . 0.0 109.942 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -74.03 104.28 4.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.222 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 60.1 mt -87.3 138.86 31.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.495 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.478 HG23 ' OD1' ' A' ' 124' ' ' ASN . 15.8 m -61.52 -40.42 86.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.158 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.478 ' OD1' HG23 ' A' ' 123' ' ' VAL . 2.0 m-20 -71.25 -15.58 62.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.032 0.444 . . . . 0.0 110.823 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -84.35 -25.68 28.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.93 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -109.18 -17.16 13.92 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.679 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 48.3 t -111.11 135.64 51.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.503 0.192 . . . . 0.0 111.496 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -119.52 14.34 12.74 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.886 0.851 . . . . 0.0 109.266 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 59.8 mm-40 -108.24 171.25 7.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.094 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -64.69 114.9 4.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.317 . . . . 0.0 110.354 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.1 mt -88.52 120.81 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.649 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.73 159.62 41.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 0.0 110.989 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 78.8 m -103.13 127.23 50.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 61.1 m -112.85 143.48 44.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.11 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.457 ' HG3' ' H ' ' A' ' 137' ' ' SER . 5.3 tp-100 -71.09 123.45 22.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.319 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -97.47 42.72 1.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.224 0.535 . . . . 0.0 110.252 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.457 ' H ' ' HG3' ' A' ' 135' ' ' GLN . 18.6 m -134.16 100.2 13.07 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.158 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.22 99.25 0.89 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.36 2.04 . . . . 0.0 112.137 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.8 t -108.33 154.52 21.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.756 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.422 ' HA ' ' OG ' ' A' ' 144' ' ' SER . 4.0 p-10 -88.46 -1.35 58.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.33 0.586 . . . . 0.0 110.157 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -112.3 113.45 25.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.528 174.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.468 ' HB3' HG21 ' A' ' 85' ' ' THR . 45.4 t 62.97 48.18 4.0 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.242 0.544 . . . . 0.0 110.428 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -161.97 -57.29 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.642 -0.789 . . . . 0.0 113.094 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 140' ' ' ASP . 29.1 p -78.4 -41.12 34.01 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -172.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.84 11.3 29.84 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.5 pt -132.37 46.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.504 0.668 . . . . 0.0 110.5 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -81.1 33.83 2.42 Favored Glycine 0 N--CA 1.453 -0.199 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.684 -175.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.5 mt -77.21 -16.04 59.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.368 0.604 . . . . 0.0 109.956 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -171.97 -173.61 38.86 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.596 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.99 122.86 51.22 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.08 120.71 7.23 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.378 1.385 . . . . 0.0 110.623 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 47.7 m -152.87 162.0 41.84 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.4 tt -127.57 136.46 60.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.776 0.322 . . . . 0.0 110.351 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.48 123.44 19.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 155' ' ' LEU . 5.6 tt -58.73 -28.56 65.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.653 -176.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -65.92 -17.01 64.82 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.701 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.5 m -80.68 -29.51 36.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 117.003 0.401 . . . . 0.0 111.505 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.8 pt -95.15 -9.47 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.746 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--O 1.245 0.857 0 O-C-N 124.206 0.941 . . . . 0.0 111.33 179.326 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 130' ' ' ASN . 7.3 p . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -78.62 -23.81 45.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.444 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 82.0 m-85 -130.0 90.98 40.89 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.433 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.81 148.94 72.2 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.597 2.198 . . . . 0.0 113.294 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -89.3 135.9 30.73 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.439 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -51.87 135.34 50.28 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.452 2.101 . . . . 0.0 112.234 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.0 -11.14 60.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.176 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -92.57 8.11 40.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 111.272 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.2 mm -90.01 126.98 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.893 0.378 . . . . 0.0 110.106 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 81.7 p -82.67 159.6 22.6 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.672 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.501 ' HB ' HE22 ' A' ' 111' ' ' GLN . 38.2 t -54.98 -43.15 67.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.108 0.48 . . . . 0.0 110.574 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -62.3 -46.62 87.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.547 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -66.46 -40.48 89.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.141 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' CYS . . . -61.15 -38.34 86.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.861 0.362 . . . . 0.0 110.443 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.457 HG21 HD11 ' A' ' 110' ' ' LEU . 62.9 m -67.47 -46.35 73.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.134 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.97 -41.77 97.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 110.449 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -69.67 -24.04 63.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.615 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 13.6 t -73.83 -21.25 60.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.132 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.42 170.6 24.79 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.622 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.99 -33.09 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.843 0.321 . . . . 0.0 111.714 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -96.96 19.91 12.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.225 0.536 . . . . 0.0 110.372 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.1 139.86 53.52 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.149 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -99.21 122.17 42.04 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.24 118.56 10.12 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.2 t -139.94 150.33 44.41 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.096 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.592 ' SG ' HD11 ' A' ' 108' ' ' LEU . 49.5 m -113.71 124.13 51.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.858 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 8.4 m -114.93 141.51 47.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.06 0.457 . . . . 0.0 110.946 -173.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.401 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 22.1 t-20 -75.25 -37.78 60.85 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.891 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.401 ' HG3' ' OD1' ' A' ' 66' ' ' ASN . 61.6 mttp -123.92 140.19 53.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.889 0.376 . . . . 0.0 110.611 -176.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.31 121.76 29.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.816 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 m -116.76 115.58 25.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -92.57 134.5 34.93 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.35 -30.3 70.67 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.208 -167.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.2 -21.83 70.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.297 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.81 -18.36 25.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.306 . . . . 0.0 111.277 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.57 ' HB ' ' OD1' ' A' ' 76' ' ' ASP . 14.9 m -121.28 129.99 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.155 0.502 . . . . 0.0 111.149 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.2 t -88.88 -6.71 57.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.26 -175.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.57 ' OD1' ' HB ' ' A' ' 74' ' ' VAL . 10.1 p-10 -84.23 2.75 38.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.1 mt -125.09 138.17 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.15 108.42 19.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.032 0.444 . . . . 0.0 110.679 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.02 -36.9 68.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.204 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.22 -45.82 83.88 Favored Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.956 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.92 -45.95 89.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.377 0.608 . . . . 0.0 110.191 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.8 tp -66.32 -40.68 90.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.035 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -44.84 80.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.797 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.17 -42.0 98.42 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.882 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.6 p -72.42 -43.91 63.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.741 0.305 . . . . 0.0 111.807 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.73 -27.47 60.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.844 0.354 . . . . 0.0 110.417 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.67 -35.44 74.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.969 0.414 . . . . 0.0 110.55 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -69.54 -22.37 63.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.601 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.4 tp -83.57 -37.43 22.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.961 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.7 mt -72.44 -44.77 61.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.482 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.96 -100.49 1.1 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.74 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.55 46.4 1.17 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.126 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.62 159.03 30.92 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.76 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 p -146.57 70.21 1.21 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.117 0.484 . . . . 0.0 110.717 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.51 76.75 1.11 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.116 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 p -62.8 -19.29 63.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.12 0.486 . . . . 0.0 111.575 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 2.0 mp0 -57.81 -30.86 66.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.365 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -113.59 17.01 21.22 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.964 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.0 tp -98.83 142.53 30.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.65 0.262 . . . . 0.0 111.012 -175.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.88 -158.99 30.92 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.095 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.3 tp -109.24 126.45 53.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -114.29 138.33 50.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.753 0.311 . . . . 0.0 110.805 -173.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -123.54 152.3 41.94 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.376 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 60.64 59.16 2.24 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.62 0.575 . . . . 0.0 109.958 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 4.0 t -118.48 139.33 51.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.3 p -122.74 132.28 54.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.606 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -65.83 147.85 52.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.505 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.592 HD11 ' SG ' ' A' ' 64' ' ' CYS . 75.4 mt -97.45 140.66 31.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.182 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -86.8 140.54 29.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.326 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.457 HD11 HG21 ' A' ' 53' ' ' THR . 62.3 mt -92.69 123.19 35.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.678 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.501 HE22 ' HB ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -67.66 139.0 56.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.024 176.501 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 58.1 mt -96.82 120.92 60.81 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.994 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -45.31 117.11 1.52 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.396 2.731 . . . . 0.0 113.424 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 49.0 mm 72.97 -62.08 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.714 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.4 mm -95.86 80.6 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.282 0.563 . . . . 0.0 110.522 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.22 63.36 0.11 Allowed Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.227 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 59.4 mt 66.09 87.88 0.11 Allowed Pre-proline 0 N--CA 1.464 0.259 0 CA-C-O 121.153 0.502 . . . . 0.0 110.864 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.59 38.73 0.69 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.172 2.581 . . . . 0.0 112.957 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 51.6 mt -119.85 122.35 68.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.812 0.339 . . . . 0.0 110.676 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -87.36 74.94 9.33 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -80.82 157.91 25.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.257 -170.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 80.0 mt -74.22 135.45 42.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.44 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.89 -34.56 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.727 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -71.78 -13.47 61.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.724 0.297 . . . . 0.0 111.387 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -82.98 -25.71 31.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.736 0.303 . . . . 0.0 110.908 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -109.34 -12.4 14.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.068 0.461 . . . . 0.0 111.255 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 53.3 t -106.81 135.22 48.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -119.93 6.78 10.86 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.306 0.574 . . . . 0.0 110.751 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 46.0 mt-30 -108.42 169.2 8.79 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.437 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 14.5 p30 -70.22 134.36 47.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.936 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.6 mt -94.07 126.24 46.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.549 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.58 158.81 43.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.205 0.526 . . . . 0.0 111.623 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 56.2 m -97.67 121.0 39.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.679 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 82.1 m -112.2 140.37 46.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.61 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -69.4 133.55 47.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.167 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -80.48 33.71 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.282 0.563 . . . . 0.0 111.368 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.8 t -141.17 117.85 7.55 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.851 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.8 139.98 58.16 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.232 2.622 . . . . 0.0 112.519 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.1 m -79.57 7.17 8.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.933 0.397 . . . . 0.0 111.302 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.01 -32.35 73.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.972 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.64 -25.58 66.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.926 0.393 . . . . 0.0 110.931 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.3 t -90.43 -5.89 55.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.065 0.46 . . . . 0.0 110.254 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.66 133.96 1.61 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.136 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.3 p -82.91 -10.76 58.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.897 0.38 . . . . 0.0 111.126 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.5 mt -110.57 11.08 22.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.915 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 48.1 pt -116.16 33.44 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.399 -0.521 . . . . 0.0 112.171 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -84.18 42.22 3.06 Favored Glycine 0 C--N 1.321 -0.297 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 67.0 mt -87.93 -2.56 58.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.172 -0.514 . . . . 0.0 111.689 -171.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 167.54 -165.76 38.86 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.06 138.61 22.34 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 117.114 0.457 . . . . 0.0 109.928 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.53 121.92 6.23 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.766 1.644 . . . . 0.0 110.693 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 31.9 m -149.78 157.57 43.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.202 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 14.9 tt -124.91 129.75 73.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.183 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.35 121.13 12.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.246 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.4 tt -65.12 -20.74 66.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.408 -173.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.444 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.81 -9.45 70.4 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.166 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.409 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 74.6 p -78.14 -25.91 47.57 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 117.378 0.589 . . . . 0.0 110.901 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.9 pt -96.01 -9.45 9.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.171 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--O 1.242 0.71 0 O-C-N 124.104 0.877 . . . . 0.0 112.537 177.778 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.459 ' HB ' ' OD1' ' A' ' 130' ' ' ASN . 7.3 p . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.247 0.546 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 40' ' ' ARG . 27.0 mtm180 -76.96 -24.33 52.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.599 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.419 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 86.0 m-85 -123.44 87.21 52.01 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.24 148.25 68.03 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.245 1.963 . . . . 0.0 112.43 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.5 t -85.01 132.66 45.01 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.68 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.49 136.0 48.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.569 2.18 . . . . 0.0 112.386 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -10.28 57.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -90.05 2.35 55.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.567 0.222 . . . . 0.0 111.187 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.484 ' O ' HG12 ' A' ' 123' ' ' VAL . 34.1 mm -87.94 126.82 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.281 0.563 . . . . 0.0 110.527 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.655 HG21 ' HG3' ' A' ' 120' ' ' GLN . 59.3 p -87.42 160.0 18.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.539 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 m -57.11 -36.93 52.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.025 0.44 . . . . 0.0 110.76 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 50.8 tptt -68.4 -46.84 68.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.41 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -62.35 -41.22 98.42 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.502 0.192 . . . . 0.0 111.011 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.34 98.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.051 0.453 . . . . 0.0 110.99 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.8 m -67.69 -47.77 68.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.097 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 65.3 mm-40 -66.36 -28.15 68.43 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.005 0.431 . . . . 0.0 110.882 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.468 ' HE2' ' OXT' ' A' ' 159' ' ' LEU . 51.1 tptt -59.97 -40.89 90.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.334 177.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.561 ' SG ' HD13 ' A' ' 155' ' ' LEU . 80.8 m -92.96 -20.66 20.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.912 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.43 177.09 23.34 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.73 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.48 -8.04 57.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.86 0.362 . . . . 0.0 111.668 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -94.35 4.27 54.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.004 0.43 . . . . 0.0 110.988 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.65 147.44 48.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.262 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -104.31 121.55 43.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.15 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.7 tp -70.93 118.68 14.01 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.7 t -135.38 149.02 49.56 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.368 -171.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.582 ' SG ' HD21 ' A' ' 108' ' ' LEU . 62.0 m -102.54 118.77 37.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.819 174.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -117.51 130.27 56.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.171 0.51 . . . . 0.0 111.162 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -77.97 -24.94 47.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.786 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.93 138.69 54.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.197 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.14 120.92 19.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.082 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 m -114.46 116.46 28.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -88.03 126.26 34.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.04 77.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.41 -169.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.63 -7.8 75.04 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.562 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.9 -17.73 17.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.841 0.353 . . . . 0.0 110.8 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.54 131.67 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.22 0.533 . . . . 0.0 111.134 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.0 p -83.56 -9.01 59.21 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.88 -0.74 49.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.904 0.383 . . . . 0.0 111.401 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mt -124.78 142.94 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -89.26 98.52 11.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.525 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.74 -33.53 76.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.647 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.52 -38.81 96.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.6 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.72 -48.84 49.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.671 0.272 . . . . 0.0 110.455 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.88 -40.11 91.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.854 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.6 -37.5 86.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.753 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.25 -46.88 39.59 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.751 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 p -72.85 -44.93 60.79 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.421 ' CD2' ' HB ' ' A' ' 153' ' ' ILE . 11.3 tp -73.97 -24.92 59.69 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.756 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 41.1 ttmt -56.86 -32.03 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.004 0.431 . . . . 0.0 110.543 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -68.5 -24.08 64.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.691 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.2 tp -83.46 -35.0 25.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 109.897 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.0 mt -71.5 -40.8 72.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.329 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.42 -103.76 2.98 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -103.62 82.78 0.39 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.951 -0.643 . . . . 0.0 111.826 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.38 173.11 25.38 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.0 t -161.62 151.9 17.32 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.44 69.11 0.29 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.608 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 34.5 p -61.87 -25.75 67.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.859 0.361 . . . . 0.0 111.91 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 1.5 mp0 -59.11 -22.46 60.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.163 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -122.55 27.1 6.1 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -109.8 148.49 31.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.692 0.282 . . . . 0.0 111.054 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 158.49 -148.37 17.46 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.729 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.9 mt -106.6 129.73 54.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.01 0.433 . . . . 0.0 109.928 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.564 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 15.7 m-85 -112.1 137.02 50.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.836 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.95 149.67 45.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.312 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 63.4 51.6 2.58 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.532 0.52 . . . . 0.0 110.334 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.5 m -92.23 135.62 33.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.711 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.5 p -114.97 145.48 42.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.091 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -77.12 133.71 38.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.582 HD21 ' SG ' ' A' ' 64' ' ' CYS . 19.2 mt -88.88 138.24 31.59 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.961 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.8 108.08 8.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.032 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.29 119.5 37.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.83 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -96.95 138.98 33.65 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.4 mt -70.23 124.23 90.37 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.413 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.67 95.89 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.247 1.964 . . . . 0.0 111.011 174.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.9 mm -80.41 122.45 35.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.056 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 77.9 mt -59.02 96.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.483 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 144.33 -29.63 1.9 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -175.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.3 pt -128.54 103.81 19.63 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.844 0.354 . . . . 0.0 110.064 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.19 78.26 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.796 2.331 . . . . 0.0 112.841 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 55.8 mt -97.07 115.26 36.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.655 ' HG3' HG21 ' A' ' 48' ' ' THR . 6.3 tp60 -153.44 86.74 1.22 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.031 0.443 . . . . 0.0 110.28 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -88.11 145.06 26.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.092 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 96.2 mt -76.99 133.71 39.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.709 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 47' ' ' ILE . 11.4 p -67.07 -37.98 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.714 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -71.33 -16.44 62.44 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.071 0.462 . . . . 0.0 110.825 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -84.68 -26.54 27.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.503 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -100.09 -17.07 17.63 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.257 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 16.2 t -110.96 139.35 46.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.26 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -111.89 2.22 16.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.758 0.79 . . . . 0.0 109.547 172.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 26.7 mp0 -108.2 170.73 7.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.918 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.459 ' OD1' ' HB ' ' A' ' 39' ' ' VAL . 22.2 m-80 -65.2 134.62 54.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 21.9 mm -95.74 124.26 48.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.87 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.07 159.29 42.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.874 0.369 . . . . 0.0 111.102 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 78.6 m -107.86 118.96 38.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 73.7 m -110.24 147.26 34.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.118 0.485 . . . . 0.0 111.348 -169.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 137' ' ' SER . 4.9 tp60 -69.78 122.17 18.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.204 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -75.11 -8.96 58.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.463 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 135' ' ' GLN . 15.0 m -100.83 136.98 19.69 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.22 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.32 51.86 3.66 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.435 2.09 . . . . 0.0 111.694 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.3 p -67.76 -54.0 22.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.019 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.41 6.38 48.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.607 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -140.64 51.21 1.65 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.863 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 m -76.92 60.99 1.87 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.949 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 174.41 156.55 14.05 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.5 m -91.41 -26.17 19.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.806 0.336 . . . . 0.0 110.807 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 95.1 mt -83.26 4.5 26.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.944 0.402 . . . . 0.0 111.201 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.8 pt -125.42 43.23 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.545 0.688 . . . . 0.0 110.252 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.24 46.6 3.24 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.584 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.14 -32.0 72.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.953 0.406 . . . . 0.0 110.32 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 170.5 -179.66 42.45 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.39 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.16 129.36 25.71 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.76 122.79 11.24 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 121.881 1.72 . . . . 0.0 110.289 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . 2.6 t -153.54 159.4 42.2 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.319 -171.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.421 ' HB ' ' CD2' ' A' ' 86' ' ' LEU . 7.4 tp -127.12 130.76 71.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.278 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.89 122.29 14.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.286 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.561 HD13 ' SG ' ' A' ' 56' ' ' CYS . 59.7 tp -62.67 -25.32 68.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.638 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.419 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -72.83 -16.82 78.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.901 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.5 m -74.6 -29.12 61.19 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.228 0.514 . . . . 0.0 111.326 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.4 pt -95.56 -4.41 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.069 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.468 ' OXT' ' HE2' ' A' ' 55' ' ' LYS . 89.3 mt . . . . . 0 C--O 1.252 1.188 0 O-C-N 123.804 0.69 . . . . 0.0 111.885 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 130' ' ' ASN . 7.4 p . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.079 0.466 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -76.43 -22.9 54.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.12 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 157' ' ' SER . 60.2 m-85 -122.61 86.91 49.37 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.421 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.78 144.85 55.21 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.179 1.92 . . . . 0.0 112.487 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.23 132.01 54.47 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.59 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.28 135.09 45.79 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.113 1.876 . . . . 0.0 111.537 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -72.9 -10.22 59.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.037 -170.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -90.13 2.44 55.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.434 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.4 mm -86.75 127.25 40.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.981 0.419 . . . . 0.0 110.736 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 43.2 p -82.16 159.95 23.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.659 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.0 t -57.91 -40.92 78.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.9 0.381 . . . . 0.0 110.792 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -64.4 -44.97 89.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.759 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -62.67 -46.13 89.61 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.962 0.411 . . . . 0.0 110.611 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.483 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -61.04 -37.6 83.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.813 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.8 m -67.43 -45.08 77.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.803 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -63.73 -31.49 72.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.336 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 159' ' ' LEU . 57.1 tptt -62.42 -40.89 98.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.817 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.601 ' SG ' HD13 ' A' ' 155' ' ' LEU . 71.8 m -94.29 -16.21 23.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.855 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.06 161.96 23.75 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.182 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -74.62 -11.08 60.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.969 0.414 . . . . 0.0 110.851 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -91.41 14.63 14.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.109 0.481 . . . . 0.0 110.204 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.75 141.77 51.5 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.469 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -111.9 124.61 52.73 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.483 HD11 ' HB3' ' A' ' 52' ' ' ALA . 95.9 mt -66.08 121.28 14.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.965 0.412 . . . . 0.0 110.165 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 41.2 t -122.62 134.36 54.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.662 -175.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 67.8 m -93.9 116.13 28.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.366 174.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.423 ' HB2' ' ND2' ' A' ' 130' ' ' ASN . 50.3 m -120.32 130.19 54.33 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.709 0.29 . . . . 0.0 110.751 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -79.92 -21.5 43.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.003 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -123.93 142.03 51.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.49 126.65 33.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.17 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.0 m -120.71 115.1 22.67 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -92.24 135.07 34.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.63 72.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.022 -171.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.18 -7.37 82.0 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.784 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -98.26 -17.53 18.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.088 0.47 . . . . 0.0 110.865 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.568 HG21 HD12 ' A' ' 77' ' ' ILE . 13.0 m -120.63 132.35 70.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.299 0.571 . . . . 0.0 111.264 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.3 p -82.56 -18.2 42.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.504 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -86.78 11.71 12.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.568 HD12 HG21 ' A' ' 74' ' ' VAL . 27.6 mt -130.3 136.01 59.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.612 0.244 . . . . 0.0 110.617 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -87.85 107.57 18.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.947 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.63 -28.35 67.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.336 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.1 -41.48 97.07 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.589 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.26 -44.23 97.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.052 0.453 . . . . 0.0 110.319 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.31 -38.88 88.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.843 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.18 -36.97 85.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.344 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.19 -46.18 94.7 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.614 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 p -73.07 -43.42 61.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.938 0.399 . . . . 0.0 111.773 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.34 -26.33 58.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.353 -176.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 29.8 ttpp -56.98 -30.69 64.33 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.751 0.31 . . . . 0.0 110.926 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -63.15 -22.79 67.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.322 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.66 -27.55 20.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.951 0.405 . . . . 0.0 110.769 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.2 mt -82.23 -40.85 17.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.136 0.493 . . . . 0.0 110.801 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.03 -126.14 8.44 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.66 41.11 3.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.339 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -153.73 173.77 32.38 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.2 m -153.56 91.93 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.794 0.33 . . . . 0.0 111.335 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.54 69.86 3.21 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.3 p -68.2 -12.51 61.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.78 -33.94 73.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.82 0.343 . . . . 0.0 111.511 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -107.49 20.06 32.94 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.998 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.2 tp -100.24 139.88 35.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.879 0.371 . . . . 0.0 111.252 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.88 -146.97 11.83 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.819 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.56 HD23 HD13 ' A' ' 77' ' ' ILE . 4.2 mm? -109.56 125.33 52.41 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.77 136.83 47.69 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.167 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -120.03 152.74 37.07 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.999 -175.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 61.33 57.84 2.3 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.545 0.688 . . . . 0.0 109.803 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 96.7 m -106.42 135.66 47.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.548 -174.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.0 m -128.34 131.1 48.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -79.84 145.83 32.55 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.417 . . . . 0.0 111.228 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -95.55 140.84 29.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -75.76 131.24 39.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.153 0.501 . . . . 0.0 109.757 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.8 tp -83.09 119.44 24.5 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -90.29 117.88 29.37 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 60.1 mt -100.68 113.95 65.7 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.13 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 31.3 Cg_exo -59.25 115.83 2.85 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.46 2.107 . . . . 0.0 111.509 176.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 25.1 pt -132.16 174.8 12.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.302 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.3 mm -66.09 105.62 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.504 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.99 -36.89 2.83 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.906 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.4 pt -144.07 78.01 14.1 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 121.213 0.53 . . . . 0.0 110.789 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' PRO . 65.9 Cg_endo -85.75 60.25 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.623 2.215 . . . . 0.0 111.022 177.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.1 mt -78.59 122.18 33.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.882 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.454 ' HB3' HG21 ' A' ' 48' ' ' THR . 14.0 mm-40 -123.83 82.31 2.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.027 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -87.58 144.81 26.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.475 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 76.1 mt -71.48 131.32 43.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.928 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.4 -35.46 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.467 -174.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.99 -12.68 61.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.134 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 122' ' ' LEU . 53.1 tp60 -83.19 -25.92 31.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.725 0.298 . . . . 0.0 110.656 -173.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -102.3 -17.35 15.93 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.212 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 16.8 t -110.33 137.06 48.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.688 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 128' ' ' LYS . 3.4 mppt? -110.36 3.88 20.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.376 0.608 . . . . 0.0 109.93 172.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 27.8 mp0 -108.75 169.85 8.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.849 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.522 ' HB2' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -66.72 140.56 57.88 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.673 0.273 . . . . 0.0 110.813 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.5 mm -97.53 120.5 46.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.138 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.22 154.86 45.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.836 0.351 . . . . 0.0 110.741 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.408 ' C ' ' SG ' ' A' ' 152' ' ' CYS . 73.9 m -105.64 114.28 28.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.015 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 59.6 m -109.6 140.94 42.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -69.72 136.4 50.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.728 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -80.27 55.09 2.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.305 0.574 . . . . 0.0 111.043 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.7 t -138.84 103.58 7.54 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.557 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -78.15 46.73 2.17 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.594 2.196 . . . . 0.0 112.471 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.5 m -84.77 0.79 49.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.627 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -86.86 -20.21 27.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.157 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -101.12 15.87 27.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.681 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 m -91.85 33.47 1.04 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.267 -176.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.52 -0.97 63.69 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.796 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.3 m -70.93 134.55 47.32 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 96.2 mt -88.21 45.2 1.26 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.519 0.676 . . . . 0.0 110.485 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 33.6 pt -113.18 43.05 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.236 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -77.6 39.12 1.71 Allowed Glycine 0 N--CA 1.454 -0.153 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.169 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 46.1 mt -82.99 -16.31 47.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.425 0.631 . . . . 0.0 109.711 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 152.17 -155.81 26.34 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.734 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.7 mp -104.8 127.66 28.38 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -66.46 121.32 8.57 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.44 1.427 . . . . 0.0 110.21 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.408 ' SG ' ' C ' ' A' ' 133' ' ' CYS . 0.7 OUTLIER -155.41 169.15 24.92 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.379 -172.504 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.36 132.45 55.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.388 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.11 123.39 17.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.341 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.601 HD13 ' SG ' ' A' ' 56' ' ' CYS . 42.4 tp -61.79 -25.82 67.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.781 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.452 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.24 -17.14 75.69 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.409 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.5 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 8.5 t -73.41 -26.77 61.11 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.968 0.384 . . . . 0.0 110.95 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 pt -102.21 -2.34 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.532 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.44 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 90.2 mt . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.595 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.258 0.551 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -76.47 -29.04 56.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.357 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -125.14 91.91 48.33 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.51 150.64 75.46 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.395 2.063 . . . . 0.0 112.643 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.71 133.36 29.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.736 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.86 136.31 51.39 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.732 2.288 . . . . 0.0 112.395 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.81 -11.73 61.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.208 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -86.02 3.2 43.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.677 0.275 . . . . 0.0 111.732 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.483 ' O ' HG12 ' A' ' 123' ' ' VAL . 34.9 mm -92.06 123.91 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 0.0 110.274 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 61.4 p -80.29 160.84 25.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.298 175.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.33 -40.87 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 65.7 tttp -65.46 -47.52 75.83 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.879 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -59.6 -43.5 93.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 110.69 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.7 98.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.732 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.44 HG21 HD23 ' A' ' 110' ' ' LEU . 29.6 m -68.97 -39.03 79.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.689 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 73.8 mm-40 -59.56 -32.19 70.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.042 0.448 . . . . 0.0 110.756 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -60.58 -33.52 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.082 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 60' ' ' ALA . 85.5 m -100.49 9.55 42.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.752 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.57 80.05 0.66 Allowed Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.45 -172.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -177.5 -72.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.977 0.418 . . . . 0.0 110.864 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -116.86 12.92 14.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.452 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . . . -149.08 163.89 36.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.05 0.453 . . . . 0.0 111.591 -171.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -134.52 143.23 47.32 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.9 tp -67.29 134.59 51.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.057 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 t -139.69 145.97 39.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.858 0.361 . . . . 0.0 110.358 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.702 ' SG ' HD11 ' A' ' 108' ' ' LEU . 29.5 m -113.9 120.63 41.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.745 176.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.544 ' O ' ' HB3' ' A' ' 129' ' ' GLN . 13.5 m -115.49 144.71 43.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -89.91 -26.55 20.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -124.69 145.24 49.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.35 128.36 33.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.614 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 m -120.38 115.09 22.84 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 171.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -91.65 136.58 33.03 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.34 -27.51 69.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.564 -170.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.41 -12.26 80.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.881 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.61 -17.47 19.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 0.0 111.364 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.483 ' HB ' ' OD1' ' A' ' 76' ' ' ASP . 10.5 m -121.23 125.96 74.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.427 0.632 . . . . 0.0 111.09 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.2 p -86.85 -6.57 58.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.975 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD1' ' HB ' ' A' ' 74' ' ' VAL . 8.8 p-10 -83.12 -2.26 54.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.939 0.399 . . . . 0.0 111.351 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mt -110.41 143.14 20.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.456 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -88.2 99.45 12.22 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.11 -26.93 68.76 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.27 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.08 -42.66 91.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.391 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.3 -44.8 94.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.961 0.41 . . . . 0.0 110.461 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.7 mt -62.89 -40.52 97.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.714 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.73 -42.03 91.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.74 -41.28 99.86 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.684 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.6 p -72.48 -43.99 62.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.699 0.285 . . . . 0.0 111.531 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.72 -27.6 61.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.846 0.355 . . . . 0.0 110.803 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 18.4 ttmm -57.75 -32.65 67.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.048 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.35 -22.72 64.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.562 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.414 HD21 ' SG ' ' A' ' 133' ' ' CYS . 59.3 tp -79.92 -33.81 39.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.2 0.524 . . . . 0.0 110.245 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 94' ' ' SER . 71.4 mt -85.21 -47.31 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.998 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.26 -100.72 0.34 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.827 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -111.57 12.99 27.8 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.426 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.65 171.11 24.19 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.795 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.438 ' HA ' HD12 ' A' ' 90' ' ' ILE . 7.5 p -157.51 102.26 1.89 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.719 0.295 . . . . 0.0 110.886 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.28 85.48 0.6 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.191 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.4 p -67.09 -9.05 35.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.817 0.341 . . . . 0.0 111.724 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -62.54 -31.33 72.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.223 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.6 23.21 9.69 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.787 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.9 tp -105.14 144.44 31.94 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.403 0.281 . . . . 0.0 110.945 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 163.96 -149.52 16.82 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.845 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.8 mt -107.89 132.96 52.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 152' ' ' CYS . 22.5 m-85 -114.9 143.18 45.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -125.84 152.96 44.79 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 110.483 -0.192 . . . . 0.0 110.483 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 57.97 58.15 3.74 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.575 0.702 . . . . 0.0 109.643 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 6.9 t -120.35 144.25 47.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.83 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.1 t -126.06 140.65 52.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.446 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -79.09 147.44 32.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.911 0.386 . . . . 0.0 110.71 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.702 HD11 ' SG ' ' A' ' 64' ' ' CYS . 62.3 mt -102.31 141.49 35.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.594 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -100.29 126.03 46.57 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.44 HD23 HG21 ' A' ' 53' ' ' THR . 3.0 pp -77.95 136.2 37.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.027 0.441 . . . . 0.0 110.305 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -73.95 126.28 30.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.37 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 60.0 mt -99.74 114.3 65.55 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.109 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.79 83.95 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.044 1.83 . . . . 0.0 111.481 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.5 mt -77.37 -80.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.645 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.8 mm -112.1 93.57 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.047 0.451 . . . . 0.0 111.129 -175.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 118' ' ' PRO . . . 64.13 49.73 64.89 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.109 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 41.1 mt -111.76 89.08 10.57 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 116' ' ' GLY . 72.9 Cg_endo -89.35 39.58 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.757 2.305 . . . . 0.0 111.888 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.4 mm -103.79 120.95 54.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.093 0.473 . . . . 0.0 110.482 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -101.4 85.75 2.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.34 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.78 103.73 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.604 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 97.6 mt -70.36 131.76 44.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.067 0.46 . . . . 0.0 110.256 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 47' ' ' ILE . 10.5 p -66.74 -35.78 75.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.497 -173.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -70.95 -16.37 62.65 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.912 0.387 . . . . 0.0 110.999 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -83.58 -28.32 28.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.509 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -114.42 -14.72 12.16 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.823 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.3 t -108.38 116.68 32.42 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -100.16 -4.48 29.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.445 0.641 . . . . 0.0 110.18 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 65' ' ' CYS . 23.1 mp0 -91.56 168.29 11.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.242 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.65 131.68 45.0 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.589 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 29.3 mt -93.79 126.96 46.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.569 -174.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.42 ' HB1' ' SG ' ' A' ' 152' ' ' CYS . . . -135.38 158.43 44.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.327 0.585 . . . . 0.0 111.656 -176.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.414 ' SG ' HD21 ' A' ' 89' ' ' LEU . 37.1 t -110.0 115.13 29.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.653 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.5 m -110.78 139.49 46.04 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.731 -170.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.44 139.33 49.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.628 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.13 64.0 3.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.473 0.654 . . . . 0.0 110.558 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.4 m -105.23 92.96 6.08 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.404 173.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -77.86 50.76 3.37 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.532 2.155 . . . . 0.0 112.869 -174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.0 t -166.27 136.52 3.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.43 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -77.82 -12.39 59.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.309 0.576 . . . . 0.0 110.307 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.71 54.14 2.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.847 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.4 t -135.58 33.94 2.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.954 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.18 50.0 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.216 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.8 t 65.51 43.73 3.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.005 0.431 . . . . 0.0 110.344 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 92.7 mt 59.0 86.06 0.09 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.294 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 12.7 pt -122.26 61.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.321 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -78.73 14.8 11.6 Favored Glycine 0 C--O 1.23 -0.148 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.756 175.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 36.2 mt -87.93 -10.34 50.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.148 0.499 . . . . 0.0 110.146 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 165.51 173.26 33.86 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.553 ' H ' HD23 ' A' ' 150' ' ' LEU . 0.7 OUTLIER -95.02 134.16 25.18 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 117.031 0.416 . . . . 0.0 110.53 -178.518 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.64 123.84 11.95 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.596 2.197 . . . . 0.0 111.182 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.492 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 3.6 t -153.67 163.83 39.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.857 -174.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.44 133.15 60.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.58 130.05 34.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.539 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.64 -24.61 67.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.315 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -72.91 -15.37 78.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.586 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 m -80.6 -29.61 36.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.033 0.417 . . . . 0.0 111.299 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 29.4 pt -100.49 -9.65 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.787 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 C--O 1.249 1.078 0 O-C-N 123.85 0.719 . . . . 0.0 112.382 177.907 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.436 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 7.1 p . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 121.423 0.63 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.572 ' HD2' ' CE1' ' A' ' 41' ' ' PHE . 3.3 tmt_? -68.37 -34.27 75.76 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.411 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CE1' ' HD2' ' A' ' 40' ' ' ARG . 90.3 m-85 -118.69 87.49 32.42 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.6 151.25 69.94 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.508 2.139 . . . . 0.0 112.542 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.3 t -82.35 128.26 67.95 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.294 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.16 137.15 45.97 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.049 2.499 . . . . 0.0 112.613 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.23 -11.04 47.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.575 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -86.37 -1.42 57.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.122 0.487 . . . . 0.0 111.243 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.34 122.39 41.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.162 0.506 . . . . 0.0 111.01 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 70.5 p -81.93 163.81 21.96 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.436 174.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.505 HG12 HD23 ' A' ' 110' ' ' LEU . 21.9 t -57.0 -39.43 65.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 0.0 110.594 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.41 -46.37 73.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.164 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -58.77 -44.31 90.62 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 110.378 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 62' ' ' LEU . . . -61.89 -45.9 91.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.095 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.495 ' OG1' HD21 ' A' ' 110' ' ' LEU . 90.9 m -64.56 -46.68 81.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.211 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -67.3 -28.39 67.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.013 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -64.26 -40.92 96.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.44 . . . . 0.0 110.061 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' HD13 ' A' ' 155' ' ' LEU . 81.0 m -101.09 14.03 33.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.196 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.42 168.8 8.66 Favored Glycine 0 CA--C 1.518 0.26 0 N-CA-C 114.266 0.467 . . . . 0.0 114.266 -171.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 72.02 -67.84 0.24 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.014 0.926 . . . . 0.0 111.991 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -94.21 -8.49 39.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -171.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 56' ' ' CYS . . . -138.65 163.6 31.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.412 0.625 . . . . 0.0 111.864 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -128.3 138.23 52.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.296 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' ' 52' ' ' ALA . 12.1 mt -69.27 134.77 49.58 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.787 0.327 . . . . 0.0 110.837 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.478 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 38.2 t -140.62 129.94 23.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.133 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.483 ' SG ' HD11 ' A' ' 108' ' ' LEU . 59.9 m -102.33 116.99 33.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.65 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 129' ' ' GLN . 9.0 m -118.98 143.33 47.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.307 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -71.33 -37.38 71.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.719 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -126.83 141.27 51.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.036 0.446 . . . . 0.0 111.594 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.22 122.58 28.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.424 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 m -103.32 115.25 30.19 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.436 ' OH ' ' HA ' ' A' ' 39' ' ' VAL . 87.7 m-85 -91.36 133.18 35.67 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.68 67.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.582 -168.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.32 -20.84 76.63 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.581 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.86 -14.5 26.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.643 0.259 . . . . 0.0 111.471 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 77' ' ' ILE . 21.8 m -121.72 150.31 25.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.562 178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -108.39 2.91 22.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -95.64 1.77 53.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.03 0.443 . . . . 0.0 110.893 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.407 HD12 HG21 ' A' ' 74' ' ' VAL . 46.0 mt -119.25 136.5 56.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.946 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -86.86 108.01 18.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.049 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.34 -30.2 69.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.084 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.25 -39.67 96.18 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.608 -176.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.9 -47.43 88.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.121 0.486 . . . . 0.0 110.189 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 88.5 mt -67.43 -45.58 75.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.896 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -63.78 -41.14 98.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.952 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.85 -46.81 93.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.421 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.9 p -73.32 -40.6 64.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.901 0.382 . . . . 0.0 111.854 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -74.24 -23.21 59.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.425 -177.532 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 38.2 ttpt -54.63 -32.64 59.28 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.708 -174.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -62.9 -32.41 73.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.84 0.352 . . . . 0.0 110.485 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 89' ' ' LEU . 3.1 tm? -82.73 -34.86 27.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.42 -44.83 99.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.42 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.7 -74.78 2.47 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.492 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.81 -89.11 0.85 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.242 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.77 -172.28 45.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.996 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.6 m 62.91 59.08 1.41 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.71 0.404 . . . . 0.0 111.629 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.77 12.69 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.969 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.7 p -75.98 -18.87 59.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.829 0.347 . . . . 0.0 111.708 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.04 -13.7 62.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.323 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.44 23.93 10.83 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.38 142.5 38.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.56 -149.62 12.97 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.619 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.07 126.19 54.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -112.38 139.78 47.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.928 -173.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -120.25 154.03 35.49 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.671 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 61.9 58.7 1.86 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.691 0.757 . . . . 0.0 109.898 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.478 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 90.4 m -101.72 142.69 32.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.037 -173.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.8 p -132.94 137.33 46.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.567 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -80.89 144.92 31.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.793 0.33 . . . . 0.0 110.359 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.483 HD11 ' SG ' ' A' ' 64' ' ' CYS . 62.3 mt -91.33 124.99 35.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.54 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -85.71 145.65 27.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.697 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.505 HD23 HG12 ' A' ' 49' ' ' VAL . 91.9 mt -97.49 126.21 42.63 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.316 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -89.28 101.86 14.52 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 170.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 54.1 mt -98.97 123.22 50.0 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.901 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.22 90.34 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.432 2.088 . . . . 0.0 112.169 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 55.8 mt -79.6 92.86 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.4 tp 39.53 64.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 122.125 0.964 . . . . 0.0 111.842 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -149.79 -100.04 0.21 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.04 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.7 pt -130.68 106.49 15.56 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.942 0.401 . . . . 0.0 110.966 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.77 96.97 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.839 2.359 . . . . 0.0 112.173 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 67.8 mt -97.91 127.56 50.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.369 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -78.82 73.42 5.37 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.35 106.43 10.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.422 -175.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 64.8 mt -70.85 136.69 48.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.437 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.475 ' HA ' HG22 ' A' ' 49' ' ' VAL . 13.1 p -65.96 -29.65 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.241 -174.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.14 -13.35 61.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.077 0.465 . . . . 0.0 110.842 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -83.77 -27.69 28.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -108.74 -16.13 14.25 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.014 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.408 ' SG ' HG12 ' A' ' 131' ' ' ILE . 48.6 t -109.16 111.93 23.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.781 177.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -103.43 9.52 37.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.607 0.718 . . . . 0.0 109.97 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 65' ' ' CYS . 2.1 mp0 -105.12 168.56 8.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.692 -1.14 . . . . 0.0 107.967 176.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.42 ' CB ' ' HB ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -70.1 128.56 36.71 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.378 178.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.408 HG12 ' SG ' ' A' ' 127' ' ' CYS . 23.3 mt -88.18 125.24 41.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.825 -174.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.09 155.9 49.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.202 0.525 . . . . 0.0 111.275 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 64.8 m -106.0 129.76 54.06 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.8 m -111.34 139.34 46.82 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -77.36 134.18 38.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.075 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -84.47 54.23 2.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.65 . . . . 0.0 110.293 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.1 m -118.4 123.28 29.42 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.583 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.58 98.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.52 2.147 . . . . 0.0 112.448 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.0 m -78.39 56.48 1.75 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.436 0.636 . . . . 0.0 109.878 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -83.43 47.7 1.3 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.919 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.41 -27.99 56.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.467 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.2 t -130.64 37.29 3.84 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.33 -141.97 41.9 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.61 -176.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 47.1 m -84.07 -14.91 49.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.177 0.513 . . . . 0.0 110.148 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.8 tp -80.75 72.36 7.71 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.371 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 23.0 pt -130.61 51.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.183 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.32 33.7 2.01 Favored Glycine 0 N--CA 1.455 -0.089 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.426 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 53.7 mt -89.38 -26.99 20.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.066 0.46 . . . . 0.0 109.875 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 148.58 -176.7 27.26 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.218 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.5 mp -111.0 135.55 20.84 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.42 121.04 6.52 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.356 1.371 . . . . 0.0 110.727 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 42.5 m -152.55 160.54 43.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.131 -173.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.06 136.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.198 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.31 124.57 20.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.334 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.495 HD13 ' SG ' ' A' ' 56' ' ' CYS . 57.6 tp -61.12 -29.57 69.85 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.641 -175.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.414 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -66.27 -16.02 64.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.661 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.1 m -70.87 -30.16 66.46 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 117.061 0.43 . . . . 0.0 111.102 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 41.5 pt -99.8 -9.1 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.425 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 C--O 1.251 1.152 0 O-C-N 123.639 0.587 . . . . 0.0 111.784 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -76.25 -27.81 56.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.889 0.376 . . . . 0.0 111.081 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.519 ' O ' ' HA3' ' A' ' 156' ' ' GLY . 54.8 m-85 -136.71 97.57 11.29 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.77 139.66 44.4 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.874 2.383 . . . . 0.0 112.76 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -81.64 134.75 50.27 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.406 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.93 135.05 50.39 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.272 1.981 . . . . 0.0 111.914 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.06 -10.39 59.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.695 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.66 4.68 48.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.799 0.333 . . . . 0.0 111.177 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.3 mm -93.15 117.48 36.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.139 0.495 . . . . 0.0 110.586 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 32.9 p -77.38 159.68 29.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.531 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 123' ' ' VAL . 44.1 t -54.27 -42.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.918 0.389 . . . . 0.0 110.614 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -60.63 -47.07 87.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.997 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -67.26 -35.95 80.58 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.488 0.185 . . . . 0.0 111.045 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.25 80.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 110.062 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.1 m -67.71 -47.52 69.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.659 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -65.08 -34.56 78.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -63.38 -37.54 87.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.629 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.64 ' SG ' HD13 ' A' ' 155' ' ' LEU . 92.5 m -91.04 -19.85 22.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.748 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.47 178.78 29.82 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.479 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -82.54 -16.52 48.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -91.97 11.82 23.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.237 0.542 . . . . 0.0 110.606 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 134' ' ' CYS . . . -132.67 126.51 32.79 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.838 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -95.45 128.41 42.28 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.214 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 33.0 mt -65.44 122.87 18.17 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.871 0.367 . . . . 0.0 110.196 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.425 ' HB3' ' SG ' ' A' ' 105' ' ' CYS . 19.6 m -134.01 131.72 39.25 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.31 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.495 ' SG ' HD11 ' A' ' 108' ' ' LEU . 66.7 m -107.75 118.06 35.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.182 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER -116.68 140.05 49.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.812 -175.69 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.42 -19.76 49.2 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.818 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -126.42 140.98 52.06 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.608 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.23 127.0 32.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.282 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.4 m -119.95 115.83 24.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -95.1 132.03 40.46 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.76 -27.27 68.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.856 -171.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.81 -23.64 72.57 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.877 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -94.67 -18.58 21.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.184 0.492 . . . . 0.0 111.507 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.478 HG21 HD12 ' A' ' 77' ' ' ILE . 16.8 m -121.52 125.01 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.324 0.583 . . . . 0.0 111.429 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 p -85.99 -14.75 43.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.827 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -73.45 -15.04 61.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.187 0.518 . . . . 0.0 111.178 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.478 HD12 HG21 ' A' ' 74' ' ' VAL . 43.9 mt -103.75 130.32 54.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.89 106.73 3.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.125 0.488 . . . . 0.0 110.587 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.69 -29.4 68.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.03 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.41 -44.11 95.8 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.721 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.8 mt -63.25 -46.41 95.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.247 0.546 . . . . 0.0 110.266 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.35 -43.15 95.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.123 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.65 -39.1 88.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.721 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.25 -46.2 88.15 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.438 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 p -68.75 -42.74 77.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.829 0.347 . . . . 0.0 111.498 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.96 -26.21 59.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -57.89 -32.55 67.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.822 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -63.17 -28.65 70.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.487 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 60' ' ' ALA . 66.5 tp -86.83 -37.41 17.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.458 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.0 mt -72.3 -37.16 57.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.77 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.92 -73.12 0.22 Allowed Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -135.52 128.75 4.78 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.142 -0.552 . . . . 0.0 111.838 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.8 -170.05 33.12 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.575 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.7 p -157.97 115.28 2.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.93 0.395 . . . . 0.0 111.053 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.06 78.83 1.67 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 29.8 p -70.06 -18.87 63.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -172.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.41 -33.17 74.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.835 0.35 . . . . 0.0 111.324 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.438 ' HA3' ' OG ' ' A' ' 157' ' ' SER . . . -108.03 15.03 37.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.881 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 96' ' ' THR . 45.1 tp -104.02 141.6 35.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.591 0.234 . . . . 0.0 110.7 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 166.4 -156.47 28.38 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.576 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.1 mt -106.25 122.87 47.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.463 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 16.4 m-85 -106.34 133.72 50.6 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.016 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -119.69 154.49 34.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.717 -175.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.452 ' HA ' ' OE1' ' A' ' 104' ' ' GLN . 13.4 mm-40 59.08 58.15 3.24 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 3.5 t -120.66 138.86 53.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.25 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.7 m -129.73 149.93 51.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.822 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -78.93 147.47 33.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.947 0.403 . . . . 0.0 110.753 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 64' ' ' CYS . 69.8 mt -89.93 137.74 32.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.614 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.91 129.06 34.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.039 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.27 118.79 30.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.919 0.39 . . . . 0.0 111.074 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -105.51 101.42 10.95 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 56.3 mt -114.73 113.53 44.79 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.094 -175.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.97 122.49 3.38 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.246 1.964 . . . . 0.0 111.288 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.4 mt -100.73 80.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.948 0.404 . . . . 0.0 110.309 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.0 mm 64.37 98.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.285 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 167.97 -68.74 0.17 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.484 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.1 mm -110.03 115.13 55.37 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -65.84 89.46 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.565 2.177 . . . . 0.0 111.837 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.7 mt -109.18 124.24 65.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.983 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -113.14 76.25 0.97 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -87.48 104.46 16.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.647 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 52.8 mt -72.86 135.64 45.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.433 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.427 ' HA ' HG22 ' A' ' 49' ' ' VAL . 10.9 p -65.24 -29.67 47.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.925 -176.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -71.5 -16.77 62.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.995 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -83.86 -26.04 29.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.789 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.41 -17.1 14.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.359 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 131' ' ' ILE . 38.4 t -111.95 114.77 27.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.643 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.452 ' HB2' ' NZ ' ' A' ' 128' ' ' LYS . 9.4 mtmp? -99.88 2.12 43.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.473 0.654 . . . . 0.0 110.043 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 0.8 OUTLIER -107.51 173.4 6.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.649 -176.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -63.13 122.78 16.95 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.485 HG12 ' SG ' ' A' ' 127' ' ' CYS . 17.7 mt -91.29 117.33 34.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.161 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.69 154.07 50.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.201 0.524 . . . . 0.0 111.012 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.421 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 75.7 m -109.81 129.11 55.67 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.477 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 21.3 m -112.35 140.57 46.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.511 ' HG3' ' H ' ' A' ' 137' ' ' SER . 6.4 tp60 -70.62 129.52 39.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.204 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -86.87 28.46 0.89 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.101 0.477 . . . . 0.0 111.78 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.511 ' H ' ' HG3' ' A' ' 135' ' ' GLN . 60.7 m -102.33 108.18 56.21 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.836 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.69 45.74 2.03 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.329 2.019 . . . . 0.0 112.124 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.9 p -79.85 -59.12 2.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.672 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.19 3.73 15.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.084 0.468 . . . . 0.0 110.616 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.59 -15.65 36.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.687 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.0 m -82.03 67.36 8.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.788 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -141.09 139.99 10.01 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.539 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.7 t -94.75 -14.96 24.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.111 0.482 . . . . 0.0 110.093 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.3 mt -95.08 19.95 9.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.883 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.5 pt -127.55 55.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.569 0.7 . . . . 0.0 110.795 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -78.44 21.4 3.66 Favored Glycine 0 CA--C 1.517 0.159 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.329 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -71.22 -29.38 65.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.875 0.369 . . . . 0.0 110.48 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 154.52 -170.86 32.95 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.977 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.3 mp -108.08 129.18 24.45 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -70.77 120.96 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.634 1.556 . . . . 0.0 110.95 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 61.3 m -153.45 161.92 41.79 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.6 133.42 68.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.838 0.351 . . . . 0.0 110.651 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.43 125.89 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.01 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.64 HD13 ' SG ' ' A' ' 56' ' ' CYS . 45.4 tp -65.11 -26.82 68.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.158 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 41' ' ' PHE . . . -66.8 -19.4 69.44 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.891 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.438 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 30.8 m -68.88 -29.13 67.35 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.176 0.488 . . . . 0.0 110.997 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.4 pt -101.03 -1.43 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.863 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.247 0.924 0 O-C-N 124.034 0.834 . . . . 0.0 111.79 178.366 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.419 ' HB ' ' OD1' ' A' ' 130' ' ' ASN . 7.2 p . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -62.78 -30.83 71.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.744 -175.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.519 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 51.0 m-85 -138.03 91.47 13.15 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.223 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.56 144.95 62.61 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.188 1.925 . . . . 0.0 112.508 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -82.16 131.95 54.82 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.89 134.43 41.92 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.99 1.793 . . . . 0.0 111.943 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.13 -17.28 64.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.91 -172.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -81.81 2.87 28.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.87 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.45 ' O ' HG12 ' A' ' 123' ' ' VAL . 30.9 mm -89.6 127.24 42.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.976 0.417 . . . . 0.0 110.53 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 55.5 p -83.93 163.78 19.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.419 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.1 t -56.15 -43.18 75.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.936 0.398 . . . . 0.0 110.795 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -62.43 -46.59 87.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -67.98 -37.42 81.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.245 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.32 99.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.839 0.352 . . . . 0.0 110.713 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.477 HG21 HD11 ' A' ' 110' ' ' LEU . 39.8 m -62.68 -45.75 91.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.42 -30.6 71.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.23 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -72.67 -31.44 65.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.336 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 133' ' ' CYS . 83.0 m -77.71 -22.33 50.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.124 0.488 . . . . 0.0 110.122 173.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.07 172.88 34.26 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.218 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -78.82 -21.01 48.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.879 0.371 . . . . 0.0 110.651 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.81 19.63 6.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.799 0.333 . . . . 0.0 110.908 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 134' ' ' CYS . . . -140.68 143.57 35.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.992 0.425 . . . . 0.0 110.663 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -117.88 134.84 54.54 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.747 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.92 125.73 25.79 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.782 0.325 . . . . 0.0 110.295 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 107' ' ' LYS . 16.7 m -129.84 126.14 37.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.194 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 89.5 m -103.92 115.43 30.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 3.0 m -119.27 138.67 52.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 -172.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -81.0 -18.86 45.39 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.002 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -123.24 138.3 54.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.181 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.18 121.51 23.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.715 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 m -118.6 115.79 25.29 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 74' ' ' VAL . 59.2 m-85 -95.07 126.69 40.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.076 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.51 -31.32 72.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.531 -169.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.41 -20.42 67.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.934 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -102.36 -16.73 16.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 70' ' ' TYR . 19.5 m -119.11 135.69 58.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.075 0.464 . . . . 0.0 111.331 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.1 p -86.11 -16.11 39.02 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -72.45 -6.1 41.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 111.476 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.6 mt -119.09 139.05 47.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.381 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -89.13 102.39 15.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.85 -35.9 82.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.021 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.21 97.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.577 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.5 mt -64.97 -48.53 83.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.053 0.454 . . . . 0.0 110.528 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 151' ' ' PRO . 41.7 mt -68.12 -45.53 73.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.071 -175.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.37 -37.19 84.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.662 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.93 -45.05 96.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.068 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 p -72.8 -42.23 64.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.814 0.34 . . . . 0.0 111.798 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.78 -26.29 59.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.501 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 53.7 tttp -56.87 -29.0 62.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.889 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -60.57 -26.37 66.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.257 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.37 -36.95 26.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.913 0.387 . . . . 0.0 110.673 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.3 mt -72.02 -36.19 56.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.63 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.76 -118.59 4.86 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.742 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.86 58.39 1.25 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.255 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.75 -174.36 30.49 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -149.59 152.46 35.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.933 0.397 . . . . 0.0 110.405 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.84 51.41 0.19 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.6 p -71.7 -14.1 61.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.306 -0.447 . . . . 0.0 111.959 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.17 -21.16 64.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.435 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.53 19.22 24.3 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 100' ' ' GLY . 7.3 tt -113.33 143.15 44.93 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -175.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.501 ' N ' HD23 ' A' ' 99' ' ' LEU . . . 165.63 -136.72 4.31 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.008 -1.092 . . . . 0.0 113.234 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 94.2 mt -113.5 133.22 55.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.567 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 33.3 m-85 -118.81 124.86 48.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.317 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -120.47 159.58 24.86 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.724 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 60.24 58.0 2.75 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 7.0 t -121.97 153.59 38.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.941 -168.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.1 p -136.53 130.51 32.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.042 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 68.6 mttm -81.87 148.93 28.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.146 0.498 . . . . 0.0 110.837 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.436 HD11 ' SG ' ' A' ' 64' ' ' CYS . 94.2 mt -92.46 135.54 33.96 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.863 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -100.63 132.29 46.09 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 53' ' ' THR . 61.9 mt -66.69 116.04 7.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.037 0.446 . . . . 0.0 110.736 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -106.68 101.13 10.6 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.552 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.8 mm -112.89 111.68 50.91 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.51 88.35 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.964 1.776 . . . . 0.0 111.856 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 51.7 mt -86.06 81.37 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.444 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.405 ' O ' HG13 ' A' ' 115' ' ' ILE . 9.8 tp -162.7 43.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 122.214 1.007 . . . . 0.0 109.607 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 126.09 -75.59 0.4 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.029 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 65.2 mt -115.94 112.87 42.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -78.55 78.3 3.71 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.265 1.977 . . . . 0.0 111.538 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.1 mt -63.44 132.03 29.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.83 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -122.16 97.5 5.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.786 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -87.95 160.52 17.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.397 0.618 . . . . 0.0 111.399 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 71.7 mt -67.01 134.14 51.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.591 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 47' ' ' ILE . 12.1 p -66.12 -32.5 58.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.573 -174.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -68.82 -16.12 63.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.639 0.256 . . . . 0.0 110.797 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -85.13 -26.6 26.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.655 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -95.35 -19.04 20.27 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.472 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.641 ' SG ' HG12 ' A' ' 131' ' ' ILE . 45.6 t -111.88 112.45 24.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.592 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.4 2.01 36.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.143 0.497 . . . . 0.0 110.703 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 2.1 mp0 -105.54 172.03 7.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.571 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.419 ' OD1' ' HB ' ' A' ' 39' ' ' VAL . 28.9 m-80 -63.97 125.97 26.16 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.641 HG12 ' SG ' ' A' ' 127' ' ' CYS . 14.1 mt -92.64 125.36 45.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.773 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.5 157.16 47.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.033 0.444 . . . . 0.0 111.316 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 155' ' ' LEU . 30.6 m -105.74 116.42 31.92 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 57.1 m -108.98 139.74 43.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -79.42 129.62 34.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.058 0.456 . . . . 0.0 111.102 -173.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -82.62 68.65 9.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.372 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 p -57.05 126.09 72.15 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.243 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.91 51.79 3.76 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.88 2.387 . . . . 0.0 112.223 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.1 t -157.94 139.26 13.53 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.914 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -94.01 104.28 16.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.933 0.397 . . . . 0.0 111.047 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -106.97 25.22 11.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.31 0.576 . . . . 0.0 109.494 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 m -77.99 69.92 4.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.848 -175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -119.63 -141.31 6.4 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.879 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.1 t -98.35 -11.54 22.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.775 0.321 . . . . 0.0 110.799 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 91.7 mt -89.12 15.55 8.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.902 0.382 . . . . 0.0 111.441 -174.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 39.7 pt -122.71 33.6 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.241 0.543 . . . . 0.0 110.708 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -81.45 -6.54 89.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.306 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.5 mt -75.33 -35.34 61.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.851 0.357 . . . . 0.0 110.616 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 147.18 -179.97 23.7 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 20.5 mt -95.37 130.54 31.96 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.45 ' HB3' HD22 ' A' ' 82' ' ' LEU . 17.2 Cg_exo -66.45 122.95 10.5 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.124 1.883 . . . . 0.0 111.114 175.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.409 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -155.09 168.88 25.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -177.04 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.7 tt -135.48 136.26 50.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.38 124.62 21.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.624 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.584 HD13 ' SG ' ' A' ' 133' ' ' CYS . 53.4 tp -64.55 -25.69 68.09 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.999 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.519 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.52 -17.11 76.1 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.449 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.9 m -74.06 -29.35 61.85 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 117.249 0.525 . . . . 0.0 111.205 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.5 pt -97.16 -3.77 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.756 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.341 -0.838 . . . . 0.0 111.858 178.949 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 121.184 0.516 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -73.19 -26.67 61.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.145 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -130.85 88.71 45.21 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.11 147.96 74.32 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.742 2.295 . . . . 0.0 113.264 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.29 134.69 45.25 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.14 176.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.91 135.82 43.52 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.655 2.237 . . . . 0.0 112.287 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.77 -16.06 63.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.144 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -92.09 10.37 29.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.769 0.319 . . . . 0.0 111.234 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.4 mm -93.59 123.32 45.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.218 0.533 . . . . 0.0 110.683 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 66.4 p -80.19 160.83 25.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.415 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.64 -40.38 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.216 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -62.39 -46.46 88.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.869 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -62.44 -43.83 97.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.863 0.363 . . . . 0.0 110.473 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' CYS . . . -61.4 -39.48 90.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.712 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.2 m -62.66 -47.54 83.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.798 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -71.71 -36.27 70.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.496 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -75.25 -20.37 59.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.18 0.514 . . . . 0.0 110.553 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 20.7 t -72.49 -21.73 61.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.229 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.45 160.06 20.02 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.993 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -82.83 -14.52 54.2 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -115.57 23.54 12.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.142 0.496 . . . . 0.0 110.534 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 89' ' ' LEU . . . -124.99 148.68 48.32 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.468 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -113.67 129.21 56.61 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.505 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 26.2 mt -64.45 119.22 10.0 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.545 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 42.6 t -129.5 127.25 40.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.383 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.543 ' SG ' HD21 ' A' ' 108' ' ' LEU . 45.0 m -97.68 119.72 36.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.923 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 41.7 m -117.38 129.36 55.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.753 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -71.86 -27.95 63.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -123.34 139.03 54.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.712 0.291 . . . . 0.0 110.379 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.6 124.3 26.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.528 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.8 m -117.19 115.33 25.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.836 0.351 . . . . 0.0 110.286 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -93.52 133.05 37.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.05 -33.89 75.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.362 -169.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.53 -12.7 64.39 Favored Glycine 0 C--O 1.229 -0.189 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.06 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.99 -15.48 18.26 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.622 -0.34 . . . . 0.0 111.418 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.585 HG21 HD12 ' A' ' 77' ' ' ILE . 14.7 m -120.79 127.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.536 0.684 . . . . 0.0 111.5 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p -85.62 -11.64 53.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.279 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.55 -1.09 55.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.842 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.619 HD13 HD23 ' A' ' 101' ' ' LEU . 30.0 mt -118.08 134.54 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.896 0.379 . . . . 0.0 111.387 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.07 102.13 10.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.873 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.34 -30.08 68.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.112 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.76 -42.34 99.74 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.32 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.96 -44.77 99.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.162 0.506 . . . . 0.0 110.041 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.78 -44.29 97.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.608 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.37 -45.4 84.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.712 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.98 -45.02 97.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.659 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.5 p -73.34 -44.83 58.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.508 HD22 HD13 ' A' ' 99' ' ' LEU . 18.2 tp -73.83 -22.55 59.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.623 0.249 . . . . 0.0 111.411 -177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 63.2 tttm -54.16 -29.79 46.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 111.043 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -63.01 -22.23 66.7 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.938 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 60' ' ' ALA . 52.4 tp -90.62 -30.5 17.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.04 -40.29 51.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.694 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.79 -78.67 1.99 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.437 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.33 84.91 0.31 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.275 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.98 -174.76 34.59 Favored Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.919 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -155.75 120.94 4.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.77 0.319 . . . . 0.0 110.435 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -136.56 62.4 0.6 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 32.1 p -69.6 -15.91 63.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -172.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -60.02 -29.08 68.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.401 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.72 16.95 43.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.763 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.508 HD13 HD22 ' A' ' 86' ' ' LEU . 37.7 tp -103.16 143.2 32.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.055 0.455 . . . . 0.0 110.962 -176.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.63 -150.16 13.77 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.286 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.619 HD23 HD13 ' A' ' 77' ' ' ILE . 4.2 mm? -111.01 129.1 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.45 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 33.3 m-85 -113.46 136.4 52.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.387 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -119.97 151.94 38.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.363 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 62.29 58.19 1.81 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.345 0.593 . . . . 0.0 109.952 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.545 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 76.3 m -108.42 136.37 48.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.711 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.6 t -132.66 143.99 50.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -72.11 140.51 48.93 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.546 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.543 HD21 ' SG ' ' A' ' 64' ' ' CYS . 33.8 mt -83.85 142.71 30.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.1 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -74.68 132.71 41.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.589 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.6 mt -81.81 146.78 29.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 -175.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -85.96 104.04 15.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.505 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.9 mt -88.48 116.04 65.08 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.229 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.92 120.21 7.78 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.974 2.449 . . . . 0.0 112.722 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 117' ' ' ILE . 66.6 mt -91.21 120.33 39.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.686 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.1 mm -65.99 93.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.094 0.473 . . . . 0.0 110.039 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 131.32 -32.79 2.9 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.707 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.458 ' O ' ' HB ' ' A' ' 114' ' ' ILE . 42.3 mt -130.1 96.71 24.67 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.25 84.14 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.44 2.094 . . . . 0.0 112.33 -176.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.9 mt -86.56 131.64 34.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.849 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.509 ' HB2' HG21 ' A' ' 48' ' ' THR . 13.0 pt20 -134.63 90.25 2.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.815 0.817 . . . . 0.0 109.489 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.3 p30 -85.05 132.67 34.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.845 -173.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 91.4 mt -69.03 129.53 40.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.587 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.66 -36.08 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.844 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -69.97 -18.02 63.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.227 0.537 . . . . 0.0 110.549 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -84.14 -26.16 29.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.481 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -103.26 -17.78 15.17 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.326 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 36.7 t -111.48 123.28 49.9 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.847 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -100.79 7.0 44.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.321 0.581 . . . . 0.0 109.978 172.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 28.1 mp0 -108.83 170.04 8.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.117 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -65.4 128.87 37.66 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.3 mt -96.08 123.64 48.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.336 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.88 158.6 43.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.119 0.485 . . . . 0.0 111.668 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 46.9 m -107.48 114.25 28.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.917 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 26.3 m -110.42 141.91 42.86 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -175.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.434 ' HG3' ' H ' ' A' ' 137' ' ' SER . 19.3 tp60 -66.38 122.13 16.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.105 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -85.72 24.08 1.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.124 0.487 . . . . 0.0 111.515 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.434 ' H ' ' HG3' ' A' ' 135' ' ' GLN . 45.3 m -77.52 143.22 67.79 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.073 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.49 60.05 4.92 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.79 2.326 . . . . 0.0 112.19 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.0 m -60.32 121.86 13.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.596 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.91 83.46 5.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.319 0.58 . . . . 0.0 110.835 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -125.29 74.27 1.37 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.996 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.5 t -101.64 49.24 0.87 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.278 0.561 . . . . 0.0 110.255 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -112.43 169.61 13.13 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.864 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 37.1 t -99.74 -16.35 18.16 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.188 0.518 . . . . 0.0 110.01 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.6 pp -79.66 8.39 6.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.558 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 34.6 pt -106.64 51.46 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.542 0.686 . . . . 0.0 110.826 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -81.76 8.13 60.43 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.714 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 101' ' ' LEU . 78.9 mt -71.2 -30.71 66.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.898 0.38 . . . . 0.0 110.147 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 121.76 -166.71 14.49 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.592 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 150' ' ' LEU . 1.1 pt? -111.0 142.14 25.65 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 30.5 Cg_exo -62.18 123.68 12.95 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.458 2.106 . . . . 0.0 111.307 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.449 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 4.1 t -154.01 164.77 37.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.8 tt -133.95 135.76 54.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.874 0.369 . . . . 0.0 110.668 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.25 128.22 35.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.5 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.9 tt -62.94 -29.02 70.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.894 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -67.72 -16.19 67.58 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.831 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.9 m -77.2 -27.66 53.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.019 0.41 . . . . 0.0 111.161 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.6 pt -103.6 -1.44 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.168 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.594 179.343 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 8.3 p . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 121.307 0.575 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -74.38 -24.47 59.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.129 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -125.57 87.34 55.95 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.01 152.87 73.11 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.551 2.167 . . . . 0.0 113.044 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.9 t -93.02 132.7 30.24 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.399 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.27 136.01 46.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.381 2.054 . . . . 0.0 112.06 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -71.76 -10.24 59.48 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.187 -172.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -92.97 12.57 23.45 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.414 ' O ' HG12 ' A' ' 123' ' ' VAL . 40.0 mm -95.17 132.08 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.737 0.303 . . . . 0.0 110.751 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 71.1 p -80.37 159.52 25.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.883 176.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.68 -44.2 80.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.874 0.368 . . . . 0.0 110.367 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 52.9 tptt -62.25 -46.82 87.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.079 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -64.75 -41.84 95.61 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.599 0.238 . . . . 0.0 111.415 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -63.89 -42.3 97.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.572 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.3 m -64.13 -39.03 93.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 15.9 mm-40 -60.94 -34.98 75.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.803 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -74.04 -29.88 62.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.498 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 133' ' ' CYS . 73.7 m -73.51 -20.7 60.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.882 0.372 . . . . 0.0 110.679 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.56 -177.92 20.23 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.713 -178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.29 -13.25 28.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.966 0.383 . . . . 0.0 111.529 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -105.18 14.52 28.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.175 0.512 . . . . 0.0 110.666 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.516 ' HB2' HD13 ' A' ' 89' ' ' LEU . . . -129.14 144.38 51.19 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.82 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -123.21 142.63 50.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.738 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 52' ' ' ALA . 87.4 mt -65.72 129.47 39.88 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.104 0.478 . . . . 0.0 110.928 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 48.4 t -124.85 131.83 53.39 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.159 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.554 ' SG ' HD11 ' A' ' 108' ' ' LEU . 59.3 m -96.3 115.79 27.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.702 175.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.5 m -121.34 132.68 54.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.834 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -84.1 -20.33 32.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.125 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -123.95 137.83 54.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.715 0.293 . . . . 0.0 110.229 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.88 126.65 30.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.293 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -120.08 115.94 24.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.469 ' O ' HG22 ' A' ' 74' ' ' VAL . 62.3 m-85 -94.43 129.84 41.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.021 0.439 . . . . 0.0 110.294 -175.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.65 -28.53 69.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.578 -172.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -64.23 -24.97 69.38 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.736 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.84 -18.64 17.06 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.364 -0.492 . . . . 0.0 111.345 -175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 70' ' ' TYR . 18.7 m -113.69 134.14 57.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.331 0.586 . . . . 0.0 111.051 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.6 p -90.69 -11.54 39.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.574 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.31 -5.99 53.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.871 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.0 mt -117.85 138.91 47.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.148 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.46 99.47 7.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.3 0.571 . . . . 0.0 109.793 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -66.61 -32.55 73.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.179 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.64 -38.44 95.67 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.608 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.85 -48.13 72.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.189 0.518 . . . . 0.0 110.416 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 88.1 mt -62.64 -44.4 96.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.911 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.47 -43.69 98.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.17 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.36 -44.17 97.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.681 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 p -72.37 -42.49 65.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.878 0.37 . . . . 0.0 111.683 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.432 HD13 HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -74.48 -27.09 60.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.347 -176.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.1 -29.16 65.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.895 0.379 . . . . 0.0 110.904 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -60.98 -24.21 65.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.191 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 60' ' ' ALA . 92.6 mt -85.53 -35.0 21.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.014 0.435 . . . . 0.0 110.538 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.9 mt -70.34 -41.81 78.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.232 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.82 -88.17 0.78 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.855 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.01 62.83 0.6 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.005 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.55 178.7 40.88 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.2 p -146.63 138.8 24.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.728 0.264 . . . . 0.0 110.999 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.82 63.24 0.42 Allowed Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.7 p -69.73 -22.66 63.36 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -72.44 -18.63 61.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.799 0.333 . . . . 0.0 111.45 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.53 ' HA3' ' OG ' ' A' ' 157' ' ' SER . . . -110.65 12.63 30.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.596 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 100' ' ' GLY . 1.5 tt -110.43 141.42 43.54 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.422 ' N ' HD23 ' A' ' 99' ' ' LEU . . . 167.79 -142.95 7.84 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.33 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.5 tp -114.03 128.93 56.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -116.18 140.3 49.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.627 0.251 . . . . 0.0 110.608 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -124.26 153.31 41.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.424 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 61.99 57.91 2.0 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.639 0.733 . . . . 0.0 109.703 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.484 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 89.4 m -106.41 130.35 54.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.416 -175.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.1 m -115.03 134.26 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.408 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -73.7 139.49 45.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.1 0.476 . . . . 0.0 111.25 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.554 HD11 ' SG ' ' A' ' 64' ' ' CYS . 77.0 mt -99.24 121.58 41.24 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 172.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -74.91 134.47 41.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.948 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.8 mt -79.5 135.14 36.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.783 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -101.73 139.78 36.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.731 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.2 mt -100.01 116.35 64.7 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.65 78.5 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.302 2.001 . . . . 0.0 111.0 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.65 130.19 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.079 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.57 107.05 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 124.11 -34.21 3.61 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 22.8 mt -122.08 83.62 44.87 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.38 88.6 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.015 2.477 . . . . 0.0 112.909 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.3 mm -98.91 119.75 47.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.793 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -139.61 69.28 1.36 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.373 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -87.82 136.26 33.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.293 0.568 . . . . 0.0 111.345 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 89.2 mt -79.16 134.92 36.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.82 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 47' ' ' ILE . 14.8 p -66.94 -41.25 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.841 -175.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -72.18 -9.16 58.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.744 0.307 . . . . 0.0 111.338 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 122' ' ' LEU . 27.2 tt0 -84.11 -25.96 29.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.872 -173.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -106.88 -16.35 14.48 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.855 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.6 t -109.59 132.96 53.66 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.968 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -112.21 12.05 20.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.256 0.55 . . . . 0.0 110.319 173.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 25.8 mp0 -107.64 169.26 8.7 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.32 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -66.34 136.59 56.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.772 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 23.6 mm -95.48 125.67 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.835 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.02 155.05 47.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 0.0 111.176 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 13.1 m -98.29 128.72 44.87 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 64.4 m -112.97 140.37 47.84 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.986 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.477 ' OE1' HD21 ' A' ' 89' ' ' LEU . 5.4 tp60 -83.18 141.74 31.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.265 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -78.45 44.48 0.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.299 0.571 . . . . 0.0 111.029 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.4 m -59.82 135.02 89.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.758 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.84 51.8 2.82 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.91 2.406 . . . . 0.0 112.508 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.2 t -153.96 98.75 2.2 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -105.03 168.19 9.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.775 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.78 -50.71 71.27 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.284 0.365 . . . . 0.0 111.872 -174.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.2 m -77.63 -21.29 52.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.294 -172.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -91.62 -49.57 2.93 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.882 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.3 m -92.35 2.99 56.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.796 0.331 . . . . 0.0 111.244 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.7 mt 61.04 48.35 6.55 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.202 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.426 ' C ' ' H ' ' A' ' 148' ' ' LEU . 32.3 pt -130.58 63.9 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.571 0.7 . . . . 0.0 110.733 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -77.21 25.87 1.88 Allowed Glycine 0 CA--C 1.516 0.102 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.32 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 146' ' ' ILE . 45.5 mt -73.93 -27.09 60.85 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.172 0.511 . . . . 0.0 110.159 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 152.68 -171.82 31.8 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.29 134.6 22.55 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -71.97 121.05 7.25 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.55 1.5 . . . . 0.0 110.566 174.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 53.7 m -152.72 162.69 40.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.03 137.25 57.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.627 0.251 . . . . 0.0 110.549 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.32 123.79 19.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.385 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 68.8 tp -62.47 -27.35 69.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.197 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.409 ' HA2' ' CD2' ' A' ' 159' ' ' LEU . . . -69.81 -16.19 72.08 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.61 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.53 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 26.6 m -82.86 -24.59 33.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.974 0.387 . . . . 0.0 111.729 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.7 pt -103.97 11.14 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.409 ' CD2' ' HA2' ' A' ' 156' ' ' GLY . 4.7 pp . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.245 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.309 0.576 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -78.0 -25.64 48.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.422 -178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -125.67 89.3 52.73 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.43 146.0 73.11 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.688 2.258 . . . . 0.0 113.184 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 155' ' ' LEU . 41.1 t -84.53 132.57 46.52 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.306 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -51.63 135.01 48.2 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.226 1.95 . . . . 0.0 112.073 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.53 -18.23 64.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.38 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -92.32 9.82 32.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.74 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.5 mm -96.96 119.44 45.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.095 0.474 . . . . 0.0 110.553 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 71.6 p -76.49 160.97 29.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.333 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.31 -36.54 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.004 0.43 . . . . 0.0 110.582 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -67.08 -46.95 72.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.693 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -63.79 -40.99 98.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 110.758 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.63 94.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.798 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 m -65.84 -43.21 89.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.898 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -64.06 -34.82 78.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.993 0.425 . . . . 0.0 110.846 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -68.34 -40.48 81.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.941 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 96.0 m -87.52 -5.78 58.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.33 170.38 23.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.92 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.43 -16.59 54.06 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.771 -0.252 . . . . 0.0 111.437 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -97.92 15.29 24.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.916 0.388 . . . . 0.0 110.862 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.474 ' HB2' HD13 ' A' ' 89' ' ' LEU . . . -130.15 146.34 51.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.902 0.382 . . . . 0.0 111.06 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.577 ' HB2' HD21 ' A' ' 136' ' ' ASN . 45.1 tt0 -135.03 144.19 47.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.89 136.68 56.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 110.984 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.3 t -139.1 140.19 37.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.254 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.548 ' SG ' HD11 ' A' ' 108' ' ' LEU . 56.3 m -109.54 117.37 33.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.525 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 1.8 m -117.04 141.88 47.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.746 -175.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.469 ' HA ' ' OE1' ' A' ' 129' ' ' GLN . 56.3 t30 -84.66 -22.15 29.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.415 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -124.7 140.59 52.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.13 127.43 28.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.691 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.8 m -119.1 115.15 23.67 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -90.22 134.42 34.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.99 -31.36 72.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.55 -169.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.02 -9.49 86.9 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.692 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.26 -16.58 24.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.037 0.446 . . . . 0.0 110.606 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.454 HG21 HD12 ' A' ' 77' ' ' ILE . 16.8 m -120.46 150.2 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.822 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.0 p -96.31 -20.48 18.48 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -82.45 0.67 41.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.813 0.339 . . . . 0.0 111.472 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.454 HD12 HG21 ' A' ' 74' ' ' VAL . 39.0 mt -120.61 130.21 74.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -88.5 109.78 20.33 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.198 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -63.92 -29.22 70.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.432 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.84 -35.84 91.38 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.548 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.7 mt -68.25 -48.07 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.942 0.401 . . . . 0.0 110.318 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.28 -40.18 89.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.999 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.68 -34.73 77.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.989 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.8 -47.97 88.55 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.581 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 p -73.68 -41.31 62.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.867 0.365 . . . . 0.0 111.794 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.464 HD13 HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -72.73 -24.84 61.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.145 -177.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 38.5 ttmt -55.7 -30.26 60.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 110.727 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -61.48 -27.72 68.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.819 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 60' ' ' ALA . 86.3 mt -88.41 -29.63 20.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.507 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.4 mt -72.76 -40.56 61.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.085 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.27 -70.32 2.15 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.161 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.74 104.76 0.3 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.17 -169.41 39.02 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.8 m -148.57 128.6 13.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.965 0.382 . . . . 0.0 110.83 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.69 49.45 0.11 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.712 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.4 p -74.11 -11.91 60.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.951 0.405 . . . . 0.0 111.377 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -64.76 -13.85 56.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.547 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.47 24.76 8.97 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.78 143.83 39.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.37 -147.87 13.5 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.655 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.0 mt -106.72 128.91 54.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.051 0.453 . . . . 0.0 109.945 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.453 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 20.8 m-85 -114.2 131.89 56.3 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.816 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -120.36 154.53 34.95 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.506 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 59.35 58.18 3.1 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.33 0.586 . . . . 0.0 109.576 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 4.2 t -116.36 155.74 27.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.29 -171.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 t -138.53 131.52 29.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -72.41 147.38 46.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.099 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.548 HD11 ' SG ' ' A' ' 64' ' ' CYS . 91.4 mt -98.73 124.83 43.82 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -82.97 135.88 34.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.971 0.415 . . . . 0.0 110.637 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.5 mt . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.513 -177.068 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 . . . . . 0 C--O 1.234 0.25 0 CA-C-O 121.098 0.475 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 60.1 mt -87.3 138.86 31.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.495 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.478 HG23 ' OD1' ' A' ' 124' ' ' ASN . 15.8 m -61.52 -40.42 86.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.158 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.478 ' OD1' HG23 ' A' ' 123' ' ' VAL . 2.0 m-20 -71.25 -15.58 62.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.032 0.444 . . . . 0.0 110.823 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -84.35 -25.68 28.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.93 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -109.18 -17.16 13.92 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.679 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 48.3 t -111.11 135.64 51.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.503 0.192 . . . . 0.0 111.496 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -119.52 14.34 12.74 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.886 0.851 . . . . 0.0 109.266 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 59.8 mm-40 -108.24 171.25 7.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.094 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -64.69 114.9 4.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.317 . . . . 0.0 110.354 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.1 mt -88.52 120.81 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.649 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.73 159.62 41.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 0.0 110.989 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 78.8 m -103.13 127.23 50.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 61.1 m -112.85 143.48 44.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.11 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.411 ' HA ' HD11 ' A' ' 89' ' ' LEU . 5.3 tp-100 -71.09 123.45 22.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.319 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.577 HD21 ' HB2' ' A' ' 61' ' ' GLN . 94.2 m-20 . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 121.224 0.535 . . . . 0.0 110.252 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 121.368 0.604 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -171.97 -173.61 38.86 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.596 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.99 122.86 51.22 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.08 120.71 7.23 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.378 1.385 . . . . 0.0 110.623 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 47.7 m -152.87 162.0 41.84 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.4 tt -127.57 136.46 60.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.776 0.322 . . . . 0.0 110.351 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.48 123.44 19.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 155' ' ' LEU . 5.6 tt -58.73 -28.56 65.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.653 -176.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -65.92 -17.01 64.82 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.701 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.5 m -80.68 -29.51 36.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 117.003 0.401 . . . . 0.0 111.505 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.8 pt -95.15 -9.47 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.746 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--O 1.245 0.857 0 O-C-N 124.206 0.941 . . . . 0.0 111.33 179.326 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 130' ' ' ASN . 7.3 p . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -78.62 -23.81 45.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.444 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 82.0 m-85 -130.0 90.98 40.89 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.433 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.81 148.94 72.2 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.597 2.198 . . . . 0.0 113.294 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -89.3 135.9 30.73 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.439 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -51.87 135.34 50.28 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.452 2.101 . . . . 0.0 112.234 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.0 -11.14 60.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.176 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -92.57 8.11 40.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 111.272 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.2 mm -90.01 126.98 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.893 0.378 . . . . 0.0 110.106 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 81.7 p -82.67 159.6 22.6 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.672 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.2 t -54.98 -43.15 67.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.108 0.48 . . . . 0.0 110.574 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -62.3 -46.62 87.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.547 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -66.46 -40.48 89.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.141 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' CYS . . . -61.15 -38.34 86.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.861 0.362 . . . . 0.0 110.443 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.457 HG21 HD11 ' A' ' 110' ' ' LEU . 62.9 m -67.47 -46.35 73.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.134 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.97 -41.77 97.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 110.449 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -69.67 -24.04 63.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.615 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 13.6 t -73.83 -21.25 60.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.132 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.42 170.6 24.79 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.622 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.99 -33.09 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.843 0.321 . . . . 0.0 111.714 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.96 19.91 12.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.225 0.536 . . . . 0.0 110.372 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.1 139.86 53.52 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.149 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -99.21 122.17 42.04 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.24 118.56 10.12 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.2 t -139.94 150.33 44.41 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.096 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.592 ' SG ' HD11 ' A' ' 108' ' ' LEU . 49.5 m -113.71 124.13 51.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.858 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 8.4 m -114.93 141.51 47.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.06 0.457 . . . . 0.0 110.946 -173.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.401 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 22.1 t-20 -75.25 -37.78 60.85 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.891 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.401 ' HG3' ' OD1' ' A' ' 66' ' ' ASN . 61.6 mttp -123.92 140.19 53.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.889 0.376 . . . . 0.0 110.611 -176.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.31 121.76 29.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.816 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 m -116.76 115.58 25.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -92.57 134.5 34.93 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.35 -30.3 70.67 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.208 -167.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.2 -21.83 70.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.297 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.81 -18.36 25.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.306 . . . . 0.0 111.277 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.57 ' HB ' ' OD1' ' A' ' 76' ' ' ASP . 14.9 m -121.28 129.99 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.155 0.502 . . . . 0.0 111.149 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.2 t -88.88 -6.71 57.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.26 -175.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.57 ' OD1' ' HB ' ' A' ' 74' ' ' VAL . 10.1 p-10 -84.23 2.75 38.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.1 mt -125.09 138.17 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.15 108.42 19.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.032 0.444 . . . . 0.0 110.679 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.02 -36.9 68.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.204 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.22 -45.82 83.88 Favored Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.956 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.92 -45.95 89.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.377 0.608 . . . . 0.0 110.191 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.8 tp -66.32 -40.68 90.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.035 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -44.84 80.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.797 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.17 -42.0 98.42 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.882 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.6 p -72.42 -43.91 63.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.741 0.305 . . . . 0.0 111.807 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.73 -27.47 60.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.844 0.354 . . . . 0.0 110.417 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.67 -35.44 74.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.969 0.414 . . . . 0.0 110.55 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -69.54 -22.37 63.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.601 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.4 tp -83.57 -37.43 22.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.961 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.7 mt -72.44 -44.77 61.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.482 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.96 -100.49 1.1 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.74 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.55 46.4 1.17 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.126 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.62 159.03 30.92 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.76 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 p -146.57 70.21 1.21 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.117 0.484 . . . . 0.0 110.717 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.51 76.75 1.11 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.116 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 p -62.8 -19.29 63.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.12 0.486 . . . . 0.0 111.575 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 2.0 mp0 -57.81 -30.86 66.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.365 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -113.59 17.01 21.22 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.964 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.0 tp -98.83 142.53 30.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.65 0.262 . . . . 0.0 111.012 -175.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.88 -158.99 30.92 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.095 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.3 tp -109.24 126.45 53.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -114.29 138.33 50.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.753 0.311 . . . . 0.0 110.805 -173.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -123.54 152.3 41.94 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.376 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 60.64 59.16 2.24 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.62 0.575 . . . . 0.0 109.958 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 4.0 t -118.48 139.33 51.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.3 p -122.74 132.28 54.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.606 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -65.83 147.85 52.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.505 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.592 HD11 ' SG ' ' A' ' 64' ' ' CYS . 75.4 mt -97.45 140.66 31.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.182 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -86.8 140.54 29.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.326 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.457 HD11 HG21 ' A' ' 53' ' ' THR . 62.3 mt . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.678 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 C--O 1.237 0.411 0 CA-C-O 121.478 0.656 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 80.0 mt -74.22 135.45 42.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.44 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.89 -34.56 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.727 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -71.78 -13.47 61.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.724 0.297 . . . . 0.0 111.387 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -82.98 -25.71 31.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.736 0.303 . . . . 0.0 110.908 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -109.34 -12.4 14.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.068 0.461 . . . . 0.0 111.255 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 53.3 t -106.81 135.22 48.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -119.93 6.78 10.86 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.306 0.574 . . . . 0.0 110.751 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 46.0 mt-30 -108.42 169.2 8.79 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.437 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 14.5 p30 -70.22 134.36 47.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.936 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.6 mt -94.07 126.24 46.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.549 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.58 158.81 43.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.205 0.526 . . . . 0.0 111.623 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 56.2 m -97.67 121.0 39.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.679 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 82.1 m -112.2 140.37 46.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.61 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -69.4 133.55 47.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.167 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.282 0.563 . . . . 0.0 111.368 -177.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 67.0 mt . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.644 0.259 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 167.54 -165.76 38.86 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.06 138.61 22.34 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 117.114 0.457 . . . . 0.0 109.928 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.53 121.92 6.23 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.766 1.644 . . . . 0.0 110.693 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 31.9 m -149.78 157.57 43.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.202 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 14.9 tt -124.91 129.75 73.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.183 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.35 121.13 12.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.246 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.4 tt -65.12 -20.74 66.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.408 -173.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.444 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.81 -9.45 70.4 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.166 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.409 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 74.6 p -78.14 -25.91 47.57 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 117.378 0.589 . . . . 0.0 110.901 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.9 pt -96.01 -9.45 9.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.171 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--O 1.242 0.71 0 O-C-N 124.104 0.877 . . . . 0.0 112.537 177.778 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.459 ' HB ' ' OD1' ' A' ' 130' ' ' ASN . 7.3 p . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.247 0.546 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 40' ' ' ARG . 27.0 mtm180 -76.96 -24.33 52.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.599 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.419 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 86.0 m-85 -123.44 87.21 52.01 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.24 148.25 68.03 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.245 1.963 . . . . 0.0 112.43 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.5 t -85.01 132.66 45.01 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.68 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.49 136.0 48.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.569 2.18 . . . . 0.0 112.386 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -10.28 57.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -90.05 2.35 55.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.567 0.222 . . . . 0.0 111.187 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.484 ' O ' HG12 ' A' ' 123' ' ' VAL . 34.1 mm -87.94 126.82 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.281 0.563 . . . . 0.0 110.527 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 59.3 p -87.42 160.0 18.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.539 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 m -57.11 -36.93 52.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.025 0.44 . . . . 0.0 110.76 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 50.8 tptt -68.4 -46.84 68.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.41 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -62.35 -41.22 98.42 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.502 0.192 . . . . 0.0 111.011 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.34 98.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.051 0.453 . . . . 0.0 110.99 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.8 m -67.69 -47.77 68.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.097 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 65.3 mm-40 -66.36 -28.15 68.43 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.005 0.431 . . . . 0.0 110.882 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.468 ' HE2' ' OXT' ' A' ' 159' ' ' LEU . 51.1 tptt -59.97 -40.89 90.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.334 177.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.561 ' SG ' HD13 ' A' ' 155' ' ' LEU . 80.8 m -92.96 -20.66 20.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.912 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.43 177.09 23.34 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.73 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.48 -8.04 57.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.86 0.362 . . . . 0.0 111.668 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -94.35 4.27 54.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.004 0.43 . . . . 0.0 110.988 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.65 147.44 48.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.262 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -104.31 121.55 43.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.15 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.7 tp -70.93 118.68 14.01 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.7 t -135.38 149.02 49.56 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.368 -171.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.582 ' SG ' HD21 ' A' ' 108' ' ' LEU . 62.0 m -102.54 118.77 37.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.819 174.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -117.51 130.27 56.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.171 0.51 . . . . 0.0 111.162 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -77.97 -24.94 47.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.786 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.93 138.69 54.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.197 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.14 120.92 19.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.082 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 m -114.46 116.46 28.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -88.03 126.26 34.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.04 77.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.41 -169.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.63 -7.8 75.04 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.562 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.9 -17.73 17.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.841 0.353 . . . . 0.0 110.8 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.54 131.67 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.22 0.533 . . . . 0.0 111.134 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.0 p -83.56 -9.01 59.21 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.88 -0.74 49.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.904 0.383 . . . . 0.0 111.401 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mt -124.78 142.94 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -89.26 98.52 11.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.525 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.74 -33.53 76.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.647 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.52 -38.81 96.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.6 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.72 -48.84 49.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.671 0.272 . . . . 0.0 110.455 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.88 -40.11 91.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.854 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.6 -37.5 86.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.753 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.25 -46.88 39.59 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.751 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 p -72.85 -44.93 60.79 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.421 ' CD2' ' HB ' ' A' ' 153' ' ' ILE . 11.3 tp -73.97 -24.92 59.69 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.756 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 41.1 ttmt -56.86 -32.03 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.004 0.431 . . . . 0.0 110.543 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -68.5 -24.08 64.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.691 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.2 tp -83.46 -35.0 25.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 109.897 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.0 mt -71.5 -40.8 72.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.329 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.42 -103.76 2.98 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -103.62 82.78 0.39 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.951 -0.643 . . . . 0.0 111.826 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.38 173.11 25.38 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.0 t -161.62 151.9 17.32 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.44 69.11 0.29 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.608 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 34.5 p -61.87 -25.75 67.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.859 0.361 . . . . 0.0 111.91 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 1.5 mp0 -59.11 -22.46 60.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.163 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -122.55 27.1 6.1 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -109.8 148.49 31.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.692 0.282 . . . . 0.0 111.054 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 158.49 -148.37 17.46 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.729 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.9 mt -106.6 129.73 54.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.01 0.433 . . . . 0.0 109.928 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.564 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 15.7 m-85 -112.1 137.02 50.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.836 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.95 149.67 45.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.312 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 63.4 51.6 2.58 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.532 0.52 . . . . 0.0 110.334 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.5 m -92.23 135.62 33.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.711 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.5 p -114.97 145.48 42.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.091 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -77.12 133.71 38.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.582 HD21 ' SG ' ' A' ' 64' ' ' CYS . 19.2 mt -88.88 138.24 31.59 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.961 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.8 108.08 8.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.032 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.83 176.637 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--O 1.233 0.203 0 CA-C-O 121.281 0.562 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 96.2 mt -76.99 133.71 39.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.709 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 47' ' ' ILE . 11.4 p -67.07 -37.98 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.714 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -71.33 -16.44 62.44 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.071 0.462 . . . . 0.0 110.825 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -84.68 -26.54 27.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.503 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -100.09 -17.07 17.63 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.257 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 16.2 t -110.96 139.35 46.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.26 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -111.89 2.22 16.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.758 0.79 . . . . 0.0 109.547 172.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 1.8 mp0 -108.2 170.73 7.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.918 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.459 ' OD1' ' HB ' ' A' ' 39' ' ' VAL . 22.2 m-80 -65.2 134.62 54.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 21.9 mm -95.74 124.26 48.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.87 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.07 159.29 42.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.874 0.369 . . . . 0.0 111.102 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 78.6 m -107.86 118.96 38.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 73.7 m -110.24 147.26 34.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.118 0.485 . . . . 0.0 111.348 -169.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -69.78 122.17 18.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.204 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.463 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.953 0.406 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 170.5 -179.66 42.45 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.39 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.16 129.36 25.71 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.76 122.79 11.24 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 121.881 1.72 . . . . 0.0 110.289 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . 2.6 t -153.54 159.4 42.2 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.319 -171.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.421 ' HB ' ' CD2' ' A' ' 86' ' ' LEU . 7.4 tp -127.12 130.76 71.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.278 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.89 122.29 14.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.286 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.561 HD13 ' SG ' ' A' ' 56' ' ' CYS . 59.7 tp -62.67 -25.32 68.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.638 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.419 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -72.83 -16.82 78.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.901 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.5 m -74.6 -29.12 61.19 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.228 0.514 . . . . 0.0 111.326 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.4 pt -95.56 -4.41 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.069 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.468 ' OXT' ' HE2' ' A' ' 55' ' ' LYS . 89.3 mt . . . . . 0 C--O 1.252 1.188 0 O-C-N 123.804 0.69 . . . . 0.0 111.885 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 130' ' ' ASN . 7.4 p . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.079 0.466 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -76.43 -22.9 54.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.12 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 157' ' ' SER . 60.2 m-85 -122.61 86.91 49.37 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.421 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.78 144.85 55.21 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.179 1.92 . . . . 0.0 112.487 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.23 132.01 54.47 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.59 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.28 135.09 45.79 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.113 1.876 . . . . 0.0 111.537 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -72.9 -10.22 59.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.037 -170.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -90.13 2.44 55.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.434 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.4 mm -86.75 127.25 40.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.981 0.419 . . . . 0.0 110.736 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 43.2 p -82.16 159.95 23.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.659 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.0 t -57.91 -40.92 78.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.9 0.381 . . . . 0.0 110.792 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -64.4 -44.97 89.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.759 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -62.67 -46.13 89.61 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.962 0.411 . . . . 0.0 110.611 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.483 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -61.04 -37.6 83.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.813 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.8 m -67.43 -45.08 77.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.803 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -63.73 -31.49 72.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.336 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 159' ' ' LEU . 57.1 tptt -62.42 -40.89 98.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.817 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.601 ' SG ' HD13 ' A' ' 155' ' ' LEU . 71.8 m -94.29 -16.21 23.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.855 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.06 161.96 23.75 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.182 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -74.62 -11.08 60.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.969 0.414 . . . . 0.0 110.851 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -91.41 14.63 14.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.109 0.481 . . . . 0.0 110.204 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.75 141.77 51.5 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.469 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -111.9 124.61 52.73 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.483 HD11 ' HB3' ' A' ' 52' ' ' ALA . 95.9 mt -66.08 121.28 14.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.965 0.412 . . . . 0.0 110.165 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 41.2 t -122.62 134.36 54.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.662 -175.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 67.8 m -93.9 116.13 28.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.366 174.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.423 ' HB2' ' ND2' ' A' ' 130' ' ' ASN . 50.3 m -120.32 130.19 54.33 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.709 0.29 . . . . 0.0 110.751 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -79.92 -21.5 43.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.003 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -123.93 142.03 51.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.49 126.65 33.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.17 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.0 m -120.71 115.1 22.67 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -92.24 135.07 34.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.63 72.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.022 -171.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.18 -7.37 82.0 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.784 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -98.26 -17.53 18.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.088 0.47 . . . . 0.0 110.865 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.568 HG21 HD12 ' A' ' 77' ' ' ILE . 13.0 m -120.63 132.35 70.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.299 0.571 . . . . 0.0 111.264 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.3 p -82.56 -18.2 42.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.504 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -86.78 11.71 12.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.568 HD12 HG21 ' A' ' 74' ' ' VAL . 27.6 mt -130.3 136.01 59.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.612 0.244 . . . . 0.0 110.617 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -87.85 107.57 18.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.947 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.63 -28.35 67.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.336 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.1 -41.48 97.07 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.589 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.26 -44.23 97.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.052 0.453 . . . . 0.0 110.319 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.31 -38.88 88.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.843 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.18 -36.97 85.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.344 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.19 -46.18 94.7 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.614 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 p -73.07 -43.42 61.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.938 0.399 . . . . 0.0 111.773 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.34 -26.33 58.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.353 -176.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 29.8 ttpp -56.98 -30.69 64.33 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.751 0.31 . . . . 0.0 110.926 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -63.15 -22.79 67.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.322 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.66 -27.55 20.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.951 0.405 . . . . 0.0 110.769 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.2 mt -82.23 -40.85 17.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.136 0.493 . . . . 0.0 110.801 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.03 -126.14 8.44 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.66 41.11 3.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.339 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -153.73 173.77 32.38 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.2 m -153.56 91.93 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.794 0.33 . . . . 0.0 111.335 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.54 69.86 3.21 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.3 p -68.2 -12.51 61.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.78 -33.94 73.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.82 0.343 . . . . 0.0 111.511 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -107.49 20.06 32.94 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.998 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.2 tp -100.24 139.88 35.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.879 0.371 . . . . 0.0 111.252 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.88 -146.97 11.83 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.819 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.56 HD23 HD13 ' A' ' 77' ' ' ILE . 4.2 mm? -109.56 125.33 52.41 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.77 136.83 47.69 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.167 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -120.03 152.74 37.07 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.999 -175.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 61.33 57.84 2.3 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.545 0.688 . . . . 0.0 109.803 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 96.7 m -106.42 135.66 47.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.548 -174.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.0 m -128.34 131.1 48.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -79.84 145.83 32.55 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.417 . . . . 0.0 111.228 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -95.55 140.84 29.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -75.76 131.24 39.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.153 0.501 . . . . 0.0 109.757 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.8 tp . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -177.114 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 . . . . . 0 CA--C 1.517 -0.302 0 CA-C-O 120.792 0.33 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 76.1 mt -71.48 131.32 43.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.928 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.4 -35.46 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.467 -174.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.99 -12.68 61.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.134 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 122' ' ' LEU . 8.1 tp-100 -83.19 -25.92 31.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.725 0.298 . . . . 0.0 110.656 -173.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -102.3 -17.35 15.93 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.212 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 16.8 t -110.33 137.06 48.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.688 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 128' ' ' LYS . 3.4 mppt? -110.36 3.88 20.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.376 0.608 . . . . 0.0 109.93 172.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 27.8 mp0 -108.75 169.85 8.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.849 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.522 ' HB2' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -66.72 140.56 57.88 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.673 0.273 . . . . 0.0 110.813 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.5 mm -97.53 120.5 46.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.138 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.22 154.86 45.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.836 0.351 . . . . 0.0 110.741 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.408 ' C ' ' SG ' ' A' ' 152' ' ' CYS . 73.9 m -105.64 114.28 28.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.015 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 59.6 m -109.6 140.94 42.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.72 136.4 50.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.728 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 . . . . . 0 N--CA 1.464 0.237 0 CA-C-O 121.305 0.574 . . . . 0.0 111.043 -177.84 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 46.1 mt . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 121.425 0.631 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 152.17 -155.81 26.34 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.734 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.7 mp -104.8 127.66 28.38 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -66.46 121.32 8.57 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.44 1.427 . . . . 0.0 110.21 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.408 ' SG ' ' C ' ' A' ' 133' ' ' CYS . 0.7 OUTLIER -155.41 169.15 24.92 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.379 -172.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.36 132.45 55.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.388 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.11 123.39 17.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.341 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.601 HD13 ' SG ' ' A' ' 56' ' ' CYS . 42.4 tp -61.79 -25.82 67.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.781 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.452 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.24 -17.14 75.69 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.409 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.5 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 8.5 t -73.41 -26.77 61.11 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.968 0.384 . . . . 0.0 110.95 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 pt -102.21 -2.34 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.532 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.44 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 90.2 mt . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.595 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.258 0.551 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -76.47 -29.04 56.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.357 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -125.14 91.91 48.33 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.51 150.64 75.46 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.395 2.063 . . . . 0.0 112.643 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.71 133.36 29.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.736 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.86 136.31 51.39 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.732 2.288 . . . . 0.0 112.395 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.81 -11.73 61.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.208 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -86.02 3.2 43.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.677 0.275 . . . . 0.0 111.732 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.483 ' O ' HG12 ' A' ' 123' ' ' VAL . 34.9 mm -92.06 123.91 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 0.0 110.274 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 61.4 p -80.29 160.84 25.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.298 175.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.33 -40.87 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 65.7 tttp -65.46 -47.52 75.83 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.879 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -59.6 -43.5 93.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 110.69 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.7 98.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.732 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.44 HG21 HD23 ' A' ' 110' ' ' LEU . 29.6 m -68.97 -39.03 79.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.689 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 73.8 mm-40 -59.56 -32.19 70.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.042 0.448 . . . . 0.0 110.756 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -60.58 -33.52 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.082 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 60' ' ' ALA . 85.5 m -100.49 9.55 42.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.752 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.57 80.05 0.66 Allowed Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.45 -172.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -177.5 -72.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.977 0.418 . . . . 0.0 110.864 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -116.86 12.92 14.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.452 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . . . -149.08 163.89 36.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.05 0.453 . . . . 0.0 111.591 -171.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -134.52 143.23 47.32 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.9 tp -67.29 134.59 51.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.057 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 t -139.69 145.97 39.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.858 0.361 . . . . 0.0 110.358 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.702 ' SG ' HD11 ' A' ' 108' ' ' LEU . 29.5 m -113.9 120.63 41.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.745 176.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.544 ' O ' ' HB3' ' A' ' 129' ' ' GLN . 13.5 m -115.49 144.71 43.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -89.91 -26.55 20.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -124.69 145.24 49.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.35 128.36 33.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.614 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 m -120.38 115.09 22.84 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 171.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -91.65 136.58 33.03 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.34 -27.51 69.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.564 -170.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.41 -12.26 80.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.881 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.61 -17.47 19.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 0.0 111.364 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.483 ' HB ' ' OD1' ' A' ' 76' ' ' ASP . 10.5 m -121.23 125.96 74.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.427 0.632 . . . . 0.0 111.09 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.2 p -86.85 -6.57 58.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.975 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD1' ' HB ' ' A' ' 74' ' ' VAL . 8.8 p-10 -83.12 -2.26 54.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.939 0.399 . . . . 0.0 111.351 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mt -110.41 143.14 20.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.456 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -88.2 99.45 12.22 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.11 -26.93 68.76 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.27 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.08 -42.66 91.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.391 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.3 -44.8 94.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.961 0.41 . . . . 0.0 110.461 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.7 mt -62.89 -40.52 97.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.714 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.73 -42.03 91.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.74 -41.28 99.86 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.684 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.6 p -72.48 -43.99 62.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.699 0.285 . . . . 0.0 111.531 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.72 -27.6 61.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.846 0.355 . . . . 0.0 110.803 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 18.4 ttmm -57.75 -32.65 67.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.048 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.35 -22.72 64.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.562 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.414 HD21 ' SG ' ' A' ' 133' ' ' CYS . 59.3 tp -79.92 -33.81 39.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.2 0.524 . . . . 0.0 110.245 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 94' ' ' SER . 71.4 mt -85.21 -47.31 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.998 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.26 -100.72 0.34 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.827 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -111.57 12.99 27.8 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.426 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.65 171.11 24.19 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.795 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.438 ' HA ' HD12 ' A' ' 90' ' ' ILE . 7.5 p -157.51 102.26 1.89 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.719 0.295 . . . . 0.0 110.886 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.28 85.48 0.6 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.191 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.4 p -67.09 -9.05 35.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.817 0.341 . . . . 0.0 111.724 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -62.54 -31.33 72.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.223 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.6 23.21 9.69 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.787 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.9 tp -105.14 144.44 31.94 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.403 0.281 . . . . 0.0 110.945 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 163.96 -149.52 16.82 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.845 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.8 mt -107.89 132.96 52.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 152' ' ' CYS . 22.5 m-85 -114.9 143.18 45.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -125.84 152.96 44.79 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 110.483 -0.192 . . . . 0.0 110.483 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 57.97 58.15 3.74 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.575 0.702 . . . . 0.0 109.643 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 6.9 t -120.35 144.25 47.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.83 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.1 t -126.06 140.65 52.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.446 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -79.09 147.44 32.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.911 0.386 . . . . 0.0 110.71 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.702 HD11 ' SG ' ' A' ' 64' ' ' CYS . 62.3 mt -102.31 141.49 35.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.594 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -100.29 126.03 46.57 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.44 HD23 HG21 ' A' ' 53' ' ' THR . 3.0 pp . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 121.027 0.441 . . . . 0.0 110.305 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.573 0.225 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 97.6 mt -70.36 131.76 44.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.067 0.46 . . . . 0.0 110.256 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 47' ' ' ILE . 10.5 p -66.74 -35.78 75.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.497 -173.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -70.95 -16.37 62.65 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.912 0.387 . . . . 0.0 110.999 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -83.58 -28.32 28.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.509 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -114.42 -14.72 12.16 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.823 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.3 t -108.38 116.68 32.42 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -100.16 -4.48 29.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.445 0.641 . . . . 0.0 110.18 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 65' ' ' CYS . 23.1 mp0 -91.56 168.29 11.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.242 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.65 131.68 45.0 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.589 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 29.3 mt -93.79 126.96 46.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.569 -174.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.42 ' HB1' ' SG ' ' A' ' 152' ' ' CYS . . . -135.38 158.43 44.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.327 0.585 . . . . 0.0 111.656 -176.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.414 ' SG ' HD21 ' A' ' 89' ' ' LEU . 37.1 t -110.0 115.13 29.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.653 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.5 m -110.78 139.49 46.04 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.731 -170.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.44 139.33 49.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.628 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.4 t30 . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 121.473 0.654 . . . . 0.0 110.558 -178.207 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 36.2 mt . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.148 0.499 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 165.51 173.26 33.86 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.553 ' H ' HD23 ' A' ' 150' ' ' LEU . 0.7 OUTLIER -95.02 134.16 25.18 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 117.031 0.416 . . . . 0.0 110.53 -178.518 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.64 123.84 11.95 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.596 2.197 . . . . 0.0 111.182 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.492 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 3.6 t -153.67 163.83 39.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.857 -174.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.44 133.15 60.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.58 130.05 34.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.539 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.64 -24.61 67.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.315 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -72.91 -15.37 78.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.586 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 m -80.6 -29.61 36.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.033 0.417 . . . . 0.0 111.299 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 29.4 pt -100.49 -9.65 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.787 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 C--O 1.249 1.078 0 O-C-N 123.85 0.719 . . . . 0.0 112.382 177.907 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.436 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 7.1 p . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 121.423 0.63 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.572 ' HD2' ' CE1' ' A' ' 41' ' ' PHE . 3.3 tmt_? -68.37 -34.27 75.76 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.411 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CE1' ' HD2' ' A' ' 40' ' ' ARG . 90.3 m-85 -118.69 87.49 32.42 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.6 151.25 69.94 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.508 2.139 . . . . 0.0 112.542 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.3 t -82.35 128.26 67.95 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.294 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.16 137.15 45.97 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.049 2.499 . . . . 0.0 112.613 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.23 -11.04 47.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.575 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -86.37 -1.42 57.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.122 0.487 . . . . 0.0 111.243 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.34 122.39 41.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.162 0.506 . . . . 0.0 111.01 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 70.5 p -81.93 163.81 21.96 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.436 174.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.505 HG12 HD23 ' A' ' 110' ' ' LEU . 21.9 t -57.0 -39.43 65.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 0.0 110.594 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.41 -46.37 73.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.164 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -58.77 -44.31 90.62 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 110.378 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 62' ' ' LEU . . . -61.89 -45.9 91.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.095 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.495 ' OG1' HD21 ' A' ' 110' ' ' LEU . 90.9 m -64.56 -46.68 81.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.211 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -67.3 -28.39 67.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.013 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -64.26 -40.92 96.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.44 . . . . 0.0 110.061 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' HD13 ' A' ' 155' ' ' LEU . 81.0 m -101.09 14.03 33.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.196 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.42 168.8 8.66 Favored Glycine 0 CA--C 1.518 0.26 0 N-CA-C 114.266 0.467 . . . . 0.0 114.266 -171.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 72.02 -67.84 0.24 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.014 0.926 . . . . 0.0 111.991 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -94.21 -8.49 39.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -171.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 56' ' ' CYS . . . -138.65 163.6 31.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.412 0.625 . . . . 0.0 111.864 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -128.3 138.23 52.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.296 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' ' 52' ' ' ALA . 12.1 mt -69.27 134.77 49.58 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.787 0.327 . . . . 0.0 110.837 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.478 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 38.2 t -140.62 129.94 23.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.133 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.483 ' SG ' HD11 ' A' ' 108' ' ' LEU . 59.9 m -102.33 116.99 33.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.65 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 129' ' ' GLN . 9.0 m -118.98 143.33 47.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.307 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -71.33 -37.38 71.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.719 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -126.83 141.27 51.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.036 0.446 . . . . 0.0 111.594 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.22 122.58 28.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.424 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 m -103.32 115.25 30.19 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.436 ' OH ' ' HA ' ' A' ' 39' ' ' VAL . 87.7 m-85 -91.36 133.18 35.67 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.68 67.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.582 -168.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.32 -20.84 76.63 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.581 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.86 -14.5 26.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.643 0.259 . . . . 0.0 111.471 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 77' ' ' ILE . 21.8 m -121.72 150.31 25.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.562 178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -108.39 2.91 22.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -95.64 1.77 53.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.03 0.443 . . . . 0.0 110.893 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.407 HD12 HG21 ' A' ' 74' ' ' VAL . 46.0 mt -119.25 136.5 56.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.946 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -86.86 108.01 18.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.049 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.34 -30.2 69.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.084 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.25 -39.67 96.18 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.608 -176.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.9 -47.43 88.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.121 0.486 . . . . 0.0 110.189 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 88.5 mt -67.43 -45.58 75.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.896 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -63.78 -41.14 98.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.952 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.85 -46.81 93.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.421 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.9 p -73.32 -40.6 64.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.901 0.382 . . . . 0.0 111.854 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -74.24 -23.21 59.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.425 -177.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 38.2 ttpt -54.63 -32.64 59.28 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.708 -174.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.9 -32.41 73.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.84 0.352 . . . . 0.0 110.485 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 89' ' ' LEU . 3.1 tm? -82.73 -34.86 27.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.42 -44.83 99.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.42 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.7 -74.78 2.47 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.492 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.81 -89.11 0.85 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.242 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.77 -172.28 45.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.996 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.6 m 62.91 59.08 1.41 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.71 0.404 . . . . 0.0 111.629 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.77 12.69 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.969 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.7 p -75.98 -18.87 59.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.829 0.347 . . . . 0.0 111.708 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.04 -13.7 62.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.323 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.44 23.93 10.83 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.38 142.5 38.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.56 -149.62 12.97 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.619 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.07 126.19 54.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -112.38 139.78 47.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.928 -173.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -120.25 154.03 35.49 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.671 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 61.9 58.7 1.86 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.691 0.757 . . . . 0.0 109.898 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.478 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 90.4 m -101.72 142.69 32.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.037 -173.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.8 p -132.94 137.33 46.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.567 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -80.89 144.92 31.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.793 0.33 . . . . 0.0 110.359 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.483 HD11 ' SG ' ' A' ' 64' ' ' CYS . 62.3 mt -91.33 124.99 35.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.54 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -85.71 145.65 27.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.697 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.505 HD23 HG12 ' A' ' 49' ' ' VAL . 91.9 mt . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.316 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 C--O 1.235 0.315 0 CA-C-O 121.105 0.478 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 64.8 mt -70.85 136.69 48.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.437 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.475 ' HA ' HG22 ' A' ' 49' ' ' VAL . 13.1 p -65.96 -29.65 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.241 -174.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.14 -13.35 61.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.077 0.465 . . . . 0.0 110.842 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -83.77 -27.69 28.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -108.74 -16.13 14.25 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.014 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.408 ' SG ' HG12 ' A' ' 131' ' ' ILE . 48.6 t -109.16 111.93 23.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.781 177.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -103.43 9.52 37.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.607 0.718 . . . . 0.0 109.97 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 65' ' ' CYS . 2.1 mp0 -105.12 168.56 8.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.692 -1.14 . . . . 0.0 107.967 176.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.42 ' CB ' ' HB ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -70.1 128.56 36.71 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.378 178.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.408 HG12 ' SG ' ' A' ' 127' ' ' CYS . 23.3 mt -88.18 125.24 41.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.825 -174.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.09 155.9 49.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.202 0.525 . . . . 0.0 111.275 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 64.8 m -106.0 129.76 54.06 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.8 m -111.34 139.34 46.82 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -77.36 134.18 38.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.075 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.65 . . . . 0.0 110.293 -178.797 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 53.7 mt . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 121.066 0.46 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 148.58 -176.7 27.26 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.218 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.5 mp -111.0 135.55 20.84 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.42 121.04 6.52 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.356 1.371 . . . . 0.0 110.727 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 42.5 m -152.55 160.54 43.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.131 -173.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.06 136.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.198 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.31 124.57 20.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.334 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.495 HD13 ' SG ' ' A' ' 56' ' ' CYS . 57.6 tp -61.12 -29.57 69.85 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.641 -175.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.414 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -66.27 -16.02 64.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.661 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.1 m -70.87 -30.16 66.46 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 117.061 0.43 . . . . 0.0 111.102 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 41.5 pt -99.8 -9.1 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.425 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 C--O 1.251 1.152 0 O-C-N 123.639 0.587 . . . . 0.0 111.784 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -76.25 -27.81 56.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.889 0.376 . . . . 0.0 111.081 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.519 ' O ' ' HA3' ' A' ' 156' ' ' GLY . 54.8 m-85 -136.71 97.57 11.29 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.77 139.66 44.4 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.874 2.383 . . . . 0.0 112.76 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -81.64 134.75 50.27 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.406 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.93 135.05 50.39 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.272 1.981 . . . . 0.0 111.914 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.06 -10.39 59.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.695 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.66 4.68 48.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.799 0.333 . . . . 0.0 111.177 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.3 mm -93.15 117.48 36.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.139 0.495 . . . . 0.0 110.586 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 32.9 p -77.38 159.68 29.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.531 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 123' ' ' VAL . 44.1 t -54.27 -42.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.918 0.389 . . . . 0.0 110.614 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -60.63 -47.07 87.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.997 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -67.26 -35.95 80.58 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.488 0.185 . . . . 0.0 111.045 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.25 80.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 110.062 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.1 m -67.71 -47.52 69.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.659 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -65.08 -34.56 78.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -63.38 -37.54 87.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.629 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.64 ' SG ' HD13 ' A' ' 155' ' ' LEU . 92.5 m -91.04 -19.85 22.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.748 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.47 178.78 29.82 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.479 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -82.54 -16.52 48.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -91.97 11.82 23.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.237 0.542 . . . . 0.0 110.606 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 134' ' ' CYS . . . -132.67 126.51 32.79 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.838 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -95.45 128.41 42.28 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.214 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 33.0 mt -65.44 122.87 18.17 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.871 0.367 . . . . 0.0 110.196 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.425 ' HB3' ' SG ' ' A' ' 105' ' ' CYS . 19.6 m -134.01 131.72 39.25 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.31 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.495 ' SG ' HD11 ' A' ' 108' ' ' LEU . 66.7 m -107.75 118.06 35.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.182 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER -116.68 140.05 49.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.812 -175.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.42 -19.76 49.2 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.818 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -126.42 140.98 52.06 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.608 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.23 127.0 32.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.282 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.4 m -119.95 115.83 24.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -95.1 132.03 40.46 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.76 -27.27 68.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.856 -171.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.81 -23.64 72.57 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.877 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -94.67 -18.58 21.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.184 0.492 . . . . 0.0 111.507 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.478 HG21 HD12 ' A' ' 77' ' ' ILE . 16.8 m -121.52 125.01 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.324 0.583 . . . . 0.0 111.429 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 p -85.99 -14.75 43.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.827 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -73.45 -15.04 61.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.187 0.518 . . . . 0.0 111.178 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.478 HD12 HG21 ' A' ' 74' ' ' VAL . 43.9 mt -103.75 130.32 54.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.89 106.73 3.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.125 0.488 . . . . 0.0 110.587 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.69 -29.4 68.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.03 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.41 -44.11 95.8 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.721 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.8 mt -63.25 -46.41 95.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.247 0.546 . . . . 0.0 110.266 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.35 -43.15 95.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.123 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.65 -39.1 88.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.721 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.25 -46.2 88.15 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.438 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 p -68.75 -42.74 77.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.829 0.347 . . . . 0.0 111.498 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.96 -26.21 59.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -57.89 -32.55 67.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.822 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -63.17 -28.65 70.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.487 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 60' ' ' ALA . 66.5 tp -86.83 -37.41 17.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.458 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.0 mt -72.3 -37.16 57.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.77 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.92 -73.12 0.22 Allowed Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -135.52 128.75 4.78 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.142 -0.552 . . . . 0.0 111.838 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.8 -170.05 33.12 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.575 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.7 p -157.97 115.28 2.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.93 0.395 . . . . 0.0 111.053 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.06 78.83 1.67 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 29.8 p -70.06 -18.87 63.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -172.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.41 -33.17 74.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.835 0.35 . . . . 0.0 111.324 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.438 ' HA3' ' OG ' ' A' ' 157' ' ' SER . . . -108.03 15.03 37.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.881 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 96' ' ' THR . 45.1 tp -104.02 141.6 35.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.591 0.234 . . . . 0.0 110.7 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 166.4 -156.47 28.38 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.576 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.1 mt -106.25 122.87 47.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.463 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 16.4 m-85 -106.34 133.72 50.6 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.016 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -119.69 154.49 34.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.717 -175.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.452 ' HA ' ' OE1' ' A' ' 104' ' ' GLN . 13.4 mm-40 59.08 58.15 3.24 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 3.5 t -120.66 138.86 53.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.25 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.7 m -129.73 149.93 51.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.822 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -78.93 147.47 33.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.947 0.403 . . . . 0.0 110.753 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 64' ' ' CYS . 69.8 mt -89.93 137.74 32.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.614 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.91 129.06 34.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.039 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 120.919 0.39 . . . . 0.0 111.074 -176.86 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t0 . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 121.134 0.492 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 52.8 mt -72.86 135.64 45.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.433 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.427 ' HA ' HG22 ' A' ' 49' ' ' VAL . 10.9 p -65.24 -29.67 47.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.925 -176.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -71.5 -16.77 62.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.995 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -83.86 -26.04 29.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.789 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.41 -17.1 14.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.359 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 131' ' ' ILE . 38.4 t -111.95 114.77 27.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.643 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.452 ' HB2' ' NZ ' ' A' ' 128' ' ' LYS . 9.4 mtmp? -99.88 2.12 43.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.473 0.654 . . . . 0.0 110.043 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 0.8 OUTLIER -107.51 173.4 6.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.649 -176.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -63.13 122.78 16.95 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.485 HG12 ' SG ' ' A' ' 127' ' ' CYS . 17.7 mt -91.29 117.33 34.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.161 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.69 154.07 50.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.201 0.524 . . . . 0.0 111.012 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.421 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 75.7 m -109.81 129.11 55.67 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.477 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 21.3 m -112.35 140.57 46.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -70.62 129.52 39.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.204 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 . . . . . 0 C--N 1.326 -0.417 0 CA-C-O 121.101 0.477 . . . . 0.0 111.78 -176.568 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 154.52 -170.86 32.95 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.977 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.3 mp -108.08 129.18 24.45 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -70.77 120.96 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.634 1.556 . . . . 0.0 110.95 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 61.3 m -153.45 161.92 41.79 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.6 133.42 68.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.838 0.351 . . . . 0.0 110.651 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.43 125.89 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.01 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.64 HD13 ' SG ' ' A' ' 56' ' ' CYS . 45.4 tp -65.11 -26.82 68.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.158 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 41' ' ' PHE . . . -66.8 -19.4 69.44 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.891 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.438 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 30.8 m -68.88 -29.13 67.35 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.176 0.488 . . . . 0.0 110.997 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.4 pt -101.03 -1.43 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.863 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.247 0.924 0 O-C-N 124.034 0.834 . . . . 0.0 111.79 178.366 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.419 ' HB ' ' OD1' ' A' ' 130' ' ' ASN . 7.2 p . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -62.78 -30.83 71.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.744 -175.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.519 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 51.0 m-85 -138.03 91.47 13.15 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.223 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.56 144.95 62.61 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.188 1.925 . . . . 0.0 112.508 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -82.16 131.95 54.82 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.89 134.43 41.92 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.99 1.793 . . . . 0.0 111.943 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.13 -17.28 64.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.91 -172.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -81.81 2.87 28.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.87 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.45 ' O ' HG12 ' A' ' 123' ' ' VAL . 30.9 mm -89.6 127.24 42.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.976 0.417 . . . . 0.0 110.53 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 55.5 p -83.93 163.78 19.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.419 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.1 t -56.15 -43.18 75.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.936 0.398 . . . . 0.0 110.795 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -62.43 -46.59 87.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -67.98 -37.42 81.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.245 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.32 99.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.839 0.352 . . . . 0.0 110.713 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.477 HG21 HD11 ' A' ' 110' ' ' LEU . 39.8 m -62.68 -45.75 91.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.42 -30.6 71.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.23 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -72.67 -31.44 65.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.336 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 133' ' ' CYS . 83.0 m -77.71 -22.33 50.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.124 0.488 . . . . 0.0 110.122 173.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.07 172.88 34.26 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.218 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -78.82 -21.01 48.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.879 0.371 . . . . 0.0 110.651 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.81 19.63 6.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.799 0.333 . . . . 0.0 110.908 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 134' ' ' CYS . . . -140.68 143.57 35.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.992 0.425 . . . . 0.0 110.663 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -117.88 134.84 54.54 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.747 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.92 125.73 25.79 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.782 0.325 . . . . 0.0 110.295 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 107' ' ' LYS . 16.7 m -129.84 126.14 37.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.194 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 89.5 m -103.92 115.43 30.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 3.0 m -119.27 138.67 52.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 -172.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -81.0 -18.86 45.39 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.002 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -123.24 138.3 54.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.181 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.18 121.51 23.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.715 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 m -118.6 115.79 25.29 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 74' ' ' VAL . 59.2 m-85 -95.07 126.69 40.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.076 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.51 -31.32 72.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.531 -169.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.41 -20.42 67.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.934 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -102.36 -16.73 16.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 70' ' ' TYR . 19.5 m -119.11 135.69 58.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.075 0.464 . . . . 0.0 111.331 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.1 p -86.11 -16.11 39.02 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -72.45 -6.1 41.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 111.476 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.6 mt -119.09 139.05 47.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.381 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -89.13 102.39 15.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.85 -35.9 82.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.021 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.21 97.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.577 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.5 mt -64.97 -48.53 83.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.053 0.454 . . . . 0.0 110.528 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 151' ' ' PRO . 41.7 mt -68.12 -45.53 73.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.071 -175.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.37 -37.19 84.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.662 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.93 -45.05 96.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.068 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 p -72.8 -42.23 64.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.814 0.34 . . . . 0.0 111.798 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.78 -26.29 59.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.501 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 53.7 tttp -56.87 -29.0 62.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.889 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -60.57 -26.37 66.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.257 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.37 -36.95 26.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.913 0.387 . . . . 0.0 110.673 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.3 mt -72.02 -36.19 56.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.63 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.76 -118.59 4.86 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.742 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.86 58.39 1.25 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.255 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.75 -174.36 30.49 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -149.59 152.46 35.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.933 0.397 . . . . 0.0 110.405 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.84 51.41 0.19 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.6 p -71.7 -14.1 61.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.306 -0.447 . . . . 0.0 111.959 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.17 -21.16 64.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.435 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.53 19.22 24.3 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 100' ' ' GLY . 7.3 tt -113.33 143.15 44.93 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -175.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.501 ' N ' HD23 ' A' ' 99' ' ' LEU . . . 165.63 -136.72 4.31 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.008 -1.092 . . . . 0.0 113.234 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 94.2 mt -113.5 133.22 55.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.567 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 33.3 m-85 -118.81 124.86 48.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.317 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -120.47 159.58 24.86 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.724 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 60.24 58.0 2.75 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 7.0 t -121.97 153.59 38.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.941 -168.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.1 p -136.53 130.51 32.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.042 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 68.6 mttm -81.87 148.93 28.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.146 0.498 . . . . 0.0 110.837 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.436 HD11 ' SG ' ' A' ' 64' ' ' CYS . 94.2 mt -92.46 135.54 33.96 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.863 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -100.63 132.29 46.09 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 53' ' ' THR . 61.9 mt . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 121.037 0.446 . . . . 0.0 110.736 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.236 0.39 0 CA-C-O 121.397 0.618 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 71.7 mt -67.01 134.14 51.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.591 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 47' ' ' ILE . 12.1 p -66.12 -32.5 58.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.573 -174.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -68.82 -16.12 63.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.639 0.256 . . . . 0.0 110.797 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -85.13 -26.6 26.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.655 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -95.35 -19.04 20.27 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.472 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.641 ' SG ' HG12 ' A' ' 131' ' ' ILE . 45.6 t -111.88 112.45 24.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.592 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.4 2.01 36.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.143 0.497 . . . . 0.0 110.703 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 2.1 mp0 -105.54 172.03 7.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.571 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.419 ' OD1' ' HB ' ' A' ' 39' ' ' VAL . 28.9 m-80 -63.97 125.97 26.16 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.641 HG12 ' SG ' ' A' ' 127' ' ' CYS . 14.1 mt -92.64 125.36 45.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.773 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.5 157.16 47.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.033 0.444 . . . . 0.0 111.316 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 155' ' ' LEU . 30.6 m -105.74 116.42 31.92 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 57.1 m -108.98 139.74 43.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -79.42 129.62 34.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.058 0.456 . . . . 0.0 111.102 -173.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.372 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.5 mt . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.851 0.357 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 147.18 -179.97 23.7 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 20.5 mt -95.37 130.54 31.96 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.45 ' HB3' HD22 ' A' ' 82' ' ' LEU . 17.2 Cg_exo -66.45 122.95 10.5 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.124 1.883 . . . . 0.0 111.114 175.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.409 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -155.09 168.88 25.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -177.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.7 tt -135.48 136.26 50.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.38 124.62 21.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.624 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.584 HD13 ' SG ' ' A' ' 133' ' ' CYS . 53.4 tp -64.55 -25.69 68.09 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.999 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.519 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.52 -17.11 76.1 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.449 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.9 m -74.06 -29.35 61.85 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 117.249 0.525 . . . . 0.0 111.205 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.5 pt -97.16 -3.77 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.756 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.341 -0.838 . . . . 0.0 111.858 178.949 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 121.184 0.516 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -73.19 -26.67 61.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.145 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -130.85 88.71 45.21 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.11 147.96 74.32 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.742 2.295 . . . . 0.0 113.264 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.29 134.69 45.25 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.14 176.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.91 135.82 43.52 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.655 2.237 . . . . 0.0 112.287 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.77 -16.06 63.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.144 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -92.09 10.37 29.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.769 0.319 . . . . 0.0 111.234 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.4 mm -93.59 123.32 45.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.218 0.533 . . . . 0.0 110.683 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 66.4 p -80.19 160.83 25.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.415 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.64 -40.38 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.216 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -62.39 -46.46 88.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.869 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -62.44 -43.83 97.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.863 0.363 . . . . 0.0 110.473 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' CYS . . . -61.4 -39.48 90.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.712 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.2 m -62.66 -47.54 83.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.798 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -71.71 -36.27 70.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.496 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -75.25 -20.37 59.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.18 0.514 . . . . 0.0 110.553 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 20.7 t -72.49 -21.73 61.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.229 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.45 160.06 20.02 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.993 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -82.83 -14.52 54.2 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -115.57 23.54 12.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.142 0.496 . . . . 0.0 110.534 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 89' ' ' LEU . . . -124.99 148.68 48.32 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.468 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -113.67 129.21 56.61 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.505 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 26.2 mt -64.45 119.22 10.0 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.545 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 42.6 t -129.5 127.25 40.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.383 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.543 ' SG ' HD21 ' A' ' 108' ' ' LEU . 45.0 m -97.68 119.72 36.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.923 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 41.7 m -117.38 129.36 55.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.753 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -71.86 -27.95 63.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -123.34 139.03 54.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.712 0.291 . . . . 0.0 110.379 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.6 124.3 26.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.528 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.8 m -117.19 115.33 25.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.836 0.351 . . . . 0.0 110.286 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -93.52 133.05 37.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.05 -33.89 75.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.362 -169.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.53 -12.7 64.39 Favored Glycine 0 C--O 1.229 -0.189 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.06 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.99 -15.48 18.26 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.622 -0.34 . . . . 0.0 111.418 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.585 HG21 HD12 ' A' ' 77' ' ' ILE . 14.7 m -120.79 127.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.536 0.684 . . . . 0.0 111.5 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p -85.62 -11.64 53.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.279 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.55 -1.09 55.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.842 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.619 HD13 HD23 ' A' ' 101' ' ' LEU . 30.0 mt -118.08 134.54 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.896 0.379 . . . . 0.0 111.387 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.07 102.13 10.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.873 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.34 -30.08 68.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.112 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.76 -42.34 99.74 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.32 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.96 -44.77 99.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.162 0.506 . . . . 0.0 110.041 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.78 -44.29 97.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.608 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.37 -45.4 84.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.712 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.98 -45.02 97.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.659 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.5 p -73.34 -44.83 58.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.508 HD22 HD13 ' A' ' 99' ' ' LEU . 18.2 tp -73.83 -22.55 59.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.623 0.249 . . . . 0.0 111.411 -177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 63.2 tttm -54.16 -29.79 46.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 111.043 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -63.01 -22.23 66.7 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.938 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 60' ' ' ALA . 52.4 tp -90.62 -30.5 17.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.04 -40.29 51.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.694 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.79 -78.67 1.99 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.437 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.33 84.91 0.31 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.275 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.98 -174.76 34.59 Favored Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.919 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -155.75 120.94 4.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.77 0.319 . . . . 0.0 110.435 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -136.56 62.4 0.6 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 32.1 p -69.6 -15.91 63.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -172.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -60.02 -29.08 68.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.401 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.72 16.95 43.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.763 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.508 HD13 HD22 ' A' ' 86' ' ' LEU . 37.7 tp -103.16 143.2 32.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.055 0.455 . . . . 0.0 110.962 -176.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.63 -150.16 13.77 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.286 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.619 HD23 HD13 ' A' ' 77' ' ' ILE . 4.2 mm? -111.01 129.1 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.45 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 33.3 m-85 -113.46 136.4 52.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.387 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -119.97 151.94 38.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.363 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 62.29 58.19 1.81 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.345 0.593 . . . . 0.0 109.952 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.545 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 76.3 m -108.42 136.37 48.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.711 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.6 t -132.66 143.99 50.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -72.11 140.51 48.93 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.546 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.543 HD21 ' SG ' ' A' ' 64' ' ' CYS . 33.8 mt -83.85 142.71 30.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.1 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -74.68 132.71 41.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.589 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.6 mt . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 -175.017 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.3 p30 . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.163 0.506 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 91.4 mt -69.03 129.53 40.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.587 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.66 -36.08 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.844 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -69.97 -18.02 63.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.227 0.537 . . . . 0.0 110.549 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -84.14 -26.16 29.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.481 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -103.26 -17.78 15.17 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.326 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 36.7 t -111.48 123.28 49.9 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.847 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -100.79 7.0 44.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.321 0.581 . . . . 0.0 109.978 172.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 2.2 mp0 -108.83 170.04 8.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.117 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -65.4 128.87 37.66 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.3 mt -96.08 123.64 48.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.336 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.88 158.6 43.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.119 0.485 . . . . 0.0 111.668 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 46.9 m -107.48 114.25 28.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.917 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 26.3 m -110.42 141.91 42.86 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -175.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -66.38 122.13 16.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.105 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 121.124 0.487 . . . . 0.0 111.515 -174.781 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 101' ' ' LEU . 78.9 mt . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 121.76 -166.71 14.49 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.592 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 150' ' ' LEU . 1.1 pt? -111.0 142.14 25.65 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 30.5 Cg_exo -62.18 123.68 12.95 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.458 2.106 . . . . 0.0 111.307 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.449 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 4.1 t -154.01 164.77 37.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.8 tt -133.95 135.76 54.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.874 0.369 . . . . 0.0 110.668 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.25 128.22 35.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.5 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.9 tt -62.94 -29.02 70.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.894 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -67.72 -16.19 67.58 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.831 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.9 m -77.2 -27.66 53.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.019 0.41 . . . . 0.0 111.161 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.6 pt -103.6 -1.44 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.168 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.594 179.343 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 8.3 p . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 121.307 0.575 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -74.38 -24.47 59.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.129 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -125.57 87.34 55.95 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.01 152.87 73.11 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.551 2.167 . . . . 0.0 113.044 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.9 t -93.02 132.7 30.24 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.399 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.27 136.01 46.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.381 2.054 . . . . 0.0 112.06 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -71.76 -10.24 59.48 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.187 -172.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -92.97 12.57 23.45 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.414 ' O ' HG12 ' A' ' 123' ' ' VAL . 40.0 mm -95.17 132.08 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.737 0.303 . . . . 0.0 110.751 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 71.1 p -80.37 159.52 25.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.883 176.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.68 -44.2 80.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.874 0.368 . . . . 0.0 110.367 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 52.9 tptt -62.25 -46.82 87.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.079 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -64.75 -41.84 95.61 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.599 0.238 . . . . 0.0 111.415 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -63.89 -42.3 97.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.572 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.3 m -64.13 -39.03 93.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 15.9 mm-40 -60.94 -34.98 75.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.803 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -74.04 -29.88 62.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.498 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 133' ' ' CYS . 73.7 m -73.51 -20.7 60.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.882 0.372 . . . . 0.0 110.679 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.56 -177.92 20.23 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.713 -178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.29 -13.25 28.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.966 0.383 . . . . 0.0 111.529 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -105.18 14.52 28.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.175 0.512 . . . . 0.0 110.666 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.516 ' HB2' HD13 ' A' ' 89' ' ' LEU . . . -129.14 144.38 51.19 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.82 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -123.21 142.63 50.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.738 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 52' ' ' ALA . 87.4 mt -65.72 129.47 39.88 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.104 0.478 . . . . 0.0 110.928 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 48.4 t -124.85 131.83 53.39 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.159 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.554 ' SG ' HD11 ' A' ' 108' ' ' LEU . 59.3 m -96.3 115.79 27.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.702 175.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.5 m -121.34 132.68 54.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.834 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -84.1 -20.33 32.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.125 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -123.95 137.83 54.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.715 0.293 . . . . 0.0 110.229 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.88 126.65 30.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.293 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -120.08 115.94 24.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.469 ' O ' HG22 ' A' ' 74' ' ' VAL . 62.3 m-85 -94.43 129.84 41.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.021 0.439 . . . . 0.0 110.294 -175.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.65 -28.53 69.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.578 -172.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -64.23 -24.97 69.38 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.736 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.84 -18.64 17.06 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.364 -0.492 . . . . 0.0 111.345 -175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 70' ' ' TYR . 18.7 m -113.69 134.14 57.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.331 0.586 . . . . 0.0 111.051 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.6 p -90.69 -11.54 39.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.574 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.31 -5.99 53.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.871 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.0 mt -117.85 138.91 47.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.148 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.46 99.47 7.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.3 0.571 . . . . 0.0 109.793 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -66.61 -32.55 73.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.179 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.64 -38.44 95.67 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.608 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.85 -48.13 72.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.189 0.518 . . . . 0.0 110.416 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 88.1 mt -62.64 -44.4 96.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.911 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.47 -43.69 98.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.17 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.36 -44.17 97.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.681 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 p -72.37 -42.49 65.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.878 0.37 . . . . 0.0 111.683 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.432 HD13 HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -74.48 -27.09 60.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.347 -176.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.1 -29.16 65.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.895 0.379 . . . . 0.0 110.904 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -60.98 -24.21 65.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.191 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 60' ' ' ALA . 92.6 mt -85.53 -35.0 21.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.014 0.435 . . . . 0.0 110.538 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.9 mt -70.34 -41.81 78.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.232 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.82 -88.17 0.78 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.855 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.01 62.83 0.6 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.005 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.55 178.7 40.88 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.2 p -146.63 138.8 24.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.728 0.264 . . . . 0.0 110.999 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.82 63.24 0.42 Allowed Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.7 p -69.73 -22.66 63.36 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -72.44 -18.63 61.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.799 0.333 . . . . 0.0 111.45 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.53 ' HA3' ' OG ' ' A' ' 157' ' ' SER . . . -110.65 12.63 30.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.596 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 100' ' ' GLY . 1.5 tt -110.43 141.42 43.54 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.422 ' N ' HD23 ' A' ' 99' ' ' LEU . . . 167.79 -142.95 7.84 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.33 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.5 tp -114.03 128.93 56.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -116.18 140.3 49.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.627 0.251 . . . . 0.0 110.608 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -124.26 153.31 41.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.424 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 61.99 57.91 2.0 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.639 0.733 . . . . 0.0 109.703 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.484 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 89.4 m -106.41 130.35 54.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.416 -175.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.1 m -115.03 134.26 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.408 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -73.7 139.49 45.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.1 0.476 . . . . 0.0 111.25 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.554 HD11 ' SG ' ' A' ' 64' ' ' CYS . 77.0 mt -99.24 121.58 41.24 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 172.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -74.91 134.47 41.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.948 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.8 mt . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.783 -172.972 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.293 0.568 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 89.2 mt -79.16 134.92 36.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.82 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 47' ' ' ILE . 14.8 p -66.94 -41.25 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.841 -175.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -72.18 -9.16 58.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.744 0.307 . . . . 0.0 111.338 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 122' ' ' LEU . 27.2 tt0 -84.11 -25.96 29.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.872 -173.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -106.88 -16.35 14.48 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.855 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.6 t -109.59 132.96 53.66 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.968 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -112.21 12.05 20.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.256 0.55 . . . . 0.0 110.319 173.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 25.8 mp0 -107.64 169.26 8.7 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.32 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -66.34 136.59 56.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.772 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 23.6 mm -95.48 125.67 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.835 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.02 155.05 47.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 0.0 111.176 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 13.1 m -98.29 128.72 44.87 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 64.4 m -112.97 140.37 47.84 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.986 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.477 ' OE1' HD21 ' A' ' 89' ' ' LEU . 5.4 tp60 -83.18 141.74 31.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.265 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 121.299 0.571 . . . . 0.0 111.029 -179.708 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.5 mt . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 121.172 0.511 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 152.68 -171.82 31.8 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.29 134.6 22.55 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -71.97 121.05 7.25 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.55 1.5 . . . . 0.0 110.566 174.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 53.7 m -152.72 162.69 40.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.03 137.25 57.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.627 0.251 . . . . 0.0 110.549 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.32 123.79 19.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.385 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 68.8 tp -62.47 -27.35 69.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.197 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.409 ' HA2' ' CD2' ' A' ' 159' ' ' LEU . . . -69.81 -16.19 72.08 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.61 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.53 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 26.6 m -82.86 -24.59 33.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.974 0.387 . . . . 0.0 111.729 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.7 pt -103.97 11.14 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.409 ' CD2' ' HA2' ' A' ' 156' ' ' GLY . 4.7 pp . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.245 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.309 0.576 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -78.0 -25.64 48.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.422 -178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -125.67 89.3 52.73 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.43 146.0 73.11 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.688 2.258 . . . . 0.0 113.184 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 155' ' ' LEU . 41.1 t -84.53 132.57 46.52 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.306 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -51.63 135.01 48.2 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.226 1.95 . . . . 0.0 112.073 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.53 -18.23 64.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.38 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -92.32 9.82 32.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.74 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.5 mm -96.96 119.44 45.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.095 0.474 . . . . 0.0 110.553 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 71.6 p -76.49 160.97 29.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.333 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.31 -36.54 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.004 0.43 . . . . 0.0 110.582 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -67.08 -46.95 72.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.693 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -63.79 -40.99 98.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 110.758 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.63 94.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.798 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 m -65.84 -43.21 89.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.898 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -64.06 -34.82 78.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.993 0.425 . . . . 0.0 110.846 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -68.34 -40.48 81.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.941 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 96.0 m -87.52 -5.78 58.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.33 170.38 23.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.92 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.43 -16.59 54.06 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.771 -0.252 . . . . 0.0 111.437 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -97.92 15.29 24.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.916 0.388 . . . . 0.0 110.862 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.474 ' HB2' HD13 ' A' ' 89' ' ' LEU . . . -130.15 146.34 51.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.902 0.382 . . . . 0.0 111.06 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.577 ' HB2' HD21 ' A' ' 136' ' ' ASN . 45.1 tt0 -135.03 144.19 47.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.89 136.68 56.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.956 0.408 . . . . 0.0 110.984 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.3 t -139.1 140.19 37.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.254 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.548 ' SG ' HD11 ' A' ' 108' ' ' LEU . 56.3 m -109.54 117.37 33.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.525 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 1.8 m -117.04 141.88 47.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.746 -175.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.469 ' HA ' ' OE1' ' A' ' 129' ' ' GLN . 56.3 t30 -84.66 -22.15 29.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.415 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -124.7 140.59 52.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.13 127.43 28.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.691 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.8 m -119.1 115.15 23.67 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -90.22 134.42 34.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.99 -31.36 72.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.55 -169.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.02 -9.49 86.9 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.692 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.26 -16.58 24.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.037 0.446 . . . . 0.0 110.606 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.454 HG21 HD12 ' A' ' 77' ' ' ILE . 16.8 m -120.46 150.2 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.822 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.0 p -96.31 -20.48 18.48 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -82.45 0.67 41.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.813 0.339 . . . . 0.0 111.472 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.454 HD12 HG21 ' A' ' 74' ' ' VAL . 39.0 mt -120.61 130.21 74.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -88.5 109.78 20.33 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.198 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -63.92 -29.22 70.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.432 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.84 -35.84 91.38 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.548 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.7 mt -68.25 -48.07 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.942 0.401 . . . . 0.0 110.318 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.28 -40.18 89.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.999 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.68 -34.73 77.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.989 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.8 -47.97 88.55 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.581 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 142' ' ' SER . 3.0 p -73.68 -41.31 62.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.867 0.365 . . . . 0.0 111.794 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.464 HD13 HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -72.73 -24.84 61.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.145 -177.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 38.5 ttmt -55.7 -30.26 60.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 110.727 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -61.48 -27.72 68.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.819 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 60' ' ' ALA . 86.3 mt -88.41 -29.63 20.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.507 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.4 mt -72.76 -40.56 61.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.085 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.27 -70.32 2.15 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.161 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.74 104.76 0.3 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.17 -169.41 39.02 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.8 m -148.57 128.6 13.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.965 0.382 . . . . 0.0 110.83 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.69 49.45 0.11 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.712 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.4 p -74.11 -11.91 60.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.951 0.405 . . . . 0.0 111.377 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -64.76 -13.85 56.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.547 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.47 24.76 8.97 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.78 143.83 39.06 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.37 -147.87 13.5 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.655 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.0 mt -106.72 128.91 54.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.051 0.453 . . . . 0.0 109.945 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.453 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 20.8 m-85 -114.2 131.89 56.3 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.816 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -120.36 154.53 34.95 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.506 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 59.35 58.18 3.1 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.33 0.586 . . . . 0.0 109.576 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 4.2 t -116.36 155.74 27.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.29 -171.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 t -138.53 131.52 29.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -72.41 147.38 46.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.099 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.548 HD11 ' SG ' ' A' ' 64' ' ' CYS . 91.4 mt -98.73 124.83 43.82 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -82.97 135.88 34.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.971 0.415 . . . . 0.0 110.637 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.5 mt -67.67 132.81 48.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.513 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -83.58 154.77 23.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.356 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.9 mt -70.02 117.04 50.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.928 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.31 101.96 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.997 2.464 . . . . 0.0 112.746 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.8 mm 56.49 77.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.74 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.4 tp -89.3 64.44 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 122.288 1.042 . . . . 0.0 109.779 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.75 -54.73 4.68 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.508 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 58.3 mt -91.25 130.72 38.89 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.03 79.64 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.197 1.931 . . . . 0.0 112.176 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 58.0 mt -91.86 129.11 43.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.902 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -109.54 82.09 1.54 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.168 0.508 . . . . 0.0 109.942 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -74.03 104.28 4.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.222 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 60.1 mt -87.3 138.86 31.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.495 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.478 HG23 ' OD1' ' A' ' 124' ' ' ASN . 15.8 m -61.52 -40.42 86.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.158 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.478 ' OD1' HG23 ' A' ' 123' ' ' VAL . 2.0 m-20 -71.25 -15.58 62.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.032 0.444 . . . . 0.0 110.823 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -84.35 -25.68 28.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.93 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -109.18 -17.16 13.92 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.679 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 48.3 t -111.11 135.64 51.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.503 0.192 . . . . 0.0 111.496 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -119.52 14.34 12.74 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.886 0.851 . . . . 0.0 109.266 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 59.8 mm-40 -108.24 171.25 7.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.094 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -64.69 114.9 4.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.317 . . . . 0.0 110.354 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.1 mt -88.52 120.81 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.649 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.73 159.62 41.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 0.0 110.989 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 78.8 m -103.13 127.23 50.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 61.1 m -112.85 143.48 44.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.11 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.457 ' HG3' ' H ' ' A' ' 137' ' ' SER . 5.3 tp-100 -71.09 123.45 22.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.319 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.577 HD21 ' HB2' ' A' ' 61' ' ' GLN . 94.2 m-20 -97.47 42.72 1.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.224 0.535 . . . . 0.0 110.252 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.457 ' H ' ' HG3' ' A' ' 135' ' ' GLN . 18.6 m -134.16 100.2 13.07 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.158 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.22 99.25 0.89 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.36 2.04 . . . . 0.0 112.137 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.8 t -108.33 154.52 21.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.756 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.422 ' HA ' ' OG ' ' A' ' 144' ' ' SER . 4.0 p-10 -88.46 -1.35 58.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.33 0.586 . . . . 0.0 110.157 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -112.3 113.45 25.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.528 174.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.468 ' HB3' HG21 ' A' ' 85' ' ' THR . 45.4 t 62.97 48.18 4.0 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.242 0.544 . . . . 0.0 110.428 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -161.97 -57.29 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.642 -0.789 . . . . 0.0 113.094 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 140' ' ' ASP . 29.1 p -78.4 -41.12 34.01 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -172.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.84 11.3 29.84 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.5 pt -132.37 46.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.504 0.668 . . . . 0.0 110.5 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -81.1 33.83 2.42 Favored Glycine 0 N--CA 1.453 -0.199 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.684 -175.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.5 mt -77.21 -16.04 59.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.368 0.604 . . . . 0.0 109.956 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -171.97 -173.61 38.86 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.596 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.99 122.86 51.22 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.08 120.71 7.23 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.378 1.385 . . . . 0.0 110.623 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 47.7 m -152.87 162.0 41.84 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.4 tt -127.57 136.46 60.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.776 0.322 . . . . 0.0 110.351 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.48 123.44 19.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 155' ' ' LEU . 5.6 tt -58.73 -28.56 65.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.653 -176.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -65.92 -17.01 64.82 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.701 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.5 m -80.68 -29.51 36.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 117.003 0.401 . . . . 0.0 111.505 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.8 pt -95.15 -9.47 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.746 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--O 1.245 0.857 0 O-C-N 124.206 0.941 . . . . 0.0 111.33 179.326 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 130' ' ' ASN . 7.3 p . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -78.62 -23.81 45.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.444 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 82.0 m-85 -130.0 90.98 40.89 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.433 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.81 148.94 72.2 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.597 2.198 . . . . 0.0 113.294 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.0 t -89.3 135.9 30.73 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.439 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -51.87 135.34 50.28 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.452 2.101 . . . . 0.0 112.234 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.0 -11.14 60.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.176 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -92.57 8.11 40.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 111.272 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.2 mm -90.01 126.98 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.893 0.378 . . . . 0.0 110.106 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 81.7 p -82.67 159.6 22.6 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.672 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.501 ' HB ' HE22 ' A' ' 111' ' ' GLN . 38.2 t -54.98 -43.15 67.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.108 0.48 . . . . 0.0 110.574 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -62.3 -46.62 87.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.547 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -66.46 -40.48 89.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.141 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' CYS . . . -61.15 -38.34 86.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.861 0.362 . . . . 0.0 110.443 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.457 HG21 HD11 ' A' ' 110' ' ' LEU . 62.9 m -67.47 -46.35 73.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.134 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.97 -41.77 97.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 110.449 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -69.67 -24.04 63.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.615 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 13.6 t -73.83 -21.25 60.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.132 -177.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.42 170.6 24.79 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.622 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.99 -33.09 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.843 0.321 . . . . 0.0 111.714 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.96 19.91 12.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.225 0.536 . . . . 0.0 110.372 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.1 139.86 53.52 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.149 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -99.21 122.17 42.04 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.24 118.56 10.12 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.2 t -139.94 150.33 44.41 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.096 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.592 ' SG ' HD11 ' A' ' 108' ' ' LEU . 49.5 m -113.71 124.13 51.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.858 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 8.4 m -114.93 141.51 47.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.06 0.457 . . . . 0.0 110.946 -173.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.401 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 22.1 t-20 -75.25 -37.78 60.85 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.891 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.401 ' HG3' ' OD1' ' A' ' 66' ' ' ASN . 61.6 mttp -123.92 140.19 53.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.889 0.376 . . . . 0.0 110.611 -176.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.31 121.76 29.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.816 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 m -116.76 115.58 25.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -92.57 134.5 34.93 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.35 -30.3 70.67 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.208 -167.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.2 -21.83 70.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.297 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.81 -18.36 25.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.306 . . . . 0.0 111.277 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.57 ' HB ' ' OD1' ' A' ' 76' ' ' ASP . 14.9 m -121.28 129.99 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.155 0.502 . . . . 0.0 111.149 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.2 t -88.88 -6.71 57.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.26 -175.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.57 ' OD1' ' HB ' ' A' ' 74' ' ' VAL . 10.1 p-10 -84.23 2.75 38.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.1 mt -125.09 138.17 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -88.15 108.42 19.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.032 0.444 . . . . 0.0 110.679 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.02 -36.9 68.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.204 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.22 -45.82 83.88 Favored Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.956 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.92 -45.95 89.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.377 0.608 . . . . 0.0 110.191 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.8 tp -66.32 -40.68 90.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.035 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -44.84 80.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.797 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.17 -42.0 98.42 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.882 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.6 p -72.42 -43.91 63.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.741 0.305 . . . . 0.0 111.807 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.73 -27.47 60.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.844 0.354 . . . . 0.0 110.417 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.67 -35.44 74.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.969 0.414 . . . . 0.0 110.55 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -69.54 -22.37 63.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.601 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.4 tp -83.57 -37.43 22.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.961 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.7 mt -72.44 -44.77 61.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.482 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.96 -100.49 1.1 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.74 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.55 46.4 1.17 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.126 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -161.62 159.03 30.92 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.76 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 p -146.57 70.21 1.21 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.117 0.484 . . . . 0.0 110.717 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.51 76.75 1.11 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.116 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 p -62.8 -19.29 63.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.12 0.486 . . . . 0.0 111.575 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 2.0 mp0 -57.81 -30.86 66.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.365 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -113.59 17.01 21.22 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.964 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.0 tp -98.83 142.53 30.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.65 0.262 . . . . 0.0 111.012 -175.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.88 -158.99 30.92 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.095 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.3 tp -109.24 126.45 53.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -114.29 138.33 50.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.753 0.311 . . . . 0.0 110.805 -173.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -123.54 152.3 41.94 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.376 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 60.64 59.16 2.24 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.62 0.575 . . . . 0.0 109.958 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 4.0 t -118.48 139.33 51.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.3 p -122.74 132.28 54.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.606 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -65.83 147.85 52.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.505 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.592 HD11 ' SG ' ' A' ' 64' ' ' CYS . 75.4 mt -97.45 140.66 31.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.182 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -86.8 140.54 29.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.326 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.457 HD11 HG21 ' A' ' 53' ' ' THR . 62.3 mt -92.69 123.19 35.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.678 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.501 HE22 ' HB ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -67.66 139.0 56.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.024 176.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 58.1 mt -96.82 120.92 60.81 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.994 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -45.31 117.11 1.52 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.396 2.731 . . . . 0.0 113.424 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 49.0 mm 72.97 -62.08 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.714 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.4 mm -95.86 80.6 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.282 0.563 . . . . 0.0 110.522 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.22 63.36 0.11 Allowed Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.227 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 59.4 mt 66.09 87.88 0.11 Allowed Pre-proline 0 N--CA 1.464 0.259 0 CA-C-O 121.153 0.502 . . . . 0.0 110.864 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.59 38.73 0.69 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.172 2.581 . . . . 0.0 112.957 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 51.6 mt -119.85 122.35 68.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.812 0.339 . . . . 0.0 110.676 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -87.36 74.94 9.33 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -80.82 157.91 25.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.257 -170.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 80.0 mt -74.22 135.45 42.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.44 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.89 -34.56 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.727 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -71.78 -13.47 61.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.724 0.297 . . . . 0.0 111.387 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -82.98 -25.71 31.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.736 0.303 . . . . 0.0 110.908 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -109.34 -12.4 14.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.068 0.461 . . . . 0.0 111.255 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 53.3 t -106.81 135.22 48.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -119.93 6.78 10.86 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.306 0.574 . . . . 0.0 110.751 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 46.0 mt-30 -108.42 169.2 8.79 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.437 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 14.5 p30 -70.22 134.36 47.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.936 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.6 mt -94.07 126.24 46.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.549 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.58 158.81 43.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.205 0.526 . . . . 0.0 111.623 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 56.2 m -97.67 121.0 39.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.679 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 82.1 m -112.2 140.37 46.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.61 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -69.4 133.55 47.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.167 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -80.48 33.71 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.282 0.563 . . . . 0.0 111.368 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.8 t -141.17 117.85 7.55 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.851 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.8 139.98 58.16 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.232 2.622 . . . . 0.0 112.519 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.1 m -79.57 7.17 8.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.933 0.397 . . . . 0.0 111.302 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.01 -32.35 73.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.972 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.64 -25.58 66.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.926 0.393 . . . . 0.0 110.931 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.3 t -90.43 -5.89 55.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.065 0.46 . . . . 0.0 110.254 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.66 133.96 1.61 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.136 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.3 p -82.91 -10.76 58.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.897 0.38 . . . . 0.0 111.126 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.5 mt -110.57 11.08 22.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.915 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 48.1 pt -116.16 33.44 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.399 -0.521 . . . . 0.0 112.171 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -84.18 42.22 3.06 Favored Glycine 0 C--N 1.321 -0.297 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 67.0 mt -87.93 -2.56 58.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.172 -0.514 . . . . 0.0 111.689 -171.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 167.54 -165.76 38.86 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.06 138.61 22.34 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 117.114 0.457 . . . . 0.0 109.928 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.53 121.92 6.23 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.766 1.644 . . . . 0.0 110.693 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 31.9 m -149.78 157.57 43.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.202 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 14.9 tt -124.91 129.75 73.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.183 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.35 121.13 12.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.246 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.4 tt -65.12 -20.74 66.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.408 -173.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.444 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.81 -9.45 70.4 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.166 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.409 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 74.6 p -78.14 -25.91 47.57 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 117.378 0.589 . . . . 0.0 110.901 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.9 pt -96.01 -9.45 9.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.171 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--O 1.242 0.71 0 O-C-N 124.104 0.877 . . . . 0.0 112.537 177.778 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.459 ' HB ' ' OD1' ' A' ' 130' ' ' ASN . 7.3 p . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.247 0.546 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 40' ' ' ARG . 27.0 mtm180 -76.96 -24.33 52.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.599 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.419 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 86.0 m-85 -123.44 87.21 52.01 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.24 148.25 68.03 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.245 1.963 . . . . 0.0 112.43 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.5 t -85.01 132.66 45.01 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.68 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.49 136.0 48.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.569 2.18 . . . . 0.0 112.386 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -10.28 57.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -90.05 2.35 55.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.567 0.222 . . . . 0.0 111.187 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.484 ' O ' HG12 ' A' ' 123' ' ' VAL . 34.1 mm -87.94 126.82 41.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.281 0.563 . . . . 0.0 110.527 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.655 HG21 ' HG3' ' A' ' 120' ' ' GLN . 59.3 p -87.42 160.0 18.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.539 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 m -57.11 -36.93 52.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.025 0.44 . . . . 0.0 110.76 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 50.8 tptt -68.4 -46.84 68.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.41 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -62.35 -41.22 98.42 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.502 0.192 . . . . 0.0 111.011 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.34 98.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.051 0.453 . . . . 0.0 110.99 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.8 m -67.69 -47.77 68.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.097 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 65.3 mm-40 -66.36 -28.15 68.43 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.005 0.431 . . . . 0.0 110.882 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.468 ' HE2' ' OXT' ' A' ' 159' ' ' LEU . 51.1 tptt -59.97 -40.89 90.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.334 177.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.561 ' SG ' HD13 ' A' ' 155' ' ' LEU . 80.8 m -92.96 -20.66 20.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.912 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.43 177.09 23.34 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.73 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.48 -8.04 57.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.86 0.362 . . . . 0.0 111.668 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -94.35 4.27 54.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.004 0.43 . . . . 0.0 110.988 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -124.65 147.44 48.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.262 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -104.31 121.55 43.58 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.15 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.7 tp -70.93 118.68 14.01 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.7 t -135.38 149.02 49.56 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.368 -171.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.582 ' SG ' HD21 ' A' ' 108' ' ' LEU . 62.0 m -102.54 118.77 37.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.819 174.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -117.51 130.27 56.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.171 0.51 . . . . 0.0 111.162 -178.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -77.97 -24.94 47.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.786 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.93 138.69 54.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.197 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.14 120.92 19.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.082 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 m -114.46 116.46 28.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -88.03 126.26 34.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.04 77.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.41 -169.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.63 -7.8 75.04 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.562 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.9 -17.73 17.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.841 0.353 . . . . 0.0 110.8 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.54 131.67 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.22 0.533 . . . . 0.0 111.134 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.0 p -83.56 -9.01 59.21 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.88 -0.74 49.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.904 0.383 . . . . 0.0 111.401 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mt -124.78 142.94 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -89.26 98.52 11.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.525 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.74 -33.53 76.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.647 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.52 -38.81 96.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.6 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.72 -48.84 49.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.671 0.272 . . . . 0.0 110.455 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.88 -40.11 91.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.854 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.6 -37.5 86.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.753 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.25 -46.88 39.59 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.751 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 p -72.85 -44.93 60.79 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.421 ' CD2' ' HB ' ' A' ' 153' ' ' ILE . 11.3 tp -73.97 -24.92 59.69 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.756 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 41.1 ttmt -56.86 -32.03 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.004 0.431 . . . . 0.0 110.543 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -68.5 -24.08 64.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.691 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.2 tp -83.46 -35.0 25.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 109.897 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.0 mt -71.5 -40.8 72.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.329 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.42 -103.76 2.98 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -103.62 82.78 0.39 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.951 -0.643 . . . . 0.0 111.826 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.38 173.11 25.38 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.0 t -161.62 151.9 17.32 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.44 69.11 0.29 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.608 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 34.5 p -61.87 -25.75 67.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.859 0.361 . . . . 0.0 111.91 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 1.5 mp0 -59.11 -22.46 60.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.163 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -122.55 27.1 6.1 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.2 tp -109.8 148.49 31.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.692 0.282 . . . . 0.0 111.054 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 158.49 -148.37 17.46 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.729 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.9 mt -106.6 129.73 54.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.01 0.433 . . . . 0.0 109.928 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.564 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 15.7 m-85 -112.1 137.02 50.73 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.836 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.95 149.67 45.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.312 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 63.4 51.6 2.58 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.532 0.52 . . . . 0.0 110.334 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.5 m -92.23 135.62 33.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.711 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.5 p -114.97 145.48 42.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.091 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -77.12 133.71 38.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.582 HD21 ' SG ' ' A' ' 64' ' ' CYS . 19.2 mt -88.88 138.24 31.59 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.961 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.8 108.08 8.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.032 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.29 119.5 37.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.83 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -96.95 138.98 33.65 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 70.4 mt -70.23 124.23 90.37 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.413 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.67 95.89 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.247 1.964 . . . . 0.0 111.011 174.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.9 mm -80.41 122.45 35.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.056 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 77.9 mt -59.02 96.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.483 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 144.33 -29.63 1.9 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -175.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.3 pt -128.54 103.81 19.63 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.844 0.354 . . . . 0.0 110.064 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.19 78.26 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.796 2.331 . . . . 0.0 112.841 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 55.8 mt -97.07 115.26 36.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.655 ' HG3' HG21 ' A' ' 48' ' ' THR . 0.1 OUTLIER -153.44 86.74 1.22 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.031 0.443 . . . . 0.0 110.28 -176.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -88.11 145.06 26.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.092 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 96.2 mt -76.99 133.71 39.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.709 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 47' ' ' ILE . 11.4 p -67.07 -37.98 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.714 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -71.33 -16.44 62.44 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.071 0.462 . . . . 0.0 110.825 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -84.68 -26.54 27.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.503 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -100.09 -17.07 17.63 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.257 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 16.2 t -110.96 139.35 46.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.26 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -111.89 2.22 16.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.758 0.79 . . . . 0.0 109.547 172.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 1.8 mp0 -108.2 170.73 7.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.918 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.459 ' OD1' ' HB ' ' A' ' 39' ' ' VAL . 22.2 m-80 -65.2 134.62 54.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 21.9 mm -95.74 124.26 48.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.87 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -142.07 159.29 42.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.874 0.369 . . . . 0.0 111.102 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 78.6 m -107.86 118.96 38.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 73.7 m -110.24 147.26 34.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.118 0.485 . . . . 0.0 111.348 -169.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 137' ' ' SER . 4.9 tp60 -69.78 122.17 18.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.204 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.11 -8.96 58.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.463 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 135' ' ' GLN . 15.0 m -100.83 136.98 19.69 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.22 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.32 51.86 3.66 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.435 2.09 . . . . 0.0 111.694 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.3 p -67.76 -54.0 22.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.019 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.41 6.38 48.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.607 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -140.64 51.21 1.65 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.863 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 m -76.92 60.99 1.87 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.949 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 174.41 156.55 14.05 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.5 m -91.41 -26.17 19.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.806 0.336 . . . . 0.0 110.807 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 95.1 mt -83.26 4.5 26.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.944 0.402 . . . . 0.0 111.201 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.8 pt -125.42 43.23 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.545 0.688 . . . . 0.0 110.252 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.24 46.6 3.24 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.584 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.14 -32.0 72.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.953 0.406 . . . . 0.0 110.32 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 170.5 -179.66 42.45 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.39 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.16 129.36 25.71 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.76 122.79 11.24 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 121.881 1.72 . . . . 0.0 110.289 174.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . 2.6 t -153.54 159.4 42.2 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.319 -171.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.421 ' HB ' ' CD2' ' A' ' 86' ' ' LEU . 7.4 tp -127.12 130.76 71.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.278 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.89 122.29 14.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.286 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.561 HD13 ' SG ' ' A' ' 56' ' ' CYS . 59.7 tp -62.67 -25.32 68.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.638 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.419 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -72.83 -16.82 78.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.901 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.5 m -74.6 -29.12 61.19 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.228 0.514 . . . . 0.0 111.326 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.4 pt -95.56 -4.41 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.069 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.468 ' OXT' ' HE2' ' A' ' 55' ' ' LYS . 89.3 mt . . . . . 0 C--O 1.252 1.188 0 O-C-N 123.804 0.69 . . . . 0.0 111.885 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 130' ' ' ASN . 7.4 p . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.079 0.466 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -76.43 -22.9 54.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.12 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 157' ' ' SER . 60.2 m-85 -122.61 86.91 49.37 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.421 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.78 144.85 55.21 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.179 1.92 . . . . 0.0 112.487 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.23 132.01 54.47 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.59 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.28 135.09 45.79 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.113 1.876 . . . . 0.0 111.537 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -72.9 -10.22 59.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.037 -170.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -90.13 2.44 55.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.434 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.4 mm -86.75 127.25 40.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.981 0.419 . . . . 0.0 110.736 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 43.2 p -82.16 159.95 23.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.659 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.0 t -57.91 -40.92 78.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.9 0.381 . . . . 0.0 110.792 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -64.4 -44.97 89.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.759 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -62.67 -46.13 89.61 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.962 0.411 . . . . 0.0 110.611 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.483 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -61.04 -37.6 83.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.813 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.8 m -67.43 -45.08 77.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.803 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -63.73 -31.49 72.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.336 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 159' ' ' LEU . 57.1 tptt -62.42 -40.89 98.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.817 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.601 ' SG ' HD13 ' A' ' 155' ' ' LEU . 71.8 m -94.29 -16.21 23.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.855 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.06 161.96 23.75 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.182 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -74.62 -11.08 60.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.969 0.414 . . . . 0.0 110.851 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -91.41 14.63 14.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.109 0.481 . . . . 0.0 110.204 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.75 141.77 51.5 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.469 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -111.9 124.61 52.73 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.483 HD11 ' HB3' ' A' ' 52' ' ' ALA . 95.9 mt -66.08 121.28 14.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.965 0.412 . . . . 0.0 110.165 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 41.2 t -122.62 134.36 54.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.662 -175.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 67.8 m -93.9 116.13 28.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.366 174.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.423 ' HB2' ' ND2' ' A' ' 130' ' ' ASN . 50.3 m -120.32 130.19 54.33 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.709 0.29 . . . . 0.0 110.751 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -79.92 -21.5 43.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.003 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -123.93 142.03 51.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.49 126.65 33.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.17 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.0 m -120.71 115.1 22.67 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -92.24 135.07 34.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.63 72.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.022 -171.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.18 -7.37 82.0 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.784 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -98.26 -17.53 18.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.088 0.47 . . . . 0.0 110.865 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.568 HG21 HD12 ' A' ' 77' ' ' ILE . 13.0 m -120.63 132.35 70.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.299 0.571 . . . . 0.0 111.264 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.3 p -82.56 -18.2 42.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.504 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -86.78 11.71 12.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.568 HD12 HG21 ' A' ' 74' ' ' VAL . 27.6 mt -130.3 136.01 59.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.612 0.244 . . . . 0.0 110.617 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -87.85 107.57 18.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.947 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.63 -28.35 67.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.336 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.1 -41.48 97.07 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.589 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.26 -44.23 97.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.052 0.453 . . . . 0.0 110.319 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.31 -38.88 88.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.843 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.18 -36.97 85.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.344 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.19 -46.18 94.7 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.614 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 p -73.07 -43.42 61.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.938 0.399 . . . . 0.0 111.773 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.34 -26.33 58.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.353 -176.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 29.8 ttpp -56.98 -30.69 64.33 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.751 0.31 . . . . 0.0 110.926 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -63.15 -22.79 67.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.322 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.66 -27.55 20.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.951 0.405 . . . . 0.0 110.769 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.2 mt -82.23 -40.85 17.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.136 0.493 . . . . 0.0 110.801 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.03 -126.14 8.44 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.66 41.11 3.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.339 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -153.73 173.77 32.38 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.2 m -153.56 91.93 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.794 0.33 . . . . 0.0 111.335 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.54 69.86 3.21 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.3 p -68.2 -12.51 61.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.78 -33.94 73.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.82 0.343 . . . . 0.0 111.511 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -107.49 20.06 32.94 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.998 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.2 tp -100.24 139.88 35.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.879 0.371 . . . . 0.0 111.252 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.88 -146.97 11.83 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.819 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.56 HD23 HD13 ' A' ' 77' ' ' ILE . 4.2 mm? -109.56 125.33 52.41 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.77 136.83 47.69 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.167 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -120.03 152.74 37.07 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.999 -175.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 61.33 57.84 2.3 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.545 0.688 . . . . 0.0 109.803 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 96.7 m -106.42 135.66 47.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.548 -174.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.0 m -128.34 131.1 48.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -79.84 145.83 32.55 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.417 . . . . 0.0 111.228 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -95.55 140.84 29.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -75.76 131.24 39.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.153 0.501 . . . . 0.0 109.757 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.8 tp -83.09 119.44 24.5 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -90.29 117.88 29.37 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 60.1 mt -100.68 113.95 65.7 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.13 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 31.3 Cg_exo -59.25 115.83 2.85 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.46 2.107 . . . . 0.0 111.509 176.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 25.1 pt -132.16 174.8 12.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.302 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.3 mm -66.09 105.62 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.504 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.99 -36.89 2.83 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.906 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.4 pt -144.07 78.01 14.1 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 121.213 0.53 . . . . 0.0 110.789 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' PRO . 65.9 Cg_endo -85.75 60.25 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.623 2.215 . . . . 0.0 111.022 177.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.1 mt -78.59 122.18 33.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.882 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.454 ' HB3' HG21 ' A' ' 48' ' ' THR . 14.0 mm-40 -123.83 82.31 2.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.027 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -87.58 144.81 26.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.475 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 76.1 mt -71.48 131.32 43.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.928 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.4 -35.46 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.467 -174.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.99 -12.68 61.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.134 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 122' ' ' LEU . 8.1 tp-100 -83.19 -25.92 31.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.725 0.298 . . . . 0.0 110.656 -173.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -102.3 -17.35 15.93 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.212 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 16.8 t -110.33 137.06 48.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.688 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 128' ' ' LYS . 3.4 mppt? -110.36 3.88 20.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.376 0.608 . . . . 0.0 109.93 172.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 27.8 mp0 -108.75 169.85 8.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.849 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.522 ' HB2' ' HB ' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -66.72 140.56 57.88 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.673 0.273 . . . . 0.0 110.813 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.5 mm -97.53 120.5 46.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.138 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.22 154.86 45.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.836 0.351 . . . . 0.0 110.741 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.408 ' C ' ' SG ' ' A' ' 152' ' ' CYS . 73.9 m -105.64 114.28 28.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.015 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 59.6 m -109.6 140.94 42.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.72 136.4 50.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.728 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -80.27 55.09 2.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.305 0.574 . . . . 0.0 111.043 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.7 t -138.84 103.58 7.54 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.557 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -78.15 46.73 2.17 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.594 2.196 . . . . 0.0 112.471 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.5 m -84.77 0.79 49.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.627 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -86.86 -20.21 27.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.157 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -101.12 15.87 27.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.681 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 m -91.85 33.47 1.04 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.267 -176.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.52 -0.97 63.69 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.796 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.3 m -70.93 134.55 47.32 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 96.2 mt -88.21 45.2 1.26 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.519 0.676 . . . . 0.0 110.485 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 33.6 pt -113.18 43.05 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.236 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -77.6 39.12 1.71 Allowed Glycine 0 N--CA 1.454 -0.153 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.169 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 46.1 mt -82.99 -16.31 47.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.425 0.631 . . . . 0.0 109.711 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 152.17 -155.81 26.34 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.734 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.7 mp -104.8 127.66 28.38 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -66.46 121.32 8.57 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.44 1.427 . . . . 0.0 110.21 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.408 ' SG ' ' C ' ' A' ' 133' ' ' CYS . 0.7 OUTLIER -155.41 169.15 24.92 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.379 -172.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.36 132.45 55.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.388 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.11 123.39 17.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.341 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.601 HD13 ' SG ' ' A' ' 56' ' ' CYS . 42.4 tp -61.79 -25.82 67.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.781 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.452 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.24 -17.14 75.69 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.409 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.5 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 8.5 t -73.41 -26.77 61.11 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.968 0.384 . . . . 0.0 110.95 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 22.2 pt -102.21 -2.34 9.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.532 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.44 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 90.2 mt . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.258 -0.877 . . . . 0.0 112.595 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.258 0.551 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -76.47 -29.04 56.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.357 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -125.14 91.91 48.33 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.51 150.64 75.46 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.395 2.063 . . . . 0.0 112.643 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.71 133.36 29.45 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.736 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.86 136.31 51.39 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.732 2.288 . . . . 0.0 112.395 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.81 -11.73 61.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.208 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -86.02 3.2 43.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.677 0.275 . . . . 0.0 111.732 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.483 ' O ' HG12 ' A' ' 123' ' ' VAL . 34.9 mm -92.06 123.91 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 0.0 110.274 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 61.4 p -80.29 160.84 25.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.298 175.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.33 -40.87 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 65.7 tttp -65.46 -47.52 75.83 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.879 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -59.6 -43.5 93.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 110.69 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.99 -41.7 98.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.732 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.44 HG21 HD23 ' A' ' 110' ' ' LEU . 29.6 m -68.97 -39.03 79.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.689 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 73.8 mm-40 -59.56 -32.19 70.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.042 0.448 . . . . 0.0 110.756 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -60.58 -33.52 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.082 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 60' ' ' ALA . 85.5 m -100.49 9.55 42.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.752 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.57 80.05 0.66 Allowed Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.45 -172.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -177.5 -72.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.977 0.418 . . . . 0.0 110.864 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -116.86 12.92 14.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.452 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . . . -149.08 163.89 36.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.05 0.453 . . . . 0.0 111.591 -171.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -134.52 143.23 47.32 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.9 tp -67.29 134.59 51.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.057 -178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 t -139.69 145.97 39.04 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.858 0.361 . . . . 0.0 110.358 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.702 ' SG ' HD11 ' A' ' 108' ' ' LEU . 29.5 m -113.9 120.63 41.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.745 176.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.544 ' O ' ' HB3' ' A' ' 129' ' ' GLN . 13.5 m -115.49 144.71 43.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -89.91 -26.55 20.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -124.69 145.24 49.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.35 128.36 33.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.614 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 m -120.38 115.09 22.84 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 171.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -91.65 136.58 33.03 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.34 -27.51 69.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.564 -170.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.41 -12.26 80.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.881 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.61 -17.47 19.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 0.0 111.364 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.483 ' HB ' ' OD1' ' A' ' 76' ' ' ASP . 10.5 m -121.23 125.96 74.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.427 0.632 . . . . 0.0 111.09 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.2 p -86.85 -6.57 58.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.975 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD1' ' HB ' ' A' ' 74' ' ' VAL . 8.8 p-10 -83.12 -2.26 54.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.939 0.399 . . . . 0.0 111.351 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mt -110.41 143.14 20.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.456 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -88.2 99.45 12.22 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.11 -26.93 68.76 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.27 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.08 -42.66 91.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.391 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.3 -44.8 94.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.961 0.41 . . . . 0.0 110.461 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.7 mt -62.89 -40.52 97.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.714 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.73 -42.03 91.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.661 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.74 -41.28 99.86 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.684 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.6 p -72.48 -43.99 62.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.699 0.285 . . . . 0.0 111.531 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.72 -27.6 61.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.846 0.355 . . . . 0.0 110.803 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 18.4 ttmm -57.75 -32.65 67.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.048 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.35 -22.72 64.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.562 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.414 HD21 ' SG ' ' A' ' 133' ' ' CYS . 59.3 tp -79.92 -33.81 39.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.2 0.524 . . . . 0.0 110.245 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 94' ' ' SER . 71.4 mt -85.21 -47.31 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.998 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.26 -100.72 0.34 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.827 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -111.57 12.99 27.8 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.426 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.65 171.11 24.19 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.795 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.438 ' HA ' HD12 ' A' ' 90' ' ' ILE . 7.5 p -157.51 102.26 1.89 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.719 0.295 . . . . 0.0 110.886 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -73.28 85.48 0.6 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.191 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.4 p -67.09 -9.05 35.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.817 0.341 . . . . 0.0 111.724 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -62.54 -31.33 72.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.223 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.6 23.21 9.69 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.787 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.9 tp -105.14 144.44 31.94 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.403 0.281 . . . . 0.0 110.945 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 163.96 -149.52 16.82 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.845 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.8 mt -107.89 132.96 52.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 152' ' ' CYS . 22.5 m-85 -114.9 143.18 45.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -125.84 152.96 44.79 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 110.483 -0.192 . . . . 0.0 110.483 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 57.97 58.15 3.74 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.575 0.702 . . . . 0.0 109.643 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 6.9 t -120.35 144.25 47.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.83 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.1 t -126.06 140.65 52.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.446 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -79.09 147.44 32.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.911 0.386 . . . . 0.0 110.71 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.702 HD11 ' SG ' ' A' ' 64' ' ' CYS . 62.3 mt -102.31 141.49 35.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.594 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -100.29 126.03 46.57 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.44 HD23 HG21 ' A' ' 53' ' ' THR . 3.0 pp -77.95 136.2 37.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.027 0.441 . . . . 0.0 110.305 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -73.95 126.28 30.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.37 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 60.0 mt -99.74 114.3 65.55 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.109 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.79 83.95 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.044 1.83 . . . . 0.0 111.481 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.5 mt -77.37 -80.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.645 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.8 mm -112.1 93.57 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.047 0.451 . . . . 0.0 111.129 -175.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 118' ' ' PRO . . . 64.13 49.73 64.89 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.109 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 41.1 mt -111.76 89.08 10.57 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 116' ' ' GLY . 72.9 Cg_endo -89.35 39.58 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.757 2.305 . . . . 0.0 111.888 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.4 mm -103.79 120.95 54.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.093 0.473 . . . . 0.0 110.482 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -101.4 85.75 2.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.34 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.78 103.73 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.604 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 97.6 mt -70.36 131.76 44.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.067 0.46 . . . . 0.0 110.256 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 47' ' ' ILE . 10.5 p -66.74 -35.78 75.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.497 -173.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -70.95 -16.37 62.65 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.912 0.387 . . . . 0.0 110.999 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -83.58 -28.32 28.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.509 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -114.42 -14.72 12.16 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.823 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.3 t -108.38 116.68 32.42 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 174.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -100.16 -4.48 29.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.445 0.641 . . . . 0.0 110.18 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 65' ' ' CYS . 23.1 mp0 -91.56 168.29 11.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.242 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.65 131.68 45.0 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.589 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 29.3 mt -93.79 126.96 46.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.569 -174.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.42 ' HB1' ' SG ' ' A' ' 152' ' ' CYS . . . -135.38 158.43 44.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.327 0.585 . . . . 0.0 111.656 -176.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.414 ' SG ' HD21 ' A' ' 89' ' ' LEU . 37.1 t -110.0 115.13 29.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.653 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 49.5 m -110.78 139.49 46.04 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.731 -170.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.44 139.33 49.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.628 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.13 64.0 3.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.473 0.654 . . . . 0.0 110.558 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.4 m -105.23 92.96 6.08 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.404 173.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -77.86 50.76 3.37 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.532 2.155 . . . . 0.0 112.869 -174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.0 t -166.27 136.52 3.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.43 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -77.82 -12.39 59.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.309 0.576 . . . . 0.0 110.307 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.71 54.14 2.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.847 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.4 t -135.58 33.94 2.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.954 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.18 50.0 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.216 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.8 t 65.51 43.73 3.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.005 0.431 . . . . 0.0 110.344 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 92.7 mt 59.0 86.06 0.09 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.294 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 12.7 pt -122.26 61.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.321 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -78.73 14.8 11.6 Favored Glycine 0 C--O 1.23 -0.148 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.756 175.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 36.2 mt -87.93 -10.34 50.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.148 0.499 . . . . 0.0 110.146 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 165.51 173.26 33.86 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.553 ' H ' HD23 ' A' ' 150' ' ' LEU . 0.7 OUTLIER -95.02 134.16 25.18 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 117.031 0.416 . . . . 0.0 110.53 -178.518 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.64 123.84 11.95 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.596 2.197 . . . . 0.0 111.182 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.492 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 3.6 t -153.67 163.83 39.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.857 -174.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.44 133.15 60.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.58 130.05 34.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.539 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.64 -24.61 67.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.315 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -72.91 -15.37 78.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.586 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 m -80.6 -29.61 36.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.033 0.417 . . . . 0.0 111.299 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 29.4 pt -100.49 -9.65 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.787 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 C--O 1.249 1.078 0 O-C-N 123.85 0.719 . . . . 0.0 112.382 177.907 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.436 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 7.1 p . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 121.423 0.63 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.572 ' HD2' ' CE1' ' A' ' 41' ' ' PHE . 3.3 tmt_? -68.37 -34.27 75.76 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.411 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CE1' ' HD2' ' A' ' 40' ' ' ARG . 90.3 m-85 -118.69 87.49 32.42 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.6 151.25 69.94 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.508 2.139 . . . . 0.0 112.542 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.3 t -82.35 128.26 67.95 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.294 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.16 137.15 45.97 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.049 2.499 . . . . 0.0 112.613 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.23 -11.04 47.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.575 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -86.37 -1.42 57.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.122 0.487 . . . . 0.0 111.243 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.34 122.39 41.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.162 0.506 . . . . 0.0 111.01 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 70.5 p -81.93 163.81 21.96 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.436 174.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.505 HG12 HD23 ' A' ' 110' ' ' LEU . 21.9 t -57.0 -39.43 65.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.843 0.354 . . . . 0.0 110.594 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.41 -46.37 73.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.164 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -58.77 -44.31 90.62 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 110.378 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 62' ' ' LEU . . . -61.89 -45.9 91.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.095 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.495 ' OG1' HD21 ' A' ' 110' ' ' LEU . 90.9 m -64.56 -46.68 81.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.211 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -67.3 -28.39 67.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.013 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -64.26 -40.92 96.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.44 . . . . 0.0 110.061 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' HD13 ' A' ' 155' ' ' LEU . 81.0 m -101.09 14.03 33.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.196 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.42 168.8 8.66 Favored Glycine 0 CA--C 1.518 0.26 0 N-CA-C 114.266 0.467 . . . . 0.0 114.266 -171.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 72.02 -67.84 0.24 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.014 0.926 . . . . 0.0 111.991 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -94.21 -8.49 39.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -171.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 56' ' ' CYS . . . -138.65 163.6 31.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.412 0.625 . . . . 0.0 111.864 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -128.3 138.23 52.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.296 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' ' 52' ' ' ALA . 12.1 mt -69.27 134.77 49.58 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.787 0.327 . . . . 0.0 110.837 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.478 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 38.2 t -140.62 129.94 23.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.133 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.483 ' SG ' HD11 ' A' ' 108' ' ' LEU . 59.9 m -102.33 116.99 33.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.65 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 129' ' ' GLN . 9.0 m -118.98 143.33 47.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.307 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -71.33 -37.38 71.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.719 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -126.83 141.27 51.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.036 0.446 . . . . 0.0 111.594 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.22 122.58 28.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.424 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 m -103.32 115.25 30.19 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.436 ' OH ' ' HA ' ' A' ' 39' ' ' VAL . 87.7 m-85 -91.36 133.18 35.67 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.68 67.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.582 -168.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.32 -20.84 76.63 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.581 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.86 -14.5 26.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.643 0.259 . . . . 0.0 111.471 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 77' ' ' ILE . 21.8 m -121.72 150.31 25.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.562 178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -108.39 2.91 22.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -95.64 1.77 53.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.03 0.443 . . . . 0.0 110.893 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.407 HD12 HG21 ' A' ' 74' ' ' VAL . 46.0 mt -119.25 136.5 56.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.946 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -86.86 108.01 18.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.049 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.34 -30.2 69.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.084 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.25 -39.67 96.18 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.608 -176.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.9 -47.43 88.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.121 0.486 . . . . 0.0 110.189 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 88.5 mt -67.43 -45.58 75.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.896 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -63.78 -41.14 98.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.952 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.85 -46.81 93.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.421 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.9 p -73.32 -40.6 64.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.901 0.382 . . . . 0.0 111.854 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -74.24 -23.21 59.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.425 -177.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 38.2 ttpt -54.63 -32.64 59.28 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.708 -174.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.9 -32.41 73.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.84 0.352 . . . . 0.0 110.485 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 89' ' ' LEU . 3.1 tm? -82.73 -34.86 27.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.42 -44.83 99.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.42 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.7 -74.78 2.47 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.492 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.81 -89.11 0.85 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.242 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.77 -172.28 45.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.996 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.6 m 62.91 59.08 1.41 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.71 0.404 . . . . 0.0 111.629 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.77 12.69 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.969 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.7 p -75.98 -18.87 59.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.829 0.347 . . . . 0.0 111.708 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.04 -13.7 62.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.323 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -115.44 23.93 10.83 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.38 142.5 38.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.56 -149.62 12.97 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 119.751 -1.214 . . . . 0.0 113.619 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.07 126.19 54.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -112.38 139.78 47.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.928 -173.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -120.25 154.03 35.49 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.671 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 61.9 58.7 1.86 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.691 0.757 . . . . 0.0 109.898 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.478 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 90.4 m -101.72 142.69 32.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.037 -173.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.8 p -132.94 137.33 46.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.567 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -80.89 144.92 31.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.793 0.33 . . . . 0.0 110.359 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.483 HD11 ' SG ' ' A' ' 64' ' ' CYS . 62.3 mt -91.33 124.99 35.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.54 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -85.71 145.65 27.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.697 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.505 HD23 HG12 ' A' ' 49' ' ' VAL . 91.9 mt -97.49 126.21 42.63 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.316 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -89.28 101.86 14.52 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 170.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 54.1 mt -98.97 123.22 50.0 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.901 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.22 90.34 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.432 2.088 . . . . 0.0 112.169 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 55.8 mt -79.6 92.86 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.4 tp 39.53 64.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 122.125 0.964 . . . . 0.0 111.842 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -149.79 -100.04 0.21 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.04 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.7 pt -130.68 106.49 15.56 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.942 0.401 . . . . 0.0 110.966 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.77 96.97 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.839 2.359 . . . . 0.0 112.173 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 67.8 mt -97.91 127.56 50.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.369 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -78.82 73.42 5.37 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.35 106.43 10.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.422 -175.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 64.8 mt -70.85 136.69 48.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.437 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.475 ' HA ' HG22 ' A' ' 49' ' ' VAL . 13.1 p -65.96 -29.65 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.241 -174.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.14 -13.35 61.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.077 0.465 . . . . 0.0 110.842 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -83.77 -27.69 28.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -108.74 -16.13 14.25 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.014 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.408 ' SG ' HG12 ' A' ' 131' ' ' ILE . 48.6 t -109.16 111.93 23.82 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.781 177.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -103.43 9.52 37.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.607 0.718 . . . . 0.0 109.97 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 65' ' ' CYS . 2.1 mp0 -105.12 168.56 8.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.692 -1.14 . . . . 0.0 107.967 176.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.42 ' CB ' ' HB ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -70.1 128.56 36.71 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.378 178.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.408 HG12 ' SG ' ' A' ' 127' ' ' CYS . 23.3 mt -88.18 125.24 41.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.825 -174.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.09 155.9 49.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.202 0.525 . . . . 0.0 111.275 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 64.8 m -106.0 129.76 54.06 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.8 m -111.34 139.34 46.82 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -77.36 134.18 38.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.075 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -84.47 54.23 2.93 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.65 . . . . 0.0 110.293 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.1 m -118.4 123.28 29.42 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.583 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.58 98.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.52 2.147 . . . . 0.0 112.448 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.0 m -78.39 56.48 1.75 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.436 0.636 . . . . 0.0 109.878 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -83.43 47.7 1.3 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.919 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.41 -27.99 56.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.467 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.2 t -130.64 37.29 3.84 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.33 -141.97 41.9 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.61 -176.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 47.1 m -84.07 -14.91 49.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.177 0.513 . . . . 0.0 110.148 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.8 tp -80.75 72.36 7.71 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.371 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 23.0 pt -130.61 51.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.183 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.32 33.7 2.01 Favored Glycine 0 N--CA 1.455 -0.089 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.426 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 53.7 mt -89.38 -26.99 20.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.066 0.46 . . . . 0.0 109.875 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 148.58 -176.7 27.26 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.218 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.5 mp -111.0 135.55 20.84 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.42 121.04 6.52 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.356 1.371 . . . . 0.0 110.727 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 42.5 m -152.55 160.54 43.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.131 -173.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.06 136.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.198 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.31 124.57 20.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.334 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.495 HD13 ' SG ' ' A' ' 56' ' ' CYS . 57.6 tp -61.12 -29.57 69.85 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.641 -175.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.414 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -66.27 -16.02 64.17 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.661 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.1 m -70.87 -30.16 66.46 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 117.061 0.43 . . . . 0.0 111.102 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 41.5 pt -99.8 -9.1 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.425 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 C--O 1.251 1.152 0 O-C-N 123.639 0.587 . . . . 0.0 111.784 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -76.25 -27.81 56.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.889 0.376 . . . . 0.0 111.081 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.519 ' O ' ' HA3' ' A' ' 156' ' ' GLY . 54.8 m-85 -136.71 97.57 11.29 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.002 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.77 139.66 44.4 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.874 2.383 . . . . 0.0 112.76 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -81.64 134.75 50.27 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.406 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.93 135.05 50.39 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.272 1.981 . . . . 0.0 111.914 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.06 -10.39 59.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.695 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.66 4.68 48.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.799 0.333 . . . . 0.0 111.177 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.3 mm -93.15 117.48 36.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.139 0.495 . . . . 0.0 110.586 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 32.9 p -77.38 159.68 29.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.531 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 123' ' ' VAL . 44.1 t -54.27 -42.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.918 0.389 . . . . 0.0 110.614 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -60.63 -47.07 87.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.997 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -67.26 -35.95 80.58 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.488 0.185 . . . . 0.0 111.045 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.25 80.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 110.062 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.1 m -67.71 -47.52 69.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.659 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -65.08 -34.56 78.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.809 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -63.38 -37.54 87.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.629 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.64 ' SG ' HD13 ' A' ' 155' ' ' LEU . 92.5 m -91.04 -19.85 22.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.748 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.47 178.78 29.82 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.479 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -82.54 -16.52 48.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -91.97 11.82 23.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.237 0.542 . . . . 0.0 110.606 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 134' ' ' CYS . . . -132.67 126.51 32.79 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.838 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -95.45 128.41 42.28 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.214 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 33.0 mt -65.44 122.87 18.17 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.871 0.367 . . . . 0.0 110.196 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.425 ' HB3' ' SG ' ' A' ' 105' ' ' CYS . 19.6 m -134.01 131.72 39.25 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.31 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.495 ' SG ' HD11 ' A' ' 108' ' ' LEU . 66.7 m -107.75 118.06 35.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.182 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER -116.68 140.05 49.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.812 -175.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -79.42 -19.76 49.2 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.818 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -126.42 140.98 52.06 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.608 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.23 127.0 32.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.282 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.4 m -119.95 115.83 24.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -95.1 132.03 40.46 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.76 -27.27 68.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.856 -171.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.81 -23.64 72.57 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.877 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -94.67 -18.58 21.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.184 0.492 . . . . 0.0 111.507 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.478 HG21 HD12 ' A' ' 77' ' ' ILE . 16.8 m -121.52 125.01 73.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.324 0.583 . . . . 0.0 111.429 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.4 p -85.99 -14.75 43.63 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.827 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -73.45 -15.04 61.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.187 0.518 . . . . 0.0 111.178 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.478 HD12 HG21 ' A' ' 74' ' ' VAL . 43.9 mt -103.75 130.32 54.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -70.89 106.73 3.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.125 0.488 . . . . 0.0 110.587 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.69 -29.4 68.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.03 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.41 -44.11 95.8 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.721 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.8 mt -63.25 -46.41 95.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.247 0.546 . . . . 0.0 110.266 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.35 -43.15 95.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.123 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.65 -39.1 88.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.721 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.25 -46.2 88.15 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.438 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 p -68.75 -42.74 77.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.829 0.347 . . . . 0.0 111.498 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.96 -26.21 59.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -57.89 -32.55 67.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.822 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -63.17 -28.65 70.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.487 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 60' ' ' ALA . 66.5 tp -86.83 -37.41 17.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.458 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.0 mt -72.3 -37.16 57.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.77 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.92 -73.12 0.22 Allowed Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -135.52 128.75 4.78 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.142 -0.552 . . . . 0.0 111.838 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.8 -170.05 33.12 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.575 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.7 p -157.97 115.28 2.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.93 0.395 . . . . 0.0 111.053 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.06 78.83 1.67 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 29.8 p -70.06 -18.87 63.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -172.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.41 -33.17 74.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.835 0.35 . . . . 0.0 111.324 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.438 ' HA3' ' OG ' ' A' ' 157' ' ' SER . . . -108.03 15.03 37.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.881 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 96' ' ' THR . 45.1 tp -104.02 141.6 35.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.591 0.234 . . . . 0.0 110.7 -174.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 166.4 -156.47 28.38 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.576 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.1 mt -106.25 122.87 47.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.463 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 16.4 m-85 -106.34 133.72 50.6 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.016 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -119.69 154.49 34.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.717 -175.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.452 ' HA ' ' OE1' ' A' ' 104' ' ' GLN . 13.4 mm-40 59.08 58.15 3.24 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 3.5 t -120.66 138.86 53.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.25 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.7 m -129.73 149.93 51.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.822 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -78.93 147.47 33.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.947 0.403 . . . . 0.0 110.753 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 64' ' ' CYS . 69.8 mt -89.93 137.74 32.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.614 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.91 129.06 34.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.039 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.27 118.79 30.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.919 0.39 . . . . 0.0 111.074 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -105.51 101.42 10.95 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 56.3 mt -114.73 113.53 44.79 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.094 -175.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.97 122.49 3.38 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.246 1.964 . . . . 0.0 111.288 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.4 mt -100.73 80.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.948 0.404 . . . . 0.0 110.309 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 49.0 mm 64.37 98.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.285 177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 167.97 -68.74 0.17 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.484 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.1 mm -110.03 115.13 55.37 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -65.84 89.46 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.565 2.177 . . . . 0.0 111.837 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.7 mt -109.18 124.24 65.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.983 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -113.14 76.25 0.97 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -87.48 104.46 16.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.647 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 52.8 mt -72.86 135.64 45.18 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.433 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.427 ' HA ' HG22 ' A' ' 49' ' ' VAL . 10.9 p -65.24 -29.67 47.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.925 -176.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -71.5 -16.77 62.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.995 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -83.86 -26.04 29.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.789 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -107.41 -17.1 14.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.359 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 131' ' ' ILE . 38.4 t -111.95 114.77 27.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.643 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.452 ' HB2' ' NZ ' ' A' ' 128' ' ' LYS . 9.4 mtmp? -99.88 2.12 43.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.473 0.654 . . . . 0.0 110.043 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 0.8 OUTLIER -107.51 173.4 6.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.649 -176.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -63.13 122.78 16.95 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.485 HG12 ' SG ' ' A' ' 127' ' ' CYS . 17.7 mt -91.29 117.33 34.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.161 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.69 154.07 50.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.201 0.524 . . . . 0.0 111.012 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.421 ' HB3' ' HB1' ' A' ' 60' ' ' ALA . 75.7 m -109.81 129.11 55.67 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.477 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 21.3 m -112.35 140.57 46.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.511 ' HG3' ' H ' ' A' ' 137' ' ' SER . 6.4 tp60 -70.62 129.52 39.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.204 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -86.87 28.46 0.89 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.101 0.477 . . . . 0.0 111.78 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.511 ' H ' ' HG3' ' A' ' 135' ' ' GLN . 60.7 m -102.33 108.18 56.21 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.836 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.69 45.74 2.03 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.329 2.019 . . . . 0.0 112.124 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.9 p -79.85 -59.12 2.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.672 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.19 3.73 15.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.084 0.468 . . . . 0.0 110.616 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.59 -15.65 36.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.687 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.0 m -82.03 67.36 8.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.788 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -141.09 139.99 10.01 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.539 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.7 t -94.75 -14.96 24.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.111 0.482 . . . . 0.0 110.093 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.3 mt -95.08 19.95 9.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.883 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.5 pt -127.55 55.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.569 0.7 . . . . 0.0 110.795 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -78.44 21.4 3.66 Favored Glycine 0 CA--C 1.517 0.159 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.329 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -71.22 -29.38 65.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.875 0.369 . . . . 0.0 110.48 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 154.52 -170.86 32.95 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.977 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.3 mp -108.08 129.18 24.45 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -70.77 120.96 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.634 1.556 . . . . 0.0 110.95 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 61.3 m -153.45 161.92 41.79 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.6 133.42 68.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.838 0.351 . . . . 0.0 110.651 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.43 125.89 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.01 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.64 HD13 ' SG ' ' A' ' 56' ' ' CYS . 45.4 tp -65.11 -26.82 68.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.158 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 41' ' ' PHE . . . -66.8 -19.4 69.44 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.891 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.438 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 30.8 m -68.88 -29.13 67.35 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.176 0.488 . . . . 0.0 110.997 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.4 pt -101.03 -1.43 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.863 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.247 0.924 0 O-C-N 124.034 0.834 . . . . 0.0 111.79 178.366 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.419 ' HB ' ' OD1' ' A' ' 130' ' ' ASN . 7.2 p . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -62.78 -30.83 71.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.744 -175.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.519 ' HB3' ' C ' ' A' ' 156' ' ' GLY . 51.0 m-85 -138.03 91.47 13.15 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.223 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.56 144.95 62.61 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.188 1.925 . . . . 0.0 112.508 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -82.16 131.95 54.82 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.89 134.43 41.92 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.99 1.793 . . . . 0.0 111.943 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.13 -17.28 64.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.91 -172.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -81.81 2.87 28.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.87 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.45 ' O ' HG12 ' A' ' 123' ' ' VAL . 30.9 mm -89.6 127.24 42.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.976 0.417 . . . . 0.0 110.53 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 55.5 p -83.93 163.78 19.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.419 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.1 t -56.15 -43.18 75.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.936 0.398 . . . . 0.0 110.795 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -62.43 -46.59 87.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -67.98 -37.42 81.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.245 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.32 99.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.839 0.352 . . . . 0.0 110.713 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.477 HG21 HD11 ' A' ' 110' ' ' LEU . 39.8 m -62.68 -45.75 91.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.913 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -64.42 -30.6 71.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.23 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -72.67 -31.44 65.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.336 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 133' ' ' CYS . 83.0 m -77.71 -22.33 50.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.124 0.488 . . . . 0.0 110.122 173.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.07 172.88 34.26 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.218 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -78.82 -21.01 48.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.879 0.371 . . . . 0.0 110.651 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.81 19.63 6.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.799 0.333 . . . . 0.0 110.908 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 134' ' ' CYS . . . -140.68 143.57 35.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.992 0.425 . . . . 0.0 110.663 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -117.88 134.84 54.54 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.747 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.92 125.73 25.79 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.782 0.325 . . . . 0.0 110.295 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 107' ' ' LYS . 16.7 m -129.84 126.14 37.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.194 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 129' ' ' GLN . 89.5 m -103.92 115.43 30.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 3.0 m -119.27 138.67 52.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 -172.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -81.0 -18.86 45.39 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.002 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -123.24 138.3 54.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.181 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.18 121.51 23.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.715 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.3 m -118.6 115.79 25.29 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 74' ' ' VAL . 59.2 m-85 -95.07 126.69 40.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.076 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.51 -31.32 72.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.531 -169.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.41 -20.42 67.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.934 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -102.36 -16.73 16.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 70' ' ' TYR . 19.5 m -119.11 135.69 58.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.075 0.464 . . . . 0.0 111.331 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.1 p -86.11 -16.11 39.02 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -72.45 -6.1 41.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 111.476 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.6 mt -119.09 139.05 47.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.381 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -89.13 102.39 15.04 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.85 -35.9 82.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.021 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.21 97.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.577 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.5 mt -64.97 -48.53 83.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.053 0.454 . . . . 0.0 110.528 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 151' ' ' PRO . 41.7 mt -68.12 -45.53 73.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.071 -175.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -62.37 -37.19 84.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.662 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.93 -45.05 96.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.068 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 p -72.8 -42.23 64.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.814 0.34 . . . . 0.0 111.798 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.78 -26.29 59.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.501 -174.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 53.7 tttp -56.87 -29.0 62.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.889 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -60.57 -26.37 66.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.257 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.37 -36.95 26.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.913 0.387 . . . . 0.0 110.673 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.3 mt -72.02 -36.19 56.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.63 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.76 -118.59 4.86 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.742 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -96.86 58.39 1.25 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.255 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.75 -174.36 30.49 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 t -149.59 152.46 35.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.933 0.397 . . . . 0.0 110.405 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.84 51.41 0.19 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.6 p -71.7 -14.1 61.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.306 -0.447 . . . . 0.0 111.959 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.17 -21.16 64.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.435 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -111.53 19.22 24.3 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 100' ' ' GLY . 7.3 tt -113.33 143.15 44.93 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -175.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.501 ' N ' HD23 ' A' ' 99' ' ' LEU . . . 165.63 -136.72 4.31 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.008 -1.092 . . . . 0.0 113.234 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 94.2 mt -113.5 133.22 55.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.567 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 33.3 m-85 -118.81 124.86 48.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.317 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -120.47 159.58 24.86 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.724 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 60.24 58.0 2.75 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 7.0 t -121.97 153.59 38.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.941 -168.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.1 p -136.53 130.51 32.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.042 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 63' ' ' SER . 68.6 mttm -81.87 148.93 28.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.146 0.498 . . . . 0.0 110.837 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.436 HD11 ' SG ' ' A' ' 64' ' ' CYS . 94.2 mt -92.46 135.54 33.96 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.863 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -100.63 132.29 46.09 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 53' ' ' THR . 61.9 mt -66.69 116.04 7.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.037 0.446 . . . . 0.0 110.736 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -106.68 101.13 10.6 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.552 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.8 mm -112.89 111.68 50.91 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.51 88.35 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.964 1.776 . . . . 0.0 111.856 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 51.7 mt -86.06 81.37 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.444 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.405 ' O ' HG13 ' A' ' 115' ' ' ILE . 9.8 tp -162.7 43.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 122.214 1.007 . . . . 0.0 109.607 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 126.09 -75.59 0.4 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.029 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 65.2 mt -115.94 112.87 42.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -78.55 78.3 3.71 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.265 1.977 . . . . 0.0 111.538 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.1 mt -63.44 132.03 29.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.83 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -122.16 97.5 5.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.786 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -87.95 160.52 17.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.397 0.618 . . . . 0.0 111.399 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 71.7 mt -67.01 134.14 51.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.591 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 47' ' ' ILE . 12.1 p -66.12 -32.5 58.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.573 -174.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -68.82 -16.12 63.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.639 0.256 . . . . 0.0 110.797 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -85.13 -26.6 26.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.655 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -95.35 -19.04 20.27 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.472 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.641 ' SG ' HG12 ' A' ' 131' ' ' ILE . 45.6 t -111.88 112.45 24.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.592 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.4 2.01 36.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.143 0.497 . . . . 0.0 110.703 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 2.1 mp0 -105.54 172.03 7.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.571 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.419 ' OD1' ' HB ' ' A' ' 39' ' ' VAL . 28.9 m-80 -63.97 125.97 26.16 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.641 HG12 ' SG ' ' A' ' 127' ' ' CYS . 14.1 mt -92.64 125.36 45.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.773 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.5 157.16 47.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.033 0.444 . . . . 0.0 111.316 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 155' ' ' LEU . 30.6 m -105.74 116.42 31.92 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 57.1 m -108.98 139.74 43.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -79.42 129.62 34.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.058 0.456 . . . . 0.0 111.102 -173.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -82.62 68.65 9.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.372 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 p -57.05 126.09 72.15 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.243 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.91 51.79 3.76 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.88 2.387 . . . . 0.0 112.223 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.1 t -157.94 139.26 13.53 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.914 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -94.01 104.28 16.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.933 0.397 . . . . 0.0 111.047 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -106.97 25.22 11.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.31 0.576 . . . . 0.0 109.494 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 m -77.99 69.92 4.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.848 -175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -119.63 -141.31 6.4 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.879 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.1 t -98.35 -11.54 22.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.775 0.321 . . . . 0.0 110.799 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 91.7 mt -89.12 15.55 8.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.902 0.382 . . . . 0.0 111.441 -174.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 39.7 pt -122.71 33.6 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.241 0.543 . . . . 0.0 110.708 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -81.45 -6.54 89.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.306 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.5 mt -75.33 -35.34 61.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.851 0.357 . . . . 0.0 110.616 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 147.18 -179.97 23.7 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 20.5 mt -95.37 130.54 31.96 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.45 ' HB3' HD22 ' A' ' 82' ' ' LEU . 17.2 Cg_exo -66.45 122.95 10.5 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.124 1.883 . . . . 0.0 111.114 175.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.409 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -155.09 168.88 25.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -177.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.7 tt -135.48 136.26 50.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.38 124.62 21.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.624 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.584 HD13 ' SG ' ' A' ' 133' ' ' CYS . 53.4 tp -64.55 -25.69 68.09 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.999 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.519 ' C ' ' HB3' ' A' ' 41' ' ' PHE . . . -71.52 -17.11 76.1 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.449 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.9 m -74.06 -29.35 61.85 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 117.249 0.525 . . . . 0.0 111.205 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.5 pt -97.16 -3.77 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.756 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.341 -0.838 . . . . 0.0 111.858 178.949 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 121.184 0.516 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -73.19 -26.67 61.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.145 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -130.85 88.71 45.21 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.11 147.96 74.32 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.742 2.295 . . . . 0.0 113.264 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.29 134.69 45.25 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.14 176.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.91 135.82 43.52 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.655 2.237 . . . . 0.0 112.287 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.77 -16.06 63.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.144 -172.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -92.09 10.37 29.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.769 0.319 . . . . 0.0 111.234 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.4 mm -93.59 123.32 45.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.218 0.533 . . . . 0.0 110.683 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 66.4 p -80.19 160.83 25.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.415 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.64 -40.38 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.216 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -62.39 -46.46 88.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.869 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -62.44 -43.83 97.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.863 0.363 . . . . 0.0 110.473 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 56' ' ' CYS . . . -61.4 -39.48 90.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.712 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.2 m -62.66 -47.54 83.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.798 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -71.71 -36.27 70.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.496 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -75.25 -20.37 59.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.18 0.514 . . . . 0.0 110.553 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 20.7 t -72.49 -21.73 61.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.229 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.45 160.06 20.02 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.993 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -82.83 -14.52 54.2 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -115.57 23.54 12.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.142 0.496 . . . . 0.0 110.534 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 89' ' ' LEU . . . -124.99 148.68 48.32 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.468 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -113.67 129.21 56.61 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.505 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 26.2 mt -64.45 119.22 10.0 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.545 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 42.6 t -129.5 127.25 40.42 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.383 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.543 ' SG ' HD21 ' A' ' 108' ' ' LEU . 45.0 m -97.68 119.72 36.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.923 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 102' ' ' PHE . 41.7 m -117.38 129.36 55.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.753 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -71.86 -27.95 63.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -123.34 139.03 54.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.712 0.291 . . . . 0.0 110.379 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.6 124.3 26.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.528 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.8 m -117.19 115.33 25.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.836 0.351 . . . . 0.0 110.286 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -93.52 133.05 37.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.05 -33.89 75.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.362 -169.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.53 -12.7 64.39 Favored Glycine 0 C--O 1.229 -0.189 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.06 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.99 -15.48 18.26 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.622 -0.34 . . . . 0.0 111.418 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.585 HG21 HD12 ' A' ' 77' ' ' ILE . 14.7 m -120.79 127.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.536 0.684 . . . . 0.0 111.5 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p -85.62 -11.64 53.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.279 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.55 -1.09 55.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.842 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.619 HD13 HD23 ' A' ' 101' ' ' LEU . 30.0 mt -118.08 134.54 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.896 0.379 . . . . 0.0 111.387 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -81.07 102.13 10.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.873 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.34 -30.08 68.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.112 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.76 -42.34 99.74 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.32 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.96 -44.77 99.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.162 0.506 . . . . 0.0 110.041 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.78 -44.29 97.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.608 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 87' ' ' LYS . . . -65.37 -45.4 84.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.712 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.98 -45.02 97.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.659 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.5 p -73.34 -44.83 58.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.508 HD22 HD13 ' A' ' 99' ' ' LEU . 18.2 tp -73.83 -22.55 59.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.623 0.249 . . . . 0.0 111.411 -177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 83' ' ' ALA . 63.2 tttm -54.16 -29.79 46.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 0.0 111.043 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -63.01 -22.23 66.7 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.938 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 60' ' ' ALA . 52.4 tp -90.62 -30.5 17.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.04 -40.29 51.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.694 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.79 -78.67 1.99 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.437 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.33 84.91 0.31 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.275 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.98 -174.76 34.59 Favored Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.919 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.8 m -155.75 120.94 4.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.77 0.319 . . . . 0.0 110.435 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -136.56 62.4 0.6 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 32.1 p -69.6 -15.91 63.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -172.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -60.02 -29.08 68.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.401 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.72 16.95 43.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.763 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.508 HD13 HD22 ' A' ' 86' ' ' LEU . 37.7 tp -103.16 143.2 32.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.055 0.455 . . . . 0.0 110.962 -176.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 170.63 -150.16 13.77 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.286 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.619 HD23 HD13 ' A' ' 77' ' ' ILE . 4.2 mm? -111.01 129.1 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.45 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 33.3 m-85 -113.46 136.4 52.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.387 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -119.97 151.94 38.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.363 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 62.29 58.19 1.81 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.345 0.593 . . . . 0.0 109.952 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.545 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 76.3 m -108.42 136.37 48.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.711 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.6 t -132.66 143.99 50.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -72.11 140.51 48.93 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.546 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.543 HD21 ' SG ' ' A' ' 64' ' ' CYS . 33.8 mt -83.85 142.71 30.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.1 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -74.68 132.71 41.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.589 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.6 mt -81.81 146.78 29.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 -175.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -85.96 104.04 15.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.505 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.9 mt -88.48 116.04 65.08 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.229 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.92 120.21 7.78 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.974 2.449 . . . . 0.0 112.722 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 117' ' ' ILE . 66.6 mt -91.21 120.33 39.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.686 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.1 mm -65.99 93.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.094 0.473 . . . . 0.0 110.039 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 131.32 -32.79 2.9 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.707 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.458 ' O ' ' HB ' ' A' ' 114' ' ' ILE . 42.3 mt -130.1 96.71 24.67 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.25 84.14 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.44 2.094 . . . . 0.0 112.33 -176.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.9 mt -86.56 131.64 34.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.849 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.509 ' HB2' HG21 ' A' ' 48' ' ' THR . 13.0 pt20 -134.63 90.25 2.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.815 0.817 . . . . 0.0 109.489 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.3 p30 -85.05 132.67 34.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.845 -173.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 91.4 mt -69.03 129.53 40.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.587 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.66 -36.08 76.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.844 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -69.97 -18.02 63.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.227 0.537 . . . . 0.0 110.549 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -84.14 -26.16 29.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.481 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -103.26 -17.78 15.17 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.326 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 36.7 t -111.48 123.28 49.9 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.847 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -100.79 7.0 44.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.321 0.581 . . . . 0.0 109.978 172.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 2.2 mp0 -108.83 170.04 8.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.117 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -65.4 128.87 37.66 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.3 mt -96.08 123.64 48.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.336 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.88 158.6 43.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.119 0.485 . . . . 0.0 111.668 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 46.9 m -107.48 114.25 28.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.917 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 26.3 m -110.42 141.91 42.86 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -175.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.434 ' HG3' ' H ' ' A' ' 137' ' ' SER . 19.3 tp60 -66.38 122.13 16.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.105 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -85.72 24.08 1.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.124 0.487 . . . . 0.0 111.515 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.434 ' H ' ' HG3' ' A' ' 135' ' ' GLN . 45.3 m -77.52 143.22 67.79 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.073 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.49 60.05 4.92 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.79 2.326 . . . . 0.0 112.19 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.0 m -60.32 121.86 13.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.596 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.91 83.46 5.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.319 0.58 . . . . 0.0 110.835 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -125.29 74.27 1.37 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.996 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.5 t -101.64 49.24 0.87 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.278 0.561 . . . . 0.0 110.255 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -112.43 169.61 13.13 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.864 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 37.1 t -99.74 -16.35 18.16 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.188 0.518 . . . . 0.0 110.01 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.6 pp -79.66 8.39 6.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.558 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 34.6 pt -106.64 51.46 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.542 0.686 . . . . 0.0 110.826 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -81.76 8.13 60.43 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.714 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 101' ' ' LEU . 78.9 mt -71.2 -30.71 66.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.898 0.38 . . . . 0.0 110.147 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 121.76 -166.71 14.49 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.592 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 150' ' ' LEU . 1.1 pt? -111.0 142.14 25.65 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 30.5 Cg_exo -62.18 123.68 12.95 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.458 2.106 . . . . 0.0 111.307 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.449 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 4.1 t -154.01 164.77 37.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.8 tt -133.95 135.76 54.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.874 0.369 . . . . 0.0 110.668 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.25 128.22 35.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.5 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 155' ' ' LEU . 1.9 tt -62.94 -29.02 70.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.894 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -67.72 -16.19 67.58 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.831 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.9 m -77.2 -27.66 53.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.019 0.41 . . . . 0.0 111.161 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.6 pt -103.6 -1.44 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.168 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.594 179.343 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 8.3 p . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 121.307 0.575 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -74.38 -24.47 59.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.129 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -125.57 87.34 55.95 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.01 152.87 73.11 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.551 2.167 . . . . 0.0 113.044 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.9 t -93.02 132.7 30.24 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.399 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.27 136.01 46.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.381 2.054 . . . . 0.0 112.06 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -71.76 -10.24 59.48 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.187 -172.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -92.97 12.57 23.45 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.414 ' O ' HG12 ' A' ' 123' ' ' VAL . 40.0 mm -95.17 132.08 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.737 0.303 . . . . 0.0 110.751 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 122' ' ' LEU . 71.1 p -80.37 159.52 25.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.883 176.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.68 -44.2 80.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.874 0.368 . . . . 0.0 110.367 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 52.9 tptt -62.25 -46.82 87.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.079 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -64.75 -41.84 95.61 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.599 0.238 . . . . 0.0 111.415 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -63.89 -42.3 97.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.572 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.3 m -64.13 -39.03 93.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 15.9 mm-40 -60.94 -34.98 75.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.803 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -74.04 -29.88 62.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.498 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 133' ' ' CYS . 73.7 m -73.51 -20.7 60.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.882 0.372 . . . . 0.0 110.679 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.56 -177.92 20.23 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.713 -178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.29 -13.25 28.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.966 0.383 . . . . 0.0 111.529 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -105.18 14.52 28.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.175 0.512 . . . . 0.0 110.666 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.516 ' HB2' HD13 ' A' ' 89' ' ' LEU . . . -129.14 144.38 51.19 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.82 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -123.21 142.63 50.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.738 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 52' ' ' ALA . 87.4 mt -65.72 129.47 39.88 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.104 0.478 . . . . 0.0 110.928 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 105' ' ' CYS . 48.4 t -124.85 131.83 53.39 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.159 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.554 ' SG ' HD11 ' A' ' 108' ' ' LEU . 59.3 m -96.3 115.79 27.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.702 175.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.5 m -121.34 132.68 54.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.834 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -84.1 -20.33 32.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.125 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -123.95 137.83 54.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.715 0.293 . . . . 0.0 110.229 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.88 126.65 30.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.293 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -120.08 115.94 24.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.469 ' O ' HG22 ' A' ' 74' ' ' VAL . 62.3 m-85 -94.43 129.84 41.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.021 0.439 . . . . 0.0 110.294 -175.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.65 -28.53 69.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.578 -172.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -64.23 -24.97 69.38 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.736 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.84 -18.64 17.06 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.364 -0.492 . . . . 0.0 111.345 -175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 70' ' ' TYR . 18.7 m -113.69 134.14 57.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.331 0.586 . . . . 0.0 111.051 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.6 p -90.69 -11.54 39.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.574 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.31 -5.99 53.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.871 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.0 mt -117.85 138.91 47.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.148 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.46 99.47 7.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.3 0.571 . . . . 0.0 109.793 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -66.61 -32.55 73.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.179 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.64 -38.44 95.67 Favored Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.608 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.85 -48.13 72.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.189 0.518 . . . . 0.0 110.416 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 88.1 mt -62.64 -44.4 96.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.911 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.47 -43.69 98.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.17 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.36 -44.17 97.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.681 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 p -72.37 -42.49 65.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.878 0.37 . . . . 0.0 111.683 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.432 HD13 HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -74.48 -27.09 60.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.347 -176.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.1 -29.16 65.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.895 0.379 . . . . 0.0 110.904 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -60.98 -24.21 65.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.191 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 60' ' ' ALA . 92.6 mt -85.53 -35.0 21.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.014 0.435 . . . . 0.0 110.538 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 55.9 mt -70.34 -41.81 78.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.232 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.82 -88.17 0.78 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.855 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.01 62.83 0.6 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.005 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.55 178.7 40.88 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.2 p -146.63 138.8 24.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.728 0.264 . . . . 0.0 110.999 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.82 63.24 0.42 Allowed Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.7 p -69.73 -22.66 63.36 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -72.44 -18.63 61.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.799 0.333 . . . . 0.0 111.45 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.53 ' HA3' ' OG ' ' A' ' 157' ' ' SER . . . -110.65 12.63 30.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.596 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 100' ' ' GLY . 1.5 tt -110.43 141.42 43.54 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.422 ' N ' HD23 ' A' ' 99' ' ' LEU . . . 167.79 -142.95 7.84 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.726 -1.226 . . . . 0.0 113.33 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.5 tp -114.03 128.93 56.6 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -116.18 140.3 49.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.627 0.251 . . . . 0.0 110.608 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -124.26 153.31 41.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.424 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 61.99 57.91 2.0 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.639 0.733 . . . . 0.0 109.703 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.484 ' HB3' ' OG ' ' A' ' 63' ' ' SER . 89.4 m -106.41 130.35 54.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.416 -175.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.1 m -115.03 134.26 55.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.408 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -73.7 139.49 45.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.1 0.476 . . . . 0.0 111.25 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.554 HD11 ' SG ' ' A' ' 64' ' ' CYS . 77.0 mt -99.24 121.58 41.24 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 172.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -74.91 134.47 41.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.948 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.8 mt -79.5 135.14 36.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.783 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -101.73 139.78 36.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.731 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.2 mt -100.01 116.35 64.7 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.65 78.5 3.51 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.302 2.001 . . . . 0.0 111.0 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.65 130.19 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.079 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.57 107.05 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 124.11 -34.21 3.61 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 22.8 mt -122.08 83.62 44.87 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.38 88.6 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.015 2.477 . . . . 0.0 112.909 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.3 mm -98.91 119.75 47.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.793 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -139.61 69.28 1.36 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.373 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -87.82 136.26 33.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.293 0.568 . . . . 0.0 111.345 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 89.2 mt -79.16 134.92 36.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.82 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 47' ' ' ILE . 14.8 p -66.94 -41.25 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.841 -175.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -72.18 -9.16 58.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.744 0.307 . . . . 0.0 111.338 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 122' ' ' LEU . 27.2 tt0 -84.11 -25.96 29.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.872 -173.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -106.88 -16.35 14.48 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.855 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.6 t -109.59 132.96 53.66 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.968 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -112.21 12.05 20.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.256 0.55 . . . . 0.0 110.319 173.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 64' ' ' CYS . 25.8 mp0 -107.64 169.26 8.7 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.32 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -66.34 136.59 56.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.772 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 23.6 mm -95.48 125.67 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.835 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.02 155.05 47.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 0.0 111.176 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 13.1 m -98.29 128.72 44.87 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 64.4 m -112.97 140.37 47.84 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.986 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.477 ' OE1' HD21 ' A' ' 89' ' ' LEU . 5.4 tp60 -83.18 141.74 31.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.265 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -78.45 44.48 0.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.299 0.571 . . . . 0.0 111.029 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.4 m -59.82 135.02 89.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.758 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.84 51.8 2.82 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.91 2.406 . . . . 0.0 112.508 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.2 t -153.96 98.75 2.2 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -105.03 168.19 9.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.775 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.78 -50.71 71.27 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.284 0.365 . . . . 0.0 111.872 -174.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.2 m -77.63 -21.29 52.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.294 -172.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -91.62 -49.57 2.93 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.882 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.3 m -92.35 2.99 56.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.796 0.331 . . . . 0.0 111.244 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.7 mt 61.04 48.35 6.55 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.202 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.426 ' C ' ' H ' ' A' ' 148' ' ' LEU . 32.3 pt -130.58 63.9 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.571 0.7 . . . . 0.0 110.733 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -77.21 25.87 1.88 Allowed Glycine 0 CA--C 1.516 0.102 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.32 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 146' ' ' ILE . 45.5 mt -73.93 -27.09 60.85 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.172 0.511 . . . . 0.0 110.159 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 152.68 -171.82 31.8 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.29 134.6 22.55 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -71.97 121.05 7.25 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.55 1.5 . . . . 0.0 110.566 174.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 53.7 m -152.72 162.69 40.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.03 137.25 57.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.627 0.251 . . . . 0.0 110.549 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.32 123.79 19.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.385 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 68.8 tp -62.47 -27.35 69.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.197 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.409 ' HA2' ' CD2' ' A' ' 159' ' ' LEU . . . -69.81 -16.19 72.08 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.61 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.53 ' OG ' ' HA3' ' A' ' 98' ' ' GLY . 26.6 m -82.86 -24.59 33.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.974 0.387 . . . . 0.0 111.729 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.7 pt -103.97 11.14 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.409 ' CD2' ' HA2' ' A' ' 156' ' ' GLY . 4.7 pp . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.245 175.602 . . . . . . . . 1 1 . 1 stop_ save_